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This thesis documents the contribution of my bioinformatics research activities, including 
novel software development, to a range of research projects aimed at investigating the 
interactions between bacterial and viral pathogens and their hosts.  The focus is largely on 
farm animal species and their pathogens, although some of the research has a wider 
scientific impact.   
RNA interference (RNAi) refers to a variety of related regulatory pathways present in 
animals, plants and insects.  The major pathways are microRNAs (miRNAs), small-interfering 
RNAs (siRNAs) and PIWI-interacting RNAs (piRNAs).  Marek’s disease virus is an important 
pathogen of poultry, causing T-cell lymphoma.  We identified the presence and expression 
patterns of several MDV-encoded microRNAs, including the identification of 5 novel 
microRNAs.  We also showed that not only do virus-encoded microRNAs dominate the 
mirNome within chicken cells, but also that specific host-microRNAs are down-regulated.  
We also identify novel virus-encoded microRNAs in other Herpesviridae and provide the 
first evidence of miRNA evolution by duplication in viruses.  In related work, we present a 
novel microRNA generated by the canonical miRNA biogenesis pathway in Avian Leukosis 
Virus, another avian oncogenic virus, and publish data showing the expression pattern of 
known chicken microRNAs across a range of important avian cells.  Two of the other RNAi 
pathways (siRNA and piRNA) form an important part of the antiviral response in 
arthropods.  We have published work demonstrating an siRNA antiviral response to 
bluetongue virus and Schmallenberg virus in cells from the Culicoides midge, an important 
insect vector, as well as work demonstrating the importance of the piRNA pathway in the 
antiviral response to Semliki forest virus (SFV).  Further work on flaviviruses in ticks 
demonstrates the active suppression of the siRNA response by Langat Virus, as well as a key 
difference between the siRNA responses in Mosquitos compared to ticks. 
Salmonella is one of the most important zoonoses, with an estimated 1.4 million cases of 
human salmonellosis per annum in the USA alone.  Salmonella infections of farm animals 
are an important route into the human food chain.  This thesis presents work on the 
comparative structure and function of 13 fimbrial operons within Salmonella enterica 
serovar Enteritidis as well as a genomic comparison of that serovar with Salmonella 
enterica serovar Gallinarum, a chicken-specific serovar.  We characterised the global 
expression profile of Salmonella enterica serovar Typhimurium during colonization of the 
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chicken intestine, and we have published the genomes of four strains of Salmonella 
eneterica serovars of well-defined virulence in food-producing animals.  Our work in this 
area led to us publishing an important and comprehensive review of the automatic 
annotation of bacterial genomes. 
Finally, I present work on novel software development.  ProGenExpress, a software tool 
that allows the easy and accurate integration and visualisation of quantitative data with the 
genome annotation of bacteria;  Meta4 is a web application that allows data sharing of 
bacterial genome annotations from metagenomes;  CORNA, a software tool that allows 
scientists to link together microRNA targets, gene expression and functional annotation; 
viRome, a software tool for the analysis of siRNA and piRNA responses in virus-infection 
studies;  DetectiV, a software tool for the analysis of pathogen-detection microarray data; 
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In this thesis I present my work from over 12 years spent in UK academia, working as a 
bioinformatics researcher in the field of farm animal health and food security.  Naturally, as 
a bioinformatician, my work has focused on the analysis of data from a variety of genomics 
and post-genomics technologies.  The pace-of-change in genomics has been incredible, and 
in my career, spanning 16 years in industry and academia, I have witnessed technologies 
rise and subsequently die as other, better technologies come along.  Data types and sizes 
have also changed an incredible amount during my career, and problems that would have 
been impossible just a few years ago now seem routine.  Of course, this is because 
advances in computing have kept pace with advances in genomics: disk storage is much 
cheaper, the internet is faster, as are computer processors.  There have been advances in 
parallel computing and the rise of cloud computing.  All of these have helped us cope with 
the pace of change in genomics and bioinformatics. 
Bioinformatics, by its very nature, is a collaborative science, and it is my opinion that the 
very best science is carried out when multidisciplinary teams come together, with 
complementary expertise, to tackle a problem.  I present in this thesis a range of 
collaborative research papers and projects.  In some of them, I have been the major driver 
of that research, as either first or last author.  In others, I was simply part of the team that 
produced the research.  A list of the papers included in the thesis, and my contribution to 
each one, is given in appendix I.   
As a bioinformatician, one of the key outputs of my research has been open-source 
software, written and released for others to use, and I describe some of these software 
tools in section 4.  The main driver behind the development of these tools has always been 
that there is an unmet need in the community, and often I became familiar with that unmet 
need through collaboration with researchers.  Many of the collaborative research papers I 
present in this thesis are related to the software tools in section 4 – this is because the 
methods used in the software were developed through collaboration with researchers who 
needed those methods.  The outputs of my research activities are often both new 
knowledge and new software, both of which have been published.  Some of the software 
tools have been published as a short “Application Note” in the journal Bioinformatics, and 
these are limited to two pages in length.  However, their short nature should not be taken 
as an indication that they are of lesser significance than longer papers.  Application Notes 
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are reviewed as thoroughly as any other paper, and much of the hard work is “hidden” – 
not only must the software be written, but also documentation and tutorials which appear 
online.   
I began my career in industry, in 1997 which was prior to the publication of the human 
genome.  Bioinformatics was in its infancy – tools such as GCG, ClustalW and BLAST were in 
common use, but genome-scale experiments and data sets were rare.  I began my academic 
career at the Institute for Animal Health in 2002, after the human genome was published, 
but prior to the publication of the chicken [1], cow [2], pig [3] and sheep genomes[4].  
Much of my work focused on the genomics and transcriptomics of important farm animal 
pathogens, such as Salmonella and Marek’s disease.  At that point, genome sequencing was 
still only carried out in large sequencing centres.  Much of the effort in bioinformatics 
outside of these centres was focused on analysis of post-genomics data, such as microarray 
data.  The Bioconductor project [5] really launched R (http://www.r-project.org) as a 
platform for bioinformatics research, a platform which I have used extensively throughout 
my research career.  As times and technologies changed, next-generation sequencing 
began to come to the fore, first 454 and Illumina/Solexa, followed by Ion Torrent, Pacific 
Biosciences and Oxford Nanopore.  The pace of change in sequencing is frightening, and the 
impact on the bioinformatics community has been huge.  Now more than ever, 
bioinformatics is key to genomics research, and the new technologies have driven a huge 
wave of novel bioinformatics research. 
Any body of research needs to be set within the wider context, and the context of this 
thesis is food security.  For mankind, feeding our species is already a problem, with some 
estimating that over 1 billion people worldwide are hungry 
(http://www.who.int/mediacentre/factsheets/fs311/en/).  In the next few decades, 
consumption of meat is set to double as the human population increases.  We therefore 
need to invest heavily into research that enables us to feed more people for less.  This focus 
sits at the heart of both research institutes I have worked at, The Institute for Animal Health 
(now The Pirbright Institute) and The Roslin Institute, University of Edinburgh.  The body of 
work described below, and in the attached papers, contributes to the knowledge of how 





2. RNA interference in viral disease 
RNA interference (RNAi) is a general term referring to a range of biological processes in 
which gene expression is inhibited by RNA molecules, typically via the targeting and 
destruction of mRNA molecules.  RNAi was first discovered in C elegans [6] after the 
observation that dsRNA was a more potent suppressor of gene activity than either sense 
strand individually.  Whilst RNA-mediated gene-silencing had been used extensively 
beforehand (e.g. [7]), it had been thought that this operated via complementary base-
pairing of mRNA, thus blocking translation.  Whilst initially the mechanism of RNAi was 
unknown, studies of the genes required for RNAi in C elegans, Drosophila, plants and funghi 
[8, 9] revealed a common underlying mechanism.  Small RNAs were identified as an 
important agent in RNAi, at first in plants and then in other organisms [10, 11].  The 
discovery and characterisation of microRNAs [12, 13] linked the emerging world of RNAi 
with a natural RNA-mediated gene regulatory mechanism, leading to the common model 
we understand today whereby short RNAs act as guides for gene silencing via the RNA-
induced silencing complex (RISC) [14]. 
There are a range of pathways that contribute to RNAi, but only three are relevant to this 
thesis – small interfering RNAs (siRNA), microRNAs (miRNA) and Piwi-interacting RNAs 
(piRNA).  My work has involved the study of these pathways in the context of viral 
infections of insects and farm animals, and I will describe each below. 
2.1 Characterisation of microRNAs in a range of avian viruses 
Marek’s disease (MD) is induced by Marek’s disease virus type 1 (MDV-1) and causes the 
rapid and aggressive onset of T-cell lymphoma of poultry.  MDV-1 is a highly contagious 
alphaherpesvirus, and MD is a major source of economic loss in the poultry industry 
worldwide.  The major oncogenic protein encoded by the MDV-1 genome is considered to 
be Meq [15]; however, the genome also contains genes for several microRNAs.  
Herpesviruses have exploited microRNAs most successfully, with the vast majority of virus-
encoded microRNAs in miRBase [16] coming from this family.  There is also a large body of 
literature on microRNAs and how they contribute to oncogenesis (reviewed in [17]).   
In [18], we investigated the expression of microRNAs in MSB-1, an MDV-transformed CD4+ 
T-Cell line derived from an MDV-1 induced lymphoma [19].  In this paper, a cDNA library 
was constructed from small RNAs extracted from MSB-1 cells, identifying a total of 5099 
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high quality sequence reads.  Of these, 1641 mapped to known or novel chicken 
microRNAs, 2562 to the MDV-1 Md5 strain genome and 518 to the MDV-2 genome (MSB-1 
is co-infected with both MDV-1 and MDV-2).  The reads mapping to MDV-1 included 8 
existing microRNA genes, but also identified 4 novel microRNA genes.  A further novel 
microRNA was discovered using Northern blotting.  Cloning frequency and Northern 
blotting were further used to characterise the expression of all 13 MDV-1 encoded 
microRNAs.  The major findings of this work were that (i) more than 50% of the mirNome of 
MSB-1 cells is derived from MDV-1, with a further 10% derived from MDV-2; and (ii) the 
discovery of 5 novel MDV-1 microRNA genes.  The high expression of certain microRNAs is 
an indication that they may be involved in regulating viral and host genes involved in 
infected/transformed cell lines.  Whilst this study was an important advance in the field, 
the results must be considered in context.  Findings in cell lines do not always translate 
directly in real biological systems – of note is that the expression of microRNAs we 
measured in this study did not always correlate well with a similar study in chick embryonic 
fibroblasts (CEF) [20].  Further issues include the use of cloning frequencies as a proxy for 
gene expression, and the co-infection of MSB-1 with both MDV-1 and MDV-2.  In 
2007/2008, when the study was carried out, next-generation sequencing was in its infancy.  
The study would clearly have benefitted from such an approach; indeed, Burnside and 
Morgan [20] used 454 pyrosequencing.  Despite these problems, the study was the first of 
its kind using an avian lymphoma, and enabled the identification of known and novel 
microRNAs encoded by Marek’s disease virus. 
We carried out a follow up study in [21] using microarrays to study global changes in 
microRNA expression in Marek’s disease virus-transformed cell lines.  Here we measured 
the expression of host and viral microRNAs using a customised microarray.  7 MDV-1 
transformed cell lines were used (including MSB-1).  Reticuloendotheliosis virus T (REV-T) 
and avian leucosis virus (ALV) transformed cell lines were included as examples of MDV-
negative virus transformed cell lines.  Normal splenoctyes and CD4+ T-cells were used as 
controls.  The results not only showed massive up-regulation of MDV encoded microRNAs 
(as would be expected; the control samples should not contain any MDV!), but also down-
regulation of specific host microRNAs.  By using uninfected splenoctyes, we were able to 
compare MDV-positive transformed cell lines with an MDV-negative transformed cell line, 
and this identified host microRNAs specifically down-regulated by MDV.  Key amongst these 
was gga-miR-155, orthologues of which are known to be involved in oncogenesis in humans 
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and a regulator of the T-cell response [22].  Parallel work by Prof. Nair’s group showed that 
MDV-miR-M4 is a functional orthologue of miR-155 and shares the same seed sequence 
[23].  Together, these studies raise the intriguing possibility that MDV specifically down-
regulated host miR-155 whilst expressing large amounts of miR-M4, despite these two 
sharing a similar function.  This study was the first of its kind to use microarrays to study 
global microRNA expression in Marek’s disease transformed cell lines.  We showed the 
relative expression of MDV encoded microRNAs, as well as the MDV specific down-
regulation of specific microRNAs, including miR-155 a known regulator of oncogenesis and 
the immune response.   
We went on to identify microRNAs in two other herpesviruses.  In [24], we studied 
Herpesvirus of Turkeys (HVT), a virus from the same genus (Mardivirus) as MDV.  HVT is 
widely used as a live vaccine against MDV.  Using a similar approach to the one above, [18], 
we identified 11 novel microRNAs encoded within the HVT genome, 10 of which clustered 
together within a 2.1Kb window.  The close proximity to one another, and certain groups 
having high homology to one another, provided evidence of evolution by gene duplication.  
This was a small study, but by identifying 11 novel HVT microRNAs we enabled further 
studies of their expression and function.  The HVT microRNAs are also the first in viruses to 
be show evidence of evolution by duplication.  We finally joined the next-generation 
sequencing revolution with a study in duck enteritis virus (DEV) [25].  In this study we used 
Illumina next-generation sequencing and microarrays to discover and characterise the 
expression of DEV microRNAs.  We defined 24 genomic loci with high likelihood of being a 
novel microRNA gene.  Microarray data comparing expression of 72 custom probes 
designed to putative microRNAs identified from the NGS data using DEV infected CEF 
labelled with Cy5 and uninfected CEF labelled as Cy3.  By comparing to uninfected CEF, we 
are using background noise/signal/hybridisation as a control.  Thus only microRNAs 
expressed at a greater level (p<=0.01) than background were considered to be “real” 
microRNAs.  The microarray data also provided data on expression of host microRNAs, with 
26 significantly up-regulated and 19 significantly down-regulated.  By identifying 24 novel 
DEV-encoded microRNAs, we enabled further studies of microRNA function in a virus which 
causes a highly contagious and lethal disease in waterfowl. 
In [26], we further used illumina next-generation sequencing technology to measure the 
expression of avian microRNAs in a range of haemopoietic cells.  The purpose of this study 
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was to provide a background reference dataset of microRNA expression in different avian 
cell types.  Included were 6 avian cell populations: BP25, a chickembryonic stemcell (cESC) 
line; Bu1B, naïve embryonic B lymphocytes; StimB, CD40L-induced B-cells; DT40, an avian-
leukosis virus (ALV) transformed B-cell line; HD11, a chicken macrophage cell line; and 
IAH30, a turkey macrophage cell line.  In addition to providing expression profiles for the 
individual cells/cell lines, comparison across the data set identified distinct clusters of 
microRNAs whose expression seemed to be limited to a single cell type/line.  By comparing 
stimulated to un-stimulated B-cells, we were able to provide evidence of increased 
expression of a range of microRNAs, some of which had been previously indicated in cell 
proliferation.  Again, gga-miR-155 played a prominent role, showing the largest fold-
increase in expression upon stimulation.  The data we published and released as part of this 
study will be useful to those researchers using the same or similar cell types/lines, and 
represent one of the first reference datasets for microRNA expression in chicken and turkey 
haemopoietic cells. 
The data from IAH30 demanded further attention [27].  IAH30 is a turkey macrophage cell 
line transformed by avian leucosis virus (ALV) subgroup J.  ALV is a retrovirus with a single 
stranded RNA genome (compared to the double-stranded DNA genomes of the 
Herpesviruses discussed above), and is known to induce a range of different types of cancer 
in poultry [28].  Of particular interest are a number of regulatory elements found to be 
encoded within the genomes of retroviruses, one example of which is the XSR region which 
has been identified in both Rous sarcoma virus (RSV) [29] and ALV [30].  The function of the 
XSR element is unknown, though it has been speculated that it acts as a transcriptional 
enhancer [31].  During our work for [26], we noticed a huge number of small RNA reads 
mapping to the XSR element of the ALV genome (accession Z46390.1).  Indeed, of 1.5 
million total reads in the library, just under 360000 mapped to a single locus in the XSR 
element (335 reads mapping to a region a short distance downstream).  Only 580 reads 
mapped elsewhere on the ALV genome.  The huge number of reads, and the characteristic 
expression pattern, led us to hypothesize that these reads came from a novel microRNA.  
The surrounding genomic sequence is also predicted to form a characteristic hairpin 
structure.  Using Northern blotting, we compared IAH30 cell lines with those of REV-T 
transformed turkey cell line AVOL-1 and uninfected turkey spleen cells.  The putative ALV 
XSR microRNA was shown to be expressed in IAH30 but in neither of the controls.  As IAH30 
is derived from macrophages, we also examined ALV XSR microRNA expression in 
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macrophage cells.  Expression was found by TaqMan in two other cell lines infected with 
ALV type J viruses, and in a chicken blastoderm cell line infected with ALV.  Expression was 
not detected in cells infected with ALV with the XSR region deleted or from macrophage 
cells infected with REV-T.  Taken together, these provide significant evidence that the 
putative microRNA is derived specifically from the XSR element of ALV.  By studying the 
genomes of ALV and RSV, we were able to align the XSR element from 64 viral isolates.  
Within those alignments, the putative 5’ microRNA was highly conserved (identical in 46; 1 
SNP in 16; 2 SNPs in 2).  Transfection and knockdown studies confirm that expression of the 
ALV XSR microRNA is driven by the Pol II promoter, and the microRNA is processed by 
Drosha and Dicer.  In further experiments we demonstrated that the ALV XSR microRNA is 
capable of significantly down-regulating the expression of RNA containing artificial target 
sites of perfect complementarity to the microRNA sequence. 
Our study was one of the first to demonstrate microRNA expression from a single-stranded 
RNA virus, and the first to demonstrate this in ALV.  It is also the first to provide evidence 
that a single stranded RNA virus can use the canonical microRNA processing pathway.  The 
high level of ALV XSR microRNA expression in the IAH30 cell line indicates an important role 
in ALV pathogenesis.  
2.2 siRNA and piRNA in insect vectors 
Both small interfering RNAs (siRNA) and Piwi-interacting RNAs (piRNA) are thought to 
determine the specificity of RNA silencing by recognising complementary RNA or DNA 
targets.  However, they are the result of distinct pathways: siRNAs are dependent on Dicer 
nucleases, whereas piRNAs are Dicer-independent [32-34]. Both siRNAs and piRNAs have 
been shown to be induced by virus infection in a wide range of hosts, and are thought to 
modulate a range of virus-host interactions.  Virus-derived siRNA molecules act as guides 
for RNAi-based antiviral immunity in plants, invertebrates and funghi (reviewed in [32]).  In 
animals, the primary role of piRNAs is thought to be the silencing of transposable elements 
in the germ-line.  piRNAs associate with PIWI proteins to form piRNA-induced silencing 
complex (piRISC), that recognises and silences complementary targets (reviewed in [33]). 
However, discovery of virus-derived piRNAs in Drosophila melanogaster led to speculation 
that piRNAs may also play a role in antiviral immunity [35]. 
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In collaboration with Alain Kohl’s group, we have used next-generation sequencing to 
investigate the patterns of virus-derived siRNA and piRNA expression in mosquito, midge 
and tick cells, and I will describe these studies below. 
The term “arbovirus” is used to refer to viruses that are transmitted by arthropod vectors, 
and biting arthropods (including mosquitos, ticks and midges) are an important vector of 
animal and human diseases.  These include important human pathogens such as Dengue 
virus (DENV) and West Nile virus (WNV); and important animal pathogens, such as 
bluetongue virus (BTV) and Schmallenberg virus (SBV).  Much of the research into the 
antiviral RNAi response to arboviruses has been carried out in mosquitos [36, 37], and our 
study was the first to investigate the siRNA response to arboiruses in a midge, specifically 
Culicoides sonorensis [38].  We investigated the siRNA response in C. sonorensis-derived KC 
cells and assessed whether the antiviral response targets arboviruses using both 
Bluetongue virus (BTV; which has a double-stranded RNA genome) and Schmallenberg virus 
(SBV; which has a single-stranded RNA genome).  The study is particularly important as BTV 
and SBV are important animal pathogens: BTV is a notifiable disease within the EU, 
affecting all ruminants and causing acute disease.  SBV is a recently emerged disease that 
can cause congenital malformations in newborns [39].  After infection with BTV or SBV, the 
RNAi response was measured using Illumina next-generation sequencing.  The study 
showed that Culicoides cells can and do mount an RNAi response to both the dsRNA virus 
BTV and the ssRNA virus SBV, with 21nt RNA species being the dominant form of viRNA.  
Interestingly, there were also peaks at 25-29nt, suggestive of a piRNA response, though this 
was not investigated further.  The induction of a siRNA antiviral response is a strong 
indicator that an exogenous RNAi pathway is present in Culicoides species.  This work was 
the first to characterise the antiviral siRNA response in midges, and represents an 
important advance in the field. 
As stated above, much of the arbovirus RNAi antiviral response research has focused on 
mosquitos.  Ticks are another important vector of arboviruses, and we have characterised 
the role of key RNAi proteins in the response to Langat virus (LGTV) in an Ixodes scapularis-
derived cell line [40].  In Drosophila, viRNAs integrate with the Ago-2 protein, and guide the 
degradation of target RNAs using sequence complementarity [41].  Putative Ago proteins 
have been identified in the I. scapularis genome, but their role in the antiviral response had 
not been characterised [42].  In our study, we used RNAi to knock down transcription of 
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specific Ago proteins in IDE8 cells, an I scapularis cell line, and characterised their effect on 
the LGTV replicon.  By characterising the antiviral RNAi response, we were also able to 
show that tick siRNA are 22nt in length, compared to 21nt in Drosophila and Culicoides.  
Using transfection of eGFP dsRNA, we were able to show that the 22nt siRNA response is a 
property of the host cells, not the virus.  Ours was one of the first studies to characterise 
the antiviral RNAi response in ticks. 
In the final paper in this section, our attention turns to piRNAs [43].  As we have stated 
above, piRNAs are produced by a different pathway from siRNAs, independent of Dicer.  
They are longer, and have a broader size range: 25-29nt.  Wu et al were the first to suggest 
that the piRNA pathway has an antiviral function [35], and subsequently piRNA signatures 
have been discovered in response to many other viruses, including BTV and SBV (above: 
[38]).  Our study aimed to test that hypothesis that PIWI proteins are involved in the 
antiviral response in mosquito cells: if they are involved, then it would be expected that 
silencing the proteins involved would increase viral output.  By infecting mosquito cells with 
Semliki forest virus (SFV) and selectively silencing various PIWI proteins, we were able to 
measure the effect of PIWI protein knock downs on SFV replication and indeed the piRNA 
response.  Knockdown of certain PIWI proteins resulted in a lower piRNA response and 




3. Salmonella species as important pathogens of farm animals 
The species Salmonella enterica includes over 2600 serovars representing hugely important 
pathogens of both animals and humans.  As farm animal pathogens, Salmonella serovars 
enter the human food chain, increasing the chances of zoonosis.  By definition, zoonotic 
pathogens maintain the ability to infect different host species (host generalists); however, 
within the Salmonella serovars, there are many which are only able to infect a single host 
(host specificists).  Much of the genomic research in Salmonella has exploited these 
differences by looking for signatures of host adaption encoded within the genomes of 
Salmonella serovars. 
3.1 Sequencing Salmonella genomes 
In 2008, I was part of a group who sequenced, annotated and published the genomes of 
two Salmonella enterica serovars [44]:  Enteritidis PT4, a host generalist; and Gallinarum 
287/91, a serovar that only infects poultry.  S. Enteritidis is now regarded as a pathogen of 
major public health significance, causing human food poisoning in many areas of the World 
[45].  Infection with S. Enteritidis results in fever, abdominal pain and diarrhoea.  By 
contrast, S. Gallinarum predominately infects poultry, and is the causative agent of fowl 
typhoid [46].  S. Gallinarum also tends to cause systemic disease, and therefore host 
adaptation has also co-evolved with a change in habitat within the host.  It has been 
proposed previously that S. Gallinarum and S. Enteritidis shared a common ancestor [47], 
with S. Gallinarum becoming non-motile due to a mutation in the fliC gene [48].   
Our study pre-dated next-generation sequencing, therefore both genomes were sequenced 
using traditional Sanger shotgun sequencing and annotated manually and through 
comparison to S. Typhimurium LT2.  Many similarities between Enteritidis PT4 and 
Typhimurium LT2 were found, including presence of pathogenicity islands and fimbrial gene 
clusters, a feature consistent in other promiscuous salmonellae [49].  However, the most 
striking output from the study was that, firstly, the genome sequences of the Gallinarum 
and Enteritidis strains showed a huge amount of sequence similarity, consistent with the 
hypothesis of a common ancestor; and secondly, the Gallinarum genome harbouring a large 
number of pseudogenes compared to both Enteritidis PT4 and Typhimurium LT2.  Over 300 
genes carried predicted frameshifts or stop codons, representing about 7% of the total 
coding capacity of the genome.  Important pathways and functions that have been lost 
include metabolic pathways, restricting the available sources of carbon and energy, 
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including propanediol metabolism.  Mutations also exist in the glycogen biosynthesis 
pathway and in amino acid catabolisis and biosynthesis.  Finally, mutations exist in genes 
related to motility and chemotaxis, consistent with the non-motile nature of Gallinarum.    
It is impossible to assign an evolutionary role to all of these mutations, however, the gene 
loss is striking and we hypothesised that gene loss in metabolic pathways restricts the 
ability of Gallinarum to survive outside of the host and contributes significantly to host 
adaptation.  Gene loss related to fimbrae and flagella may be methods by which Gallinarum 
evades the host immune system.  We suggested that more research is needed to fully 
investigate the contribution of these gene losses to host adaptation. 
Some of this work was followed up in 2010/11 by a PhD student who I supervised with 
Mark Stevens and David Gally [50, 51].  This time using Illumina next-generation 
sequencing, we sequenced, assembled and annotated 4 Salmonella genomes of well-
defined virulence in farm animals.  These were S. Typhimurium ST4/74, originally isolated 
from a calf; S. Choleraesuis SCA50, originally isolated from a pig; S. Dublin SD3246, again 
originally isolated from a calf; and S. Gallinarum SG9, first isolated from a case of fowl 
typhoid.  One striking conclusion from this work was that the actual sequencing component 
was trivial and cheap, taking only a few weeks and costing a few thousand pounds; 
compared to the bioinformatics analysis and (assembly, annotation) and data release, 
which took in excess of 12 months.  This contrast inspired us to write a review of bacterial 
genome annotation, which I will discuss in more detail later [52].   Genome annotation of 
the new Gallinarum strain, SG9, revealed a 277 predicted pseudogenes, and a large overlap 
in the affected pathways between SG9 and 287/91.  This adds further evidence that gene 
loss is an important method of host adaptation in Salmonella species. 
3.2 A closer look at fimbrial operons 
A further follow up study was carried out by another PhD student whom I co-supervised 
with Mark Stevens [53].  In this study we examined the repertoire, organisation and 
sequence of fimbrial operons in a range of S. Enteritidis serovars.  We attempted to 
correlate the presence/absence of fimbrial operons with host specificity, and selectively 
mutated each operon before examining the effect on colonisation.  A total of 14 fimbrial 
operons were identified, 13 genomic and one plasmid-located.  Pseudogene-causing 
mutations were found to be enriched relative to the genomic mean in fimbrial operons of 
host-restricted serovars, implying a selection pressure to “lose” these genes.  In contrast, 
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broad host range serovars appeared to have mostly intact fimbrial operons.  However, the 
presence/absence of any single fimbrial operon could not be correlated with host 
specificity.  We attempted to mutate each of the 13 chromosomally located fimbrial 
operons in S. Enteritidis, and then screened each of the mutants in a chick colonisation 
model, and only two of the fimbrial operons were found to be statistically significant.  The 
stbA:cat mutant was recovered at lower levels than wild-type, as was the peg:cat mutant.  
This is particularly significant, as the peg operon was identified as a novel fimbrial operon in 
[44], displaying only 70% identity to the operon in the orthologous position in S. 
Typhimurium.  The fact that the majority of fimbrial operons don’t seem to affect 
colonisation in isolation may be due to compensatory effects.  Indeed, it is known that gene 
expression of fimbrial operons is highly variable, and it is possible that Salmonella species 
switch these operons on and off as a method of evading the host immune system. 
3.3 Salmonella transcriptomics during colonisation 
The major mode of entry into the human food chain is through colonisation of the chicken 
caeca.  Salmonella enterica serovars Typhimurium and Enteritidis are major human 
pathogens, and healthy adult chickens often show little or no symptoms after infection with 
these serovars.  Furthermore, infection of chicks only a few days old results in caecal 
colonisation and persistent shedding, which contributes to carcass contamination at 
slaughter.  In 2011, we published a study which used microarrays to compare RNA isolated 
from S. Typhimurium infected chicken caeca with RNA from S. Typhimurium grown in LB 
broth, aiming to identify genes involved in chicken caecal colonisation[54].  The results 
demonstrated a large amount of transcriptional changes between the samples, and 
demonstrated decreased metabolic activity in Salmonella growing in the caecal lumen 
compared to Salmonella growing in LB broth.  Genes involved with the cell cycle and DNA 
replication were down-regulated in the caeca, suggesting that the bacterial cells are 
growing more slowly than in broth.  Genes involved in flagellum production were down-
regulated in the caecal lumen, as were several chemotaxis genes, and these may indicate 
an effort to evade the host immune system.  Some fimbrial genes were up-regulated, which 
may represent phased expression of some of the fimbrial operons, again potentially to 
evade the immune response.  A large number of metabolic genes were differentially 
expressed, which is not surprising given the vastly different environments, energy and 
oxygen sources represented by the caecal lumen and LB broth. 
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3.4 Reviewing bacterial genome annotation 
I first began analysing bacterial transcriptomic data in 2002, and began to include analysis 
of bacterial genomic data in 2004.  It became very clear very quickly that all of these 
genomic and post-genomic approaches relied very heavily on two things: firstly, a high 
quality reference genome, and secondly, a high quality annotation of that reference.  After 
our experiences assembling, annotating and releasing 4 Salmonella genomes in 2011, we 
were inspired to write a very well received review on the automatic annotation of bacterial 
genomes [52].  An important driver for this is the pace of change in bacterial genomics and 
DNA sequencing.  In 2008, it cost several hundred thousand pounds to sequence and 
assemble two Salmonella genomes.  Whilst automatic annotation occurred, each gene was 
checked by eye using the Artemis software, and comparisons between genomes were also 
carried out by eye using the Artemis Comparison Tool.  I recall teaching our PhD students 
how to use ACT, and sitting with them as we visually searched for pathogenicity islands and 
regions of difference (RODs).  Today, a bacterial genome can be sequenced for a few 
hundred pounds [55].  The impact of this is huge, as annotation efforts move away from 
manual to automatic.  The purpose of our review was to highlight major areas of concern in 
the automatic annotation process, and highlight areas that could be improved.  A major 
issue that we highlighted is the propagation of errors – as most automatic genome 
annotation relies on transference of annotation between homologous sequences, if the 
reference genome annotation is incorrect, this will be propagated.  Using the example of 
the eutN/eutM locus in Salmonella species, we demonstrated that it is impossible to 
resolve this locus in certain genomes using sequence evidence.  Alternately annotated as a 
single intact gene, a single pseudogene, two intact genes, two pseudogenes and one intact 
gene or one pseudogene, the eutN/eutM locus in Salmonella is an unsolvable problem for 
automatic annotation where only sequence evidence is used.  Further annotation of this 
locus in novel Salmonella genomes will be defined not by biology, but by the choice of 
reference genome used.  We also identified orthologous genes that should have the same 
gene name but do not – a subset of the nomenclature problem we highlighted further in 
the review, where we discovered 23,843 sets of genes that had differing product/protein 
names.  The gene tnp was identified as the worst, having a total of 151 different 
product/protein names across all genomes.  We also highlight the issue of spelling 
mistakes, using as an example “syntase”, a mis-spelling of “synthase” (as I wrote that, 
Microsoft Word auto-corrected “syntase” to “synthase”, proving that technology can solve 
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some of these issues).  At the time of publication, 128 proteins in UniProt [56] contain the 
mis-spelled form “syntase”.  This is not a protein, or indeed a UniProt problem, it is a 
genome annotation problem which has propagated through the public databases.  In an 
attempt to address many of these problems, we proposed three measures.  Firstly, a 
curated set of high quality, gold standard genomes which should be used as references.  
We observed that of 1851 published and completed bacterial genomes, only 102 had a 
version number of 0.2 or higher – so only 5% of submissions have been revised since 
publication.  The genome of Salmonella Typhimurium LT2 was published in 2001, yet the 
sequence version number is 0.1.  So the primary source of genome annotation for this 
strain has not been updated in over 13 years.  Defining a small set of manually curated 
genomes with updated, high quality annotations may help us avoid some of these pitfalls.  
We also propose the implementation of auto-correcting software for improved genome 
annotation – we have already seen that MS Word can correct mis-spelled biological names, 
and Google Search can also do this.  If at the point we transferred gene annotation, we also 
corrected it for common spelling mistakes, much progress could be made.  Finally, we 
propose integration of new data types – RNA-Seq data, for example, could be used to 




4. Bioinformatics software development and application 
Bioinformatics is a fascinating and innovative science which, in many ways, is no different 
to other branches of biology: we start with a problem, a question that needs to be 
answered; we develop a method that helps answer that question; if the method itself is 
innovative enough and useful to others, we publish that method; and we apply the method 
to a set of biological data, interpret the results and publish.  However, it is not as young a 
science as many think, many recognise Margaret Dayhoff’s “Comprotein” as the first 
bioinformatics publication [57], which appeared in 1962.  I myself have been involved in 
bioinformatics since 1997 (however only entering academia in 2002).  I joined the discipline 
in the pre-genome era, dealing with gene expression array data – arrays which were built 
from normalised cDNA libraries, as we didn’t have a genome to work from.  Since then, I 
have enjoyed three waves of “big data”, each larger than the last, and each causing 
scientists to claim that data analysis will be the next big bottle neck (for example, see [58]).  
At first the task was to deal with the huge amounts of data from just a few genomes 
(human; mouse; rat);  post-genome, the task was to deal with the huge amounts of 
microarray and proteomic data being generated; and in the next-generation sequencing 
era, the task is to deal with the large amount of sequencing data generated for each 
experiment.  Of course, these are vastly different data types, and bioinformaticians need to 
have the ability to adapt to these data types.   
Over the years, I have written, released, published and supported 7 software packages, all 
of which could be considered a novel “method” that enables biological research.  Each was 
born from a problem I and my collaborators had encountered, for which a suitable solution 
was not available.  Six of these software tools are packages for the statistical package R 
[59], which has had a remarkable impact on the biological sciences.  The Bioconductor 
project [5], which currently contains over 800 packages designed for the analysis of 
biological data, has over 6000 citations according to Google Scholar. 
4.1 Visualisation of quantitative data with bacterial genomes 
My first software publication came in 2005 [60], and attempted to deal with the issue of 
how to visualise large amounts of quantitative data alongside genome structure and 
annotation information in bacteria.  A particular driver was to enable this within R – we 
were analysing microarray data from bacteria using the limma [61] package, therefore 
having an integrated visualisation tool would be hugely beneficial.  The visualisation of 
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quantitative data alongside traditional genome annotation is now common, and is often 
carried out by attaching tracks to genome browsers, or using tools such as IGV, IGB or 
Tablet.  However, in 2005 this idea was in its infancy.  Some software packages did exist to 
overlay numerical data on bacterial genomes, but many of these used a colour scale to 
represent the values, which didn’t provide the granularity we required.  Others produced 
genome-scale, circular visualisations which, whilst very pretty and attractive, were hard to 
interpret.  Many of the tools were also only able to show a single value per gene, which is 
not useful for time-course experiments.  ProGenExpress therefore found its niche in being 
able to produce high-quality, quantitative plots of numerical data integrated with genome 
annotation information and represented as a horizontal or vertical track.  ProGenExpress 
could view the whole genome, or zoom into a particular region.   
Bacterial genomes present particular issues which make visualisation interesting – genes 
are often co-expressed through operons, and there are important mobile elements such as 
prophage and pathogenicity islands that represent groups of genes that may be considered 
together, as a functional unit, rather than as separate genes.  Presenting scientists with a 
list of differentially expressed genes, as is the result of limma, ignores this relatedness.  An 
example is given in the paper – using a public time-course data set, visually one can see that 
all 14 genes of the fli operon in Salmonella are down-regulated in murine-macrophages 
relative to control (we have seen above that Salmonella species often reduce motility 
during infection!).  However, 3 out of the 14 genes are not significantly down-regulated and 
would not appear in a simple gene list.  Only by visualising those three genes in the context 
of the operon can we conclude that they are down-regulated too.   
4.2 Software for pathogen detection microarrays 
Microarrays weren’t only being used for gene expression studies, they were also (and 
continue to be) used for pathogen detection.  The simple idea is that if one prints probes 
representing a majority of known pathogens (viral, bacterial, funghal, parasitic etc) then 
one can take a clinical/infected sample, extract RNA and wash it over the microarray, and 
spots representing any pathogens present should light up.  In reality, it is never as simple as 
this, however there were some notable successes.  Many credit Joe DeRisi’s lab with 
pioneering this work [62], though other groups had published previously [63], and the 
major advance Wang et al provided was the ability to use microarrays to discover novel 
viruses (rather than just those printed on the array).  I became involved in a project funded 
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by Defra in 2005 to create a “Biochip” that would represent all of the major human, animal 
and plant viruses of interest to Defra, with the vision that we would be able to create a 
single diagnostic array that would be used across all Defra’s disease surveillance 
laboratories.  Being familiar with microarray data, my role was to ensure that we had 
robust software with which to analyse the data.  The DeRisis group had recently published 
some software for pathogen-detection array data called E-Predict [64], however this 
software presented a problem for us.  E-Predict worked by creating a model of theoretical 
hybridisation profiles based on BLAST similarity profiles of the probes on the array to public 
viral genomes.  P-values were assigned to real samples by comparing the real data with the 
theoretical data using a similarity measure.  What this meant was that E-Predict was 
intimately tied to the DeRisi array, and we would have to completely rebuild the model for 
our array in order to use the software.  Also, E-Predict would need to be retrained every 
time a new set of probes was added to the array.  For these reasons, I decided to develop 
DetectiV [65], a package for R that would be capable of analysing any set of pathogen 
detection microarray data.   
DetectiV takes two sets of information – a set of numerical values extracted from an array 
and linked to probe IDs, and a set of phylogenetic information for the pathogen species 
represented by each probe.  DetectiV recognised that such data would be noisy – extract 
RNA from an infected tongue lesion, and there would be RNA from the host, pathogenic 
and non-pathogenic organisms.  Add to this the fact that RNA would cross hybridise both 
specifically and non-specifically, and one can anticipate a noisy profile.  However, DetectiV 
relied on the simple assumption that the “real” signal would be stronger than the noise 
(this is an assumption of all bioinformatics software!).  To aid in pathogen detection, we 
implemented three normalisation strategies.  The first, borrowed from gene expression 
microarrays, calculated log2 of each measurement divided by the global median for all 
probes – here the global median represented the “noise”.  The second defined a set of 
control probes on the array, and calculated log2 of each measurement divided by the mean 
value of the control probes – here the control probes represented the noise.  The final 
method defined an entire array as a control array, and calculated the log2 value of each 
measurement divided by its equivalent measurement on the control array.  In all instances, 
“real” signal should be greater than zero.  DetectiV then applied a t-test for each 
phylogenetic group, be that at the species, genus, family etc level testing the null 
hypothesis that the set of measurements for each group was no different from zero.   
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In publishing DetectiV, it was important to compare to the “state-of-the-art”, E-Predict.  We 
therefore used the data released by Urisman et al which was used to train and run E-
Predict.  Urisman et al had used E-Predict, and their pathogen detection array, to detect 
SARS, even though SARS was not represented by any probes on the array.  We also decided 
to include a SARS analysis in the DeteciV results.   
DetectiV proved more successful than E-Predict on their own dataset, successfully 
predicting the correct virus in 55 out of 56 arrays, whereas E-Predict was only successful in 
53 out of 56.  In addition, DetectiV was able to detect SARS by defining a set of probes that 
showed > 80% similarity to the SARS genome.  We then validated DetectiV on a completely 
new set of data – 8 arrays from different foot-and-mouth-disease (FMDV) types, and a 
further 4 arrays from Avian infectious bronchitis virus (IBV).  In all 12 cases, DetectiV 
predicted the correct result.  We were unable to test E-predict on the new data, as this 
would have entailed re-training of the entire model, and in many ways this shows the 
power of DetectiV – its simplicity enabled users of vastly different arrays to use the 
software without any need for complex re-training.  Despite being published in 2007, I 
know that DetectiV is still in use in diagnostic labs today. 
4.3 Metagenomics: dealing with data from multiple genomes 
The term metagenomics refers to the study of all genomes within an ecosystem, and has 
only truly been enabled by the ultra-high-throughput nature of second and third generation 
sequencing.  Metagenomics is one technique by which researchers can study the 
microbiome, which itself refers to the entire complement of microbes (bacteria, archaea, 
protists, funghi, viruses) that live in a particular ecosystem.  The diversity and novelty of 
organisms in every ecosystem is huge, with organisms adapted to all types of environment, 
including extreme conditions.  Metagenomic approaches increase the “sequencing space” 
from which we can discover novel biocatalysts [66, 67].  In 2010, we were awarded funding 
from the Technology Strategy Board to do just that – sequence a new environment, the 
rumen gut microbiome, in an attempt to discover new enzymes involved in the breakdown 
of cellulose. 
Second generation sequencing experiments routinely produce many hundreds of gigabases 
of sequence data, and therefore offer a unique insight into the genomes of microorganisms 
living in an environment.  In order to discover novel genes and enzymes, researchers must 
reconstruct genomes into sufficiently large fragments to allow full genes to be predicted.  
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Once gene predictions are complete, predicted protein sequences can be created by 
translating the genomic sequence, and protein domains assigned.  Protein domain 
assignments using, for example, profile hidden markov models (HMMs) are more sensitive 
to distant matches than homology searches such as BLAST, and are therefore more likely to 
be useful in a metagenomic context.  Our studies in ruminants suggest that over 90% of 
such metagenomic gene predictions do not have a match in NR at over 90% identity.  These 
results are currently unpublished, but they are similar to other published findings - Venter 
et al. [68] reported over 1.2 million novel genes, and Hess et al. [69] reported over 2.5 
million putative genes, 27755 containing a domain relevant to biomass degradation. 
The term “assembly” refers to the process by which researchers reconstruct the genome of 
an organism from sequenced fragments, and there have been several paradigms suggested 
for doing this, including overlap-layout-consensus, De Bruijn graphs and string graphs 
(reviewed in [70]).  Given that assembling a single genome completely is still an active area 
of research, attempts to simultaneously assembly the multiple genomes within a 
metaganomics experiment are incredibly difficult.  One issue is that metagenomic assembly 
graphs are larger and require more memory and compute resources.  Ray Meta [71] makes 
use of distributed computing and message passing; Pell et al [72] use a bloom filter and 
kmer connectivity to partition the graph.  Meta IDBA [73] also uses connectivity to reduce 
the complexity of graph, whereas MetaVelvet [74] uses both coverage binning and 
connectivity. 
Once an assembly is complete, annotation of the contigs and scaffolds must take place.  
There are additional problems that can be encountered here over and above the problems 
encountered during traditional bacterial genome annotation (which we reviewed in [52]).  
A number of tools have been published which focus specifically on metagenomic gene 
prediction, including MetaGeneAnnotator [75], Orphelia [76], FragGeneScan [77], and 
Glimmer-MG [78].  Once we know the putative location of genes, protein-coding genes can 
be further annotated with known domains, using tools such as HMMER [79] and 
InterProScan [80] and databases such as Pfam [81] and InterPro [82]. 
In 2012, we were in exactly this position.  Having deep sequenced DNA extracted from the 
rumen of 12 different animals, we had several hundred thousand assembled scaffolds, over 
3.7 million predicted genes and proteins with over 1.4 million domains annotated upon 
them.  Our task was to find novel enzymes involved in the breakdown of cellulose.  In 
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biological research, it is hugely important to form collaborative teams between 
bioinformaticians and the biologists with the expert knowledge to interpret the findings of 
in silico analyses.  In this instance, the experts were biochemists and experts in ruminal 
nutrition.  The problem very rapidly became: how do we share the results of our 
metagenomic assembly and annotation with our collaborators? 
In 2012/13, we designed, built, released and published Meta4, a simple yet powerful web 
application that allows the easy sharing of metagenomic assembly and annotation results 
with collaborators who do not have expertise in bioinformatics[83].  Meta4 fulfilled several 
unmet requirements in the field of metagenomics.  Unlike tools such as IGM/M [84], 
CAMERA [85] and MG-RAST [86], which focus on complete annotation and comparison 
problems, Meta4 is specifically focused on allowing researchers to search large and 
complex datasets for novel versions of existing/known enzymes.  At the heart of this search 
is the annotation of known domains – therefore users of Meta4 can search for 
protein/gene sequences that have a particular domain and length.  Picking a domain such 
as “PF00150 Cellulase”, for example, will bring up a list of all proteins in the database that 
contain a cellulase domain. 
Meta4 is organised as a simple relational database, in MySQL, with scripts written in Perl 
that allow users to upload data to the database from common file formats such as FASTA 
and GFF.  Further Perl scripts, using the common gateway interface (CGI) of an Apache web 
server, provide a user-friendly front-end that enables researchers to query the database.  
Meta4 is not intended to be a large global database of all known metagenomic datasets; 
rather, we envisaged that groups would set up a new instance of Meta4 for each new 
dataset, with the specific aim of sharing data with collaborators.  It is possible to set up a 
new instance of Meta4 in less than an hour, and an Amazon Machine Image (AMI) is 
available on Amazon EC2 that will allow users to create a cloud based instance. 
A feature of Meta4 is its use of web services.  By necessity, the database stores protein 
domain annotations so that users are able to query by domain; however, when looking at 
the gene prediction page, Meta4 uses the InterProScan and EBI BLAST web services to serve 
up the latest information for the protein prediction in question, ensuring users gain access 
to the most recent searches for that protein. 
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Meta4 has now been reliably working in my group for over 18 months, sharing data from 
our metagenomic sequencing and bioinformatics effort with Ingenza ltd, a small biotech 
company focused on the development of technologies for biofuels.  Using Meta4, they 
were able to take the 3.8 million proteins and reduce that dataset to around 100 candidate 
enzymes.  We are also using Meta4 to share data from a separate experiment involving 
methane emissions.   
4.4 A change in paradigm: nanopore sequencing data 
Nanopore sequencing represents a paradigm shift in DNA sequencing, and today it is the 
only sequencing technology that measures an actual single molecule of DNA, rather than 
incorporation events into a template strand.  In nanopore sequencing, a protein nanopore 
is attached to a membrane and changes in electronic signal are measured as single 
molecules of DNA pass through the pore.  Although research in solid-state nanopores is 
ongoing, most success has been had so far using biological nanopores such as α-hemolysin 
[87-89] or MspA [90].  Much of the innovative research in this area has been carried out at 
the University of Oxford by Prof Hagan Bayley’s group, and it was Prof Bayley who formed 
Oxford NanoLabs, now Oxford Nanopore Technologies (ONT).  ONT are the first company to 
bring to market a commercial nanopore sequencing device.  In the field of what ONT term 
“strand sequencing”, they have various products: MinION, GridION and PromethION.  
However, only one is now available to researchers, the MinION.   
The MinION is the world’s first mobile DNA sequencing device, measuring 10cm in length 
and powered by the USB port of a laptop.  The MinION device is compatible with 
consumable flowcells, each containing the sensor chip, application specific integrated 
circuit (ASIC) and nanopores needed to perform single-molecule sequencing.  MinION 
flowcells have 512 channels, each designed to hold a single engineered protein nanopore.  
Nanopores are embedded within a membrane and an ionic current is passed through the 
nanopore by setting a voltage across this membrane.  When a DNA molecule passes 
through the nanopore, this disrupts the current in a reproducible fashion, allowing the 
measurement of the set of bases that occupy the aperture at that exact moment.  As many 
bases occupy the aperture at any one time, ONT have developed a proprietary base-calling 
algorithm based on hidden-markov models (HMMs). 
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4.4.1 MinION workflow 
At present, the MinION library preparation workflow takes approximately 4 hours, and 
involves shearing of the DNA, end-repair, clean up and ligation before a sample can be 
pipetted onto the MinION.  These protocols are under active development, and several 
updates have been released since the beginning of the MinION access programme (MAP).   
Each MinION has a dedicated, high-specification laptop running Windows 7, with 8Gb RAM 
and a 128Gb solid state drive. The MinION device is managed by the MinKNOW software 
which gives details on pore occupancy, read length and throughput during the run.  As soon 
as the library is placed onto the device, the MinION begins sequencing.  Each 
channel/nanopore reports asynchronously, creating a single file per channel per read.  
These are created in HDF5, a compressed binary hierarchical data format.  Surprisingly, 
there are no run folders, and all data files are written to a single directory (e.g. C:\MinION).  
This rapidly becomes confusing as files from multiple runs exist in the same directory.  At 
that time, the HDF files contain metadata about the run as well as information on the signal 
and events as a DNA molecule passed through the nanopore.  This single folder is 
monitored by an agent called “metrichor”, which uploads new files to a cloud-based base-
caller.  Once base-called, the files are downloaded from the cloud, again into a single 
directory (e.g. C:\MinION\downloads).  At this stage the HDF5 files contain additional 
information, the addition of sequence data in fastq format.  A key feature of ONT’s 
technology is “2D” reads.  During library prep, DNA molecules have a hairpin adapter 
ligated to them, meaning the molecule can pass through the pore once, round the hairpin, 
and pass through a second time.  Therefore, each DNA molecule may be read twice.  These 
reads are called 2D reads and are of a higher quality than 1D reads. 
At this early stage, the requirements for library preparation, and reliance on a cloud-based 
base-caller, limit the mobility of the MinION device; however, it is clear that the future of 
the MinION is mobile DNA sequencing, with expected advances in sample preparation, and 
a stand-alone base-caller in the pipeline.  ONT have promised that a standalone, non cloud-
based base-caller will be released in the very near future.  Advances in library preparation 
are also expected that will allow field-based sequencing of samples.  It is essential that 
bioinformatics tools are developed that allow users of the MinION, both in the lab and in 




We have developed, released and published the first version of poRe, an R package that 
enables researchers to work with ONT MinION data [91].  At time of publication, only one 
other software tool was available that helped researchers work with MinION data, 
poretools [92].  Poretools is a python library, and was published approx. one week before 
poRe.  Crucially, poRe has several advantages over poretools, including ease of installation 
and availability within R [59], a sophisticated mathematical and statistical environment 
which freely available on Windows, Linux and Mac. 
poRe depends upon the RDHF5 package, an R interface to the HDF5 library.  HDF5 is a 
hierarchical, binary data format that allows the construction of arbitrary hierarchical data 
and paths.  The hierarchical format allows random access of particular data sets by 
providing the hierarchical path to that data within the file (rather than having to read the 
whole file).  Therefore very large files can be queried quickly.  However, the HDF5 offers 
only low-level C functions to access the data, and RHDF5 simply wraps those low-level 
functions in R.  Therefore, within poRe, we have written some higher level functions that 
allow users to query and extract data from the MinION HDF5 files, and we can do this 
because we know the specific path to particular datasets within those files.  An example of 
the FAST5 file structure can be seen in the supplementary data to our publication [91]. 
poRe allows users to perform several essential functions.  The first is simply organisation.  
The MinION writes data from multiple runs into the same folder, and users are often faced 
with 10,000s of FAST5 files and no way to easily interrogate or analyse them.  However, 
embedded within each FAST5 file are two key pieces of information: firstly, a random text 
string which uniquely identifies a run; and secondly, the name and version of the cloud 
base-caller used to extract FASTQ data.  poRe will read every single FAST5 file within a 
specified folder, and copy them to new folders based on the run name and the name and 
software version of the base-caller.   
Once files and data are organised, poRe also allows extraction of FASTQ and FASTA data, 
collection of key metrics about the run, plots of yield and read length, and extraction of the 
raw events data.  The raw events data can also be plotted, as a “squiggle” plot.  poRe 
received quite a lot of attention whilst the paper was a pre-print on bioRxiv, and has several 
users across Europe and in the USA. 
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4.5 MicroRNAs and gene-set enrichment 
During our research into Marek’s disease virus, questions about the function and targets of 
both host and pathogen microRNAs naturally arose.   MicroRNAs are small 21-23 nucleotide 
RNA molecules that act as guides for the RNA-induced silencing complex (RISC), and which 
mediate the decay of target mRNA molecules.  MicroRNAs therefore act as negative 
regulatory mechanism by preventing the translation of mRNA molecules into proteins.  
Despite extensive research, the exact mechanism by which microRNAs target mRNAs is 
unknown.  MicroRNAs bind, via sequence complementarity, to target mRNAs, with binding 
sites being found most often in the 3’ UTR.  However, sequence complementarity very 
rarely exists along the entire microRNA, with the “seed” region (positions 2-7) being 
particularly important.  This is an ongoing area of research, and published algorithms 
include TargetScan [93], miRanda [94], RNAHybrid [95] and PicTar [96].    
Utilising the results of these target prediction algorithms in larger experiments became 
important.  Specifically, there was a requirement to link the outputs of mRNA and miRNA 
expression studies.  For example, one might somehow extract a list of down-regulated 
genes between a pair of conditions, and ask the question “which microRNAs are implicated 
in the regulation of these genes?”.  This is exactly the question that CORNA was designed to 
answer, a piece of software we wrote and published in 2009 [97].  CORNA was one of the 
first software tools, along with SIGTERMS [98], that allowed users to input a list of mRNA 
genes and a list of predicted miRNA-mRNA targets, and which would then predict which 
microRNAs might be regulating the input gene list.  CORNA had several advantages over 
SIGTERMS, the major one being that CORNA is implemented in R and can therefore 
integrate with existing bioinformatics pipelines; whereas SIGTERMS is implemented in 
Excel, a Windows only platform that is rarely used in bioinformatics. 
CORNA uses the hypergeometric distribution to look for enriched microRNA target 
predictions in a user supplied list of mRNA genes.  For each microRNA, an observed number 
of miRNA targets in the sample provided is compared to an expected number of microRNA 
targets calculated from a population, in this case the complete set of predicted miRNA-
mRNA relationships for the species in question.  P-values can then be calculated using the 
hypergeometric distribution, and corrected (if necessary) using a variety of adjustment 
methods.  The users is therefore supplied with a list of microRNAs, the observed and 
expected number of targets in their gene list, and a p-value for the enrichment of that 
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microRNA in their dataset.  Whilst we demonstrated and published CORNA on a simulated 
dataset, we had already used the software for our own data, and achieved impressive 
results.  These are as yet unpublished, though we have a draft paper and hope to submit 
soon.  To summarise, using microarrays we established a set of genes in chicken embryo 
fibroblasts whose expression was down-regulated over a time-course of infection with REV-
T (Reticuloendotheliosis virus strain T), a virus that causes B- and T- cell lymphomas in 
chickens.  When that gene list is submitted to CORNA, along with the predicted miRNA-
mRNA targets predicted by miRanda, the top hit is gga-miR-155, a microRNA known to be 
involved in oncogenic pathways and regulation of the immune response.  Lab work 
confirmed that over the same time-course, gga-miR-155 increases in expression massively.  
CORNA also predicted several of the miR-17-92 cluster, a known cluster of oncomirs 
(reviewed in [99]).  CORNA is therefore capable of predicting the likely involvement of 
microRNAs in the regulation of gene lists supplied to it.  I was part of a group that went on 
to review the field of miRNA-mRNA bioinformatics published in 2010 [100]. 
Soon after the publication of the CORNA paper, I was involved in two additional 
publications relating to the zebra finch, a model organism often used to research the 
evolution of learned speech.  The genome of Taeniopygia guttata was sequenced, 
assembled, annotated and published in 2010 [101].  During this project, the expression of 
genes up- and down- regulated after exposure to song was measured, as were lists of genes 
under positive selection.  These gene lists were submitted to CORNA to measure the 
enrichment of GO terms, and it was CORNA that identified the enrichment of ion channel 
genes, which are known to have functions in neurological function.  CORNA was therefore 
central to the paper linking ion channel genes to song behaviour. 
In addition to the genome paper, I was also part of a group who investigated the expression 
of microRNAs before and after song exposure in the forebrain of zebra finches [102].  This 
work involved the analysis of Illumina next-generation sequencing data, and allowed us to 
identify both known and novel microRNAs whose expression changes in response to song.     
4.6 Analysis of small RNAs in insect vectors of viral disease 
I began collaborating with Alain Kohl’s group in 2011, and we have published several papers 
since then, some of them detailed in section 2.  The goal in each case was to analyse large 
sequencing datasets to summarise, analyse and visualise the patterns of small RNA 
expression, investigating different viruses and how their hosts (insects and ticks) reacted to 
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them.  Illumina sequencing datasets produce millions of short reads, and it became very 
quickly apparent that the software tools available were inadequate, inflexible and difficult 
to use.  Both Paparazzi [103] and Visitor [104] are all-in-one “pipelines” that take 
sequencing data, run alignments (using a single aligner) and produce a range of plots as 
output.  Both require use of the Linux operating system, something which many biologists 
are not familiar with.  We wanted to have more control over the alignment stage, and also 
to be able to control the appearance of any plots. 
We published viRome [105] in 2013.  Crucially, viRome does not include the alignment 
stage, and allows researchers to choose and run their own alignment software; there are 
almost 100 to choose from [106], each of which has parameters that can be optimised, and 
separating data analysis from sequence alignment allows far more flexibility.  ViRome reads 
in data in the BAM format, a standard format for sequence alignment.  Using R as the 
platform allows researchers to access the huge and powerful range of statistical and 
mathematical functions available as part of the core platform and add-on packages.  R is 
also multi-platform, running on Windows, Linux and Mac; therefore by using viRome, 
researchers instantly have more power and flexibility than if they were to use Paparazzi or 
Visitor. 
ViRome allows users to plot read length distributions on different reference genomes, 
which can be used as evidence for a siRNA (21-22nt) or piRNA (25-29nt) response.  The 
position and strand of these alignments can also be visualised along the length of the 
genome sequence, to look for bias and hot-spots.  Other patterns of piRNA expression are a 
U1 and A10 bias, and a peak of 10 nucleotides when looking at the frequency of gaps 
between 5’ ends of reads mapped to opposite strands, due to “ping-pong” amplification.  
These can also be analysed and visualised using viRome.  The software can also summarise 
all alignments and output these to a CSV file that can be opened in Excel.   
ViRome is a very flexible package and enables users a far greater flexibility in their data 
analysis.  The software was actually used in several publications prior to release and 
publication, therefore should have garnered more citations.  We continue to use viRome in 
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MicroRNA Profile of Marek’s Disease Virus-Transformed T-Cell Line
MSB-1: Predominance of Virus-Encoded MicroRNAs
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Research over the last few years has demonstrated the increasing role of microRNAs (miRNAs) as major
regulators of gene expression in diverse cellular processes and diseases. Several viruses, particularly herpes-
viruses, also use the miRNA pathway of gene regulation by encoding their own miRNAs. Marek’s disease (MD)
is a widespread lymphomatous neoplastic disease of poultry caused by the highly contagious Marek’s disease
virus type 1 (MDV-1). Recent studies using virus-infected chicken embryo fibroblasts have identified at least
eight miRNAs that map to the RL/RS region of the MDV genome. Since MDV is a lymphotropic virus that
induces T-cell lymphomas, analysis of the miRNA profile in T-cell lymphoma would be more relevant for
examining their role in oncogenesis. We determined the viral and host miRNAs expressed in MSB-1, a
lymphoblastoid cell line established from an MDV-induced lymphoma of the spleen. In this paper, we report
the identification of 13 MDV-1-encoded miRNAs (12 by direct cloning and 1 by Northern blotting) from MSB-1
cells. These miRNAs, five of which are novel MDV-1 miRNAs, map to the Meq and latency-associated
transcript regions of the MDV genome. Furthermore, we show that miRNAs encoded by MDV-1 and the
coinfected MDV-2 accounted for >60% of the 5,099 sequences of the MSB-1 “miRNAome.” Several chicken
miRNAs, some of which are known to be associated with cancer, were also cloned from MSB-1 cells. High levels
of expression of MDV-1-encoded miRNAs and potentially oncogenic host miRNAs suggest that miRNAs may
have major roles in MDV pathogenesis and neoplastic transformation.
Marek’s disease (MD) is a naturally occurring rapid-onset
aggressive T-cell lymphoma of poultry. Named after the Hun-
garian veterinarian Jośzef Marek, who first reported the dis-
ease in 1907 (41), the disease is induced by Marek’s disease
virus type 1 (MDV-1), a highly contagious alphaherpesvirus
belonging to the genus Mardivirus of the family Herpesviridae
(31). Apart from being a major disease affecting poultry health
and welfare, MD is considered to be an excellent biomedical
model for virus-induced lymphoma (7, 14). Among the 100-
plus genes predicted for the MDV genome (40, 47, 48), the
gene for the basic leucine zipper protein Meq is considered to
be the major oncogene (39, 44). Some of the functions of Meq
associated with oncogenic properties, such as its interaction
with CtBP, parallel those of other viral oncogenic sequences,
such as adenovirus E1A and Epstein-Barr virus (EBV) nuclear
antigens EBNA3A and -3C (6), highlighting the convergent
evolution of oncogenic pathways in these viruses. Recent stud-
ies have also identified the role of other genes, such as the pp38
(23), viral interleukin-8 (vIL-8) (49), ICP4 (15, 38), R-LORF4
(33), UL36 (32), and MDV-encoded telomerase RNA (22, 63)
genes, in pathogenesis.
Increasing evidence demonstrates that in addition to the
direct role of protein-encoding genes, noncoding RNAs have
profound effects in mediating neoplastic transformation (13).
Among these, the 22-nucleotide microRNAs (miRNAs) have
emerged as a major regulatory tier of gene expression, with the
potential of targeting up to 30% of genes in humans (17, 27,
37). Given their small size with the capability for regulating
multiple genes, several viruses have adopted the miRNA ma-
chinery to manipulate the cellular and viral pathways of gene
regulation by encoding their own miRNAs (19, 24, 26, 42).
Among the different families of viruses, herpesviruses have
exploited the miRNA-mediated gene regulation pathway most
successfully, since 124 of the 127 virus-encoded miRNAs in
miRBase release 10.1 (http://microrna.sanger.ac.uk) are en-
coded by herpesviruses. It has been suggested that the
miRNA-mediated regulatory mechanisms are very suited for
the herpesvirus life cycle, which is characterized by nuclear
replication and latent periods with minimal antigen expression
(19).
Specific miRNA signatures in different types of tumors have
been identified using high-throughput microarray analysis of
miRNA expression (60, 64, 67). Considering the aggressive
nature and rapid onset of tumors induced by MDV-1, analysis
of the miRNA profile of MDV-transformed tumor cells could
provide further insights into MD oncogenesis. Previous studies
using small RNAs from MDV-infected chicken embryo fibro-
blasts (CEF) have identified several miRNAs, including eight
MDV-encoded miRNAs that mapped to the Meq and the
latency-associated transcript (LAT) region of the genome (8,
9). Although identification of MDV and host miRNAs in lyti-
cally infected CEF is valuable, understanding the expression
profiles of miRNAs in the lymphocyte target cells of MD
lymphomas would be crucial to delineate their role in neoplas-
* Corresponding author. Mailing address: Division of Microbiology,
Institute for Animal Health, Compton, Berkshire, United Kingdom
RG20 7NN. Phone: 441635 577356. Fax: 441635 577263. E-mail: venu
.gopal@bbsrc.ac.uk.
 Published ahead of print on 6 February 2008.
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tic transformation. Primary MD lymphomas are often hetero-
geneous mixtures of neoplastic T cells and nontransformed
cells of other lineages (50), so analysis of the whole tumor may
not provide the miRNA profile of the transformed target cell.
However, the ability to establish homogeneous clonal popula-
tions of lymphoblastoid cell lines from primary tumors has
helped to gain insights into the gene expression profiles of MD
tumor cells (10). We reasoned that examination of the miRNA
profiles of MDV-transformed lymphoblastoid cell lines could
help to analyze their roles in neoplastic transformation and in
the maintenance of MDV latency in target T cells.
MSB-1 is an MDV-transformed CD4 T-cell line derived
from a spleen lymphoma induced by the BC-1 strain of MDV-1
(1, 30). The MSB-1 cell line, used in this study at passage level
13, has a CD4 phenotype and has been shown to be coin-
fected with MDV-1 and MDV-2 (66). The MSB-1 cell line has
both integrated and circular copies of the MDV-1 genome (56)
and induces tumors when it is inoculated into susceptible
TABLE 1. Sequences, chromosomal locations, and cloning frequencies of chicken miRNAs cloned from an MSB-1 library







gga-mir-7 TGGAAGACTAGTGATTTTGTTG 3 Z_random 12717978 12718086
gga-mir-15a TAGCAGCACATAATGGTTTGT 28 1 161540787 161540869
gga-mir-15b TAGCAGCACATCATGGTTTGCA 9 9 21649291 21649381
1 161540645 161540728
gga-mir-16 TAGCAGCACGTAAATATTGGTG 82 9 21649116 21649209
gga-mir-17-5p CAAAGTGCTTACAGTGCAGGTAA 55 1 140631124 140631208
gga-mir-18a TAAGGTGCATCTAGTGCAGATA 10 1 140630969 140631061
gga-mir-18b TAAGGTGCATCTAGTGCAGTTA 10 4 3781954 3782037
gga-mir-19a TGTGCAAATCTATGCAAAACTGA 71 1 140630835 140630915
gga-mir-19b TGTGCAAATCCATGCAAAACTGA 71 1 140630526 140630612
gga-mir-20a TAAAGTGCTTATAGTGCAGGTAG 18 1 140630649 140630746
gga-mir-20b CAAAGTGCTCATAGTGCAGGTAG 16 4 3781773 3781857
gga-mir-21 TAGCTTATCAGACTGATGTTGA 249 19 6933581 6933677
gga-mir-23b ATCACATTGCCAGGGATTAC 2 Z_random 14203199 14203284
gga-mir-24 TGGCTCAGTTCAGCAGGAACAG 6 Z_random 14203968 14204035
gga-mir-26a TTCAAGTAATCCAGGATAGGC 14 2 4034213 4034289
gga-mir-27b TTCACAGTGGCTAAGTTCTGC 10 Z_random 14203435 14203531
26 1280249 1280328
gga-mir-29b TAGCACCATTTGAAATCAGTGTT 98 1 204569 204649
gga-mir-30b TGTAAACATCCTACACTCAGCT 1 2 141145952 141146038
3 80699454 80699525
gga-mir-30c TGTAAACATCCTACACTCTCAGCT 1 23 4431115 4431203
gga-mir-30d TGTAAACATCCCCGACTGGAAGC 16 2 141142201 141142264
gga-mir-30a-5p TGTAAACATCCTCGACTGGAAGCT 13 3 80674840 80674911
gga-mir-33 GTGCATTGTAGTTGCATTG 6 1 46203134 46203202
gga-mir-34a TGGCAGTGTCTTAGCTGGTTGTT 7 21 3118925 3119033
gga-miR-92 TATTGCACTTGTCCCGGCCTGT 9 1 140630413 140630490
gga-mir-101 TACAGTACTGTGATAACTGAAG 9 Z 11651019 11651097
gga-mir-106 AAAAGTGCTTACAGTGCAGGTA 55 4 3782085 3782165
gga-mir-130a CAGTGCAATATTAAAAGGGCA 4 15 393029 393111
gga-mir-140 AGTGGTTTTACCCTATGGTAG 5 11_random 250924 251018
gga-mir-142-3p TGTAGTGTTTCCTACTTTATGGA 224 Un 130069949 130070036
gga-mir-142-5p CCCATAAAGTAGAAAGCACTAC 243 Un 130069949 130070036
gga-mir-146b TGAGAACTGAATTCCATAGGCG 44 6 22212586 22212690
gga-mir-181a AACATTCAACGCTGTCGGTGAGTT 5 8 1957561 1957664
17 945791 945881
8 1957750 1957838
gga-mir-181b AACATTCATTGCTGTCGGTGGGTTT 6 17 944157 944241
gga-mir-221 AGCTACATTGTCTGCTGGGTTTC 11 1 104369325 104369423
gga-mir-222 AGCTACATCTGGCTACTGGGT 7 1 104368821 104368918
gga-mir-301 CAGTGCAATAATATTGTCAAAGCATT 3 15 391803 391895
gga-mir-456 CAGGCTGGTTAGATGGTTGTCCT 4 3 27735429 27735540
gga-let-7i TGAGGTAGTAGTTTGTGCTGT 148 1 29988296 29988379
12 6149732 6149821








a *, novel miRNAs identified in chickens and assigned names on the basis of homology to miRNAs in other species.
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chickens (21, 35). As reported for some MD tumors, these cells
also showed truncated forms of p53 tumor suppressor protein
(62). Northern blot analysis of the expression of MDV-induced
miRNAs in MSB-1 cells showed that many of the miRNAs are
expressed at much higher levels than those in infected CEF (8,
9). These results demonstrate that the MSB-1 lymphoblastoid
cell line, which shares many properties of MD tumors, could be
used as a model system for analyzing the molecular pathways
and mechanisms of neoplastic transformation in MD tumors.
We recently reported the construction of a library, using small
RNAs fractionated from MSB-1 cells, to identify novel MDV-
2-encoded miRNAs (66). In this paper, we describe the results
of analysis of the MSB-1 “miRNAome” to examine the popu-
lation of host and viral miRNAs expressed in this transformed
cell line.
MATERIALS AND METHODS
Cells and viruses. CEF prepared from 10-day-old specific-pathogen-free em-
bryos obtained from flocks maintained at the Institute for Animal Health were
used for the propagation of viruses. Low-passage-number virus stocks of RB-1B
(58) grown in CEF for 72 to 96 h were used for the preparation of RNA for
Northern blotting analysis. The MDV-transformed lymphoblastoid cell line
MSB-1 (1) and the REV-T-transformed (16) chicken CD4 T-cell line AVOL-1
were grown at 38.5°C in 5% CO2 in RPMI 1640 medium containing 10% fetal
calf serum, 10% tryptose phosphate broth, and 1% sodium pyruvate.
Cloning and identification of miRNAs. We have previously described the
construction of a cDNA library from small RNAs prepared from MSB-1 cells
(66). Concatemerized sequences of putative miRNAs from the pGEM-T Easy
(Promega, Southampton, United Kingdom) library were determined using vec-
tor-specific primers. High-quality reads of small RNA sequences with both 5 and
3 adapters were analyzed for the characterization of miRNAs.
Northern blotting analysis. Total RNA was extracted from cultured cells by
using TRIzol reagent (Invitrogen) according to standard methods described by
the manufacturer. RNAs were also isolated from samples of MD lymphomas as
well as from livers, brains, hearts, kidneys, ovaries, lungs, thymuses, and spleens
of uninfected adult chickens, using TRIzol reagent. Samples of 20 g total RNA
were resolved in a 15% polyacrylamide-urea gel and blotted onto a GeneScreen
Plus membrane (Perkin-Elmer). DNA oligonucleotides with the exact comple-
mentary sequence to selected miRNAs were end labeled with [-32P]ATP by use
of T4 polynucleotide kinase (New England Biolabs, Hertfordshire, United King-
dom) to generate high-specific-activity probes. Hybridization, washing, and au-
toradiography were carried out as previously described (36, 53).
RESULTS
Identification of miRNAs expressed in MSB-1 cells. The
MDV-transformed lymphoblastoid T-cell line MSB-1 has been
used extensively in different laboratories for various studies,
particularly for the analysis of MDV latency programs (43). As
a tumor cell line latently infected with MDV-1, we chose
MSB-1 to analyze the miRNA profile of MD tumor cells.
Sequence analysis of 1,200 pGEM-T Easy clones of cDNA
concatemers of small RNA sequences from the MSB-1 library
identified a total of 5,099 high-quality reads. The sequences
were scored as miRNAs on the basis that their flanking se-
quences could be predicted into a stem-loop structure with low
free energyBlast (2). Homology searches of these sequences
against the miRBase (25) and GenBank (5) databases were
used to determine the identities of the different host- and
virus-encoded small RNAs. Of the total reads, 1,641 (32.2%)
matched known Gallus gallus miRNAs in the miRBase. The
most abundant host miRNAs in the MSB-1 library were gga-
miR-21, gga-miR-142-3p, gga-miR-142-5p, gga-let-7i, gga-
miR-29b, gga-miR-16 gga-miR-17-5p, gga-miR-19a, gga-miR-
19b, gga-miR-106, and gga-miR-146b. Sequence analysis of the
clones from the MSB-1 library also identified six novel chicken
miRNAs, which appeared to be homologs of hsa-miR-363,
hsa-miR-454-3p, hsa-miR-425-5p, bta-miR-191, hsa-miR-22,
and dre-miR-739. The number of reads of each host-encoded
miRNA in the library and their chromosomal locations are
shown in Table 1. In addition to these miRNAs and the virus-
encoded miRNAs (see below), 128 (2.5%) were noncoding
TABLE 2. Sequences and genomic positions of MDV-1 miRNAsa
Name Sequence (5 to 3) Length (nt) No. of hits Nucleotide positionb
MDV1-miR-M1-5p UGCUUGUUCACUGUGCGGCA(UUAU) 20–24 339 136873–136896
MDV1-miR-M1-3p (A)UGCUGCGCAUGAAAGAGCGA(A) 21–23 4 136913–136934
MDV1-miR-M2-5p (G)UUGUAUUCUGCCCGGUAGUCC(GUUU) 22–26 16 134231–134256
MDV1-miR-M2-3p (A)CGGACUGCCGCAGAAUAGC(UUU) 19–22 11 134270–134292
MDV1-miR-M3-5p (CAUG)AAAAUGUGAAACCUCUC(CCGCU) 20–25 390 134079–134104
MDV1-miR-M4-5p (UUUAA)UGCUGUAUCGGAACC(CUUCGUU) 19–26 341 134367–134393
MDV1-miR-M4-3p (CGA)AUGGUUCUGACAGCAUGAC(CU) 20–22 50 134403–134426
MDV1-miR-M5-5p AACCGUAUGCGAUCACAUUGAC 22 0 133606–133628
MDV1-miR-M5-3p (U)GUGUAUCGUGGUCGUCUACU(GUU) 21–24 176 133647–133670
MDV1-miR-M6-5p (UCU)GUUGUUCCGUAGUGUUC(UC) 18–22 278 142335–142356
MDV1-miR-M6-3p (GAG)AUCCCUGCGAAAUGACAGU(U) 19–23 14 142370–142392
MDV1-miR-M7-5p (UGU)UAUCUCGGGGAGAUCCC(GAU) 19–23 800 142508–142530
MDV1-miR-M8-5p UAUUGUUCUGUGGUUGGUUUC(GA) 21–23 18 142216–142238
MDV1-miR-M8-3p (GU)GACCUCUACGGAACAAUAG(U) 20–22 36 142258–142279
MDV1-miR-M9-5p UUUUCUCCUUCCCCCCGGAGUU(CA) 22–24 45 133374–133397
MDV1-miR-M9-3p AAACUCCGAGGGCAGGAAAAAG 22 1 133414–133435
MDV1-miR-M10-3p (UCG)AAAUCUCUACGAGAUAACA(GU) 20–23 6 142667–142690
MDV1-miR-M11-5p UUUUCCUUACCGUGUAGCUUAGA 23 2 136053–136075
MDV1-miR-M11-3p UGAGUUACAUGGUCAGGGGAUU 22 0 136092–136113
MDV1-miR-M12-3p (U)UGCAUAAUACGGAGGGUUCU(G) 21–22 35 133925–133946
MDV1-miR-13-3p GCAUGGAAACGUCCUGGGAAA 21 0 142313–142333
a Sequence variation surrounding the recovered BC-1 miRNAs is indicated by parentheses surrounding the variable nucleotides. miRNAs derived from a single
primary miRNA stem-loop precursor are indicated by a “-5p” (5 arm) or “-3p” (3 arm) suffix.
b Based on the Md5 sequence (GenBank accession no. AF243438).
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RNA fragments, 76 (1.5%) were mRNA fragments, and 174
(3.4%) showed no matches to any known RNAs.
For the identification of the virus-encoded miRNAs, BLAST
searches were carried out against the full-length sequences of
MDV-1 (Md5 strain; GenBank accession number AF243438)
and MDV-2 (HPRS-24 strain; GenBank accession number
AB049735). We have previously shown that 518 (10.2%) se-
quences from the MSB-1 library are encoded by MDV-2 (66).
However, the majority of the 2,562 (50.2%) sequences from
this library showed perfect sequence identity to the genome
sequence of the Md5 strain. These miRNA sequences, ranging
in length from 18 to 26 nucleotides, belonged to 12 distinct
MDV-1-encoded miRNAs. These included the eight miRNAs
(mdv-miR-M1 to -M8) identified previously from MDV-infected
CEF cultures (8) and four novel MDV-1-encoded miRNAs
(mdv-miR-M9 to -M12). Additionally, we identified another
novel miRNA, mdv-miR-M13, using Northern blotting analysis
of RNAs extracted from MSB-1 cells (see below). The genomic
location and cloning frequency of each of the MDV-1-encoded
miRNAs are shown in Table 2.
MDV-1 miRNAs fold into distinct hairpin structures. For
the validation of a sequence as a miRNA, demonstration of its
expression as well as its processing through the miRNA bio-
genesis pathway is required. One of the distinct indicators of
miRNA biogenesis is the presence of adjacent complementary
sequences that are able to form stable hairpins. In order to
analyze the potential precursor structures of miRNAs encoded
by MDV-1, the sequences of the 13 miRNAs with their adja-
cent 60 to 80 nucleotides were analyzed by MFOLD calcula-
tion, and the secondary structures were drawn using
RNADRAW software as described previously (66). All of the
MDV-1 miRNAs showed a stable hairpin with long paired
stems (Fig. 1), indicating that they are bona fide miRNAs. Of
the two strands of the miRNA duplex generated during bio-
genesis, only one of the strands, the miRNA strand, is incor-
porated into the RNA-induced silencing complex and guides
gene regulation (3). Although the non-miRNA strand is rap-
idly degraded, in many instances it is also captured during
cloning and may sometimes be detected with a comparable
frequency to that of the miRNA strand (66). Among the
MDV-1 miRNAs in MSB-1 cells, two mature forms, represent-
ing both strands of the duplex, were demonstrated by cloning
or Northern blotting for 8 of the 13 candidate miRNAs, in-
creasing the total number of miRNAs to 21. The suffixes “-5p”
and “-3p” were added to designations to indicate the 5 and 3
arms, respectively, of the stem-loop precursor from which the
miRNAs were derived (Table 2).
MDV-1 miRNAs show differences in cloning frequencies.
We then examined the cloning frequency of each of the
MDV-1 miRNAs as a measure of their expression levels in
MSB-1 cells. The most abundantly cloned miRNAs were mdv-
miR-M7-5p (800 hits), mdv-miR-M3-5p (390 hits), mdv-miR-
M4-5p (341 hits), mdv-miR-M1-5p (339 hits), mdv-miR-M6-5p
(278 hits), and mdv-miR-M5-3p (176 hits). Compared to this,
mdv-miR-M10, -M11, and -M13 were of very low abundance,
while mdv-miR-M2, -M8, -M9, and -M12 showed moderate
copy numbers in the library. For most miRNAs, the non-
miRNA strand of the duplex was either not cloned or had a
relative frequency much lower than that of the miRNA strand.
However, for some of the miRNAs, such as mdv-miR-M2, the
FIG. 1. Secondary structures of MDV-1 pre-miRNAs predicted us-
ing the MFOLD algorithm (68). The mature miRNA strands are
indicated in red.
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frequencies of both strands were very similar, suggesting that
both may be functional and are incorporated into the RNA-
induced silencing complex.
MDV-1 miRNAs are clustered in the repeat regions of the
MDV-1 genome. The nucleotide sequence positions of the dif-
ferent miRNAs are shown in Table 2. All 13 MDV-1-encoded
miRNAs are clustered in an 9-kb region within the RL/RS
sequences of the MDV genome (Fig. 2). The miRNAs mdv-
miR-M2, -M3, -M4, -M5, -M9, and -M12 are located upstream
of Meq and are antisense to the R-LORF8 transcript. The
miRNAs mdv-miR-M1 and -M11 lie downstream of Meq and
are embedded within the open reading frame (ORF) of the
L1/LORF5a transcript (46, 59) as well as within the intron of
the splice variant Meq-sp (51). MDV-1-encoded miRNAs
mdv-miR-M6, -M7, -M8, -M10, and -M13 are located between
the a-like sequence and the ICP4 sequence within the large
intron of the LAT of MSR (15). Of this cluster, the miRNAs
mdv-miR-M6 and mdv-miR-M13 were separated by only a
single nucleotide. The occurrence of the miRNAs in distinct
clusters in the same orientation strongly suggests that these
miRNAs are likely to be processed as multicistronic pre-
miRNA transcripts. Despite being processed from a single
transcript, there are differences in the expression levels of the
mature miRNAs, and these are thought to be due to differ-
ences in Drosha processing and/or miRNA stability.
Analysis of miRNA expression by Northern blotting. For
further confirmation of the expression of miRNAs in MSB-1
cells, Northern blot hybridization with individual MDV-1
miRNA probes was carried out on RNAs extracted from
MSB-1, AVOL-1 (an MDV-negative T-cell line), or uninfected
or RB-1B virus-infected CEF cells and from samples of MD
lymphoma. These studies confirmed that MDV-1-encoded
miRNAs are expressed at high levels in MSB-1 cells and MD
lymphomas and at low levels in infected CEF (Fig. 3). No
signals were obtained from the RNAs extracted from AVOL-1
cells and uninfected CEF, validating the specificity of the
miRNA probes. Based on the intensities of signals, the levels
of expression of the majority of miRNAs were similar in both
MSB-1 cells and lymphoma samples. Some of the most abun-
dantly cloned miRNAs, such as mdv-miR-M3, -M4, -M5, -M6,
and -M7, showed very strong signals by Northern blotting,
validating the correlation between cloning frequency and ex-
pression level. Similarly, mdv-miR-M10, -M11, and -M13,
cloned at very low frequencies from the library, gave weak
signals by Northern blotting. A previous study using Northern
blotting of RNAs extracted from MD lymphomas reported
that mdv-miR-M6 is expressed at low levels, and mdv-miR-M7
was not detected at all (8). However, our studies using probes
specific for the mdv-miR-M6-5p and mdv-miR-M7-5p strands
gave strong signals for all samples, including MD lymphomas,
indicating that the -5p strand of the duplex is the functional
miRNA strand. The failure to detect these miRNAs in North-
ern blots in the previous study was likely due to the use of the
non-miRNA strand as the probe. In most cases, both pre-
miRNAs and mature miRNAs could be detected by Northern
blotting, with the former giving much lower signals. For some
of the miRNAs, such as mdv-miR-M5-5p, mdv-miR-M9-3p,
and mdv-miR-M13, the signals of pre-miRNAs were higher
than those of the mature miRNAs, indicating less efficient
processing.
Northern blotting was also carried out on RNAs extracted
from eight different normal tissues from adult noninfected
chickens to validate the expression of some of the miRNAs
cloned from the MSB-1 library. Some of these miRNAs, in-
cluding novel chicken miRNAs such as gga-miR-363, gga-miR-
454 gga-miR-425, gga-miR-191, and gga-miR-22, could be de-
tected by Northern blot analysis, albeit with differences in
expression levels between tissues (Fig. 3b). While gga-miR-425
and gga-miR-22 showed high levels of expression in all tissues,
gga-miR-454 was detected at very low levels. The expression of
the miRNAs gga-miR-191, gga-miR-363, and gga-miR-425 in
lymphoid organs, namely, the spleen, thymus, and the lungs
(55), was at the levels observed for the lymphocyte-specific
miRNA gga-miR-142 (54, 65), which gave strong signals with
probes specific for either of the strands of the duplex in these
tissues.
DISCUSSION
As efficient inducers of cancer, oncogenic viruses have
helped to reveal several major pathways of oncogenesis. Most
of these pathways involve the interactions of virus-encoded
oncoproteins, such as simian virus 40 T antigen, adenovirus
E1A, human papillomavirus E6/E7, and EBV EBNAs (69). In
MD tumors, MDV-encoded Meq is considered to be the major
oncoprotein (39), although other proteins also contribute to
oncogenesis (44). The discovery of virus-encoded miRNAs in
several oncogenic viruses (53) has added yet another armory to
FIG. 2. Genomic locations of MDV-1 miRNAs. The schematic diagram shows where the MDV-1 miRNAs (small arrowheads) identified in this
report map. The five novel miRNAs identified in this report are shown in bold. The TRL and IRL regions flanking the unique long region and the
TRS and IRS regions flanking the unique short regions are shown. Genomic positions and orientations of MDV ORFs contained in the miRNA
loci are indicated.
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these viruses for regulating gene expression in cancer cells.
Recent studies on small RNAs from infected CEF have iden-
tified eight MDV-1-encoded miRNAs that map to the Meq
and LAT regions of the genome (8, 9). Furthermore, several
recent studies have identified specific miRNA signatures in
different tumors, providing insights into the different onco-
genic pathways in these tumors (20, 64). In order to analyze the
expression profiles of the host- and MDV-1-encoded miRNAs
in MD tumor cells, we examined the miRNAs expressed in the
MDV-transformed lymphoblastoid cell line MSB-1 by cloning
and Northern blot analysis.
One of the conspicuous findings from the analysis of the
miRNA sequences from the MSB-1 library was the very large
proportion of MDV-1-encoded miRNAs (51%) in relation to
the number of host miRNAs (Fig. 4). This level of expression
of MDV-1 miRNAs is much higher than that identified from
MDV-1-infected CEF, where only 0.6% of the nearly 172,000
reads were miRNAs encoded by MDV-1 (9). The low level of
expression of MDV-1 miRNAs in CEF (also evident from the
results of the Northern blotting analysis) could partly be ex-
plained by the smaller proportions of infected cells in CEF
cultures in comparison to MSB-1 cell cultures, where each cell
has multiple copies of the MDV genome. However, the in-
creased expression of MDV-1 miRNAs in MSB-1 cells may
also be related to the increased lymphocyte-specific expression
of these miRNAs in these transformed target cells. An in-
creased proportion of virus-encoded miRNAs over host-en-
coded miRNAs is not uncommon in transformed cell lines. For
example, miRNAs encoded by Kaposi’s sarcoma-associated
herpesvirus and EBV accounted for 40% of the entire
miRNA pool identified from the BC-1 cell line coinfected with
these two viruses (11). Once the 518 (10%) MDV-2-encoded
miRNAs that we reported previously (66) were also consid-
ered, the total proportion of virus-encoded miRNAs in the
MSB-1 library was 61%, compared to the 32.2% expression of
host-encoded miRNAs. The reasons for the fivefold difference
in the levels of miRNAs encoded by the two viruses are not
known but may be connected with the differences in relative
copy numbers of the two viruses. The precise copy numbers or
replication rates of the two viruses in MSB-1 cells are not
known. However, on CEF cocultivated with MSB-1 cells,
MDV-2 produced 10-fold more plaques than did MDV-1, sug-
gesting that MDV-2 is better adapted for faster replication on
CEF (66).
Previous studies of MDV-1-infected CEF identified eight
miRNAs that mapped to the Meq and LAT regions of the
MDV genome (8, 9). We also cloned all eight of these miRNAs
from the MSB-1 library. However, we also identified 5 new
MDV-1 miRNAs, taking the total number of MDV-1-encoded
miRNAs to 13. As in the case of the eight previously identified
miRNAs, the five new MDV-1 miRNAs mapped to the Meq
and LAT regions of the genome (Fig. 2). In the MDV genome,
FIG. 3. (a) Northern blotting analysis for determining the expres-
sion of MDV-1 miRNAs. Twenty micrograms of total RNA from
MSB-1 cells, the MDV-negative lymphoid cell line AVOL-1, MDV-1-
infected CEF, uninfected CEF, or MD lymphoma tissues was sepa-
rated in a 15% denaturing polyacrylamide gel, blotted, and probed
with end-labeled antisense oligonucleotides to the indicated miRNAs.
Size markers to indicate the positions of the pre-miRNA and the
mature miRNA are shown. The cellular U6 snRNA served as the
loading control, and a representative blot of this set is shown. (b)
Analysis of tissue-specific expression of Gallus gallus (gga-) miRNAs
identified in the MSB-1 library. Total RNAs (20 g) extracted from
different tissues of chickens were separated in polyacrylamide gels and
probed with end-labeled antisense oligonucleotides specific for the
individual miRNAs indicated. The cellular U6 snRNA served as the
loading control.
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while most of the genes are transcriptionally silent in latently
infected and tumor cells, the repeat (RL/RS) regions are gen-
erally active (34, 45, 61). Thus, it is not surprising that all of the
miRNAs that are expressed at high levels in latently infected/
tumor cells are located in a transcriptionally active region of
the genome. The genomic locations of the eight previously
reported MDV-1-encoded miRNAs have been described (8,
9). Two of the new miRNAs, mdv-miR-M9 and mdv-miR-
M12, are also located upstream of the Meq promoter region,
like the previously identified miR-M2 to miR-M5 miRNAs,
suggesting that these six miRNAs are part of the same tran-
scriptional unit in the same transcriptional orientation as Meq.
The high levels of expression of all six of these miRNAs,
demonstrated by strong signals in Northern blotting of RNAs
from MSB-1 and tumor cells (Fig. 3), suggest that these miRNAs
may have major roles in regulating the expression of viral and
host genes in latently infected/transformed T cells. The tran-
scription unit of these miRNAs is also antisense to another
potential transcript, RLORF8, demonstrated in both CEF and
lymphoblastoid cells (52), and hence has the potential to reg-
ulate the expression of RLORF8. A recent study demonstrated
that EBV-encoded miR-BART2 can downregulate the viral
DNA polymerase BALF5 via a similar mechanism (4). How-
ever, unlike miR-M2 and miR-M4, which are embedded in the
RLORF8 ORF, the newly identified miRNAs miR-M9 and
miR-M12 are located downstream of the ORF (Fig. 2).
One of the previously identified miRNAs, miR-M1, mapped
downstream of Meq embedded in the ORF of the L1/
RLORF5a transcript, although it is not clear whether it affects
the expression of this transcript (33, 46, 59). We have identified
a new miRNA, mdv-miR-M11, located just downstream of the
Meq ORF (Fig. 2). The importance of this novel miRNA is not
known, but it is expressed at only very low levels, as indicated
by a low cloning frequency in the library and weak signals in
Northern blot analysis.
In addition to the three miRNAs, miR-M6 to -M8, that
mapped to the LAT region, our studies have revealed miR-
M10 and miR-M13, two novel miRNAs encoded from this
region. Because these miRNAs are located very close to
miR-M6 to -M8 and are in the same transcriptional orienta-
tion, these two miRNAs are highly likely to be part of the same
cluster. However, compared to miR-M6 to -M8, which are
expressed at very high levels (Table 2 and Fig. 3), the levels of
expression of miR-M10 and miR-M13, shown by Northern
blotting and cloning frequencies, are very low. Although the
reasons for their low expression levels are not known, the
efficiency in processing of the mature miRNAs could be a
factor, especially because of their close proximity within the
cluster. For example, miR-M13 is located between the highly
expressed miR-M6 and miR-M8 miRNAs, with the mature
miRNA sequence of miR-M6 being separated from that of
miR-M13 by only a single nucleotide (Table 2). Similarly, the
newly identified miR-M10 (only 6 hits in the library) is located
just adjacent to the most highly expressed miRNA, miR-M7,
which had 800 hits in the library.
Although the expression levels of MDV-1-encoded miRNAs
in MSB-1 cells were generally similar to those in tumor tissues,
there were clear differences in expression level between in-
fected CEF and transformed MSB-1 cells, with the latter gen-
erally expressing higher levels of all miRNAs. However, it was
also interesting to see clear differences between miRNAs in
the specificity of the strand expressed in infected CEF and
MSB-1 cells. The most striking example of strand-specific ex-
pression was noted for miR-M7, where the mature miRNA
strand, miR-M7-5p, had 800 hits, accounting for 16% of the
entire MSB-1 library. Northern blot analysis also revealed very
strong expression of this miRNA in both MSB-1 cells and
tumor tissues. Although weak signals for miR-M7-5p were
detected in the infected CEF, this strand was not identified
even once among the nearly 172,000 high-quality reads of small
RNA sequences from infected CEF (9), suggesting that this
miRNA strand is processed only at very low levels in lytically
infected CEF. This cluster of miRNAs maps antisense to the
ICP4 gene and to the large intron in the 5 end of the putative
LAT, expressed at high levels in transformed cells/lymphomas
as well as in the late stages of lytic infection of CEF (57).
Although the reasons for the differences in processing of the
two miRNA strands during miRNA biogenesis in this region
between CEF and lymphocytes are not clear, it would be in-
teresting to see whether any of the miRNAs play a role in
switching between lytic replication and latency. Intriguingly,
mdv-miR-M7 also showed evidence of RNA editing. However,
FIG. 4. Pie chart showing proportions of MDV-1, MDV-2, and chicken miRNAs and other molecules cloned from the MSB-1 library.
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in the absence of knowledge on the targets of any of the
MDV-1-encoded miRNAs, the significance of this remains un-
known.
Analysis of the miRNA repertoire from MSB-1 cells also
identified several host miRNAs, some of which were cloned at
high frequencies indicating high levels of expression (Table 1).
Some of the more abundant host miRNAs, such as those
within the miR-17-92 cluster, have been shown to be amplified
in several types of cancer (28, 29). Since these miRNAs have
been shown to accelerate the formation of lymphoid malignan-
cies in mouse models (29), the increased expression of these
miRNAs in MSB-1 cells could be significant. Similarly, other
highly expressed miRNAs, such as miR-21 (249 hits), let-7i
(148 hits), the two strands of miR-142 (224 and 243 hits),
miR-15a (28 hits), and miR-16 (82 hits), have also been asso-
ciated with various malignancies, including chronic lympho-
cytic leukemia (12, 18), suggesting that these miRNAs may
contribute toward MDV oncogenicity. Currently, we are ex-
amining the roles of different host miRNAs in the induction of
lymphomas by MDV. Our studies on MSB-1 cells also revealed
six novel chicken miRNAs. The expression of five of these
novel miRNAs could be detected by Northern blotting of dif-
ferent chicken tissues, although the expression of miR-454 in
all tissues was very weak (Fig. 3b). The expression of both
strands of miR-142 appeared to be restricted to the lympho-
cyte-enriched lungs, thymus, and spleen (Fig. 3b), suggesting
that it is likely to be a lymphoid cell-specific miRNA.
We have carried out a study to examine the miRNAome of
a herpesvirus-induced lymphoma in chickens by determining
the miRNAs expressed in a lymphoblastoid cell line derived
from a lymphoma. This study is the first of its kind with an
avian lymphoma and has demonstrated that the analysis of the
miRNA repertoire would enable investigation of some of the
potential pathways used by viruses in neoplastic transforma-
tion. A major challenge in the next stage would be the identi-
fication of potential targets for some of the miRNAs overex-
pressed in these cells to identify networks of molecular events
regulated by the altered miRNAome in these cells. The
present study has not identified miRNAs that are downregu-
lated in transformed cells, whose profiles are also very impor-
tant for understanding the global events involved in transfor-
mation. Currently, we are using microarray analysis of global
viral/host miRNA expression in MD tumor cells in relation to
that in normal lymphocytes to determine the entire repertoire
of upregulated and downregulated miRNAs to identify the
extent to which MDV exploits the cellular miRNA pathways to
induce neoplastic transformation.
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MicroRNAs (miRNAs) are increasingly recognized to play crucial roles in regulation of gene
expression in different biological events, including many sporadic forms of cancer. However,
despite the involvement of several viruses in inducing cancer, only a limited number of studies
have been carried out to examine the miRNA expression signatures in virus-induced neoplasia,
particularly in herpesvirus-induced tumours where virus-encoded miRNAs also contribute
significantly to the miRNome of the tumour cell. Marek’s disease (MD) is a naturally occurring,
rapid-onset CD4+ T-cell lymphoma of poultry, induced by the highly contagious Marek’s disease
virus (MDV). High levels of expression of virus-encoded miRNAs and altered expression of several
host-encoded miRNAs were demonstrated in the MDV-transformed lymphoblastoid cell line
MSB-1. In order to identify the miRNA expression signature specific to MDV-transformed cells,
we examined the global miRNA expression profiles in seven distinct MDV-transformed cell lines by
microarray analysis. This study revealed that, in addition to the high levels of MDV-encoded
miRNAs, these MD tumour-derived lymphoblastoid cell lines showed altered expression of several
host-encoded miRNAs. Comparison of the miRNA expression profiles of these cell lines with the
MDV-negative, retrovirus-transformed AVOL-1 cell line showed that miR-150 and miR-223 are
downregulated irrespective of the viral aetiology, whereas downregulation of miR-155 was
specific for MDV-transformed tumour cells. Thus, increased expression of MDV-encoded miRNAs
with specific downregulation of miR-155 can be considered as unique expression signatures for
MD tumour cells. Analysis of the functional targets of these miRNAs would contribute to the
understanding of the molecular pathways of MD oncogenicity.
INTRODUCTION
MicroRNAs (miRNAs) are small (approx. 22–25 nt long),
non-coding RNAs that regulate gene expression by base
pairing with the RNA transcripts, targeting them for
translational repression or degradation. All metazoan
genomes encode miRNAs and the latest release (12.0) of
miRBase (http://microrna.sanger.ac.uk) contains 8619
hairpin precursor miRNAs in various species (Griffiths-
Jones et al., 2008). In the past few years, there have been
huge increases in the number of studies on miRNA and
cancer. Profiling of global miRNA expression levels
(miRNome) has generated extensive data on miRNA
expression in various forms of cancer. These studies have
reiterated the important role of miRNAs in all aspects of
cancer biology, including proliferation, apoptosis, inva-
sion/metastasis and angiogenesis (Fabbri et al., 2008; Lee &
Dutta, 2009). Such studies have also provided information
on the developmental lineage, differentiation state and
prognosis of malignant cells (Lowery et al., 2008; Schotte
et al., 2008). Nearly all of these studies have been carried
out on non-infectious forms of cancer. Current estimates
suggest that viruses are involved in 15–20 % of human
cancers worldwide (Javier & Butel, 2008) and oncogenic
viruses have been instrumental in delineating several
molecular pathways of neoplastic transformation. Despite
this, comparatively little is known on global miRNA
expression profiles of virus-induced cancers (Martinez
et al., 2008; Yeung et al., 2008). In many tumours,
particularly those associated with oncogenic herpesviruses
(Cosmopoulos et al., 2008; Cullen, 2006; Gottwein &
Cullen, 2008; Pfeffer et al., 2005; Sullivan & Grundhoff,
2007), high levels of expression of virus-encoded miRNAs
Supplementary figures and tables are available with the online version of
this paper.
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add further complexity to the miRNome of the trans-
formed cell (Ghosh et al., 2008).
Marek’s disease virus (MDV) is a highly contagious,
oncogenic alphaherpesvirus of the genus Mardivirus; it is
associated with Marek’s disease (MD), a naturally occur-
ring, rapid-onset T-cell lymphoma of chicken (Calnek,
1986). The MDV genome encodes several miRNAs that
map to the MDV-encoded oncogene Meq and the LAT
(latency-associated transcript) regions of the virus
(Burnside et al., 2006; Burnside & Morgan, 2007).
Although the target genes regulated by MDV-encoded
miRNAs are yet to be discovered, high levels of their
expression in MDV-transformed cell lines and tumours
suggest that they play important roles in oncogenesis
(Morgan et al., 2008; Xu et al., 2008). From a small RNA
library generated from MDV-transformed lymphoblastoid
cell line MSB-1 (Akiyama & Kato, 1974), we have
previously demonstrated high levels of expression of
MDV-encoded miRNAs (Yao et al., 2007, 2008). Elevated
levels of expression of some of these miRNAs were also
confirmed by real-time quantitative PCR in these cells (Xu
et al., 2008). Several host miRNAs that are associated
directly with oncogenicity, such as miR-17-92, miR-21 and
let-7i, were also present at a high frequency in the MSB-1
library, suggesting a role for these miRNAs in neoplastic
transformation of these cells (Yao et al., 2008). Although
analysis of miRNAs by cloning (Yao et al., 2008) or high-
throughput sequencing (Burnside et al., 2008) is used to
identify upregulated miRNAs in tumours or transformed
cells, such studies do not provide differential expression
profiles of miRNAs in different cell types. Comparisons of
miRNA expression profiles between neoplastically trans-
formed and normal cells using miRNA microarrays have
enabled the identification of specific miRNA expression
signatures in different types of cancer cell, some of which
have been shown to be useful indicators of cell type, stage
of differentiation and even prognosis of the cancer (Calin
& Croce, 2006; Rosenfeld et al., 2008). Only a limited
number of studies comparing the global miRNA expression
profiles of virally transformed tumour cells have been
carried out, particularly in tumour cells transformed by
oncogenic herpesviruses that themselves encode multiple
miRNAs (Sullivan & Grundhoff, 2007). Here we describe
the results of the comparison of the miRNA expression
profile of seven different MDV-transformed T-lympho-
blastoid cell lines with that of normal chicken splenocyte or
CD4+ T-cell populations.
METHODS
Transformed cell lines. Small RNA prepared from seven independent
CD4+ T-lymphoma cell lines derived from MDV-1-induced tumours
was used for miRNA expression profiling. The cell lines studied are
MDCC-MSB1 from a spleen lymphoma induced by the BC-1 strain of
MDV-1 (Akiyama & Kato, 1974), MDCC-HP8 from a GA strain-
induced tumour (Nazerian, 1987) and five cell lines (MDCC-226S,
MDCC-265L, MDCC-273S, MDCC-299K and MDCC-299L) estab-
lished from lymphomas of birds infected with RB-1B virus
(Petherbridge et al., 2004). Reticuloendotheliosis virus T (REV-T
strain)-transformed CD4+ T-cell line AVOL-1 (Yao et al., 2008) and
avian leukosis virus (ALV) HPRS F42 strain-transformed B-cell line
HP45 (Nazerian, 1987) were included in the experiments as MDV-
negative transformed cell lines. Cell lines were grown at 38.5 uC in 5 %
CO2 in RPMI 1640 medium containing 10 % fetal calf serum, 10 %
tryptose phosphate broth and 1 % sodium pyruvate.
Chicken splenocytes, CD4+ T cells and magnetic cell sorting.
Single-cell suspensions of lymphocytes were prepared from spleen
tissues of uninfected birds by using Histopaque-1083 (Sigma-Aldrich)
density-gradient centrifugation. CD4+ T cells were isolated by
magnetic cell sorting using mouse anti-chicken CD4 antibodies
(Chan et al., 1988) and goat anti-mouse IgG microbeads (Miltenyi
Biotec). After each antibody treatment, cells were washed three times
with PBS containing 0.5 % bovine serum albumin. At each wash, the
cell suspension was centrifuged at 450 g for 10 min. Positively stained
cells were sorted through an AutoMACS Pro Separator (Miltenyi
Biotec). Purity of the sorted cells was confirmed to be .99 % by flow
cytometry after labelling with monoclonal anti-goat/sheep IgG–
fluorescein isothiocyanate (Sigma) antibody (data not shown).
Microarray analysis of miRNA expression. Preparation of probes
and hybridization to the arrays were carried out by using methods
described previously (Lawrie et al., 2007, 2008). Briefly, 500 ng
purified miRNA from lymphoblastoid cell lines, normal splenocytes
or CD4+ T-cell populations was labelled with either Cy3 or Cy5 dye
using an Array 900microRNA RT kit from Genisphere and hybridized
to the mRNA microarray described previously (Lawrie et al., 2008).
The array contains miRNA probe sets (designed from miRBase v. 9.2)
spotted in quadruplicate non-adjacently (the sequences of the probes
are available at http://www.microRNAworld.com). Where the homo-
logous sequences of miRNAs in different species are identical, miRNA
sequences from only one species was spotted on the array. In
addition, probes for the mature MDV-1-encoded miRNAs miR-M2-
3p, miR-M2-5p, miR-M3-3p, miR-M3-5p, miR-M4-3p, miR-M4-5p,
miR-M5-3p, miR-M11-5p and miR-M12-3p (Yao et al., 2008) were
also included on the array. A model design with splenocytes and/or
CD4+ T cells as reference was used and the expression values are
depicted as log ratios of test and reference samples. Image analysis was
done by using BlueFuse software (BlueGnome).
Statistical analysis of microarray data. Data were normalized
within each microarray by subtracting the mean log2 ratio from each
measurement. Quantile normalization was then used to standardize
the data across arrays, and a linear model was fitted to each miRNA
using Limma (Smyth, 2005). The resultant P-values were adjusted for
multiple testing by using the Benjamini–Hochberg correction of the
false-discovery rate (Benjamini & Hochberg, 1995). The P-values and
mean expression were calculated for each cell type. Those miRNAs
showing consistent differential expression across all cell types were
subjected to a second analysis where all samples were treated as ‘virus-
infected’, regardless of cell type. A similar analysis in Limma was
performed, resulting in P-values calculated for expression across all
cell types. The data were sorted according to the log2 ratio and heat
maps were produced by using R (http://www.R-project.org).
Inducible expression of mature miRNAs. Constructs for inducible
expression of miRNAs were generated in the pRTS-1-SVP-Tom(2)
vector, constructed from the pRTS-1 plasmid (Bornkamm et al., 2005)
by replacing the hygromycin B-resistance gene with a puromycin-
resistance gene. The inducible bidirectional promoter in this construct
expresses monomeric red fluorescent protein td-tomato (Shaner et al.,
2004) and the miRNA of interest simultaneously in a tightly regulated,
doxycycline (Dox)-inducible system. The inserted sequence of each
miRNA consists of the stem–loop structure and 100–200 bp of
upstream and downstream flanking genome sequences, a feature
Y. Yao and others
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designed to ensure that the expressed miRNAs are processed as naturally
as possible. The approximately 500 bp fragment of each miRNA was
obtained by RT-PCR using RNA extracted from chicken embryo




AGCAG-39). As the sequence of the chicken orthologue was not
available, we used hsa-miR-150 for generating the expression constructs
of miR-150, using RNA prepared from HEK293T cells with primers 59-
AGATCTCTTCCTGCCCTCTTTGATG-39 and 59-CTCGAGCA-
ATAGAAACAGGTGTACTTTG-39. More recently, the mature gga-
mir-150 sequence was shown to be identical to the hsa-miR-150
sequence except for a single nucleotide substitution (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL6541). Agarose gel-
purified PCR fragments were cloned into the BglII and XhoI sites of the
pRTS-1-SVP-Tom(2) vector and confirmed by sequence analysis. For
the expression of cloned miRNAs, HEK293T cells were transfected with
the pRTS-1–miRNA constructs by using Lipofectamine 2000
(Invitrogen) and stable cells were selected with puromycin (1 mg ml21).
Respective miRNAs induced with the addition of Dox (1 mg ml21) were
detected by Northern blotting analysis.
Luciferase reporter assays. In order to demonstrate that the Dox-
induced miRNAs in stably transfected HEK293T cells are functional,
we carried out reporter assays on one of the stable cell lines expressing
gga-miR-155 by analysing its effect on the previously characterized
target Pu.1. For this, we generated a reporter construct in which a
110 bp fragment of the chicken Pu.1 39 untranslated region (UTR)
transcript (GenBank accession no. NM_205023) that contained the
predicted miR-155-response element (MRE) is inserted downstream
of Renilla luciferase in the psiCHECK-2 vector (Promega) to generate
the Pu.1-39UTR-wt construct. A mutant construct (Pu.1-39UTR-mt)
with mutations in the MRE sequences was also constructed. The
details of the oligonucleotides used for generating the chicken Pu.1-
39UTR reporter constructs are shown elsewhere (Zhao et al., 2009).
HEK293T cells stably expressing gga-miR-223 were used as a control.
Transfection into HEK293T cells for luciferase reporter assays was
carried out in 96-well plates with Lipofectamine 2000 (Invitrogen).
Firefly and Renilla luciferase activities were measured consecutively
with the Dual-Luciferase Reporter Assay system (Promega), using a
Lucy-1 luminometer (Anthos Labtec). In all cases, the constitutively
expressed firefly luciferase activity in the psiCHECK-2 vector served
as a normalization control for transfection efficiency.
Preparation of RNA for Northern blotting. Preparation of RNA
for Northern blotting analysis from splenocytes, CD4+ and CD42
populations of T lymphocytes, MDV- and retrovirus-transformed
cell lines, and HEK293T cells stably selected for recombinant pRTS-1
vectors expressing miRNAs was carried out by using standard
methods as described previously (Yao et al., 2007, 2008). Antisense
oligonucleotides to the miRNAs gga-miR-155, gga-miR-223 and
hsa-miR-150 were used as probes.
RESULTS
In order to determine the miRNA expression signature in
MDV-induced tumours, we compared the global gene
expression profiles of seven MDV-transformed cell lines by
microarray analysis using miRNA probe sets designed from
miRBase v. 9.2. The tests validating the sensitivity,
specificity and reproducibility of these arrays have been
described previously (Lawrie et al., 2008). Ratios of miRNA
expression levels in transformed cell lines normalized to the
reference samples of normal chicken splenocytes or CD4+
cells were used for the analysis. These studies showed that
the grouping of miRNAs in the seven MDV-1-transformed
cell lines was distinct from that in the MDV-1-negative
lymphocyte cell line AVOL-1 when splenocytes were used
as a reference (Fig. 1a). When purified CD4+ T cells were
used as a reference, the expression profiles of miRNAs in
four of these cell lines (Fig. 1b) were largely in agreement
with those obtained by using reference splenocytes
(detailed data on the log2 fold changes and the P-values
for each of the cell lines are provided in Supplementary
Tables S1 and S2, available in JGV Online). The miRNA
profiles of the cell lines in both of these analyses were
generally consistent, although individual cell lines did show
differences (Supplementary Figs S1 and S2).
MDV-1-encoded miRNAs are upregulated in
transformed cell lines
The inclusion of mature probe sequences of nine MDV-1-
encoded miRNA sequences (Yao et al., 2008) alongside the
host miRNA probe sets in the miRNA microarray enabled
assessment of the levels of expression of virus- and host-
encoded miRNAs in these cell lines. Compared with the
MDV-negative REV-T-transformed cell line AVOL-1, all of
the MDV-transformed cell lines showed upregulation of
MDV-1-encoded miRNAs (Fig. 1a), although the expres-
sion levels of individual miRNAs were not uniform in these
cells.
Changes in host miRNA profiles in MD tumour cell
lines
Examination of the global miRNA expression profiles of
the seven MDV-1-transformed cell lines revealed changes
in several host miRNAs (Fig. 1). Major differences in the
host miRNA expression profiles could also be observed
between MDV-1-transformed cell lines and the MDV-
negative cell line AVOL-1, demonstrating the differences in
the molecular oncogenic pathways between these cell lines.
Microarray readouts from our studies did demonstrate
differences between cell lines with regard to the expression
of individual miRNAs. Although such differences could be
important for individual cell lines, our main interest was to
look for miRNA profiles that are conserved in all MDV cell
lines, as this could give insights into the fundamental
molecular pathways of miRNA-mediated gene regulation
in MDV transformation. Our results showed that several
host-encoded miRNAs, such as miR-155, miR-223, miR-
150, miR-451, miR-26a and miR-126, were downregulated
in all MDV-transformed cell lines relative to the levels in
normal splenocytes or CD4+ T cells (Fig. 1). As miR-223
and miR-150 were also downregulated in retrovirus-
transformed AVOL-1 cells, the reduced expression of
these two miRNAs is thought to be a broader feature of
transformed T cells, irrespective of the viral aetiology.
However, this was not the case with miR-155, the levels
of which were consistently reduced in all of the seven
miRNA expression in MDV-transformed T-cell lines
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MDV-1-transformed lymphoblastoid cell lines whilst the
expression levels in the AVOL-1 cell line were very high
(Fig. 1a), demonstrating that the downregulation of miR-
155 is a feature unique to MDV transformation of T cells.
As all of the MDV-1-transformed cell lines used in this
study have a CD4+ T-cell phenotype, we also wondered
whether it is appropriate to use whole splenocyte popula-
tions as the reference sample in the analysis. In order to
rule out the possibility that the altered expression profiles
of miRNAs in the MDV-transformed cell lines are not due
to the use of splenocytes as the reference, we also repeated
the analysis of miRNA expression in four MDV-1-
transformed cell lines with purified CD4+ T cells as the
reference. Overall, the results were largely consistent with
the values obtained by using normal splenocytes as the
reference (Fig. 1b). However, the use of purified CD4+
cells as the reference resulted in the demonstration of
increased expression of several more host miRNAs, such as
miR-146b, miR-454, miR-7b, miR-34a, miR-18a, miR-
133a, miR-29a and gga-1et-7d (Fig. 1b). As the splenocyte
reference data represent the miRNA expression of multiple
Fig. 1. Heat maps showing clustering of
differentially expressed miRNAs (adjusted
P,0.05) in MDV-transformed cell lines. (a)
miRNAs identified in the seven MDV-trans-
formed cell lines (names of cell lines are shown
below each lane) in comparison to those in the
MDV-1-negative REV-transformed AVOL-1
cell line. The data shown are normalized by
using uninfected splenocytes as the reference.
(b) Heat map showing differentially expressed
miRNAs in four of the above MDV-transformed
cell lines (shown below each lane), normalized
against expression in normal CD4+ T cells as
the reference. A colour key indicating low
(green) to high (red) values and the P-values is
also shown.
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lymphocyte populations, it was not surprising to see
changes in the miRNA expression patterns when purified
CD4+ T cells were used as the reference. Data on the log2
fold changes and P-values for each cell line using
splenocytes or purified CD4+ T cells as the reference can
be seen in Supplementary Tables S1 and S2, respectively.
Analysis of miRNA expression by Northern
blotting
For further validation of the microarray data demonstrat-
ing the reduced expression of miR-155, miR-223 and miR-
150 in MDV-transformed tumour cell lines, we carried out
Northern blotting analysis comparing the levels of these
miRNAs in four MDV-transformed cell lines with those in
normal lymphocyte populations and retrovirus-trans-
formed cell lines AVOL-1 and HP45. Northern blotting
analysis confirmed the observations of reduced expression
of these three miRNAs in the microarray readouts of
MDV-transformed cells. The levels of gga-miR-155 signal
detected were very low in the normal splenocyte and
CD4+/CD42 T-cell populations (Fig. 2a). These low levels
were reduced further in all MDV-transformed cell lines
included in the assay. In contrast, stronger gga-miR-155
signals were evident in avian retrovirus-transformed cell
lines HP45 and AVOL-1. The levels of gga-miR-223 were
lower in normal CD4+ T cells than in whole spleen-cell or
CD42 T-cell populations. However, no hybridization
signals for gga-miR-223 expression were evident in any
of the cell lines transformed by either MDV-1 or avian
retroviruses, suggesting that the downregulation of gga-
miR-223 is a broader feature of lymphocyte transforma-
tion, irrespective of the viral aetiology. The expression of
miR-150 also appeared to be restricted to the untrans-
formed cells, as there was no evidence of its expression in
transformed cells. Although miR-150 and miR-223 expres-
sion appeared to be similar in this respect, the levels of
miR-150 were much higher in CD4+ T cells (Fig. 2a). We
also evaluated the Dox-inducible expression of miR-155,
miR-223 and miR-150 from the pRTS-1 vector
(Bornkamm et al., 2005). Northern blotting analysis of
HEK293T cells expressing the pRTS-1–miRNA constructs
showed high levels of expression of each of the three
mature miRNAs, regulated tightly in a Dox-inducible
manner (Fig. 2b).
For functional evaluation of the efficacy of this inducible
expression system for identifying potential miRNA targets,
we examined the ability of the pRTS-1–miR-155 expression
vector to silence the reporter construct containing the wild-
type or the mutant MRE region of the 39 UTR of Pu.1, a
validated target of miR-155 (Zhao et al., 2009). This assay
showed that the relative Renilla luciferase levels of reporter
constructs with wild-type MRE sequences were reduced
specifically by nearly 60 % compared with the mutant MRE
construct (Fig. 3a). This reduction in luciferase levels was
dependent on the induction of miR-155 in these cells by
Dox treatment. The specificity of the reporter assay was
demonstrated further by the absence of reduction in
luciferase levels in cells expressing gga-miR-223 (Fig. 3a).
The tightly regulated nature of the Dox-inducible expres-
sion system used here was demonstrated by the non-leaky
expression of the td-tomato marker gene in the untreated
(Dox2) cells (Fig. 3b).
DISCUSSION
Global changes in miRNA expression profiles using
microarray analysis are used increasingly to identify
specific miRNA expression signatures associated with
several human malignancies (Calin & Croce, 2006, 2007;
Lawrie et al., 2008). Most of these studies have been carried
out on tumour tissues or cell lines derived from various
sporadic forms of cancer (Ozen et al., 2008; Ruike et al.,
2008). These studies have highlighted the direct oncogenic
potential of the cluster of miRNAs such as miR-21, miR-
155 and miR-17-92, providing valuable insights into the
Fig. 2. Northern blotting analysis of differentially expressed
miRNAs. (a) Twenty micrograms of total RNA extracted from the
indicated cells was separated on a 15 % denaturing polyacryl-
amide gel, blotted and hybridized with end-labelled antisense
oligonucleotide probes to gga-miR-155, gga-miR-223 and hsa-
miR-150. The cellular U6 small nuclear RNA served as the loading
control. (b) Dox-inducible expression of miRNAs from pRTS-1
constructs in HEK293T cells. Mature miRNAs (indicated by an
arrow) in Dox+ samples are shown. Absence of signals in the
untreated (Dox”) lanes demonstrates the specificity of the miRNA
inducible system. Bands representing each of the three pre-
miRNAs can also be seen.
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molecular pathways of oncogenesis (Wiemer, 2007).
Oncogenic viruses account for a large proportion of
neoplasms in man and animals (Javier & Butel, 2008).
Although the induction of many of these tumours has until
recently been attributed mainly to virus-encoded onco-
proteins, an increasing amount of data indicates that
miRNAs, encoded either by the host or by viruses
themselves in the case of oncogenic herpesviruses
(Cullen, 2006, 2009; Pfeffer et al., 2004, 2005; Sullivan &
Grundhoff, 2007), play significant roles in oncogenesis.
We and others have documented recently that the highly
oncogenic MDV-1 encodes several novel miRNAs
(Burnside & Morgan, 2007; Burnside et al., 2008; Morgan
et al., 2008; Yao et al., 2008). High levels of expression of
these miRNAs in lymphomas and transformed cell lines
have been demonstrated by direct cloning, Northern
blotting and quantitative RT-PCR (Burnside et al., 2006;
Xu et al., 2008; Yao et al., 2008). Although these studies
have been valuable in identifying miRNAs that are
expressed at high levels in these cells, they do not always
provide comprehensive miRNA expression profiles, par-
ticularly of those miRNAs that are downregulated in the
transformed cells. With a view to examining the global
expression of miRNAs in MDV-transformed cells, we
carried out miRNA expression profiling of seven inde-
pendent MDV-transformed tumour cell lines by using
miRNA microarray analysis. Each of these cell lines was
derived from an independent MD lymphoma. As demon-
strated previously with MSB-1 cells (Yao et al., 2007, 2008),
MDV-1-encoded miRNAs were indeed the most abundant
miRNAs in all of the cell lines. High-level expression of
virus-encoded miRNAs appears to be a feature common to
virus-transformed cell lines, as cells transformed by other
oncogenic herpesviruses, such as Kaposi’s sarcoma-asso-
ciated herpesvirus (KSHV) and Epstein–Barr virus, also
showed high levels of expression of virus-encoded miRNAs
(Cai et al., 2005; Lawrie et al., 2008; Pratt et al., 2009).
Higher copy numbers of viral genomes and active
transcription of miRNA genes may account for the higher
expression of virus-encoded miRNAs in the virus-trans-
formed cell lines, although one cannot rule out the
possibility of differential processing of virus-encoded
miRNAs in these cells. The functions and putative targets
of most of the MDV-encoded miRNAs remain unknown.
However, we have shown recently that MDV-miR-M4, one
of the most abundantly expressed virus-encoded miRNAs
in all of the cell lines, is a functional orthologue of miR-155
with the potential to target important lymphocyte-specific
transcription factors such as Pu.1 (Zhao et al., 2009). More
efforts in the future to identify the potential targets of other
MDV-encoded miRNAs (Morgan et al., 2008) will unravel
more molecular pathways of oncogenesis.
Microarray data analysis of the changes in the global
expression profiles of host-encoded miRNAs in MDV-
transformed cell lines could be grouped into (i) those that
are restricted only to some of the MDV-transformed cell
lines and (ii) those that appear to be conserved across all of
the cell lines. The changes in miRNA expression in
individual cell lines, such as the increased expression of
miR-221/miR-222 in MSB-1 cells (Lambeth et al., 2009),
Fig. 3. Functional analysis of inducible miR-155 by using a
reporter assay on the Pu.1 39 UTR. (a) Reporter assays in
HEK293T cells expressing gga-miR-155 and gga-miR-223 from
the Dox-inducible promoter in the pRTS-1 vector. Relative Renilla
luciferase levels (RL) of Dox+ and Dox” HEK293T cells
transfected with luciferase reporter constructs containing the
wild-type (Pu.1-wt) or mutant (Pu.1-mt) MRE-containing region of
the 39 UTR of the chicken Pu.1 transcript (Zhao et al., 2009) are
shown. (b) Fluorescence microscopic image of td-tomato expres-
sion in Dox+ (top left) and Dox” (top right) HEK293T cells stably
expressing pRTS-1–gga-miR-155. Bright-field images of the two
cell populations are also shown (bottom left and right).
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are likely to be important in the regulation of respective
target proteins in individual cell lines. However, in this
paper, we focus on the global changes in miRNA
expression common to all MDV-transformed cell lines.
The miRNA profile of the seven MD tumour cell lines
showed changes in the expression of several miRNAs.
These included the downregulation of miR-150, miR-223
and miR-155, confirmed by Northern blotting analyses
(Figs 1 and 2a). Of these, miR-150 and miR-223 were also
downregulated in AVOL-1 cells, demonstrating it to be a
broader feature of lymphocyte transformation, regardless
of the viral aetiology. Reduced expression of miR-150 has
also been reported in human lymphoid malignancies such
as diffuse large B cell lymphoma (Garzon & Croce, 2008;
Landgraf et al., 2007; Lawrie et al., 2008), indicating its
conserved function across different species. Increasing
evidence suggest that miR-150 functions through the
transcription factor c-myb (Garcia & Frampton, 2008; Lin
et al., 2008; Lu et al., 2008; Xiao et al., 2007; Zhou et al.,
2007), and the dysregulation of c-myb and its targets could
be important in T-cell transformation. In the case of miR-
223, although all of the regulatory mechanisms are not yet
understood fully, recent studies have indicated a clear role
for miR-223 in haematopoiesis, as well as in malignancies
(Baek et al., 2008; Garzon & Croce, 2008; Johnnidis et al.,
2008; Merkerova et al., 2008). Whilst identification of the
potential targets is important to understand fully the
molecular pathways, involvement of miR-223 appears to be
logical in MDV-induced lymphocyte transformation.
The downregulation of miR-155 observed by microarray
analysis was unique to MDV-transformed cell lines, as it
was upregulated in the MDV-negative AVOL-1 cell line
(Fig. 1). Although the levels of miR-155 in the normal
lymphocyte populations were low by Northern blotting
analysis, it was clear that MDV-transformed cell lines
showed a distinct reduction in hybridization signals,
especially when compared with the retrovirus-transformed
lymphocyte cell lines HP45 and AVOL-1 (Fig. 2a). Several
recent studies have highlighted the potential multiple roles
of miR-155 in functions ranging from innate immune
responses to oncogenicity (Garzon & Croce, 2008). The
molecular mechanisms that drive down the expression of
miR-155 in MDV-transformed cell lines are not known.
However, some of its functions on targets such as Pu.1
could be rescued by MDV-miR-M4, a highly expressed
MDV-1-encoded functional orthologue of miR-155 (Zhao
et al., 2009). Although the regulatory expression dynamics
of miR-155 and MDV-miR-M4 are not understood fully,
the existence of autoregulatory mechanisms of miR-155
expression mediated through a common set of targets
cannot be ruled out. It is interesting that, in KSHV-infected
primary effusion lymphoma cell lines, miR-155 was also
found to be downregulated in favour of the KSHV-
encoded miR-K12-11 homologue (Skalsky et al., 2007).
The data from this study have enabled us to characterize
the miRNome of MDV-transformed tumours. Although
this has provided valuable insights into the expression
profiles of miRNAs in these cell lines, the major challenge
will be in the identification of the putative targets of the
differentially expressed miRNAs in these cells. Although
bioinformatic predictions of miRNA targets are valuable,
the development of systems for functional characterization
of miRNA targets is important to understand the pathways
of oncogenesis. The tightly regulated, Dox-inducible
miRNA expression system of the differentially expressed
miRNAs that we developed in HEK293T cells will be
valuable in identifying the putative functional targets of
these miRNAs. Demonstration of the expression of mature
miRNAs in a Dox-dependent manner clearly showed the
proper processing of these miRNAs in this system. For
functional validation of the system, we analysed the
putative targeting of miR-155 on one of the validated
target proteins, Pu.1 (Zhao et al., 2009). The tightly
regulated expression of miR-155 and the specific silencing
of the relative luciferase levels with reporter assays with
wild-type 39 UTR reporter constructs (Fig. 3) provide a
platform for functional analysis of the putative targets of
differentially expressed miRNAs.
In summary, the data presented here demonstrate that
miRNA expression profiling using microarrays is a
powerful approach for analysing the relative levels of
several miRNAs simultaneously. This study, the first of its
kind in MDV-transformed cell lines, demonstrates that, in
addition to the overexpression of several MDV-encoded
miRNAs, downregulation of some of the host-encoded
miRNAs is also a hallmark of MDV transformation.
Determination of the miRNA profile is a first step towards
identification of the regulatory networks of gene expression
in these cell types.
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Herpesviruses account for 134 out of the 140 virus-encoded microRNAs (miRNAs) known today. Here we
report the identification of 11 novel miRNAs encoded by herpesvirus of turkey (HVT), a virus used as a live
vaccine in poultry against the highly oncogenic Marek’s disease virus type 1. Ten of these miRNAs were
clustered together within the repeat long region of the viral genome, demonstrating some degree of positional
conservation with other mardiviruses. Close sequence and phylogenetic relationships of some miRNAs in this
cluster indicate evolution by duplication. HVT miRNAs represent the first example of virus-encoded miRNAs
that show evolution by duplication.
MicroRNAs (miRNAs) are increasingly recognized as major
regulators of gene expression in several multicellular organ-
isms and viruses. Herpesviridae, a large family of viruses asso-
ciated with a number of diseases including cancer in humans
and animals, account for most of the virus-encoded miRNAs
known today (7, 8). Considering the distinct biological require-
ments of herpesviruses, such as long latency periods that re-
quire the avoidance of the host immune responses, it is per-
haps not very surprising that herpesviruses make extensive use
of this highly effective regulatory mechanism of gene expres-
sion (7, 9, 21).
Marek’s disease (MD) is a highly contagious rapid-onset
T-cell lymphoma of poultry caused by MD virus type 1 (MDV-
1), an alphaherpesvirus of the genus Mardivirus (11), which
also includes MDV-2 and the herpesvirus of turkeys (HVT).
Originally isolated from domestic turkeys in the late 1960s (12,
24), HVT is widely used as a live vaccine against MD because
of its antigenic relatedness to MDV-1 (1). HVT is estimated to
have separated from the MDV-1/MDV-2 lineage only about 38
million years ago (19). This relatedness is further evident from
the overall similarities in the genome structures and sequences
of these viruses (1, 14). We and others have previously re-
ported the characteristics of several miRNAs encoded by
MDV-1 and MDV-2 (5, 6, 25, 26). In the present study, we ex-
tended these investigations to identify HVT-encoded miRNAs.
For this, we size selected the small RNA (19- to 24-nucleo-
tide [nt]) population from chicken embryo fibroblast (CEF)
cultures infected with HVT by using procedures described
previously (25). Sequence analysis of 480 clones using vector-
specific primers identified a total of 1,346 high-quality reads
containing small RNA sequences with both the 5 and 3
adapters used in the cloning. BLAST homology searches (2) of
the sequences against the HVT genome (AF291866) identified
a total of 406 sequences (30%) representing 11 candidate
miRNAs. The complex steps involved in miRNA biogenesis,
including the criteria for strand selection for incorporation in
the RNA-induced silencing complex, have been described pre-
viously (4, 13). Although it is the miRNA strand that is pre-
dominantly incorporated into the RNA-induced silencing com-
plex, the non-miRNA strand could also be processed less
efficiently than miRNAs (23, 25, 26). In the present study,
mature forms representing both strands of the duplex were
demonstrated either by cloning or by Northern blotting for 8 of
the 11 HVT miRNAs. The miRNAs derived from the 5 and 3
arms of the stem-loop precursors were designated with a -5p or
-3p suffix, respectively (Fig. 1A).
Examination of the genomic locations of the 11 candidate
miRNAs showed that 10 of these miRNAs were clustered
together in the same orientation in a 2.1-kb region (positions
120864 to 122977 in the TRL/IRL region) in the HVT genome,
overlapping with two putative open reading frames, HVT074
and HVT075 (Fig. 1B). These included miRNA-6 and
miRNA-7 embedded in HVT074 and miRNA-10 in HVT075,
respectively, in the same orientations. The only HVT miRNA
outside this cluster, miRNA-11, was located in the UL region in
the same orientation to the coding region of tegument protein
UL21. The clustering of the 10 miRNAs in the same orienta-
tion in the 2.1-kb region of the TRL/IRL suggests that these
miRNAs could be derived from a single transcript. However,
the cloning frequencies of the miRNAs from this cluster
showed variations, with miRNA-7-3p being the most abundant,
with 207 hits representing more than half of the HVT miRNA
population. In contrast, miRNAs such as miRNA-1-3p,
miRNA-8-3p, and miRNA-11 were represented only once
(Fig. 1A). Such differences in the abundance of the miRNAs
have also been observed with MDV-1 and MDV-2 miRNAs
(25, 26) and are thought to be due to differences in their
processing efficiency or stability.
For validation of the authenticity of the candidate miRNAs,
we used the standard criterion of miRNA annotation (3). First,
we examined the potential precursor RNA hairpin structures
of each of the 11 putative HVT miRNA candidates by using
the 60- to 80-nt surrounding HVT genome sequence by
MFOLD calculation (27). Secondary structures drawn using
RNADRAW software showed that the miRNA precursors
with average lengths of approximately 70 nt each were able to
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form characteristic hairpin structures (Fig. 2A), supporting the
view that the cloned sequences represent novel HVT-encoded
miRNAs. We next examined the expression of the mature
HVT miRNAs by Northern blot analysis. For this, the total
RNA isolated from HVT-infected CEFs was hybridized with
individual miRNA probes. RNA from uninfected CEFs was
included as a negative control. All of the cloned sequences are
detectable in HVT-infected CEFs by Northern blotting, except
for miR-1-3p, which appeared only once in the library (Fig.
2B). The other strand of miR-1-3p precursor is detectable,
suggesting that miR-1-5p could be the miRNA strand and that
miR-1-3p could serve as the non-miRNA strand. No miRNAs
were detected with RNA extracted from the uninfected CEFs,
although weak signals were observed with the miR-10-5p
probe, which also gave a strong band between the precursor
and mature forms in the HVT-infected cells. This band, as well
as the mature band, also appears in the uninfected CEFs with
much lower intensity. The reasons behind the detection of
these signals in uninfected cells are not clear. Although
BLAST searches did not reveal any similar sequences in the
chicken genome, this cannot be ruled out, especially because of
the incomplete annotation of the chicken genome sequence.
Northern blotting detected the miRNA as well as the non-
miRNA strands in several cases, although the latter generally
showed lower expression levels based on the signal intensities
(Fig. 2B). This is also reflected by the lower ratio of the mature
non-miRNA strand to the pre-miRNA.
The discovery of 11 novel HVT-encoded miRNAs reported
here together with the previously identified 14 in MDV-1 (5, 6,
20, 26) and 17 in MDV-2 (25) makes the genus Mardivirus a
major source of virus-encoded miRNAs. Closer examination of
some of the HVT miRNA sequences showed striking similar-
ities, suggesting their generation by duplication. Gene dupli-
cation has long been recognized as a major route for evolution
of genes including miRNAs in several species (10, 16–18).
Duplications of miRNAs are generally observed in large
miRNA clusters, suggesting that the expansion of the miRNA
clusters is a major mode of miRNA evolution (10). In order to
obtain evidence of miRNA duplication in the HVT miRNA
cluster, we carried out multiple sequence alignment of the
precursors of these miRNAs. As shown in Fig. 3A, the se-
quence of the precursors of miR-2 and miR-4 showed high
sequence homology (95.3%) with identical sequences in the
loop and the mature -3p regions, while the -5p mature miRNA
region showed three substitutions, including the one in the
seed region. Similarly, the precursors of miR-8 and miR-9 are
highly homologous with only a single nucleotide difference in
both -5p and -3p mature miRNA sequences as well as in the
loop regions. The close sequence homology of the HVT
miRNAs is also evident from the phylogenetic analysis which
showed the branching of the closely related miRNAs (Fig. 3B).
Because they are antisense regulators, alteration to the
miRNA sequences of duplicated miRNAs can have a major
impact on their targeting capabilities and capacities for acquir-
ing novel functions, particularly for changes in the seed re-
gions. The duplicated HVT miRNAs miR-8 and miR-9 had
FIG. 1. Cloning of HVT miRNAs. (A) Sequences of cloned candidate miRNA species, with nucleotide positions based on the published
sequence (GenBank accession number AF291866). The methods of detection of the miRNAs or their cloning frequencies in the library are
indicated. Sequence variations surrounding the recovered HVT miRNAs are indicated by parentheses. (B) The schematic diagram showing the
positions of the miRNAs (stem-loops) in the HVT genome. The internal and terminal repeat long (TRL/IRL) and short (TRS/IRS) regions flanking
the unique long (UL) and short (US) regions of the genome are shown. Genomic positions and orientations of HVT open reading frames UL21,
HVT074, and HVT075 are shown.
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FIG. 2. Identification of cloned HVT miRNAs. (A) Secondary structures of HVT pre-miRNAs predicted using the MFOLD algorithm. The
mature miRNA strands are indicated in light gray. (B) Northern blot analysis demonstrating the expression of HVT miRNAs. Total RNAs from
HVT-infected CEFs (lanes 1) and uninfected CEFs (lanes 2) were separated on a 15% denaturing polyacrylamide gel and probed with
[-32P]ATP-radiolabeled antisense oligonucleotides to the indicated miRNAs. Size markers indicate the positions of the pre-miRNA and the
mature miRNA. The cellular U6 small nuclear RNA served as the loading control. A representative blot of this set is shown.
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identical sequences in both -5p and -3p mature miRNA se-
quences, except for a single point mutation in the seed se-
quence (Fig. 3A). Since any transcript is just 1 nt away from
being an miRNA target, such point mutations in the seed
sequence could result in the loss or gain of new targets for
these miRNAs, allowing “neofunctionalization” (22) of these
duplicated miRNAs. Similarly, the three nucleotide substitu-
tions including the one in the seed region of the -5p mature
sequences of miR-2 and miR-4 will also have the potential to
affect the expression of new targets. Although further work is
needed to examine the targets of these novel miRNAs, HVT-
encoded miRNAs represent the first clear example of evolu-
tion of miRNAs by duplication among viruses.
We thank Nick Knowles, Institute for Animal Health, Pirbright, for
assistance with the phylogenetic analysis of the miRNAs.
This work was partly funded by the BBSRC, United Kingdom.
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Duck enteritis virus (DEV) is an important herpesvirus pathogen associated with acute, highly
contagious lethal disease in waterfowls. Using a deep sequencing approach on RNA from
infected chicken embryo fibroblast cultures, we identified several novel DEV-encoded micro
(mi)RNAs. Unlike most mardivirus-encoded miRNAs, DEV-encoded miRNAs mapped mostly to
the unique long region of the genome. The precursors of DEV miR-D18 and miR-D19 overlapped
with each other, suggesting similarities to miRNA-offset RNAs, although only the DEV-miR-D18-
3p was functional in reporter assays. Identification of these novel miRNAs will add to the growing
list of virus-encoded miRNAs enabling the exploration of their roles in pathogenesis.
MicroRNAs (miRNAs) are increasingly recognized as
major regulators of gene expression in many organisms,
including viruses. Herpesviruses, belonging to a-, b- and c-
families, account for the majority of the currently known
virus-encoded miRNAs (Cullen, 2009; Gottwein & Cullen,
2008). Duck enteritis virus (DEV), also referred to as the
duck plague virus, is a highly contagious a-herpesvirus
causing an acute disease with high mortality in waterfowl.
A recent study has shown that DEV has a genome structure
similar to those of iltoviruses (Zhong et al., 2009). We and
others have previously reported the identification of
miRNAs from a number of avian herpesviruses including
14 miRNAs from Marek’s disease virus (MDV)-1
(Burnside et al., 2006; Yao et al., 2008), 18 from MDV-2
(Waidner et al., 2009; Yao et al., 2007), 17 from herpesvirus
of turkeys (HVT) (Waidner et al., 2009; Yao et al., 2009)
and seven from infectious laryngeotracheitis virus (ILTV)
(Rachamadugu et al., 2009; Waidner et al., 2009). The
functional targets of most of these miRNAs are not known.
Nevertheless, some of these miRNAs have been shown to
play major roles in virus pathogenesis (Burnside &
Morgan, 2011; Yao et al., 2009). Most virus-encoded
miRNAs have shown little sequence conservation with
those encoded by other viruses, although their locations in
the viral genomes did reveal some levels of conservation
(Waidner et al., 2009; Yao et al., 2007, 2009). To examine
whether DEV did encode miRNAs, we carried out deep-
sequence analysis on small RNA extracted from chicken
embryo fibroblast (CEF) (miRVana miRNA isolation kit;
Ambion) heavily infected with anatid herpesvirus-1 strain
568 (kindly provided by Professor Kaleta, University of
Giessen, Germany) on the Illumina GAIIx platform by
GATC Biotech. Out of the 1 345 371 sequence reads with
high base quality scores, 34 644 aligned to the DEV genome
sequence (GenBank accession no. EU082088). Of these, a
total of 19 251 that perfectly matched with the DEV
sequence represented 46 candidate miRNAs. Using the
RNA folding program Mfold (Zuker, 2003), the 60–80 nt
region surrounding each of the DEV miRNAs could be
folded into primary miRNA hairpin structures, with each
mature miRNA forming one arm of the stem. For further
confirmation of the potential DEV-encoded miRNAs,
array-based miRNA profiling was performed on DEV-
infected CEF and uninfected CEF using miRNA micro-
arrays designed to cover all chicken miRNAs in miRBase
v.17 (http://www.mirbase.org/) and the candidate DEV-
encoded miRNAs identified by deep-sequencing analysis.
The miRNA microarray expression assay and the statistical
analysis of the microarray data were performed by LC
Sciences. Probes for the chicken miRNAs (a total of 542
miRNAs; miRBase release 17) and 72 custom probes of
candidate DEV miRNAs were printed on chips in six
replicates and hybridized with Cy5-labelled small RNAs
isolated from either DEV-infected CEF or uninfected CEF.
In addition, the control probes were included on each chip
for quality controls of chip production, sample labelling
and assay conditions. Data were analysed using ANOVA
and t-tests. Normalization of expression was performed
using a cyclic LOWESS method. miRNAs showing differ-
ential expression at the P-value ,0.01 were selected for
clustering analysis, which was performed using a hierarch-
ical method based on average linkage and a Euclidean
distance metric (Eisen et al., 1998). In agreement with the
sequencing data, all the miRNAs undetectable by micro-
array are those with very low frequency particularly with
only one read from the deep sequencing. The miRNAs
displaying differential expression (P-values ,0.01) by
cluster analysis were analysed further and sequentiallySupplementary tables are available with the online version of this paper.
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named from DEV-miR-D1 to DEV-miR-D24 according to
their genomic locations. Mature miRNA species showed
sequence lengths of 19–24 nt, most of them 22 nt long. The
numbers of individual reads of each of these 24 miRNAs
varied greatly. While some of the miRNAs such as DEV-
miR-D8 were highly abundant with 3028 reads, others such
as DEV-miR-D2 was detected only as a single copy but they
are still differentially expressed as detected by miRNA
microarray (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE36258). The functional relevance of miRNAs
detected at very low levels by deep sequencing has been
questioned (Cullen, 2011). However, such low copy
miRNAs have also been detected in other viruses using
other assays such as Northern blotting or RT-PCR
(Umbach & Cullen, 2010; Waidner et al., 2009). The
features of the 24 DEV-encoded miRNAs, including the
nine miRNAs where both strands of the mature miRNA
duplex could be demonstrated, are shown in Table S1
(available in JGV Online). The secondary structure of those
miRNAs is shown in Fig. 1(a). Sequence length variability
was noted at both the 59- and 39-ends of the miRNAs as
indicated by parentheses in Table S1, generating families of
isomiRs for some of the miRNAs possibly arising from the
imprecision in precursor processing (Morin et al., 2008).
The 59-end of miRNAs, especially the 2–7 nt ‘seed sequence’,
is critical for target mRNA binding and translational
inhibition function (Bartel, 2009). Therefore, the sequence
differences at the 59-end of some DEV miRNAs provide the
potential to target multiple mRNA targets (Gottwein &
Cullen, 2008). We also examined whether any of the DEV
miRNAs showed sequence homology with existing miRNAs
in the miRBase (http://www.mirbase.org/). For this, each of
the DEV miRNA sequences were searched against those in
the miRBase database (Release 18) using a regular expression
search implemented in Perl (http://www.perl.org) that
looked for seed as well as full-length sequence matches in
other species. Although this search did not identify any full-
length homologies with other miRNAs, some of the DEV
miRNAs showed seed sequence homology with a number of
miRNAs in the database (Table S2). Our previous study
demonstrating the ability of MDV-miR-M4 and gga-miR-
155 to act as functional homologues despite only sharing
their seed regions (Zhao et al., 2009), indicated the potential
of the DEV miRNAs also to act as functional homologues of
miRNAs sharing the seed sequence. For gaining further
insights into the DEV miRNA functions, we examined the
predicted targets of the three highly expressed DEV-encoded
miRNAs using the miRNA target prediction program
Targetscan 5.2 Custom (http://www.targetscan.org) against
chicken 39-UTR. Most of the target sites were conserved
across multiple species (data not shown) thus increasing
their likelihood to be the real targets. The numbers of
predicted targets of each of three miRNAs varied greatly.
While there were over 200 predicted targets for the most
highly abundant DEV-miR-D8-3p, the second highly
expressed DEV-miR-D17-5p has only one predicted target.
There was nine predicted target genes for DEV-miR-D18-3p
(Table S3). Due to the large number of the predicted target
genes for DEV-miR-D8-3p, only those with ¢2 target sites
are shown. A number of these target genes have been
reported to be involved in other virus infections. These
include the GRIA4 (glutamate receptor, ionotrophic, AMPA
4) gene differentially expressed in Newcastle disease virus
infection (Lan et al., 2010), KPNA3 (karyopherin a3)
involved in the nuclear import of the influenza virus
(Carter, 2009), HMGB1 (high mobility group box 1) protein
involved in the release of both RNA (Barqasho et al., 2010;
Chen et al., 2008; Chu & Ng, 2003; Jung et al., 2011; Kamau
et al., 2009; Wang et al., 2006) and DNA viruses (Borde et al.,
2011) and NCAM1 (neural cell adhesion molecule 1) that
interacts with the spike protein of coronaviruses (Gao et al.,
2010). Although further studies are needed to identify the
precise functions of DEV miRNAs, it is likely that these
would involve the modulation of the functions of some of
these molecules.
In addition to the differentially expressed DEV miRNAs,
cluster analysis also indicated striking differences in cellular
miRNA expression between DEV-infected and uninfected
CEF (Fig. 2). All significantly expressed miRNAs (P-value
,0.01) with mean intensity values of more than 500
(arbitrary units) were selected for inclusion in the
heatmaps. Expression levels of 45 chicken miRNAs were
altered by DEV infection, of these, 26 miRNAs were
upregulated and 19 were downregulated. For the upregu-
lated miRNAs, only two showed a more than twofold
increase: gga-miR-203 and gga-miR-1607. Seven of the
downregulated miRNAs showed a more than twofold
decrease in their expression: miR-1759, miR-1767, miR-
466, miR-146b, miR-1690*, miR-1796, and miR-1560*.
Interestingly, miR-146b previously reported to be asso-
ciated with immune-related signal pathways in mammals
also downregulated in avian influenza virus-infected lungs
and tracheae in chicken (Lindsay, 2008; Wang et al., 2009).
The exact function of the differentially expressed miRNAs
in the DEV infection remains to be determined.
Unlike most mardivirus-encoded miRNAs that are located
at the repeat region (Fig. 1b), the majority of the DEV
miRNAs were encoded within the unique long region as six
clusters from both the coding and non-coding regions of the
15 809 bp viral genome (Fig. 1c). The miRNAs miR-D22
and miR-D23 were encoded from the coding region of ICP4
in an antisense orientation, enabling them to function in an
siRNA-like fashion (Barth et al., 2008; Seo et al., 2008, 2009;
Sullivan et al., 2005; Tang et al., 2008, 2009; Waidner et al.,
2011), as reported in MDV-2 and ILTV (Waidner et al.,
2009; Yao et al., 2007). Discovery of novel DEV-encoded
miRNAs together with the previously identified miRNAs in
MDV-1 (Burnside et al., 2006; Morgan et al., 2008; Waidner
et al., 2009; Yao et al., 2008), MDV-2 (Waidner et al., 2009;
Yao et al., 2007), HVT (Waidner et al., 2009; Yao et al., 2009)
and ILTV (Waidner et al., 2011), make avian a-herpesviruses
a rich source for viral miRNAs.
Closer examination of the genomic locations of the DEV
miRNAs revealed that the precursor sequences of two of
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the miRNAs, miR-D18 and -D19 do overlap (Fig. 3a). The
mature sequence of the two miRNAs follows the same
pattern as miRNA offset RNAs (moRNAs), a recently
discovered class of small RNAs (Shi et al., 2009) closely
related to miRNAs (Fig. 3b). moRNAs are derived from
sequences located immediately adjacent to the mature
miRNA and miRNA* strands in the pri-miRNA precursor
and have been recovered at low levels in several studies
using deep sequencing (Babiarz et al., 2008; Jurak et al.,
2010; Ruby et al., 2007; Shi et al., 2009; Umbach et al.,
2010). The stem–loop of miR-D19 does not seem stable
based on some of the set criteria (Han et al., 2006).
However, the high level expression of miR-D19 in infected
cells as evident from the number of reads by deep
sequencing (Table S1), signal intensity of 9158 arbitrary
units in microarray analysis (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE36258), detection in Northern
blot analysis (Fig. 3c) and high expression levels in infected
cells (Fig. 3e) indicate that DEV-miR-D19 is a genuine
miRNA. In order to examine the functionality of these two
miRNAs, we carried out reporter assays using Renilla
luciferase-based reporter plasmids (Zhao et al., 2009),
bearing four tandem repeats of artificial target sites with a
perfect match to each miRNA, inserted into the 39-UTR.
The reporter plasmid was co-transfected into DF-1 cells
along with the plasmid expressing miR-D18 and -D19. The
luciferase expression was assayed 36 h post-transfection
using the Dual-Glo Luciferase Assay System (Promega).
While miR-D18 was able to inhibit luciferase reporter
expression 90 % relative to a negative control reporter
plasmid, miR-D19 showed no inhibitory effect (Fig. 3d),
demonstrating that only miR-D18 is potentially functional.
In order to validate the expression of both miRNAs in this
assay, we determined the expression levels in transfected
cells using the TaqMan miRNA Assay System (Applied
Biosystems) together with the DEV-infected CEF and
normal DF-1 controls. The result showed that miR-D18
and -D19 are equally expressed although at a low level
compared with the infected cells (Fig. 3e). Despite our
efforts to demonstrate functionality to DEV-miR-D19, the
expression pattern of DEV-miR-D18 and D19 identified in
this report represent the first example of the overlapping
property of adjacent miRNAs.
Identification of novel miRNAs reported here provides the
opportunity for further studies to examine the role of these
novel miRNAs in DEV biology and pathogenesis. A recent
report comparing the genome sequence of the virulent wild-
type DEV strain 2085 and the vaccine strain of DEV has
detected differences in 54 of 78 predicted ORFs (Wang et al.,
2011), but not in any of the miRNAs reported in this study.
However, these observations are not entirely surprising as
pathogenic and vaccine strains of MDV also did not show
difference with respect to miRNAs (Xu et al., 2008). A more
direct approach to examine the functions of these miRNAs
in the disease pathogenesis will be to use viruses with
deletions in specific miRNAs in disease models (Zhao et al.,
2011). A recent report on the development of infectious
bacterial artificial chromosome clones of DEV (Wang &
Osterrieder, 2011) would enable the generation of miRNA
mutant viruses using reverse genetics approaches.
Fig. 1. Structure and genomic locations of DEV miRNAs (a) Mfold prediction of the secondary structures of DEV pre-miRNAs
with the mature miRNA strands are indicated in red; (b) genome structure of mardiviruses demonstrating the restriction of
miRNA clusters mostly to the terminal and internal short and long (TRS, IRS, TRL and IRL) repeat regions; (c) DEV genome
structure showing the internal (IR) and terminal (TR) repeat regions, with the genomic positions and direction of transcription of















































Fig. 2. DEV infection alters cellular miRNA expression profile, as
determined using microarrays. Expression profiles of miRNAs that
were significantly up or downregulated in DEV-infected CEF
compared with uninfected CEF are shown. Each miRNA was
replicated six times on each chip. Red and green indicate
upregulation and downregulation of expression, respectively.
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virus-encoded microRNA miR-BART2 down-regulates the viral DNA
polymerase BALF5. Nucleic Acids Res 36, 666–675.
Borde, C., Barnay-Verdier, S., Gaillard, C., Hocini, H., Maréchal, V. &
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MicroRNAs (miRNAs) are small, abundant, non-coding RNAs that modulate gene
expression by interfering with translation or stability of mRNA transcripts in a
sequence-specific manner. A total of 734 precursor and 996 mature miRNAs have so far
been identified in the chicken genome. A number of these miRNAs are expressed in a
cell type-specific manner, and understanding their function requires detailed examination
of their expression in different cell types. We carried out deep sequencing of small
RNA populations isolated from stimulated or transformed avian haemopoietic cell lines to
determine the changes in the expression profiles of these important regulatory molecules
during these biological events. There were significant changes in the expression of a
number of miRNAs, including miR-155, in chicken B cells stimulated with CD40 ligand.
Similarly, avian leukosis virus (ALV)-transformed DT40 cells also showed changes in miRNA
expression in relation to the naïve cells. Embryonic stem cell line BP25 demonstrated
a distinct cluster of upregulated miRNAs, many of which were shown previously to be
involved in embryonic stem cell development. Finally, chicken macrophage cell line HD11
showed changes in miRNA profiles, some of which are thought to be related to the
transformation by v-myc transduced by the virus. This work represents the first publication
of a catalog of microRNA expression in a range of important avian cells and provides
insights into the potential roles of miRNAs in the hematopoietic lineages of cells in a
model non-mammalian species.
Keywords: microRNA, B-cell, macrophages, DT40, HD11, IAH30
INTRODUCTION
MicroRNAs (miRNAs) are a large class of endogenous non-
coding RNAs 21–23 nucleotides in length. Since they were
first described nearly 20 years ago, there has been a steady
increase in their discovery and the latest Release 20 of miRBase
has 24,521 entries of miRNAs from various species, includ-
ing 734 mature miRNAs from Gallus gallus (www.mirbase.
org). Many of these miRNAs are expressed differentially during
development in a cell-specific manner. A number of previous
studies in mammals have demonstrated hematopoietic lineage-
specific expression of miRNAs, suggesting key roles for these
molecules in controlling hematopoietic machinery (Ramkissoon
et al., 2006; Merkerova et al., 2008). Chickens are used as a
model organism for a number of studies and the developing
chicken embryo has been shown to be an excellent biological
system to study the repertoire and dynamics of small regu-
latory RNAs (Glazov et al., 2008). The development of deep
sequencing technologies and bioinformatics pipelines has greatly
facilitated the discovery and quantification of expression lev-
els of miRNAs in different cell types (Friedlander et al., 2008).
We and others have previously reported the expression pro-
files of miRNAs in chicken T cells transformed by Marek’s
disease virus (MDV), and shown that the majority of the miR-
NAs expressed in these cell types are of viral origin (Burnside
et al., 2008; Yao et al., 2009; Morgan and Burnside, 2011).
Elevated expression of miRNAs such as gga-miR-155 has also
been demonstrated in chicken hematopoietic cells transformed
by reticuloendotheliosis virus (Bolisetty et al., 2009). However,
studies examining the global expression of miRNAs in differ-
ent haemopoietic cell lineages in chickens have not yet been
carried out.
In this study we carried out deep sequencing of the miRNAs
of six avian haemopoietic cell populations: BP25, a chick embry-
onic stem cell (cESC) line; Bu1B, naïve embryonic B lymphocytes;
StimB, CD40L-induced B-cells; DT40, an avian-leukosis virus
(ALV) transformed B-cell line; HD11, a chicken macrophage cell
line; and IAH30, a turkey macrophage cell line. We have deter-
mined the miRNA expression profile of the cESC line, and we
have compared the miRNA expression profiles of naïve B cells
with B-cells after stimulation with the CD40 ligand (CD40L), to
gain an understanding of the global changes in miRNA expres-
sion after signaling through the CD40 ligand interaction. We
have also determined the miRNA profiles in the ALV-transformed
B-cell line DT40 (Bachl et al., 2007) to identify the effects of
the c-myc-induced transformation on miRNA expression. To fur-
ther examine the effects of myc-induced transformation on other
cell types of the haemopoietic lineage, we have determined the
miRNA expression profiles of the chicken macrophage cell line
HD11 (Beug et al., 1979). In addition, we also examined the miR-
NAs in the turkey macrophage cell line IAH30 (Lawson et al.,
2001) to compare the miRNA profiles of chicken and turkey
macrophages.
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By analyzing the changes in expression of miRNA popula-
tions in the different cell types, our study provides insights into
the cell type-specific miRNA signatures of avian haemopoietic
cells. We believe that our data will be helpful in identifying tar-
gets and pathways associated with a number of phenotypic and
functional characteristics of these lineages of avian haemopoietic
cells.
MATERIALS AND METHODS
We made use of six cell lines for the characterization of the
miRNAs: BP25 cESC line was propagated on irradiated STO
feeder cells (ATCC collection) as previously described (Pain et al.,
1996). Naïve B cell population was prepared from embryonic
bursa of Fabricius (BF) or spleen collected from line 0 eggs
at 18-day-old of embryonation. Briefly, BF was dissected from
embryos and cell suspensions were separated by density gradi-
ent centrifugation on Ficoll-Paque under sterile conditions. B-cell
preparations of more than 95% purity were obtained by mag-
netic cell sorting on MACS separation columns LS (Miltenyi
Biotec, UK) using chicken B-cell (Bu-1)-specific monoclonal
antibody AV20 (Rothwell et al., 1996) and anti-mouse microbeads
as previously described (Kothlow et al., 2008). CD40L-induced
in vitro B-cell proliferation was carried out as previously
described using purified recombinant protein (Tregaskes et al.,
2005; Kothlow et al., 2008), and cells were harvested 48 h
after treatment with the ligand. DT40 (Buerstedde et al., 2002;
Bachl et al., 2007), HD11 (Beug et al., 1979) and IAH30
(Lawson et al., 2001) cell lines were propagated as previously
described.
RNA extraction for miRNA profiling was carried out as previ-
ously described (Yao et al., 2012) using miRVana miRNA isolation
kit (Ambion, UK). Sequencing of the miRNAs was carried out
on the Illumina GAIIx and 36 base-pair single-end sequenc-
ing. After sequencing, adaptor and primer/dimer sequences were
removed using Cutadapt (http://code.google.com/p/cutadapt/).
Using the Novoalign short read aligner (www.novocraft.com), we
mapped the reads from all the individual cell lines, including
the turkey macrophage cell line, to the known chicken mature
miRNAs downloaded from miRBase (www.miRBase.org) ver-
sion 19. Reads mapping to each miRNA were counted and
used as input for downstream analyzes. To correct for differ-
ences in library size and sequencing depth, raw mapped read
counts were scaled to reads per million mapped reads (Mortazavi
et al., 2008). Changes in miRNA expression in CD40L-stimulated
(StimB) cells compared to naïve B cells (Bu1B) were calcu-
lated as log2 ratios of normalized (RPM) counts. Similarly,
changes in the expression of individual miRNAs in DT40 cells
were also calculated in comparison to those of naïve B cells
(BU1B). Normalized counts of miRNA levels were used to gen-
erate a heatmap in order to identify candidate miRNAs that
are differentially expressed in different cell lines. The pearson
correlation coefficient was used as a similarity measure in the
heatmap cluster analyzis, and using the “average” agglomera-
tion method. Validation of expression levels of gga-miR-21, gga-
miR-26a, gga-miR142-3p, gga-miR-155 and gga-miR-223 was
carried out by quantitative RT-PCR using procedures described
(Yao et al., 2008).
RESULTS
RAW DATA
The raw data hava been submitted to the European Nucleotide
Archive (ENA) under accession number ERP002558. Counts and
normalized RPM values have been uploaded as Supplementary
Material.
miRNA EXPRESSION IN B-LYMPHOCYTES AFTER CD40L STIMULATION
Naïve B cells are activated through a combination of signals from
the antigen and through the binding of the CD40 ligand to CD40
which drives proliferation. Comparison of the naïve and CD40L-
stimulated B cells revealed significant changes in the miRNA
expression profiles (Figure 1). The miRNAs which showed sig-
nificant increase upon CD40L-stimulation included gga-miR-21,
gga-miR-155, gga-miR-146a, gga-miR-20b, gga-miR-106, gga-
miR-222, and gga-miR-22. A number of miRNAs were also down-
regulated after CD40L stimulation. This included gga-miR-26a
which showed a 4.5-fold decrease in expression. Other down-
regulated miRNAs included members of the miR-30 family of
miRNAs (gga-miR-30c, gga-miR-30d, gga-miR-30a-5p) and the
avian-specific gga-miR-1729 originally discovered in developing
chick embryo.
miRNA EXPRESSION IN DT40 CELLS
Analyzis of the expression of miRNAs in DT40 cells demonstrated
overexpression of a number of miRNAs compared to the naïve
Bu1B positive cells (Figure 2). Among the upregulated miRNAs
in DT40 cells, many miRNAs including gga-miR-18a and -18b,
-222, -20b, -148a, -221, -106, -103, -101 and -21 also increased
in CD40L-stimulated cells (Figure 3A). On the other hand, gga-
miR-100 is highly upregulated in DT40 cells compared to naïve
B cells or CD40L-stimulated cells (data not shown). Similarly,
gga-miR-146a, upregulated in CD40L-stimulated B cells, was
down-regulated in DT40 cells, providing further evidence for
its role in the immune system. A number of miRNAs, includ-
ing gga-miR-16, -30e, -30d, -30b, -30c, -26a, -147, -15b, and
-29a, down-regulated in DT40 cells were also downregulated in
CD40L-treated cells (Figure 3B). The most striking change was in
the level of gga-miR-155. This miRNA was the most up-regulated
miRNA in CD40L-stimulated B cells, but was downregulated in
the DT40 cells.
Expression levels of miRNAs obtained from the deep sequenc-
ing data were validated by carrying out quantitative RT-PCR
on gga-miR-21, gga-miR-26a, gga-miR-142-3p and gga-miR-
155 using RNA extracted from different cell types. Differences
in the expression profiles of the miRNAs determined from
deep sequencing broadly agreed with the quantitative RT-PCR
data from naïve Bu1B-positive, DT40 and stimulated B cells
(Figure 4A). Similarly, the high expression levels of gga-miR-
142-3p and gga-miR-223 in HD11 cells was also confirmed by
quantitative RT-PCR (Figure 4B).
miRNA EXPRESSION IN AVIAN MACROPHAGE CELL LINES HD11 AND
IAH30
Out of the 718,959 sequences in HD11 cells that mapped to the
mature miRNAs in miRBase, the highest level of expression was
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FIGURE 1 | Log2 fold (stimulated/naïve) change in expression (red or green bars indicating increased or decreased expression respectively) of the 50
most abundantly expressed miRNAs in CD40L-stimulated B cells (StimB) compared to the naïve B cells (BU1B).
FIGURE 2 | Log2 fold (DT40/naïve) change in expression (red or green bars indicating increased or decreased expression respectively) of the 50 most
abundantly expressed miRNAs in DT40 ALV-transformed B cells (DT40) compared to the naïve B cells (BU1B).
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FIGURE 3 | Log2 fold change in expression of microRNAs (A) up-regulated in CD40L stimulated (StimB) and DT40 transformed cells (DT40) relative to
naïve B cells (BU1B); and (B) down-regulation in CD40L stimulated (StimB) and DT40 transformed cells (DT40) relative to naïve B cells (BU1B).
FIGURE 4 | miRNA expression levels determined by qRT-PCR.
Relative expression of gga-miR-21, gga-miR-26a, gga-miR142-3p and
gga-miR-155 measured in RNA extracted from DT40 and StimB cells
compared to Bu1B cells (A) and gga-miR142-3p and gga-miR-223 in
HD11 and IAH30 compared to chicken macrophages (B). Results
represent the mean of triplicate assays with error bars showing the
standard error of the mean. Data normalized to gga-let-7a. Note the
broken axis in (A).
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observed for gga-miR-21, which accounted for 28.8% of all miR-
NAs expressed in these cells. The high level of gga-miR-21 was
demonstrated in normal macrophages also (Figure 4B). Other
miRNAs which are expressed at high levels in HD11 include gga-
miR-142-3p (10.5%), gga-miR-223 (6.9%), gga-miR-19b (4%),
gga-miR-20a (3.7%) and gga-miR-22 (3.4%).
More than half (53%) of the total 175,408,236 sequences from
the IAH30 turkey cell line mapped to known mature chicken
miRNA sequences. Of those, a large majority matched with the
gga-miR-21 (33.4%). Other chicken miRNAs that are expressed
at high levels in IAH30 cells include gga-miR-24 (5.5%), gga-
miR-27b (4%), gga-miR-19b (3.9%), gga-miR-20a (3.9%), gga-
miR-148a (3.7%), gga-miR-23b (3%), and gga-miR-92 (3%).
Further studies are required to identify the functional signifi-
cance of these miRNAs and further characterize the other turkey
miRNAs. Interestingly, gga-miR-142-3p and gga-miR-223 were
significantly downregulated in IAH30 cells compared to HD11
cells Figure 4 For gga-miR-142-3p, there are only 19 reads in
IAH30 compared to 75,670 reads in HD11. Similarly, there are 10
and 50,275 reads representing gga-miR-223 in IAH30 and HD11
respectively. This difference is further confirmed by qRT-PCR
(Figure 4B).
miRNA EXPRESSION IN cESC LINE BP25
Sequencing from cell line BP25 gave a total of 1,624,435 reads out
of which 1,146,503 (70.6%) passed QC and mapped to known
mature chicken miRNAs. The most predominant miRNA popu-
lation expressed in BP25 was indeed the ES cell-specific miRNAs
belonging to the miR-302-367 cluster. The expression levels of
five miRNAs in the miR-302-367 cluster (miR-302a, miR-302b,
miR-302c, miR-302d, and miR-367) accounted for 39.5% of all
the sequenced miRNAs. Another miRNA expressed at high levels
in the BP25 cell line is gga-miR-21 that accounted for 23.3% of
the miRNAome. In addition, miR-17-92 cluster of miRNAs (miR-
17, miR-18a, miR-19a, miR-20a, miR-19b-1, and miR-92-1) was
also expressed at relatively high levels, accounting for 12.4% of
the miRNAome in BP25.
COMPARISON OF THE miRNA PROFILES OF DIFFERENT AVIAN CELL
TYPES
Comparison of the differential expression of miRNA, based on
the normalized counts, showed clustering of miRNAs in various
avian cell types (Figure 5). For example, cESC line BP25 clearly
demonstrated clustering of highly expressed ES cell-specific miR-
NAs, which are not expressed in any of the other cell lines.
Similarly, DT40 cells showed a distinct profile of miRNA expres-
sion. The two cell lines IAH30 and HD11 coming from different
species (turkey and chicken respectively), clearly showed distinct
expression profiles despite being of macrophage origin. Naïve and
stimulated B cells showed clustering based on miRNA expression
profiles, yet demonstrated specific miRNA expression patterns,
with a group of miRNAs showing high expression in stimulated B
cells that are not present in the other cell lines.
DISCUSSION
Deep sequencing using Illumina platform can be valuable
for obtaining miRNAome data, and we have used this for
FIGURE 5 | Heatmap demonstrating differential clustering of the
miRNAs from avian cell types based on expression levels calculated
from normalized read counts (Red indicates high levels of expression
and green to indicate low levels). BP25 is the cESC line BP25 (Pain et al.,
1996); BU1B is the naïve embryonic B lymphocyte; DT40 is the data from
DT40 cells (Buerstedde et al., 2002); stimB is the CD40L-induced B-cells;
HD11 and IAH30 represent HD11 (Beug et al., 1979) and IAH30 (Lawson
et al., 2001) cell lines respectively.
determining the miRNA expression levels from cell lines of
chicken, a model avian species. Comparison of the normalized
read counts was used to obtain digital data on expression levels of
individual, already known mature miRNAs.
As in mammals, B-lymphocytes in birds are one of the critical
components of the immune system responsible for the produc-
tion of antibodies to specific antigens, pathogens and vaccines.
Chickens have a distinct organ called BF in which the naïve B
cells mature before being exported to the periphery. Naïve B
cells are activated through a combination of signals from the
antigen and through the binding of the CD40 ligand to CD40
which drives proliferation. The miRNAs which showed signif-
icant increase upon CD40L-stimulation included gga-miR-21,
gga-miR-155, gga-miR-146a, gga-miR-20b, gga-miR-106, gga-
miR-222 and gga-miR-22 (Figure 2). Some of these miRNAs have
already been well-documented for their roles in cell proliferation
and cancer. The highly expressed gga-miR-155 has been exten-
sively studied and shown to be associated with cell proliferation in
a number of cancers, as well as in autoimmunity (Leng et al., 2011;
Wang and Wu, 2012). Interestingly, miR-155 was first discovered
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in the chicken as part of the c-bic transcript in ALV-transformed
lymphomas (Clurman and Hayward, 1989). High expression of
miR-155 upon CD40L stimulation is consistent the major role
of this miRNA in proliferation. Other viral oncogenes such as v-
Rel have also been shown to drive miR-155 expression (Bolisetty
et al., 2009). As v-Rel is an NF-κB homolog, it is possible that the
increased expression of miR-155 by CD40L is mediated through
the NF-κB pathway, although other signaling systems may also be
involved. Another miRNA that shows increase in expression after
CD40L-stimulated B-cells is gga-miR-146a. As a multifaceted
miRNA, its role in hematopoiesis, immune response and cancer
has been well documented (Labbaye and Testa, 2012). Activation
of miR-146a, thought to be through the NF-κB pathway, has
also shown to be important in the innate immune responses
(Williams et al., 2008). Our study demonstrating the upregu-
lation of miR-146a through CD40L interaction further adds to
our understanding of the molecular pathways of biogenesis of
miR-146a and CD40L functions.
A number of miRNAs were also down-regulated after CD40L
stimulation. This included gga-miR-26a which showed a 4.5-fold
decrease in expression. Interleukin-2 (IL-2) is essential for the
growth and proliferation of T-cells (Cantrell and Smith, 1984),
and we have previously shown the downregulation of miR-26a
in MDV-transformed cell lines, where the decreased expression
relieved its suppressive effect on the interleukin-2, potentially
allowing proliferation (Xu et al., 2010). It is possible that the
CD40L-stimulation also makes use of a similar pathway. The most
down-regulated miRNA, which decreased in expression by almost
10-fold, was gga-miR-2954. This miRNA has only been reported
in birds (Gallus gallus and Taeniopygia guttata) and was originally
identified as being male-specific during early chick development
(Zhao et al., 2010). Another avian-specific miRNA, gga-miR-1729
was also down-regulated, a miRNA originally discovered in devel-
oping chick embryo (Glazov et al., 2008). The change in expres-
sion after CD40L stimulation suggests that these miRNAs have
roles beyond early chick development. Other down-regulated
miRNAs include members of the miR-30 family of miRNAs (gga-
miR-30c, gga-miR-30d, gga-miR-30a-5p) many of which have
been implicated in a wide range of cancers (Gaziel-Sovran et al.,
2011; Baraniskin et al., 2012; Cheng et al., 2012). Suppression of
these miRNAs may therefore be related to cell division and prolif-
eration of the B cells after stimulation with CD40L. By comparing
the miRNA expression in naïve and CD40L-activated B-cells, we
were able to identify changes in miRNA expression related to the
CD40L-induced proliferation.
ALV-transformed cell line DT40 is extensively used in molec-
ular genetic studies because it has high levels of recombination,
making it a very useful system for in vitro gene knock out stud-
ies (Buerstedde et al., 2002). Although there have been extensive
studies on important areas of cell biology using the DT40 cell sys-
tem, there is only limited understanding of the miRNA expression
and functions in this cell line. Global miRNA expression profiles
of DT40 cells showed changes in the expression of a number of
miRNAs (Figure 2). A number of miRNAs upregulated in DT40
cells also showed increased expression in CD40L-stimulated cells,
suggesting that these miRNAs have a major role in cell pro-
liferation. However, other miRNAs such as gga-miR-100 was
up-regulated mainly in DT40 cells suggesting a more important
role in transformation. Interestingly, miR-100 has been shown to
be involved in a number of cancers in humans (Jung et al., 2011;
Li et al., 2011; Oliveira et al., 2011; De Oliveira et al., 2012). On
the other hand, gga-miR-146a, which was upregulated in CD40L
stimulated B cells, is down-regulated in DT40 cells, providing
further evidence for its role in the immune system.
A number of miRNAs down-regulated in DT40, including
gga-miR-16, -30e, -30d, -30b, -30c, -26a, -147, -15b, and -29a,
were also downregulated in CD40L-stimulated cells, suggesting
conserved functions of cell division and proliferation. However,
perhaps the most striking change is in gga-miR-155, which is the
most up-regulated miRNA in CD40L stimulated B cells, but it
is the most down-regulated miRNA in ALV transformed DT40
cells. One of the well characterized targets of miR-155, the tran-
scription factor PU.1 is expressed in DT40 cells and has been
shown to be important in the activation-induced cytidine deami-
nase (AID) expression and function (Luo and Tian, 2010). AID is
important for B-cells to produce and maintain antibody diversity
(Muramatsu et al., 2000). Reduced levels of miR-155 may help in
maintaining high levels of PU.1, as these two have been shown to
demonstrate inverse correlation in their expression (Thompson
et al., 2011). Although it would be inaccurate to make direct com-
parisons of the miRNA profiles of DT40 cell lines and the naïve
B cells stimulated with CD40L because of the significant differ-
ences between the two populations, the findings from the present
study suggest the changes in the expression of some of these
miRNAs could be contributing to the proliferative and unique
recombinogenic properties of DT40 cells.
Macrophages play primary roles in both innate and adaptive
immune responses, and in vitro studies on their function using
macrophage cell lines have provided significant understand-
ing on such responses. Avian myelocytomatosis virus (MC29)-
transformed chicken macrophage cell line HD11 (Beug et al.,
1979) is widely used in examining the innate immune functions.
Although a number of miRNAs have been implicated in mod-
ulating innate immune functions, the miRNA profiles of these
cells have not been examined. Although significant further stud-
ies are required to obtain the digital miRNA expression data of
these cells, our data provide a snapshot of the expression profiles
of the miRNAs that may have relevance to studies on their func-
tion. Among all the miRNAs expressed in these cells, gga-miR-21
alone accounted for nearly a third (28.8%). However, miR-21 is
highly expressed in normal macrophages as well as the cESC line
BP25. The data presented here could be valuable in examining the
changes in miRNA expression profiles following the in vitro acti-
vation of specific signaling pathways, for which these cell types are
widely used.
IAH30 is a turkey macrophage cell line (Lawson et al., 2001)
transformed by the acutely transforming ALV subgroup J 966
virus with a transduced v-myc oncogene (Chesters et al., 2001).
Although there has been progress in sequencing of the turkey
genome (Dalloul et al., 2010), the annotation of the miRNAs is
still not complete and no mature turkey miRNA sequences are
available in miRBase. Hence we have used the deep sequencing
data from IAH30 to examine the changes in the expression of
turkey homologs of chicken miRNAs.
The two miRNAs that are significantly downregulated
in IAH30 cells compared to HD11 –gga-miR-142-3p and
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gga-miR-223 (Figure 4B) have been shown to be involved in
haemopoietic cell proliferation (Sun et al., 2010) and macrophage
differentiation (Ismail et al., 2013). The vastly different abun-
dances of these two key miRNAs suggest potential differences
between the IAH30 and HD11 macrophage cell lines which may
have implications for experiments which utilize them.
Analyzis of the miRNA profiles in the BP25 cESC line showed
that the ES cell-specific miRNAs belonging to the miR-302-367
cluster were the most predominant miRNA population expressed
in BP25. The expression levels of five miRNAs in the miR-302-367
cluster (miR-302a, miR-302b, miR-302c, miR-302d, and miR-
367) accounted for 39.5% of all the sequenced miRNAs. This
cluster of miRNAs is also expressed at high levels in human ESCs
(Gunaratne, 2009), suggesting conserved functions of these miR-
NAs in mammals and birds. It has also been demonstrated in
mammals that only a small subset of miRNAs, mostly seen as clus-
ters in the genome, are expressed in the ES cells. For example, over
75% of the miRNAs expressed in mouse ES cells are represented
by 6 loci (Calabrese et al., 2007). More recently, the miR-302-367
cluster was found to be highly expressed in differentiated blasto-
derm and primordial cells (Lee et al., 2011). Although shown to be
significantly induced in human embryonal carcinoma cells (Suh
et al., 2004), none of the miRNAs from the miR-302-367 cluster
were detected in any of the other cell lines examined in this study,
suggesting the suppression of these miRNAs upon differentiation.
miRNAs belonging to the miR-302-367 cluster have been shown
to regulate cell growth, metabolism, transcription (Dyce et al.,
2010) and chromatin modification (Ren et al., 2009), demon-
strating the potential importance of these miRNAs in maintaining
the stem cell phenotype. BP25 cell line also showed high levels
of expression of gga-miR-21 accounting for 23.3% of the miR-
NAome. Unlike in the BP25 cESC line, miR-21 levels are low in
mammalian ES cells (Gunaratne, 2009), although the potential
functional significance is not known. However, increased miR-21
expression is not unique to the chicken ES cell line, as high levels
of expression of miR-21 have been detected in a number of human
cancer cell lines (Slaby et al., 2007; Jiang et al., 2008). The miR-
17-92 cluster of miRNAs (miR-17, miR-18a, miR-19a, miR-20a,
miR-19b-1, and miR-92-1) was also expressed at relatively high
levels (accounting for 12.4% of the miRNAome) in the BP25 cell
line. As multifaceted miRNAs, these are not specific to the ESC,
and have been associated with a number of cancers (Krichevsky
and Gabriely, 2009), therefore the role of the miR-17-92 cluster in
the BP25 cESC line may be related to its proliferative functions.
Taken together, we present the expression profiles of miR-
NAs determined by deep sequence analysis of the small RNA
population from a number of avian cell types under conditions
such as CD40L stimulation of B cells. The study also provides
a snapshot of the miRNA profiles of cell lines such as DT40,
HD11 and IAH30, transformed by the activation/transduction of
myc oncogene. Although additional studies are required for pre-
cise characterization of the changes in miRNA expression and
the functional significance of these changes, this study provides
insights into the potential roles of miRNAs in the hematopoietic
lineages of cells in a model non-mammalian species.
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An Avian Retrovirus Uses Canonical Expression and Processing
Mechanisms To Generate Viral MicroRNA
Yongxiu Yao,a Lorraine P. Smith,a Venugopal Nair,a Mick Watsonb
‹Viral Oncogenesis Group, The Pirbright Institute, Compton Laboratory, Compton, Berkshire, United Kingdoma; Ark-Genomics, The Roslin Institute, R(D)SVS, University of
Edinburgh, Division of Genetics and Genomics, Easter Bush, Midlothian, United Kingdomb
To date, the vast majority of known virus-encoded microRNAs (miRNAs) are derived from polymerase II transcripts encoded by
DNA viruses. A recent demonstration that the bovine leukemia virus, a retrovirus, uses RNA polymerase III to directly tran-
scribe the pre-miRNA hairpins to generate viral miRNAs further supports the common notion that the canonical pathway of
miRNA biogenesis does not exist commonly among RNA viruses. Here, we show that an exogenous virus-specific region, termed
the E element or XSR, of avian leukosis virus subgroup J (ALV-J), a member of avian retrovirus, encodes a novel miRNA, desig-
nated E (XSR) miRNA, using the canonical miRNA biogenesis pathway. Detection of novel microRNA species derived from the E
(XSR) element, a 148-nucleotide noncoding RNA with hairpin structure, showed that the E (XSR) element has the potential to
function as a microRNA primary transcript, demonstrating a hitherto unknown function with possible roles in myeloid leukosis
associated with ALV-J.
Retroviruses are a large group of enveloped viruses associatedwith a variety of diseases in a wide range of host species. Avian
retroviruses, the Rous sarcoma virus (RSV) and avian leukosis
virus (ALV), are historically known for their ability to induce a
number of types of cancer in poultry (1). In addition to their
pathogenic roles, retroviruses have provided significant insights
into transcriptional regulation in a cell-type-specific manner (2).
The retroviral genome includes a number of cis-acting elements
(3). One such element is the 148-nucleotide exogenous virus-spe-
cific region (E or XSR) identified in the SR-A and Pr-C strains of
RSV at the 5= and the 3= sides of the src gene, respectively (4, 5).
The functions of the E (XSR) element are not clear although re-
quirement of a 400-nucleotide region that included the E (XSR)
element for oncogenicity of the recombinant avian retrovirus
NTRE7 has been shown (6). The E (XSR) sequence exhibits several
unusual features; it has a noncoding RNA capable of forming
characteristic hairpin structures (7). From its location at two dif-
ferent sites on either side of the src gene in the two RSV strains, it
is clear that the functions of E (XSR) can be exerted over distance.
Based on these observations, it was speculated that E (XSR) may
function as a transcriptional enhancer (5).
Interest in the E (XSR) element was revived when it was dem-
onstrated in the 3= noncoding region of the genome of HPRS-103,
the ALV subgroup J (ALV-J) prototype virus (8), identified in the
United Kingdom in 1988 as the causative agent of myeloid leuko-
sis, which rapidly became a worldwide health and welfare problem
in chickens (9–13). The E (XSR) sequence is conserved in the
majority of the ALV-J isolates although deletions or modifications
in this sequence have also been seen (13–16). The role of the E
(XSR) element in the pathobiology of ALV-J is not known al-
though potential C/EBP and c-Ets-1 binding sites have been pre-
dicted in the sequence (13, 14). However, ALV-J strains with de-
letions or mutations in the E (XSR) element have also been
isolated from clinical cases (9–11, 14, 17). Our previous studies
using HPRS-103 clones with precise deletions in the E (XSR) ele-
ment indicated that these elements are essential for oncogenicity,
but this was related to the genetic background of the birds (7).
Despite the presence of the E (XSR) element and its association
with the oncogenicity of RSV and ALV-J, the molecular mecha-
nisms of the E (XSR) element functions remain unclear. Although
an enhancer-like function has been speculated (5, 14), firm sup-
porting evidence is still lacking.
In many organisms, including several viruses, microRNAs
(miRNAs) are well recognized as major regulators of gene expres-
sion (18). Given their profound ability to regulate multiple tar-
gets, these molecules are exploited particularly by several DNA
viruses as tools for manipulating the cellular environment (19,
20). RNA viruses are generally thought not to contain pre-miRNA
structures to avoid endonuclease-mediated cleavage of the ge-
nome, antigenome, and mRNAs. Although retroviruses have not
been widely documented to exploit the miRNA pathway (21), a
recent demonstration of a conserved cluster of RNA polymerase
III (Pol III)-transcribed miRNAs from the bovine leukemia virus
(BLV) genome (22, 23) showed the potential of retroviruses to
encode miRNAs. The E (XSR) element sequences from ALV-J
strains show hairpin-like structures suggestive of miRNA precur-
sors although the existence of any mature miRNA has not been
demonstrated in ALV-J-infected/transformed cells. Using a deep-
sequencing approach on one of the ALV-J-transformed cell lines,
we identified a novel small-RNA population encoded from within
the E (XSR) element.
MATERIALS AND METHODS
Cells. HEK293T cells and the chicken embryo fibroblast (CEF) cell line
DF-1 (24) were maintained in Dulbecco’s modified Eagle’s medium
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(DMEM) supplemented with 10% fetal calf serum (FCS) (Sigma). A re-
ticuloendotheliosis virus T (REV-T)-transformed turkey spleen cell
(TSC) line, AVOL-1T, and IAH30, a turkey macrophage (M) cell line
(25) transformed by the acutely transforming ALV subgroup J 966 virus
with a transduced v-myc oncogene (26), were grown at 38.5°C in 5% CO2
in RPMI 1640 medium containing 10% FCS, 2% chicken serum, 10%
tryptose phosphate broth, 0.1% 2-mercaptoethanol, and 1% sodium py-
ruvate. AVO4-1B3 cells, an avian blastoderm cell line transformed by
acutely transforming ALV-J isolate 1B (27), was maintained in Eagle’s
minimal essential medium (EMEM) supplemented with 10% FCS. Tur-
key spleen cells were prepared from spleen tissues of uninfected turkey by
using Histopaque-1083 (Sigma-Aldrich) density gradient centrifugation.
Chicken macrophages were prepared from bone marrow of adult unin-
fected chickens using procedures described previously (12). Briefly, fem-
oral bone marrow was flushed out with RPMI medium, and the contents
were passed through a cell sieve. After Histopaque-1083 density gradient
centrifugation, the cells from the interface were collected, washed twice
using RPMI medium supplemented with 5% FCS and 5% chicken serum,
plated into 60-mm dishes, and cultured at 38.5°C in 5% CO2. The me-
dium was changed after 3 days, and the cells were used for virus infection.
Plasmids. The miR-155 expression plasmid pEF6-Bic was de-
scribed previously (28). The MHV-miR-M1-7-3p expression plasmid
pIDTSmartKan-MHV68-M1-7 was kindly provided by Chris Sullivan,
University of Texas, Austin, TX. The E (XSR) miRNA expression cassette
was PCR amplified from HPRS-103 genomic DNA with primers 5=-TCG
ATAGGAAGCTTAAAGCAGTGCATGGGTAGGGGT-3= and 5=-TCAC
GTAATCTAGACCACCTTACTTCCACCAATCGACG-3=. The isolated
fragments were either cloned into pGEM-T-easy by TA cloning or into
pcDNA3.1-His/myc via restriction enzyme sites HindIII and XbaI. A lu-
ciferase sensor reporter was constructed by synthesizing four tandem re-
peats of artificial target sites with a perfect match to E (XSR) miRNA as
sense and antisense oligomers; the construct was annealed and cloned into
the 3= untranslated region (UTR) of the Renilla luciferase gene through
the NotI-XhoI site in the psiCHECK-2 vector (Promega). A control mu-
tant reporter construct (sensor-mu) was generated alongside the wild-
type reporter construct to be the negative control. In the mutant con-
struct, nucleotides 2, 4, 6, and 8 of the microRNA response element
(MRE) were changed to different bases, thus preventing recognition of the
target site by the miRNA. In all cases, the cloned sequences were con-
firmed by sequence analysis.
Deep sequencing of an IAH30 small-RNA library. RNA extraction
for miRNA profiling was carried out as previously described (29) using an
miRVana miRNA isolation kit (Ambion, United Kingdom). Sequencing
of the miRNAs was carried out on an Illumina GAIIx platform by GATC
Biotech. After sequencing, adaptor and primer/dimer sequences were re-
moved, yielding approximately 1.5 million 36-bp single-end reads. Using
the Novoalign short-read mapper (Novocraft, Selangor, Malaysia), we
mapped the reads to the known chicken mature miRNAs downloaded
from miRBase (www.miRBase.org) and the HPRS-103 genome sequence
(GenBank accession number Z46390.1). To correct for differences in li-
brary size and sequencing depth, raw mapped-read counts were scaled to
reads per kilobase per million sequenced reads (30).
Northern blotting. Total RNA was extracted from cultured cells with
an miRNeasy Kit (Qiagen) according to the manufacturer’s instructions.
Samples of 20 g of total RNA were resolved using a 15% polyacryl-
amide–1 Tris-borate–EDTA– 8 M urea gel and blotted to a GeneScreen
Plus membrane (Perkin-Elmer). The probe sequences of DNA oligonu-
cleotides with sequences complementary to candidate miRNAs are as fol-
lows: miR-155 probe, 5=-CCCCTATCACGATTAGCATTAA-3=; E (XSR)
miRNA probe, 5=-CAGAGGCAACTTGAATAGTCTA-3=; and MHV68-
M1-7 probe, 5=-AATAAAGGTGGGCGCGATATC-3=. The 5.8S probe se-
quence is 5=-TTCTTCATCGACGCACGAGC-3=. The probes were end
labeled with [-32P]ATP (Amersham) and T4 polynucleotide kinase
(New England BioLabs) to generate high-specific-activity probes. Hybrid-
ization, washing, and autoradiography were carried out as previously de-
scribed (31).
Dual-luciferase assay. The transfection of DF-1 cells and Vero cells
was carried out with Lipofectamine 2000 (Invitrogen). CEFs were trans-
fected with Lipofectamine (Invitrogen), and IAH30 cells were transfected
with a Nucleofactor Transfection Kit T (Lonza). E (XSR) miRNA mimics
were synthesized by Qiagen. Approximately 3  104 cells were seeded in
each well of a 96-well plate. Except for the IAH30 cell line, which was
transfected with reporter construct alone, DF-1, CEF, and Vero cells were
cotransfected with 20 ng of each reporter construct in psiCHECK-2 vector
along with either 100 ng of (E) XSR miRNA expression plasmid (DF-1) or
a final concentration of 20 nM E (XSR) miRNA mimics (DF-1, CEF, and
Vero cells) using different transfection reagents, as stated above, as per the
manufacturer’s protocols. In all cases, constitutively expressed firefly lu-
ciferase activity in the psiCHECK-2 vector served as a normalization con-
trol for transfection efficiency.
RNA polymerase II dependence assay. HEK293T cells in six-well
plates were transfected with 2.5 g of miRNA expression vector using
Lipofectamine 2000 and, where indicated, were then treated 2 h later with
a final concentration of 50 g/ml -amanitin (32). Total RNA was ex-
tracted at 24 h posttransfection, and Northern blot analysis was per-
formed.
RNA interference (RNAi) assays. Silencer Select validated siRNAs
against human Drosha (siRNA identification numbers [ID], s26491 and
s26492, referred to as D1 and D2) and Dicer (siRNA ID s23754) were
purchased from Ambion. They have been verified experimentally by the
company in cell-based assays to reduce the expression of their individual
target genes by 80% in at least three biological replicates. HEK293T cells in
six-well plates were transfected with 20 nM Drosha or Dicer siRNA using
Lipofectamine RNAi-MAX (Invitrogen) following the manufacturer’s
recommendations. At 24 h posttransfection, cells were cotransfected with
20 nM each siRNA and 2 g of miRNA expression plasmid using Lipo-
fectamine 2000. Twenty-four hours later, RNA was extracted, and North-
ern blot analysis was performed.
Stem-loop quantitative reverse transcription-PCR (qRT-PCR) for
E (XSR) miRNA. Total RNA was extracted from cultured cells with an
miRNeasy Kit (Qiagen) according to the manufacturer’s instructions.
miRNAs were quantified using custom TaqMan stem-loop microRNA
assays (ABI) according to the manufacturer’s recommendations using 10
ng of total RNA as a template for reverse transcription with the primer
5=-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACG
ACCAGAGG-3=, followed by quantitative PCR carried out using the for-
ward primer 5=-CGGTCGACCTAGACTATTCAAGTTG-3=, reverse
primer 5=-CAGTGCAGGGTCCGAGGT-3=, and probe 5=-TGGATACGA
CCAGAGGC-3=. A TaqMan microRNA assay for let-7a (assay ID 000377)
was purchased from ABI. Each reverse transcription reaction was per-
formed twice independently, and each reaction mixture was used for trip-
licate PCR. The level of miRNA expression is presented as fold expression
relative to the background amplification obtained with RNA isolated
from either chicken M (see Fig. 2B) or untransfected DF-1 (see Fig. 4A)
and after normalization to the ubiquitously expressed cellular miRNA
let-7a.
RESULTS
E (XSR) element encodes a novel miRNA. During miRNA profil-
ing of an ALV-J-transformed turkey macrophage cell line IAH30
(25) by deep-sequence analysis on an Illumina GAIIx platform, we
observed the presence of two distinct small RNA sequences that
mapped perfectly to the E (XSR) element in the 3= UTR of the
HPRS-103 genome (GenBank accession number Z46390.1). The
total reads of the two small RNA sequences account for 24.5% of
the total IAH30 “miRNAome.” Notably, only 580 reads were scat-
tered across the 7,841-bp genome outside this region. The relative
abundance (358,998 and 335 reads, respectively) (Fig. 1A and B)
and size of these small RNAs suggested they are miRNA candi-
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dates. Closer examination of the sequence revealed that it is de-
rived from the hairpin structure of the E (XSR) element (Fig. 1A).
During miRNA biogenesis, processing of the pre-miRNA yields
the more abundant miRNA and less abundant passenger strands
(33). From our data, we conclude that the abundant species that
mapped to 5= arm of the stem-loop sequence is likely to be the
miRNA strand, while the less abundant sequence that mapped to
3= arm of the stem-loop represented the passenger strand. Impor-
tantly, the 5= arm of the stem-loop sequence is the most abundant
species present in the IAH30 library (Fig. 1C). Taken together,
these results strongly suggested that we had identified a pre-
miRNA encoded within the E (XSR) element of ALV-J.
In order to confirm that these novel miRNAs identified in the
IAH30 cell line were indeed derived from the E (XSR) sequences in
the HPRS-103 genome and did not originate from the turkey cells,
we carried out Northern blotting hybridization with the miRNA
strand probe. Northern blotting detected both mature miRNA
and pre-miRNA in IAH30 cells. No miRNAs were detected with
RNA extracted from the reticuloendotheliosis virus T (REV-T)-
transformed turkey cell line AVOL-1T and uninfected turkey
spleen cells (TSCs) (Fig. 2A). This finding was further confirmed
by TaqMan miRNA assays (Fig. 2B). IAH30 is a turkey macro-
phage cell line transformed by strain 966, an acutely transforming
virus derived from HPRS-103. To test that the expression of the E
(XSR)-derived miRNA is not limited to the transformed macro-
phages of turkey origin, we also examined the primary chicken
macrophages infected with either HPRS-103 or 966 virus. RNA
isolated from the infected cells was tested for E (XSR) miRNA
FIG 1 The E (XSR) element in the ALV-J genome encodes a novel microRNA. (A) Genomic location of E (XSR) miRNA. The structure of the ALV-J provirus
HPRS-103 genome with the long terminal repeat (LTR), gag/pol, env (gp85 and gp37), redundant transmembrane (rTM), and the E element is shown. The
secondary structure of E (XSR) pre-miRNA predicted using the MFOLD algorithm is shown on the top. The mature miRNA strands are indicated in red. The
mature miRNAs with the number of reads for each strand recovered from deep sequencing are indicated. (B) Reads representing the major populations of E
(XSR) miRNA-5p and E (XSR) miRNA-3p aligned against the precursor sequence. Dot-bracket notation was produced by applying RNAfold. (C) Most-often-
sequenced small RNA sequences from IAH30 that map to Gallus gallus miRNAs (gga prefix) listed in miRBase.
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expression using a TaqMan assay. Indeed, E (XSR) miRNA was
detected in cells infected with both types of viruses (Fig. 2B). Fur-
thermore, E (XSR) miRNA was also detected in AVO4-1B3 cells, a
chicken blastoderm cell line transformed by another acutely
transforming ALV-J isolate, 1B (27), by both Northern blotting
and TaqMan miRNA assay (Fig. 2A and B). The E (XSR) miRNA
was not detected with RNA extracted from macrophages infected
with HPRS-103 with a deletion of E (XSR) (7) or from uninfected
or REV-T-infected macrophages (Fig. 2 B). The fact that E (XSR)
miRNA was expressed in different cell types infected with a num-
ber of different ALV-J virus strains further confirmed that E (XSR)
miRNA is indeed a genuine miRNA encoded by ALV-J virus.
E (XSR) miRNA sequence is highly conserved. We next exam-
ined the evolutionary conservation of E (XSR) miRNA by aligning
all pre-miRNA sequences of NCBI-deposited ALV subgroup A,
subgroup J, and Rous sarcoma virus isolates with E element se-
quences along with the pre-miRNA sequence of E (XSR) miRNA
from HPRS-103 (see Fig. S1 in the supplemental material). Within
the 64 aligned pre-miRNA sequences of the E (XSR) element, the
miRNA strand (5= arm, miRNA-5p) was identical in 46 isolates,
with 16 isolates showing a single nucleotide change and the re-
maining 2 isolates showing 2-nucleotide differences. The seed re-
gion showed only a single nucleotide substitution among all the
sequences, suggesting evolutionary pressure on maintaining the
sequence of this region, potentially for modulating the expression
of its targets. The sequence of the passenger strand (3= arm,
miRNA-3p), on the other hand, showed more substitutions. The
loop region was highly conserved, and despite deletions or inser-
tions in this region, all of the pre-miRNA sequences were able to
form hairpin structures (data not shown). The fact that the
miRNA sequence is well conserved across all known ALV-J iso-
lates with an E (XSR) element suggests that this newly identified
ALV-J miRNA may have a conserved functional role.
E (XSR) miRNA is processed by the canonical miRNA bio-
genesis pathway. The vast majority of viral miRNAs are tran-
scribed by RNA polymerase II (Pol II) before being processed by
RNase III enzymes Drosha and Dicer. The exceptions are the Pol
III-derived tRNA-like precursor structures of mouse hepatitis vi-
rus 68 (MHV68) (32, 34) and the recently reported BLV miRNAs
(22, 23, 35). In the absence of detecting any sequence motifs of Pol
III promoter elements (22, 23) in the E (XSR) flanking sequence,
we hypothesized that this miRNA is Pol II derived. To test this, we
cloned the stem-loop structure sequence together with approxi-
mately 150 nucleotides of flanking sequence downstream of the
cytomegalovirus (CMV) promoter into pcDNA3 vector (Invitro-
gen). High-level expression of E (XSR) miRNA detected by
Northern blotting in transfected HEK293T cells suggested that the
E (XSR) miRNA is processed by the Pol II promoter (Fig. 3A). The
hypothesis of Pol II driving expression was further explored by
testing the blockage of miRNA production by treatment with
-amanitin, a selective inhibitor of Pol II (22, 32). We transfected
HEK293T cells with the plasmid expressing E (XSR) miRNA in
pcDNA3 or pGEM-T easy vector in the presence or absence of
-amanitin. As shown in Fig. 3A, -amanitin inhibits both pre-
miRNA and mature miRNA of the E (XSR) miRNA, thus support-
ing our initial Pol II prediction. A cellular miRNA miR-155 tran-
scribed under the control of the Pol II promoter pEF6-Bic and a
virus miRNA, MHV68-miR-M1-7-3p (kindly provided by C. Sul-
livan), transcribed under the control of a Pol III promoter were
used as controls. As expected, expression of both E (XSR) miRNA
and miR-155 was blocked by -amanitin treatment, whereas the
MHV68-miR-M1-7-3p miRNA was resistant (Fig. 3A). This fur-
ther confirms that the expression of E (XSR) miRNA is driven by
Pol II promoter but not Pol III promoter.
Drosha is a key enzyme in microRNA biogenesis, generating
the pre-miRNA by excising most pre-miRNA structures from Pol
II transcripts (36). To determine whether Drosha contributes to E
(XSR) miRNA processing, we used RNA interference (RNAi) to
knock down Drosha in HEK293T cells. Two Silencer Select vali-
dated siRNAs against human Drosha (Life Technologies) were
used for the knockdown of Drosha expression. We cotransfected
HEK293T cells with siRNA against Drosha and vectors expressing
either E (XSR) miRNA or control miRNA miR-155 (Fig. 3B).
Knockdown of Drosha by either siRNA resulted in a marked de-
FIG 2 E (XSR) miRNA is expressed in ALV-J-transformed cells. (A) Northern blot analysis of RNA from the blastoderm cell line AVO4-1B3, turkey macrophage
cell line IAH30, REV-T-transformed turkey spleen cell line AVOL-1T, and turkey spleen cells (TSCs) demonstrating the expression of mature and pre-miRNA
of E (XSR) miRNA. The cellular 5.8S RNA served as the loading control. (B) E (XSR) miRNA expression levels determined by qRT-PCR. Relative expression of
E (XSR) miRNA measured in RNA extracted from AVO4-1B3, IAH30, and chicken macrophages infected with either 966 (M966), HPRS-103
(MHPRS103), HPRS-103 with a deletion of the E element (MHPRS103-E), or REV-T (MRevT) as well as AVOL-1T cells and TSCs compared to
uninfected macrophage (M). Results represent the means of triplicate assays with error bars showing the standard error of the means.
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crease in the miR-155 expression which is known to be Drosha
dependent (Fig. 3B). Similar results were obtained with E (XSR)
miRNA expression following Drosha knockdown, suggesting that
E (XSR) miRNA expression is also Drosha dependent.
Dicer is the second RNA III enzyme in the miRNA biogenesis
pathway responsible for cleavage of pre-miRNA to generate ma-
ture miRNA. To confirm the contribution of Dicer to E (XSR)
miRNA expression, we cotransfected HEK293T cells with vali-
dated siRNA against Dicer (Life Technologies) and vectors ex-
pressing either E (XSR) miRNA or control miRNA miR-155 (Fig.
3C). As expected, knockdown of Dicer resulted in an increase of
the ratio of pre-miRNA to miRNA for both E (XSR) miRNA and
Dicer-dependent miR-155 (Fig. 3C). Thus, we conclude that E
(XSR) miRNA is processed by the canonical miRNA biogenesis
pathway.
E (XSR) miRNA is a biologically functional miRNA. To de-
termine whether the E (XSR) miRNA is biologically functional,
psiCHECK-2 luciferase-based reporter plasmids, bearing four
tandem repeats of artificial target sites of perfect complementarity
to the miRNA sequence inserted into the 3=UTR (Fig. 4B), either
were cotransfected into DF-1 cells along with the E (XSR) miRNA
expression plasmid or along with the E (XSR) miRNA mimics
(Qiagen) into either DF-1 cells and Vero cells using Lipofectamine
2000 (Invitrogen) or chicken embryo fibroblasts (CEF) using Li-
pofectamine (Invitrogen), or they were transfected into IAH30
using Nucleofactor Transfection Kit T (Lonza). The expression of
E (XSR) miRNA from transfected DF-1 and in IAH30 cells was
confirmed by quantitative TaqMan miRNA assay (Fig. 4A). As
shown in Fig. 4B, E (XSR) miRNA expressed from an expression
plasmid was able to inhibit luciferase reporter expression by 56%
in DF-1 cells relative to expression from a mutant reporter plas-
mid with four mutated nucleotides in the seed region. E (XSR)
miRNA mimics reduced the luciferase level by 68% in DF-1 cells,
88% in CEFs, and 98% in Vero cells, and the endogenous E (XSR)
miRNA in IAH30 cells could inhibit luciferase expression by 65%.
Thus, the reporter assay demonstrated that the miRNA is active
within the RNA-induced silencing complex (RISC) and that the E
(XSR) element is processed into functional mature miRNA in
DF-1 cells.
DISCUSSION
Of the 295 virus-encoded miRNAs deposited in the miRBase da-
tabase, the vast majority are encoded by DNA viruses. The small
size and lack of immunogenicity, combined with the ability for
specific repression of the expression of multiple target transcripts,
make the miRNAs ideal tools for the viruses to reshape gene ex-
pression in an infected cell to favor viral replication and patho-
genesis. Although there is a long way to go to gain significant
understanding of how these miRNAs function and of the portfolio
of their targets, it is clear that these small but effective regulators of
gene expression play a key role in virus biology.
Among all viruses, the members of the family Herpesviridae
account for the majority of the currently known virus-encoded
miRNAs (19, 37). In addition to the herpesviruses, a small number
of other nuclear DNA viruses, particularly polyomaviruses, have
also been shown to encode miRNAs or miRNA-like molecules
(38–45). Furthermore, no viral miRNAs have been identified us-
ing low- or high-throughput sequencing of RNA from cultured
cells infected with any of several different RNA viruses, including
hepatitis C virus (HCV), yellow fever virus (YFV), West Nile virus
(WNV), human papillomavirus (HPV), vesicular stomatitis vi-
rus (VSV), dengue virus, polio virus, human T-cell leukemia virus
type 1 (HTLV-1), and influenza A virus (21, 34, 46–48). Although
there have been several reports suggesting that HIV, an RNA virus
whose genome is reverse transcribed and incorporated into the
host DNA, may also encode miRNAs, these reports are controver-
sial (21, 34). Thus, a widely accepted example of any naturally
RNA virus-encoded miRNA was lacking until the recent report of
miRNAs encoded by bovine leukemia virus (BLV), a retrovirus
with an RNA genome (22, 23). The most compelling hypothesis
for the lack of miRNA sequences in the RNA virus genome is that
excision of an miRNA from an RNA virus would result in the
cleavage and ultimately the destruction of the viral genomic RNA,
which would likely inhibit virus replication. This hypothesis is
FIG 3 E (XSR) miRNA is processed by the canonical miRNA biogenesis pathway. (A) Northern blot analysis of E (XSR) miRNA expression plasmids
pcDNA3-XSR and pGEM-T-XSR, plasmid pEF6-Bic expressing Gallus gallus miR-155 (gga-miR-155), and MHV68-miR-M1-7 expression plasmid pIDTSmart-
Kan-MHV68-miR-M1-7 transfected into HEK293T cells with or without treatment of the Pol II inhibitor -amanitin. The cellular 5.8S RNA was used as a
loading control. (B) Northern blot analysis of E (XSR) miRNA and gga-miR-155 expression vectors transfected into HEK293T cells with or without siRNA
against human Drosha (D1 and D2). 5.8S RNA was used as a loading control. (C) Northern blot analysis of E (XSR) miRNA and gga-miR-155 expression vectors
transfected into HEK293T cells with or without siRNA against human Dicer. 5.8S RNA was used as a loading control.
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supported by the finding that BLV can overcome this obstacle by
encoding pre-miRNA structures that are only competent to be
processed into miRNAs when they are generated from sub-
genomic Pol III-derived transcripts (22, 23).
In spite of this theoretical barrier, here we provide evidence
that ALV-J uses Pol II for the production of high-level E (XSR)
miRNA. Subsequently, we have shown that the processing of the E
(XSR) miRNA is Drosha and Dicer dependent. Taken together,
this is the first example of an RNA virus that encodes an miRNA
using the canonical miRNA biogenesis pathway. This suggests that
the RNA viruses could utilize different strategies to express their
own miRNAs and that they could tolerate cis cleavage within the
genome during pre-miRNA processing. Indeed, retroviruses, a
flavivirus, and influenza virus can be engineered to express bio-
logically active miRNAs or miRNA-like molecules (49–51). The
evidence of BLV miRNAs transcribed by the Pol III promoter and
ALV E (XSR) miRNA transcribed by the Pol II promoter suggests
that future miRNA discovery efforts could be directed to other
retroviruses.
One of the conspicuous findings from the analysis of the
miRNA sequences of the IAH30 library was that E (XSR) miRNA
accounted for a quarter of the 1.469  106 sequences of the IAH30
miRNAome. An increased proportion of virus-encoded miRNAs
to host-encoded miRNAs is not uncommon in transformed cell
lines. For example, miRNAs encoded by Kaposi’s sarcoma-asso-
ciated herpesvirus and Epstein-Barr virus (EBV) accounted for
	40% of the entire miRNA pool identified from the BC-1 cell line
coinfected with these two viruses (52). The total proportion of
virus-encoded miRNAs of Marek’s disease virus type 1 (MDV-1)
and Marek’s disease virus type 2 (MDV-2) in an MSB-1 cell library
was 61% (53). The high-level expression of viral miRNAs has been
linked to their role in virus-induced oncogenesis since the cluster
1 miRNAs of MDV-1 and mdv1-mir-M4-5p, a member of cluster
1 miRNA and a functional ortholog of gga-mir-155 which are
highly expressed in the transformed cell lines and in tumors, have
been shown to play a key role in MDV-1-induced tumorigenesis
(54). A high level of expression of E (XSR) miRNA in the IAH30
cell line suggests that this miRNA has a major role in ALV-J patho-
genesis and neoplastic transformation. Although the E element
per se is not absolutely essential for tumor induction by this sub-
group of viruses, our previous work comparing the oncogenicity
of viruses derived from the parental HPRS-103 virus and from
HPRS-103 with a deletion of the E element in two genetically
distinct lines of birds showed that the E element does contribute to
oncogenicity in certain genetic lines of chicken (7). Future studies
comparing the genomes of these lines could provide insights into
the polymorphisms, including those in any potential E (XSR)
miRNA target sites that could account for such differential sus-
ceptibility phenotypes among these lines. The discoveries of the
virus-encoded miRNA targets would help us to get a clearer un-
derstanding of the role played by the viral miRNAs.
In summary, we demonstrated that an RNA virus expresses
abundant, evolutionarily conserved miRNA using the canonical
miRNA biogenesis pathway. The identification of this novel po-
tentially functional miRNA adds yet another regulatory mecha-
nism in the pathobiology of ALV and RSV.
ACKNOWLEDGMENT
This work was supported by the Biotechnology and Biological Sciences
Research Council, United Kingdom.
FIG 4 E (XSR) miRNA is a biologically functional miRNA. (A) E (XSR)
miRNA expression levels determined by qRT-PCR. Relative expression of E
(XSR) miRNA measured in RNA extracted from miRNA expression plasmid-
transfected DF-1 and IAH30 cells compared to untransfected DF-1 cells. Re-
sults represent the means of triplicate assays, with error bars showing the
standard errors of the means. (B) The top panel shows a sensor construct with
four tandem repeats of artificial target sites of perfect complementarity to the
miRNA sequence inserted into the 3= UTR at the end of the Renilla luciferase
gene in psiCHECK-2 vector (sensor) and a sensor mutant (sensor-mu) con-
struct with four mutated nucleotides in the seed region. The bottom panel
shows repression of luciferase by the sensor construct relative to the mutant
construct after cotransfection with an E (XSR) miRNA expression plasmid
into DF-1 cells (a) or cotransfection with E (XSR) miRNA mimics into DF-1,
CEF, and Vero cells (b) and transfection into IAH30 (c). The relative expres-
sion of Renilla luciferase (RL) was determined with the normalized levels of
firefly luciferase. For each sample, values from four replicates representative of
at least two independent experiments were used in the analysis. SV40, simian
virus 40.
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Arboviruses are transmitted to vertebrate hosts by biting arthropod vectors such as mosquitoes, ticks, and midges. These
viruses replicate in both arthropods and vertebrates and are thus exposed to different antiviral responses in these organ-
isms. RNA interference (RNAi) is a sequence-specific RNA degradation mechanism that has been shown to play a major
role in the antiviral response against arboviruses in mosquitoes. Culicoides midges are important vectors of arboviruses,
known to transmit pathogens of humans and livestock such as bluetongue virus (BTV) (Reoviridae), Oropouche virus
(Bunyaviridae), and likely the recently discovered Schmallenberg virus (Bunyaviridae). In this study, we investigated
whether Culicoides cells possess an antiviral RNAi response and whether this is effective against arboviruses, including
those with double-stranded RNA (dsRNA) genomes, such as BTV. Using reporter gene-based assays, we established the
presence of a functional RNAi response in Culicoides sonorensis-derived KC cells which is effective in inhibiting BTV in-
fection. Sequencing of small RNAs from KC and Aedes aegypti-derived Aag2 cells infected with BTV or the unrelated
Schmallenberg virus resulted in the production of virus-derived small interfering RNAs (viRNAs) of 21 nucleotides, simi-
lar to the viRNAs produced during arbovirus infections of mosquitoes. In addition, viRNA profiles strongly suggest that
the BTV dsRNA genome is accessible to a Dicer-type nuclease. Thus, we show for the first time that midge cells target arbo-
virus replication by mounting an antiviral RNAi response mainly resembling that of other insect vectors of arboviruses.
Biting arthropods such as mosquitoes, ticks, and midges cantransmit a variety of viruses (arboviruses) belonging to the
Flaviviridae, Bunyaviridae, Togaviridae, and Reoviridae families.
Arboviruses actively replicate in both their arthropod vector and
vertebrate host. At present, mosquito-borne viruses are probably
the best-studied arboviruses. Among these are viruses of particu-
lar relevance to public health, including members of the Flaviviri-
dae family, such as dengue virus (DENV), West Nile virus (WNV),
and Japanese encephalitis virus (JEV), or alphaviruses of the Toga-
viridae family, such as chikungunya virus (CHIKV) (1).
Midge-borne viruses also impact on public health. Oropouche
virus (OROV) infection can result in Oropouche fever, one of the
most important arboviral diseases in America (mainly in the Am-
azon region, Panama, and Caribbean) (2, 3). Culicoides are biting
haematophagous midges belonging to the family Ceratopogoni-
dae. Importantly, 96% of the 1,400 identified species attack
mammals, including humans. Culicoides are well-known vectors
of protozoans, filarial worms, and viruses (3), and more than 50
viruses belonging to the Bunyaviridae, Reoviridae, and Rhabdo-
viridae families have been isolated from different Culicoides spe-
cies. While some of these may be accidental infections, around
45% of isolated viruses are specific to Culicoides species, including
those known to cause infections of livestock all over the world,
such as African horse sickness virus (AHSV), bluetongue virus
(BTV) (Reoviridae) (3), and the recently discovered Schmallen-
berg virus (SBV) (Bunyaviridae) (4).
As arboviruses require vectors for successful transmission be-
tween vertebrate hosts, there is evolutionary pressure on keeping
the right balance between virus replication and vector survival.
Recent research on mosquito-arbovirus interactions indicates
that innate immune responses such as RNA interference (RNAi)
are key factors in restricting arbovirus replication (5–12), as de-
tailed in recent reviews (13, 14). Similar research on midge-trans-
mitted arboviruses has not been carried out despite the fact that
important arboviruses are transmitted by these vectors.
RNAi has been shown to be an important and possibly the
major antiviral response in mosquitoes (13, 14). RNAi consists
of different pathways that perform sequence-specific targeting
of RNA. However, the exogenous small interfering RNA
(siRNA) pathway is of particular interest given its antiviral
function, as demonstrated in different organisms, including
drosophila and mosquitoes (13–15). The mosquito exogenous
RNAi pathway is induced by virus-derived long double-
stranded RNA (dsRNA) either derived from replication inter-
mediates or secondary structures that are targeted by the RNase
III enzyme Dicer-2 (Dcr-2) and cut into virus-derived small
interfering RNAs (viRNAs) of mainly 21 nucleotides (nt) in
length, as is assumed through comparisons to Drosophila mela-
nogaster (5, 7, 11, 12, 16–20). These viRNAs are taken up by the
RNA-induced silencing complex (RISC), harboring an argo-
naute protein (Ago-2) as the catalytic compound. viRNAs are
then unwound, and one strand is kept in the RISC to be used as
a guide to find complementary viral RNA sequences. After base
pairing, the catalytic domain of Ago-2 cleaves the target (viral)
RNA, at least in the drosophila model, which silences viral
infections (13, 14, 21–23). The exogenous siRNA pathway can
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also be artificially induced by the addition/transfection of long
dsRNA or siRNA molecules, resulting in sequence-specific si-
lencing. Key proteins of the RNA silencing pathways, such as
Dcr-2 and Ago-2, have been shown to be conserved in drosoph-
ila and mosquitoes, and the effector mechanisms are likely to
be similar. Other Dicer and Ago proteins are involved in a
variety of small RNA silencing pathways, such as the mi-
croRNA pathway (13, 14, 23). A number of RNAi-competent
mosquito cell lines, such as Aag2 (derived from Aedes aegypti)
and U4.4 (derived from Aedes albopictus), as well as Dcr-2-
deficient cell lines (C6/36 and C7-10, both derived from Aedes
albopictus), have proven to be highly useful in studying mos-
quito RNAi responses (6, 10–12, 19, 24, 25). However, nothing
is known about the presence and function of RNAi pathways,
specifically the antiviral exogenous siRNA pathway, in midges
and their derived cell lines.
BTV is one of the best-studied midge-borne viruses. It has
been shown to replicate both in its arthropod vector and mam-
malian host (26, 27). BTV infection leads to persistent infec-
tion in infected adult Culicoides or midge-derived cell culture
(28–30). This is in contrast to infected mammalian cells, which
show strong cytopathic effects (30). Given the absence of stud-
ies on Culicoides RNAi pathways and antiviral mechanisms,
nothing is known about the interactions of BTV with vector
immune responses. Many Culicoides species have been identi-
fied as BTV vectors around the world, including Culicoides
imicola in Africa (31) and Southern Europe (32), Culicoides
obsoletus and Culicoides pulicaris in Central and Northern
Europe (33, 34), and Culicoides variipennis and Culicoides so-
norensis in America (35, 36). The BTV genome consists of 10
segments of dsRNA molecules (each comprising a coding and
noncoding strand) that are packaged within a nonenveloped
triple-layered icosahedral protein capsid (37–39) and direct
the expression of 7 structural proteins (VP1 to VP7) and 4
distinct nonstructural proteins (NS1, NS2, NS3/NS3a, and
NS4) (39–41). In contrast to the single-stranded RNA arbovi-
ruses with positive-sense (alphaviruses, flaviviruses) or nega-
tive-sense (bunyaviruses) RNA genomes that have been stud-
ied in mosquitoes or mosquito cell culture systems, the dsRNA
nature of the BTV genome adds a layer of complexity for the
antiviral RNAi response in insects. During the reovirus repli-
cation cycle, second-strand RNA synthesis is believed to occur
only after assembly and consequently within the newly formed
viral particles. As such, viral dsRNA is not necessarily accessible
to the RNAi machinery. In addition to BTV, we are also inves-
tigating the RNAi response against SBV, an unrelated negative-
strand RNA arbovirus. SBV is a recently emerged virus that
affects ruminants causing mild disease (reduced milk produc-
tion, pyrexia, and diarrhea) in adults and congenital malfor-
mations in stillborns or newborns (42, 43). SBV belongs to the
genus Orthobunyavirus within the Bunyaviridae family and
possesses a three-segmented negative-sense RNA genome. The
large (L) segment encodes the RNA-dependent-RNA polymer-
ase L, the medium (M) segment encodes a polyprotein that is
cleaved into two glycoproteins (Gn and Gc) and a nonstruc-
tural protein (NSm), while the small (S) segment encodes the
nucleoprotein (N) and a second nonstructural protein (NSs).
SBV is believed to be transmitted by Culicoides species to sus-
ceptible mammalian hosts (4). Again, little is known about
control of bunyavirus replication by RNAi responses of arthro-
pod vectors. Recently, LaCrosse virus (LACV)-infected dro-
sophila cells were shown to produce virus-specific 21-nt
viRNAs mapping to all three viral segments, similar to what has
been observed for other (mainly positive-strand RNA) arbovi-
ruses (6). In addition, LACV-infected Aedes albopictus C6/36
cells, known to be deficient in Dcr-2 activity, were shown to
produce virus-specific small RNAs of different sizes (6, 44).
In this study, (i) we investigated the presence of a functional
exogenous siRNA pathway in the C. sonorensis-derived KC cell
line and (ii) we assessed whether this antiviral response targets
midge-borne arboviruses with either dsRNA (BTV) or negative-
strand RNA (SBV) genomes. We identified an exogenous siRNA
pathway in KC cells that could be induced by dsRNA or viral
infection and is effective against two arboviruses with highly dif-
ferent genome structures. A comparative analysis with BTV- or
SBV-infected Aedes aegypti Aag2 cells suggests that the midge an-
tiviral RNAi response against these viruses resembles mainly that
of mosquitoes and points to conservation of key elements control-
ling arbovirus replication by RNAi in insect vectors.
MATERIALS AND METHODS
Cells. BSR cells, a clone of BHK-21 (kindly provided by Karl K. Conzel-
mann), were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 5% fetal bovine serum (FBS). BHK-21 cells were
grown in Glasgow minimal essential medium (GMEM) supplemented
with 10% newborn calf serum and 10% tryptose phosphate broth. CPT-
Tert cells (45), immortalized sheep choroid plexus cells (kindly provided
by D. Griffiths), were grown in Iscove’s modified Dulbecco’s medium
(IMDM) supplemented with 10% FBS. Mammalian cell lines were cul-
tured at 37°C in a 5% CO2 humidified atmosphere. KC cells, obtained
from C. sonorensis larvae, were grown in Schneider’s insect medium sup-
plemented with 10% FBS (46), Aedes aegypti-derived Aag2 mosquito cells
were grown in L-15 medium supplemented with 10% FBS and 10% tryp-
tose phosphate broth. Insect cells were maintained at 28°C.
Viruses and plasmids. BTV-1 was rescued by reverse genetics as pre-
viously described (41) and derived from the reference strain of BTV-1
originally isolated at the ARC-Onderstepoort Veterinary Institute. Virus
stocks were prepared by infecting BSR cells at a low multiplicity of infec-
tion (MOI; 0.001) and harvesting the supernatant at 72 h postinfection.
The virus suspension was centrifuged at 500  g for 5 min. SBV (kindly
provided by M. Beer) was initially isolated from blood of an infected cow
and passaged once in KC cells and 6 times in BHK-21 cells. The virus was
plaque purified, and stocks were produced in BHK-21 cells by infecting
cells at a low MOI (0.01) and harvesting the supernatant at 120 h postin-
fection, followed by 20 min of centrifugation at 3,500 rpm. Virus titers of
SBV and BTV-1 were established by standard plaque assays using CPT-
Tert cells (47).
Expression vectors for invertebrate cells, pIZ-Fluc and pAcIE1-Rluc,
expressing firefly (FFluc) and Renilla (RLuc) luciferases, respectively, have
been previously described (48), and the fluorescein-labeled plasmid DNA
was commercially obtained (Mirus).
Luciferase assays. Luciferase activities were determined using a dual-
luciferase assay kit (Promega) on a GloMax-Multi microplate multi-
mode reader following cell lysis in passive lysis buffer.
dsRNA production. dsRNA for the RNA silencing experiments was
produced with the RNAi Megascript kit using gel-purified PCR products
of a specific sequence (Table 1) flanked by T7 promoter sequences. Fluo-
rescein-labeled dsRNA was produced by T7 RNA polymerase transcrip-
tion (Invitrogen) on an enhanced green fluorescent protein (eGFP)-de-
rived PCR product (using pC1-eGFP from Clontech as the template) with
the fluorescein-labeled rNTP mix (Roche) by following the manufactur-
er’s protocol. The DNA template and single-stranded RNA were removed
by DNase1 and RNase A treatment (Ambion). dsRNA was then ethanol
precipitated, dried, and resuspended in water.
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Transfection and infection. In order to determine the transfection
efficiency, 5  105 C. sonorensis-derived KC cells were seeded per well in
24-well plates with a glass bottom prior to transfection. DNA or dsRNA
was incubated in the presence of a variety of transfection reagents (Fu-
gene, Genejammer, and Lipofectamine 2000) and added to cells according
to the manufacturer’s protocol. In the case of Fugene and Genjammer, a
ratio of 1 to 3 (micrograms of nucleic acid to transfection reagent) was
used. At 24 h posttransfection, fluorescence in cells was analyzed using a
Zeiss laser scanning microscopy (LSM) Meta microscope.
For reporter RNAi assays, 5  104 KC cells were seeded per well in
96-well plates and transfected with 250 ng pIZ-Fluc and 50 ng pAcIE1-
Rluc using Fugene. Different concentrations of dsRNA, control (eGFP-
specific) or targeting FFluc, were either cotransfected (5 ng, 1 ng, or 0.5
ng) in 50 l of Schneider’s medium, followed by the addition of 50 l
Schneider’s medium with 30% fetal calf serum (FCS) at 2 h posttransfec-
tion, or added (300 ng or 100 ng) to cells in 100 l Schneider’s medium
with 15% FCS at 24 h posttransfection. Luciferase activity was determined
at 48 h posttransfection.
Assays to test dsRNA-induced antiviral activity were performed by
seeding 1  106 KC cells per well in 24-well plates with glass bottoms.
After 24 h, either 100 ng dsRNA, control (eGFP-specific) or specific for
BTV NS1, was transfected using Lipofectamine 2000 or 500 ng dsRNA was
added to the medium in the absence of a transfection reagent. KC cells
were infected at an MOI of 0.2 with BTV-1 24 h posttransfection. At 2 h
postinfection, the inocula were removed and cells were washed once with
PBS. Supernatant was collected from cultured cells 24 h postinfection and
centrifuged at 500  g for 5 min. Viral titers were subsequently deter-
mined by endpoint dilution analysis on BSR cells and expressed as log10
50% tissue culture infective doses (TCID50)/ml, calculated using the
method of Reed and Muench (49). Cells were then fixed in 5% formalde-
hyde for 30 min at 24 h or 48 h postinfection (as indicated) and subse-
quently used for immunofluorescence assays or lysed for Western blot
analysis.
In vitro growth kinetics of SBV. The in vitro growth kinetics of SBV
were determined in KC and Aag2 cells following infection with an MOI of
10 for 1 h. Samples were collected at 0, 8, 24, and 48 h postinfection, and
virus titer was determined by plaque assays in CPT-Tert cells. Each exper-
iment was performed in triplicate and repeated twice.
Western blotting. Protein expression in BTV-1-infected KC cells was
assessed by SDS-PAGE and Western blotting using polyclonal rabbit an-
tiserum raised against NS1 (41) and a rabbit polyclonal anti-actin anti-
body as the control (Sigma; A5060).
Detection of proteins by immunofluorescence. Formaldehyde-fixed
cells were permeabilized by incubation in 0.3% Triton-PBS for 30 min,
followed by washing with PBS, a further incubation in 0.1% SDS-PBS for
10 min, and incubation in PBS. Cells were preincubated in CAS-Block for
1 h at room temperature, followed by an incubation with CAS-Block-
diluted polyclonal rabbit antiserum raised against BTV-1 NS1 (1:2,000)
(41) or SBV N (50) (1:500) for 90 min at 37°C. Cells were then washed
three times for 5 min with PBS. Following this, an anti-rabbit antibody
conjugated with Alexa 488 diluted in CAS-Block (1:3,000) was added and
incubated for 1 h at 37°C. Following a further washing step with PBS, cells
were dried and covered with 4=,6-diamidino-2-phenylindole (DAPI) con-
taining mounting medium (Vectashield; hard set), and fluorescence was
detected using a Zeiss LSM meta microscope.
Small RNA isolation and deep sequencing analysis. Sequencing of
small RNAs was performed by using the Illumina Solexa platform; KC
(8  106/well) and Aag2 (2.6  106/well) cells in 6-well plates were in-
fected by BTV-1 at an MOI of 0.2 or SBV at an MOI of 10. At 24 h
postinfection (KC cells) or 48 h postinfection (Aag2 cells), total RNA was
isolated using 1 ml TRIzol (Invitrogen) per well. Glycogen was added
prior to isopropanol addition to enhance recovery of small RNA from
samples. Total RNA was then loaded on a 15% denaturing urea acryl-
amide gel, and RNA molecules of 18 to 30 nt in size were purified from the
gel, linked to adapters, reverse transcribed, and sequenced by ARK-
Genomics (The Roslin Institute, University of Edinburgh) on the Illu-
mina Solexa platform (HiSeq 2000). Illumina adapters and sequencing
primers were removed using cutadapt (51), and the trimmed sequences
were aligned to the reference genome using Novoalign. Graphs and re-
ports were produced in R (52) using the viRome package (http://www.ark
-genomics.org/services-bioinformatics/virome). The complement-dis-
tance plots were calculated as follows: the distance between the 5= end of
reads of 24 to 30 bp that map on complementary strands was counted, and
the sum of counts was plotted against the distance. For the sequence logos,
counts of each base at each position were used to create a position-weight
matrix, and the subsequent sequence logo was plotted using the seqLogo
(53) package from Bioconductor (54). Small RNAs were mapped to SBV
(GenBank accession numbers JX853179 to JX853181) or BTV-1 (Gen-
Bank accession numbers JX680457 to JX680466).
Nucleotide sequence accession number. Small RNA sequences (of
data shown and repeats) were submitted to the European Nucleotide
Archive (accession number ERP001936).
RESULTS
An active RNAi pathway is present in the KC midge cell line. An
RNAi response can be induced in arthropod cells by sequence-
specific dsRNA either by transfection, or in case of drosophila
cells, by addition to the cell culture medium (55). We designed a
luciferase-based reporter assay in order to investigate if C. sono-
rensis-derived KC cells can induce a dsRNA-mediated RNAi re-
sponse. As little is known about the efficiency and/or toxicity of
transfection reagents in KC cells, a pilot experiment was carried
out with either fluorescently labeled dsRNA molecules or plasmid
DNA and by using different transfection reagents. At 24 h post-
seeding, KC cells were incubated with fluorescein-labeled dsRNA
or fluorescein-labeled plasmid DNA in the absence or presence of
different transfection reagents (Fugene HD, GeneJammer, or
Lipofectamine 2000) by following the manufacturer’s protocol. At
24 h postincubation, we estimated the number of transfected cells
(green cells) by fluorescence microscopy, with at least 400 cells
counted for each condition (data not shown). No obvious toxicity
was detected 24 h posttransfection (data not shown). Use of Fu-
gene and GeneJammer resulted in similar numbers of transfected
cells (between 14% and 23%). Lipofectamine 2000-mediated
transfection resulted in the highest number of transfected cells for
dsRNA (approximately 40%), similarly to what we obtained in
cells incubated with dsRNA in the absence of transfection reagent
(32.5%). In contrast, transfection of KC cells using Lipofectamine
2000 gave 5% of transfected cells after plasmid DNA transfec-
tion, compared to 27% in GeneJammer and 11% in Fugene. No
TABLE 1 List of primer sequences used
Gene Upstream/downstream primer sequence (5=¡3=)a
BTV-1 NS1 GTA ATA CGA CTC ACT ATA GGG TCGGTGGG
AATGGCTTAT
GTA ATA CGA CTC ACT ATA GGG CTTTTCTG
CATAGCATAGGGTG
eGFP, 400 nt GTA ATA CGA CTC ACT ATA GGG GGCGTGC
AGTGCTTCAGCCGC/
GTA ATA CGA CTC ACT ATA GGG GTG
GTTGTCGGGCAGCAGCAC
Firefly luciferase GTA ATA CGA CTC ACT ATA GGG ATGGAAGC
AGCCAAAAAC
GTA ATA CGA CTC ACT ATA GGG TTACACG
GCGATCTTTCC
a The T7 promoter region is indicated in italics.
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green fluorescing cells were observed if plasmid DNA was added
to cells in the absence of a transfection reagent.
Next, we determined the ability of dsRNA, either added to the
medium or transfected with GeneJammer, to silence a firefly lu-
ciferase (FFluc) reporter gene. Cells were cotransfected with plas-
mids expressing FFluc as well as Renilla luciferase (RLuc) as an
internal control expressed from baculovirus promoters (OpIE2
for FFluc in pIZ-Fluc and AcIE1 for RLuc in pAcIE1-Rluc). At 24 h
postseeding, we induced an RNAi response by transfection (Fig.
1A) or addition (Fig. 1B) of different concentrations of either
eGFP-specific control dsRNA (ds-control) or dsRNA targeting
FFluc. We assessed luciferase activities 24 h after the addition of
dsRNA. A concentration-dependent reduction of luciferase activ-
ity was found for cells treated with FFluc-specific dsRNA, regard-
less of whether dsRNA was transfected (Fig. 1A) or added to the
cell culture medium (Fig. 1B). These results show that KC cells are
able to induce a sequence-specific, dsRNA-dependent RNA si-
lencing response. In addition, our data show that, similarly to
what has been reported for Schneider-2 (S2) drosophila cells (56,
57), KC cells are able to take up dsRNA from culture medium.
The dsRNA-inducible RNAi response in midge cells displays
antiviral activity. We next investigated the ability of this pathway
to inhibit virus replication. As BTV is known to be transmitted to
susceptible mammals via Culicoides species (27), we used this vi-
rus to investigate the dsRNA-induced antiviral RNAi response in
KC cells. We first transfected the KC cells with dsRNA targeting
BTV-1 NS1 or eGFP-specific control dsRNA. After 24 h, we in-
fected the cells with BTV-1 at a multiplicity of infection (MOI) of
0.2. The success of silencing was assessed at 24 h postinfection by
immunofluorescence (Fig. 2A) and Western blot detection (Fig. 2C)
using an NS1-specific antibody. A reduction in NS1-positive cells
was detected when dsRNA targeting NS1 was transfected and com-
pared to control dsRNA. Approximately 35% of control dsRNA-
transfected cells expressed BTV-1 NS1 as assessed by fluorescence
microscopy, in contrast to 15% when dsRNA targeting NS1 was
transfected (Fig. 2B). We confirmed these results by Western blot-
ting, where levels of NS1 expression were greatly reduced in cells
transfected with virus-specific dsRNA (Fig. 2C). BTV NS1 has
been shown to be important for viral replication (58, 59), and
consequently knockdown of NS1 expression will have a negative
effect on virus production. We therefore measured BTV infectious
viral particles released in the supernatant of KC cells incubated
with dsRNA (targeting BTV-1 NS1 or control) at 24 h postinfec-
tion. As expected, a significant decrease in BTV-1 production was
detected in cells incubated with dsRNA targeting NS1 compared
to that of control infections (Fig. 2D). Similar results were ob-
tained when we added (rather than transfected) dsRNA to the
culture medium (data not shown), suggesting a capability for an-
tivirally active dsRNA uptake similar to that observed for Dro-
sophila cell lines (56, 57).
Culicoides cells can mount an RNAi response against the
dsRNA bluetongue virus. Having shown that RNAi can be in-
duced in KC cells following dsRNA transfection, we investigated
whether such a response could be induced following viral in-
fection. Induction of an antiviral RNAi response is character-
ized by the production of small RNA molecules that map to the
viral genome and/or antigenome (5, 6, 11, 12, 19, 20, 60). We
isolated total RNA from KC cells 24 h postinfection with
BTV-1, and we then sequenced small RNAs below 40 nt by
Illumina Solexa sequencing and determined the sequences, fre-
quencies, and BTV genome location. For most BTV-1 seg-
ments, the viRNA molecules produced in infected KC cells
were predominantly 21 nt in length and mapped to both the
coding and noncoding strand with similar frequencies (Fig. 3
FIG 1 KC cells have a functional dsRNA-inducible RNAi pathway. KC cells
were cotransfected with plasmids pAcIE1-Rluc and pIZ-Fluc. Following trans-
fection, different concentrations of either eGFP-specific (ds-control) or FFluc-
specific (dsFFLuc) dsRNA were either transfected (A) or added to the culture
media 24 h posttransfection of plasmids (B). The relative luciferase expression
(FFluc/RLuc) was determined at 48 h posttransfection (hpt). The mean with
standard error is shown for two independent experiments performed in trip-
licate. *, P  0.05, t test.
FIG 2 BTV-1 can be targeted by dsRNA in KC cells. (A) KC cells were trans-
fected with either eGFP-specific control dsRNA or dsRNA targeting BTV NS1
(dsNS1), followed by BTV-1 infection at 24 h posttransfection. Twenty-four
hours postinfection (hpi), cells were fixed and BTV-infected cells were visual-
ized using a BTV NS1-specific primary antibody and an anti-rabbit secondary
antibody conjugated to Alexa 488 (green signal). Cell nuclei were stained with
DAPI. (B) Quantification of fluorescent cells. Infected and noninfected cells
were counted, and the respective percentages from three independent experi-
ments for each treatment were determined. (C) BTV-1 NS1 expression was
determined by Western blot analysis in lysates of dsRNA-transfected and BTV-
1-infected KC cells at 24 h postinfection using a BTV NS1-specific primary
antibody. Western blot detection of actin was used as a loading control. (D)
BTV-1 titers in cell culture supernatant, determined 24 h postinfection. Means
from three independent experiments are shown; error bars represent standard
errors. *, P  0.05, t test.
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and 4). The 21-nt viRNAs were distributed along the coding
and noncoding genome strand with variable frequency and a
hot (high viRNA reads) and cold (low or no viRNA reads) spot
distribution, similar to what has been described for mosquito-
borne arboviruses (5, 6, 11, 12, 19, 20, 60). The frequency of the
viRNAs was segment dependent. In addition to 21-nt viRNAs,
other classes of small RNAs between 26 to 31 nt in length with
a bias for the BTV-1 coding strand were also identified. The
frequency of these longer RNAs differed per segment from few
(segment 1) to the majority of virus-specific small RNAs (seg-
ment 9) (Fig. 3 and 4). To determine if these results were spe-
cifically induced by BTV, we investigated the produced small
RNAs against BTV-1 in the nonvector cell line Aag2 (derived
from Aedes aegypti). We established by fluorescence micros-
copy that BTV-1 was able to infect Aag2 cells at levels compa-
rable to KC cells (Fig. 5). RNA was isolated 48 h postinfection,
and small RNAs were sequenced on the Illumina sequencing
platform as described before. The viRNA production pattern,
FIG 3 BTV-1 is targeted by the RNAi response in KC cells. Size distribution of small RNA molecules mapping to each segment (1 to 10) of BTV-1 in KC cells at
24 h postinfection. The y axis indicates the frequency of small RNAs; the x axis indicates the length in nucleotides. Dark grey indicates small RNAs mapping to
the coding strand, and light grey indicates small RNAs mapping to the noncoding strand.
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including the larger class of virus-specific small RNAs, was
largely conserved in Aag2 cells infected with BTV-1 (Fig. 6 and
7). Importantly, pattern, location, and frequencies of viRNA
production were conserved mainly between independent ex-
periments (data not shown). Together, these data show that the
antiviral RNAi responses following infection by BTV of C. so-
norensis-derived KC cells and Aedes aegypti-derived Aag2 cells
are broadly comparable and are predominantly characterized
by the production of 21-nt viRNAs for most of the segments.
Culicoides cells can mount an RNAi response against the
negative-strand RNA Schmallenberg virus. SBV is a recently
emerged pathogen belonging to the Orthobunyavirus genus of the
Bunyaviridae family and is thought to be most probably midge-
borne (4). We infected KC cells with SBV, and RNA was isolated
24 h postinfection to determine if a similar production pattern of
viRNA production is observed in KC cells infected with an arbo-
virus belonging to a different virus family from the Reoviridae.
Infection experiments indicated that SBV infects and replicates
FIG 4 Distribution of 21-nt viRNAs of BTV-1 in KC cells. Frequency distribution of 21-nt viRNAs to each segment (1 to 10) of BTV-1. The y axis shows the
frequency of the 21-nt viRNAs mapping to the corresponding nucleotide position on the x axis. Positive numbers and peaks represent the frequency of viRNAs
mapping to the coding strand (in 5=¡3= orientation). Negative numbers and peaks represent those viRNAs mapping to the noncoding strand (in 3=¡5=
orientation).
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with low frequency in KC cells even after high multiplicity of in-
fection (Fig. 8 A and B). Similar experiments performed on Aag2
cells showed enhanced infection and replication of SBV (Fig. 8A
and B). Therefore, SBV-infected Aag2 cells were used in order to
investigate if the results obtained for BTV-1-infected KC and Aag2
cells could be broadened to another arbovirus. Sequences, fre-
quencies, and SBV genome locations of small RNAs below 40 nt
were determined as described above. As shown in Fig. 8C, 21-nt
viRNAs are the predominant species of viRNA in KC cells and for
most of the segments in Aag2 cells. Again, a distribution along the
L, M, or S genome and antigenome with hot and cold spots was
observed (Fig. 9A). In both KC and Aag2 cells, most viRNA reads
are generated by the S segment, followed by the M and L segments
(Fig. 8C). In addition to 21-nt viRNAs, small RNAs in the size
range of 24 to 30 nt with a bias for the positive antigenome strand
were detected in Aag2-infected cells and matched with all three
viral segments, although at different frequencies. In the case of the
S segment, these larger small RNAs represented the majority of
small RNAs (Fig. 8C). As described above, similar class sizes of
small RNAs were also detected in BTV-1-infected KC and Aag2
cells. This size range of small RNAs normally represents the group
of PIWI-interacting RNA (piRNA) molecules, known to be im-
portant in suppressing transposons in germ line cells in various
organisms, including drosophila, zebrafish, and mice (61–65).
Primary piRNAs are normally antisense to the genomic regions
(mostly transposons) and target transposon-derived single-
stranded sense RNA. Upon cleavage, secondary piRNAs are pro-
duced that are mostly sense and used to find complementary an-
tisense RNA, resulting again in primary-type piRNAs. Recently,
virus-specific piRNA-like molecules have been reported for sev-
eral arboviruses, including CHIKV, Sindbis virus (SINV), and
LACV in aedine mosquitoes or their derived cell lines (6, 18, 19,
44). Due to the so-called “ping-pong” mechanism of piRNA pro-
duction, piRNAs have specific features. The primary piRNAs are
in antisense orientation and have a bias for uridine at position 1.
In contrast, secondary piRNAs are in the sense orientation and
have an adenine at position 10. In addition, complementary
piRNAs and viral piRNA-like molecules of LACV and SINV are
often separated at the 5= end by 10 nucleotides (44, 66). Most of
the SBV-specific small RNAs of 24 to 30 nt produced in Aag2 cells
have piRNA-specific features (sense [antigenome] with A10 and
antisense [genome] with U1 [Fig. 10A] and separation of comple-
mentary RNAs at the 5= end by 10 nucleotides [Fig. 10B]), in
particular those produced from the M and S segments. They are
distributed along the segments and do not map to a specific region
of the segments (Fig. 9B). In contrast, the BTV-1-specific 24- to
31-nt small RNAs produced in KC and Aag2 cells do not show any
specific sequence logo (data not shown). Pattern, location, and
frequencies of viRNA production were conserved mainly between
independent repetitions (data not shown).
Taken together, our data show that midge-derived KC cells
mount an antiviral RNAi response following infection with arbo-
viruses with different genome structures. Regardless of the virus
infecting these cells, viRNAs of 21 nt in length were found to be the
dominant class of virus-specific small RNA. Thus, the Culicoides
antiviral RNAi response resembles mainly similar pathways found
in mosquitoes. Larger small RNAs with features of piRNA-like
molecules were found for SBV-infected Aag2 cells but not KC
cells. Although similar RNA molecules were detected in BTV-in-
fected KC and Aag2 cells, these RNAs do not possess piRNA-
specific features.
DISCUSSION
RNAi (and in particular the exogenous RNAi pathway) has been
shown to be a major antiviral response against arboviruses in mos-
quitoes and an important process regulating this virus/host inter-
action (13, 14). Culicoides midges are one of the major inverte-
brate vectors of several arboviruses of humans and livestock. In
this study, we have shown that C. sonorensis-derived KC cells
mount an antiviral RNAi response.
Drosophila cells have been reported to take up dsRNA from
culture medium, a phenomenon not observed for any of the mos-
quito-derived cell lines (56, 57). Interestingly, we show that also
KC cells are able to take up dsRNA molecules directly from the
culture medium, although the precise pathway for dsRNA uptake
is not known. Several genes have been linked with the dsRNA
uptake in D. melanogaster, suggesting receptor-based endocytosis
(56, 57, 67). Due to the lack of genomic information on Culicoides,
it is currently difficult to draw any comparisons.
dsRNA and siRNA molecules have been used to target and
silence a variety of viruses in numerous organisms. Even mamma-
lian cells, believed to not naturally mount a siRNA-based antiviral
RNAi response upon viral infection, can induce an siRNA-based
antiviral RNA silencing response after transfection of siRNA mol-
ecules (68). Therefore, successful inhibition of virus production
following transfection of dsRNA targeting viral sequences cannot
be used solely as an indication that such an antiviral RNA silencing
response occurs during natural infection. A key feature of antiviral
RNAi in mosquitoes (as in other insects) is the production of
21-nt viRNA molecules (13, 14). Deep sequencing of KC cells
infected with two different midge-borne arboviruses (BTV and
SBV) shows that the majority of viRNAs for most BTV genomic
segments (8 out of 10) and all SBV segments are 21 nt in length.
viRNAs in mosquito cells (and other insects) are produced by
Dcr-2 cleavage of dsRNA molecules that could derive either from
replicative intermediates or secondary structures within the viral
transcripts (14) but also the viral genome itself in case of dsRNA
viruses such as BTV. From the available viRNA profiles, replica-
tion intermediates are generally the favored Dcr-2 substrate can-
didates. This is supported by the scattering of viRNAs across the
whole genome/antigenome, the presence of hot and cold spots of
viRNA production (5, 6, 11, 12, 19, 20, 69), and no real preference
of a longer stretch of only the genome or antigenome as the pro-
ducer of 21-nt RNAs, which would be expected if secondary RNA
structures are the favored Dcr-2 substrate. Recently, it has been
FIG 5 BTV-1 infects nonvector mosquito Aag2 cells. BTV-infected KC and
Aag2 cells were fixed at 48 h postinfection, and expression of NS1 protein was
monitored by immunofluorescence (bright signal). Cell nuclei were stained
with DAPI.
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shown that certain RNAs can be over- or underrepresented in
small RNA libraries, due to low sequencing depth and cloning bias
(70, 71). Some of the observed hot and cold spots could be the
result of such a cloning bias; however, the presence of small RNAs
mapping to the noncoding strand of BTV with a similar frequency
as to the coding strand strongly supports the dsRNA genome as
the RNAi inducer molecule. Before this study, it was not immedi-
ately apparent whether an RNAi response of 21-nt viRNAs would
be induced following infection by viruses with a dsRNA genome
like the orbivirus BTV and if the inducer molecules would be the
dsRNA genome or secondary structures in the viral transcripts.
Considering that synthesis of the negative-sense RNA during the
viral replication cycle is believed to occur only within the newly
assembled viral particles, the secondary structures of the viral
transcripts would be the favored RNAi inducer molecule; this
strategy helps dsRNA viruses also to shield them from host pro-
FIG 6 BTV-1 infection is targeted by the RNAi response in Aag2 cells. Size distribution of small RNA molecules mapping to each segment (1 to 10) of BTV-1 in
Aag2 cells at 48 h postinfection. The y axis indicates the frequency of small RNAs; the x axis indicates the length in nucleotides. Dark grey indicates small RNAs
mapping to the coding strand, and light grey indicates small RNAs mapping to the noncoding strand.
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teins such as RNA sensors that activate the antiviral interferon
pathway in mammals (72–76). Thus, viRNAs of dsRNA viruses
could have been solely derived from the secondary structures of
the coding RNA strand (which functions as mRNA), or these vi-
ruses could escape antiviral RNAi altogether (72, 75, 76). The
features of BTV viRNAs detected in our study (scattering across
the whole genome in sense and antisense patterns) indicate that at
least a small amount of dsRNA viral genome is accessible to the
RNAi machinery and probably not protected by the double-lay-
ered viral membrane particles, as recently shown for the induction
of interferon (IFN) in mammalian cells by BTV dsRNA (77).
These results are in line with the detection of viRNAs derived from
dsRNA viruses (the birnavirus drosophila X virus [DXV] as well as
drosophila totivirus) (78) during persistent infection in a dro-
sophila cell line and the increase in susceptibility for DXV in
RNAi-deficient drosophila (79). The resulting viRNAs are ex-
pected to be able to target the BTV transcripts present in the cy-
toplasm, resulting in less viral protein production and subse-
FIG 7 Distribution of 21-nt viRNAs of BTV-1 in Aag2 cells. Frequency distribution of 21-nt viRNAs in infected Aag2 cells to each segment (1 to 10) of BTV-1.
The y axis shows the frequency of the 21-nt viRNAs mapping to the corresponding nucleotide position on the x axis. Positive numbers and peaks represent the
frequency of viRNAs mapping to the coding strand (in 5=¡3= orientation). Negative numbers and peaks represent those viRNAs mapping to the noncoding
strand (in 3=¡5= orientation).
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quently reduced virus titers, as shown in this study. In addition to
the 21-nt viRNAs, larger classes of BTV-specific small RNAs of 26
to 31 nt in length were detected. This resembles the size distribu-
tion of piRNAs, a class of Dicer-independent small RNAs found in
vertebrate and invertebrates thought mainly to be important for
genome stability in germ line cells by targeting transposons (61–
65). Recently, virus-specific piRNA-like small RNAs were found
in arbovirus-infected aedine mosquitoes and derived cell lines.
These piRNA-like molecules were found to map mainly to the
coding strand of the viral genome of positive-strand RNA arbovi-
ruses but also to the antigenome of LACV (18, 19, 44). Due to their
production pathway (the so-called ping-pong amplification
mechanism), piRNAs and viral piRNA-like molecules have a spe-
cific sequence logo (61–65). BTV-specific small RNAs of 26 to 31
nt in length do not show a piRNA-like sequence logo (not shown).
It is not known how these larger BTV-specific RNA molecules are
produced, or their function, or if they are related to RNAi pro-
cesses at all. Their production is virus specific and not cell type
specific, as we also detected them in the Aag2 mosquito cell line.
In the case of SBV, 21-nt viRNAs could be detected in both KC
and Aag2 cells for all three segments in an asymmetric distribu-
tion, suggesting again a dsRNA replication intermediate as the
inducer of the RNAi response. This is in line with results observed
in drosophila cells infected with LACV (6). Compared to infection
with positive-strand RNA viruses or dsRNA viruses, no dsRNA
could be detected for negative-strand RNA viruses, at least in in-
fected vertebrate cells (80). Our results indicate that dsRNA rep-
licative intermediates are present in orthobunyavirus-infected
cells, possibly at low levels but levels still sufficient to induce an
antiviral RNAi response. Longer small RNA molecules containing
FIG 8 SBV infection and targeting by the RNAi response in KC and Aag2 cells. (A) Virus production in supernatant of KC (triangle) and Aag2 (square) cells
infected with SBV at a MOI of 10 was determined at various time points postinfection (0, 8, 24, and 48 h) by plaque assay. A representative of two independent
experiments performed in triplicate is shown; standard errors are indicated. (B) SBV-infected KC and Aag2 cells were fixed at 48 h postinfection, and SBV-
infected cells were visualized by using an SBV N-specific primary antibody (bright signal). Cell nuclei were stained with DAPI. (C) Size distribution of small RNA
molecules mapping to L, M, and S of SBV in KC cells at 24 h postinfection or in Aag2 cells at 48 h postinfection. The y axis indicates the frequency of small RNAs;
the x axis indicates the length in nucleotides. Dark grey indicates small RNAs mapping to the coding strand, and light grey indicates small RNAs mapping to the
noncoding strand.
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piRNA features were also detected in SBV-infected Aag2 cells, as
recently described for other bunyaviruses (LACV, Rift Valley fever
virus [RVFV]) in RNAi-deficient Aedes albopictus-derived C6/36
cells and other arboviruses (such as CHIKV, SINV, DENV, and
RVFV) in aedine mosquitoes and/or their derived cell lines (18,
19, 44, 81). As no piRNA-like molecules could be detected in any
of the BTV-1-infected cell lines, production of piRNA-like mole-
cules may be specific to single-stranded RNA viruses, though
more research is needed to answer this question. It is not known if
these piRNA-like molecules have an antiviral function and how
they are induced. Neither BTV nor SBV produced piRNA-like
molecules in KC cells. This could be due to either the lack of a
piRNA pathway in Culicoides species or, alternatively, a deficiency
of the KC cell line.
The detection of BTV- or SBV-specific 21-nt viRNAs indi-
cates the ability of KC cells to induce an antiviral RNAi re-
sponse. In the absence of any genomic information on Culi-
coides, we can only speculate that orthologs of exogenous RNAi
pathway proteins such as Dcr-2 or Ago-2 are present in the
midge genome. However, the presence of 21-nt viRNAs is a
strong indicator for the presence of an exogenous RNAi path-
way that is comparable to that of mosquitoes (14). This raises a
number of questions: most importantly, how is BTV or SBV
able to successfully replicate and infect its midge vectors? Plant
and true insect viruses have been reported to encode proteins
able to interfere with the antiviral RNA silencing response by
expressing RNA silencing suppressor proteins (RSS) (23, 82).
Until now, no RSS protein has been identified in arboviruses,
suggesting other strategies for inhibition or evasion of the
RNAi response. Previous data obtained from SFV infection of
mosquito cells suggests a decoy mechanism: viRNAs that are
produced at high concentrations are not able to target the virus
efficiently in contrast to viRNAs produced at low concentra-
tions that result in efficient silencing of the virus. This strategy
results in successful replication at least for some time postin-
fection, even though viRNAs are produced (12). The mosquito-
borne flaviviruses WNV and DENV have been recently shown
to express a subgenomic flavivirus RNA able to interfere with
the RNAi response in mosquito cells, thereby ensuring efficient
viral replication (83). However, all mosquito-borne arbovi-
ruses investigated thus far are efficiently targeted by the RNA
silencing response (5, 6, 11, 12, 19, 20, 60). Further research is
needed to determine if and whether SBV or BTV do have any
(even if weak) RNAi evasion/inhibition strategies.
Taken together, our findings define for the first time the pres-
ence of an RNAi response in Culicoides cells which is able to target
midge-borne arboviruses and resembles at least in part the exog-
enous antiviral RNAi pathway of mosquitoes. More work will be
FIG 9 Distribution of SBV-derived small RNAs in Aag2 cells. Frequency distribution of 21-nt viRNAs (A) or 24- to 29-nt small RNAs (B) to L, M, and S of SBV
in Aag2 cells at 48 h postinfection. The y axis shows the frequency of the 21-nt viRNAs mapping to the corresponding nucleotide position on the x axis. Positive
numbers and peaks represent the frequency of viRNAs mapping to the coding strand (in 5=¡3= orientation), and negative numbers/peaks indicate those viRNAs
mapping to the noncoding strand (in 3=¡5= orientation).
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required to determine the exact mechanisms and proteins in-
volved in the RNAi pathway in midges, but this study allows fur-
ther investigations into these processes.
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ABSTRACT
Arboviruses are transmitted by distantly related
arthropod vectors such as mosquitoes (class In-
secta) and ticks (class Arachnida). RNA interference
(RNAi) is the major antiviral mechanism in arthro-
pods against arboviruses. Unlike in mosquitoes, tick
antiviral RNAi is not understood, although this in-
formation is important to compare arbovirus/host
interactions in different classes of arbovirus vec-
tos. Using an Ixodes scapularis-derived cell line,
key Argonaute proteins involved in RNAi and the
response against tick-borne Langat virus (Flaviviri-
dae) replication were identified and phylogenetic re-
lationships characterized. Analysis of small RNAs
in infected cells showed the production of virus-
derived small interfering RNAs (viRNAs), which are
key molecules of the antiviral RNAi response. Im-
portantly, viRNAs were longer (22 nucleotides) than
those from other arbovirus vectors and mapped at
highest frequency to the termini of the viral genome,
as opposed to mosquito-borne flaviviruses. More-
over, tick-borne flaviviruses expressed subgenomic
flavivirus RNAs that interfere with tick RNAi. Our re-
sults characterize the antiviral RNAi response in tick
cells including phylogenetic analysis of genes en-
coding antiviral proteins, and viral interference with
this pathway. This shows important differences in
antiviral RNAi between the two major classes of ar-
bovirus vectors, and our data broadens our under-
standing of arthropod antiviral RNAi.
INTRODUCTION
Tick-borne arboviruses of the Flaviviridae family are highly
relevant to public health (1). Much work on tick-borne ar-
boviruses has been carried out with Langat virus (LGTV),
isolated from Ixodes granulatus and Haemaphysalis ssp.
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ticks in Malaysia and Thailand and related to tick-borne
encephalitis virus (TBEV) (1–4). Flaviviruses are positive-
stranded RNA viruses. Viral proteins are encoded in a sin-
gle open reading frame. The untranslated RNA regions
(UTRs) at the genome termini regulate replication and
translation (5–8).
Arbovirus infection of arthropod cells is character-
ized by little or no cytopathic effects (9). Studies of
vector/arbovirus interactions suggests that this may be at
least partly due to regulation of arbovirus replication by in-
nate immune responses (10). Research on vector immune
responses to arboviruses has focused on mosquitoes (11,12)
despite the fact that many European/Asian arboviruses are
tick-borne (13). Antiviral responses in mosquitoes rely on
a small RNA-based mechanism called RNA interference
(RNAi) (10,11). The exogenous small interfering (si)RNA
pathway is especially important and can be induced by
virus-derived long double-stranded (ds)RNA molecules
generated during infection (either replication intermediates
or secondary RNA structures) or dsRNA viral genome
(10). In insects, dsRNA is targeted by the Dicer enzyme
(Dcr-2) and cleaved into 21 nucleotide (nt) siRNAs, also
known as viRNAs (10,11). In Drosophila, viRNAs are in-
tegrated into the Argonaute-2 protein (Ago-2) containing
RNA-induced silencing complex, unwound and one strand
of the viRNA is retained by Ago-2 to guide degradation of
complementary (viral) RNA (14). Other Ago and Dcr pro-
teins, i.e. Dcr-1 and Ago-1, are involved in the microRNA
(miRNA) pathway (10–11,14).
Following treatment with gene-specific dsRNA or siR-
NAs, ticks and tick cell cultures can induce sequence-
specific RNAi of endogenous genes (15) and restrict viral
infections (16–18). Sequence analysis has also identified pu-
tative Ago and Dcr genes in the I. scapularis genome (19).
However, it is not known if these are transcribed and in-
volved in tick antiviral RNAi responses. All studied insect
specific viruses and plant-infecting viruses have been shown
to express RNA silencing suppressor (RSS) proteins which
interfere with the RNAi response (20). No RSS proteins
have been identified for arboviruses although evasion strate-
gies have been suggested for the alphavirus Semliki Forest
virus (SFV) (21), and the production of a subgenomic fla-
vivirus RNA (sfRNA) interfering with the RNAi response
was reported for mosquito-borne flaviviruses (22).
In this study, we identify and characterize key RNAi play-
ers of the Ago family that interfere with LGTV replica-
tion and describe characteristics of viRNAs in tick vec-
tor cells, which are different to viRNAs in mosquitoes. We
also demonstrate that the recently described RSS activity of
mosquito-borne flavivirus sfRNA can be broadened to tick-
borne LGTV and TBEV sfRNA. The results imply that the
antiviral RNAi system in ticks is more complex and has im-
portant differences to that of mosquitoes.
MATERIALS AND METHODS
Viruses and plasmids
The LGTV replicon (E5repRluc2B/3) was derived from
the infectious cDNA of LGTV E5 (4). Modifications in
the LGTV replicon were based on the previously described
replicon construct for TBEV Neudoerfl strain (23). This
construct encodes the first 17 residues of capsid, followed
by the Rluc gene, the last 27 residues of the envelope and
all non-structural proteins, as described in Supplementary
Data. For infections of tick cells, LGTV strain TP21 was
used.
Invertebrate expression vectors, pIZ-Fluc, pAcIE1-Rluc
and pIB-MBP-HDVr have been described previously
(22). The 3′UTRs of LGTV and TBEV were amplified
by polymerase chain reaction (PCR) using, respectively,
E5repRluc2B/3 or pTNd/ME (24) as templates. Inverte-
brate expression plasmids were obtained by fusing the 3′ ter-
minus to the HDVr sequence from a WNV 3′UTR expres-
sion construct (22) using PCR. The resulting products were
cloned into pDonor207 and pIB-GW plasmids (Invitrogen)
using Gateway technology.
Luciferase assays
Luciferase activities were determined using a Dual
Luciferase assay kit (Promega) in a GloMax multi-
luminometer following cell lysis in Passive Lysis Buffer.
Cell culture, transfection and infection
BHK-21 cells were grown in GMEM at 37◦C as previously
described (25). Cells (3 × 105/well) were seeded in a 6-
well plate prior to transfection with Lipofectamine2000 (In-
vitrogen) according to the manufacture’s protocol. The I.
scapularis-derived IDE8 cells were grown in L-15B medium
(26) at 32◦C in ambient air as previously described (27).
Cells (6.5 × 105/well) were seeded in 24-well plates prior to
transfection. Transient RNAi suppression assays were per-
formed by transfecting 200 ng pIZ-Fluc, 300 ng pAcIE1-
Rluc and 500 ng pIB-MBP-HDVr, TBEV 3′UTR or LGTV
3′UTR into IDE8 cells using Genejammer (Agilent) follow-
ing the manufacturer’s instructions. Silencing of reporter
genes was induced at 24 h post-transfection (hpt) through
addition of 280 ng dsRNA to the cell culture medium; lu-
ciferase was measured 48 hpt.
In case of studies involving replicon, putative RNAi
genes were silenced by the addition of 300 ng dsRNA to
cell culture medium at 6 and 30 h post-seeding (hps). Then,
capped in vitro-transcribed E5repRluc2B/3 was transfected
48 hps using Lipofectamine2000 according to the manufac-
turer’s instructions. Luciferase expression was measured 24
hpt.
For infection assays, target genes were first silenced by
transfection of 100 ng dsRNA using Lipofectamine2000,
followed by LGTV TP21 infection at 24 hpt at a multiplic-
ity of infection (MOI) of 0.1. RNA was isolated at 48 h post
infection (hpi) by Trizol.
Statistical analysis
The relative luciferase expression (RL) was calculated as:
RLi = IFluc,i/IRluc,i
Where I is the measured intensity and i is the sample. To
cancel out construct specific effects, values under treatment
(for example co-transfected with dsFFluc) were normalized
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against the same construct that was treated with a negative
control (in this example dseGFP). Thus:
NRLx = RLi,treated/RLi,neg.control
Experiments were performed in duplicate or in triplicate
and repeated independently at least three times. The inde-






Where x is the xth experiment and n is the total number of
experiments.
The significances were calculated using custom-written
scripts in R (www.r-project.org). In case of pairwise test-
ing a two-sample independent t-test was performed, as pro-
vided by R.
Multiple testing was done by applying Tukey’s HSD (also
known as Tukey’s range test), the q-value was calculated and
compared to the indexed q in the studentized range distri-
bution available in R. Significant differences (P ≤ 0.05) are
indicated in the graphs with an *.
Small RNA isolation and deep sequencing analysis
1.5 × 106 cells per tube were either transfected with 1
g of eGFP-derived dsRNA, capped in vitro-transcribed
E5repRluc2B/3 RNA, infected with LGTV TP21 (MOI 10)
or untreated. At 48 hpt or 72 hpi, RNA was isolated us-
ing 1 ml Trizol (Invitrogen) per tube, small RNAs of 18–
30 nt were sequenced and analyzed using viRome as pre-
viously described (28,29). Small RNA data was submit-
ted to the European Nucleotide Archive (accession number
ERP006219).
Reverse transcription and PCR
RNA was isolated by Trizol, following the manufacturer’s
protocol. Total RNA (500 ng for untreated/dsRNA-treated
cells as well as knockdowns followed by LGTV infection
or 5 g LGTV antigenome detection) was reverse tran-
scribed with Superscript III (Invitrogen) and using either
oligo dT primers (knockdowns), an antigenome specific
primer (LGTV antigenome detection) or random hexam-
ers (LGTV infection) following the manufacturer’s instruc-
tions. For the detection and amplification of Ago and Dcr
transcripts, PCR was carried out using 2 l of the cDNA
reaction with corresponding primers (Table 1). The eGFP-
derived PCR product was produced using eGFP-C1 (Clon-
tech) as template. In case of LGTV antigenome detection,
two rounds of PCR were performed using LGTV specific
primers. PCR products were gel-purified, cloned into the
pJet blunt1.2 vector (Fermentas) and sequenced.
LGTV RNA was determined by QRT-PCR with NS5
specific primers using the Fast SYBR Green PCR Mas-
ter Mix (Life Technologies) according to manufacturer’s in-
structions. Previously described actin primers were used as
housekeeping genes (16).
Figure 1. Characterization of exogenous-derived small RNAs in IDE8
cells. (A) Size distribution of small RNA molecules mapping either to
LGTV E5repRluc2B/3 replicon (left panel) at 48 hpt or LGTV TP21
(right panel) at 72 hpi in IDE8 cells. (B) Frequency distribution of 22 nt
small RNA molecules mapped to the E5repRluc 2B/3 replicon (5′UTR to
3′UTR) (left panel) or LGTV TP21 (right panel). The y-axis shows the fre-
quency of the 22 nt siRNAs mapping to the corresponding nucleotide po-
sition in the x-axis. Positive numbers and dark gray peaks represent the fre-
quency of siRNAs mapping to the genome (in 5′-3′ orientation) and light
gray peaks/negative numbers to the antigenome (in 3′-5′ orientation). See
also Supplementary Figure S2. (C) Frequency map of 22 nt small RNAs
mapping to the opposite strand of the LGTV replicon (left panel) or LGTV
TP21 (right panel).
In vitro transcription and dsRNA production
E5repRluc2B/3 was linearized by EcoRV and in vitro-
transcribed using a SP6 Megascript kit (Ambion) in the
presence of cap analogue according to the manufacturer’s
protocol. dsRNA was produced with the RNAi Megascript
kit (Ambion) from PCR products flanked by T7 promoter
sequences.
Phylogenetic analysis
To place the Ixodes sequences within gene trees, repre-
sentative sequences were downloaded from Genbank (see
Supplementary Figure S5 for sequence identifiers) for se-
lected arthropods (waterfleas, copepods, lice, ticks, cen-
tipedes, flies, butterflies, beetles and wasps) and deuteros-
tomes (sea squirt, human, chicken and zebrafish) that have
sufficient complete genomes and/or transcriptomes. Ago
and Piwi were aligned with translational MAFFT (30) and
poorly-aligned regions were removed manually, resulting
in an aligned matrix of 2349 positions for Ago and 2241
positions for Piwi. Due to a higher level of sequence di-
vergence and higher proporation of incomplete orthologus
sequences, Dicer was aligned under a codon model using
PRANK (31), and then GBLOCKs (32) was used to ex-
clude regions of poor alignment, resulting in an aligned
matrix of 810 positions. Gene trees were inferred with Mr-
Bayes (33) using unlinked General Time Reversible models
with Gamma-distributed rate variation for each of the three
codon positions. Two parallel MCMC chains of >25 mil-
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Table 1. List of primer sequences used























LGTV antigenome RT-PCR aattccacccatgaaatgtac
LGTV NS5 (QT-PCR) acccaagactgctacgtgtggaaa/tgaggaagtaaagggccttgctga
T7 promoter region is indicated in italics.
Figure 2. Analysis of Ago and Dcr protein-encoding genes in the Ixodes
scapularis genome. (A) and (B) are gene trees for metazoan Ago-subfamily
genes (A)and Dcr genes (B) respectively, constructed using a Bayesian ap-
proach under a GTR model (nodes are labeled if they receive >90% sup-
port; see Materials and Methods). Trees are unrooted, but presented as if
the root fell between the two Cnidarian homologs. (C) Detection of tran-
scripts encoding Ago and Dcr proteins in IDE8 cells by RT-PCR. RNA
not treated with reverse transcriptase was used as control during the PCR
reaction (no RT). See also Supplementary Figure S5.
lion steps were run for each tree (sampling every 1000 steps)
and the first 25% of steps were discarded as burn-in. Station-
arity was inferred by comparing parallel runs and inspec-
tion of the chains for each parameter: Potential Scale Re-
duction Factors approached 1.000, the variation in split fre-
quencies was <0.01, and effective sample sizes were >1000
for all parameters. The trees presented in Figure 2 and Sup-
plementary Figure S5 are maximum clade credibility trees,
with branch lengths proportional to the number of substi-
tutions. Only partitions with >90% Bayesian Posterior sup-
port are labeled.
RNA structure predictions
Consensus RNA structures were predicted using the Lo-
cARNA web server (Vienna RNA web server 1.8.2) (34)
with standard settings. Pseudoknots were identified man-
ually. Thermodynamic stability was calculated by folding
an individual sequence with RNAfold (Vienna RNA web
server 1.8.2), using a secondary structure constraint and
standard settings.
Northern blot analysis
Northern blot analysis was performed by loading 4.5 g
or 3 g of total RNA of BHK-21 or tick cells, respec-
tively, on a 1.5% agarose-2% formaldehyde MOPS gel and
transferred to a nitrocellulose (Hybond-N+, GE Health-
care) membrane using ‘top down’ blotting with 20xSSC as
transfer buffer. Transferred RNA was UV-crosslinked for
2 min. Hybridization was performed for 2 h in HybPerfect
buffer (Sigma) at 63◦C using DIG-labeled PCR product as
probe (TBEV 3′UTR or LGTV 3′ UTR). Membranes were
washed twice with 2xSSC + 0.1% SDS for 5 min, twice with
0.2xSSC + 0.1% SDS for 20 min at 63◦C and DIG was de-
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RESULTS
scapularis-derived-IDE8 cells mount RNAi responses against
LGTV and TBEV
An uncharacterized RNAi response was shown to re-
strict mosquito-borne arbovirus infections in I. scapularis-
derived ISE6 and IDE8 cells (16–18). It is not known if
RNAi is induced in tick cells following infection with tick-
borne arboviruses. Production of viRNAs is an indicator
of an antiviral RNAi response. An LGTV E5 strain repli-
con encoding the Renilla luciferase (Rluc) gene as a re-
porter (E5repRluc2B/3) was constructed to investigate an-
tiviral RNAi in IDE8 cells (Supplementary Figure S1A).
The ability to successfully transfect E5repRluc2B/3 RNA
into IDE8 cells (77%) was determined, using either fluores-
cently labeled replicon RNA or immune-fluorescence detec-
tion of NS3, respectively (Supplementary Figure S6A). Fol-
lowing transfection with E5repRluc2B/3 RNA, IDE8 cells
were lysed and Rluc expression determined at 24, 48, 72,
96 and 120 hpt. Expression was observed 24 hpt then de-
creased (Supplementary Figure S1C). Replication was ver-
ified by detection of LGTV antigenome (Supplementary
Figure S1B). These results suggest that the LGTV replicon
is inhibited by an induced antiviral response in IDE8 cells.
Previous work has documented the production of viR-
NAs in ISE6 cells; however, the sequences and their dis-
tribution on the virus genome are not known (17,18). The
production of LGTV-specific viRNAs in IDE8 cells was
therefore analyzed. At 48 hpt, total RNA was isolated and
small RNAs sequenced; frequencies and LGTV genome
location of small RNAs were determined (Table 2). 7.1%
of the small RNA sequences mapped to the LGTV repli-
con sequence. viRNAs were predominantly 22 nt in length
(59.6%) and mapped with similar frequency to the genome
and antigenome (Figure 1A, left panel). viRNAs were scat-
tered along the LGTV replicon genome/antigenome with
variable frequency into hot spots/cold spots (21) (Figure
1B, left panel). The 5′ and 3′UTRs generated the highest
viRNA frequencies (Figure 1B, left panel). Comparing the
base composition of 22 nt viRNAs of hot spots versus cold
spots showed a substantial bias away from G toward A at
the 5′ end (P < 0.0001, Fishers exact test [FET]) and a
bias away from A at the 3′ end (P < 0.0001, FET). Bias at
other positions was found but none was particularly strik-
ing (Supplementary Figure S2A). The 5′ ends of the comple-
mentary LGTV specific 22 nt RNAs were most frequently
separated by 20 nt (Figure 1C, left panel) suggesting genera-
tion from dsRNA of 20 nt with 2 nt overhangs. Experiments
performed with a previously described TBEV replicon (23)
(Supplementary Figure S2C) showed similar results regard-
ing the predominance of 22 nt viRNAs and 5.9% of to-
tal small RNAs mapping to the TBEV replicon (Table 2),
with similar frequency to the genome and antigenome. The
22 nt small RNAs mapping to TBEV, are scattered along
the genome/-antigenome. Again the highest frequency of
viRNAs was generated from the 5′ and 3′ UTRs (Supple-
mentary Figure S2D). Experiments with IDE8 cells infected
with LGTV TP21 showed the production of virus specific
small RNAs sharing several of the characteristics of LGTV
replicon-derived viRNAs, although at a lower overall fre-
quency (0.27% for virus and 7.12% for replicon (Table 2)).
The majority of viRNAs were 22 nts in length, most fre-
quently separated by 20 nts and the highest viRNA frequen-
cies were generated from and around the 5′ and 3′ ends of
the viral genome/antigenome (Figure 1, right panels and
Table 2).
The length of small RNAs in IDE8 cells is a host property
Recent studies have shown that insect viRNAs are generally
21 nt in length, in contrast to nematode Caenorhabditis el-
egans viRNAs of predominantly 22 or 23 nt depending on
the virus (21,28,36–47). To determine whether generation of
22 nt as the dominant viRNA length was a property of the
cells or the virus, an eGFP-derived dsRNA was transfected
into IDE8 cells and small RNAs analyzed. Again, 22 nt was
the dominant length (Supplementary Figure S2E) and small
RNAs mapped in hot/cold spots along the whole eGFP se-
quence and its complement (Supplementary Figure S2E).
We also analyzed viRNAs targeting the dsRNA orbivirus
St. Croix River virus (SCRV) (48,49), which persistently in-
fects IDE8 cells (Table 2). Again, the majority of SCRV viR-
NAs were 22 nt, with similar frequencies being detected on
the (+) and the (–) strand (Supplementary Figure S3).
To determine the properties of endogenous small RNA
molecules such as miRNAs, endogenous siRNAs and
PIWI-interacting (pi)RNAs (10) in IDE8 cells, the small
RNA profiles from uninfected and treated (eGFP dsRNA
and LGTV replicon) IDE8 cells were analyzed. Small
RNAs mapping to the I. scapularis genome (https://www.
vectorbase.org) had a predominant length of 22 nt (44.4%)
in all samples, with slightly higher frequencies for the sense
orientation. Moreover, a class of small RNA molecules of
27 to 29 nt was identified with a peak at 28 nt (27 nt: 6.7%,
28 nt: 10.1% and 29 nt: 5%) as strongly represented as 21
nt small RNAs (12.5%) (Supplementary Figure S4). This
indicates that 22 nt is the dominant length of small RNAs
(endogenous or viral) in IDE8 cells.
Identification of Dcr and Ago proteins involved in antiviral
RNAi in tick cells
Ago-2 and Dcr-2 proteins are key effectors in the in-
sect antiviral RNAi pathway (10,50). Dcr-1 and Ago-1
are known to be important for the insect miRNA path-
way (10,14). Previous sequence analysis has shown that
the I. scapularis genome contains at least one putative Dcr
gene, Dcr-89 (ISCW000889) and two putative Ago subfam-
ily genes; Ago-68 (ISCW011768), Ago-30 (ISCW0021130)
(19). In the present study, Basic Local Alignment Search
Tool (BLAST) similarity searches with Dcr (Dcr-1 and
Dcr-2) and Ago subfamily genes (Ago-1 and Ago-2) of
Drosophila melanogaster and Aedes aegypti were performed
to identify further putative homologs in the I. scapularis
genome. Three additional putative Ago subfamily genes;
Ago-96 (ISCW022696), Ago-16 (ISCW015916), Ago-78
(ISCW013378) and another putative Dcr gene, Dcr-90
(ISCW0008890) were identified.
To understand the function of Ixodes Ago and Dcr pro-
teins within the wider context of their evolution, gene trees
were constructed using a Bayesian approach (Figure 2A and
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Table 2. Number of small RNA reads





719782 1462846 294390 3906753 3153338
Anti-genome/coding
strand reads
553286 1242195 227753 3606509 2921677
Total viral reads 1273068 2705041 522143 7513262 6075015
Reads in total 17875799 18806256 190908946 127799016 127066875
Indicated are read numbers of small RNAs mapping to the genomes and antigenomes of St. Croix River virus, Langat virus replicon, Langat virus TP21
and TBEV replicons.
B; Supplementary Figure S5). The last common ancestor
of each of these gene families probably pre-dates the ori-
gin of the animals (51), so that saturation and long-branch
artifacts make reliable tree inference extremely challenging.
Rooting the Ago tree between the two cnidarian paralogs
identified two well-supported clades: the slowly evolving
clade homologous to drosophila Ago-1 (miRNA pathway)
and the rapidly evolving clade homologous to drosophila
Ago-2 (siRNA pathway). The Ago-1 clade exactly mirrors
the known phylogeny of the species, and clearly identifies
Ixodes Ago-78 as an ortholog of drosophila Ago-1. The
other four Ixodes Ago (-96, -68, -16, -30) then appear as
more recent Ago-2 paralogs that have evolved since the last
common ancestor of Arachnida and Pancrustacea, although
a lack of support within this clade makes it hard to draw
conclusions beyond this. The Dcr gene-tree also lacks sup-
port, and when similarly rooted using the cnidarian par-
alogs results in a pattern that is hard to interpret. With this
rooting, Ixodes Dcr-90 clusters with other arachnid Dicers
basal to an arthropod clade that includes drosophila Dcr-
1, suggesting that Dcr-90 is a Dcr-1 homologue. However,
the basal position of Ixodes Dcr-89 and the remaining crus-
tacean Dicers is difficult to reconcile with the known organ-
ismal phylogeny. If the divergent Cnidarian outgroup is ex-
cluded, then an alternative rooting immediately basal to the
deuterostome/arthropod Dcr-1 clade (marked by a black
arrow in Figure 2B) would place Dcr-89 and the remaining
Crustacean Dcrs as the most basally-branching arthropod
Dcr-2, consistent with the species phylogeny and suggesting
it is homologous to drosophila Dcr-2. Transcription of pu-
tative Ago and Dcr genes was verified in IDE8 cells (Figure
2C).
In order to investigate mediators of antiviral activity in
IDE8 cells, transcripts of individual Dcr or Ago genes were
knocked down by RNAi as previously described (16) and
the effect on the LGTV replicon determined. Efficiency
of knockdown/silencing of cells treated with dsRNA spe-
cific for Ago (Ago-68, Ago-30, Ago-16, Ago-96 and Ago-
78) and Dcr (Dcr-90 and Dcr-89) genes was determined
by semi-quantitative RT-PCR and quantified in relation to
control dsRNA using 16S as loading control (Figure 3).
Cells treated with dsRNA against Ago-68, Ago-30, Ago-96,
Ago-16, Ago-78 or Dcr-90 showed reduction in target tran-
script levels (9–40%). No significant reduction of Dcr-89
transcript was observed, due to a high variability between
samples (Figure 3).
Following successful individual knockdowns of most pu-
tative RNAi genes, the experiment was repeated, LGTV
Figure 3. Knockdown of transcripts encoding Ago or Dcr proteins. (A)
dsRNA-based silencing of Ago and Dcr encoding transcripts in IDE8
cells. Transcripts were detected by RT-PCR using gene-specific primers. A
PCR product of 16S ribosomal RNA was used as housekeeping gene and
eGFP specific dsRNA treated cells as control (crtl). (B) mRNA knock-
downs quantification by Image J software, using 16S as control. The rel-
ative mean (normalized to eGFP-dsRNA controls) with standard error is
shown for at least 10 repeats.
replicon RNA was transfected into silenced IDE8 cells and
replicon-mediated Rluc activities determined. Significant
increases in replicon Rluc activity were observed in IDE8
cells treated with dsRNA specific for Ago-30, Ago-16 and
Dcr-90, compared to control dsRNA (Figure 4A). No sig-
nificant increase of Rluc was observed following Ago-68,
-78, -96 and Dcr-89 knockdowns. To ensure that the ob-
served effect was not due to off target effects, the Ago-30
knockdown was repeated with an additional Ago-30 spe-
cific dsRNA molecule (Ago30–2); this resulted in a simi-
lar increase of luciferase activity thus confirming previous
results (Supplementary Figure S6B). Similar experiments
were also performed with silenced IDE8 cells and the effect
on LGTV infection (MOI 0.1) at 48 hpi was determined by
QRT-PCR. Significant increases in LGTV RNA levels were
observed in cells treated with dsRNA specific for Ago-68, -
30, -16 and Dcr-89, although Dcr-89 resulted only in a small
increase (Figure 4B).
Targeting of the same cells by dsRNA and LGTV repli-
con or LGTV infection was established, using fluorescently
labeled dsRNA and immunostaining of LGTV NS3 or
E protein (Supplementary Figure S6A). In summary, tick
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Figure 4. Effects of Ago and Dcr knockdowns on LGTV replication. (A)
Ago or Dcr silenced cells were transfected with capped in vitro- transcribed
LGTV E5repRluc2B/3 replicon RNA, and Rluc activity was determined
at 24 hpt. The mean with standard error is shown for three independent
experiments performed in duplicate (two experiments)/triplicate (one ex-
periment). The data were normalized to cells treated with eGFP-specific
control dsRNA. * indicate significance by Tukey’s HSD (P ≤ 0.05). (B)
Silenced cells were infected with Langat virus (MOI 0.1) and viral RNA
was determined by QRT-PCR at 48 hpi, using actin as housekeeping gene
internal standard. The mean with standard error is shown for three inde-
pendent experiments performed in triplicate. The data were normalized to
cells treated with eGFP-specific control dsRNA. * indicate significance by
Student t-test (P ≤ 0.05).
Ago-30 and Ago-16 mediate antiviral activity against both
LGTV and its replicon.
Tick-borne subgenomic flavivirus (sf)RNA interferes with an-
tiviral RNAi
sfRNA is derived from the flavivirus 3′UTR, produced
in vertebrate and invertebrate cells by mosquito and tick
borne-flaviviruses and contains a complex RNA structure
(52–54). West Nile virus (WNV) and dengue virus (DENV)
sfRNAs both interfere with RNAi (22).
Production of sfRNA and suppression of RNAi by both
LGTV and TBEV was investigated. The 3′UTRs of fla-
viviruses share common characteristics in their RNA archi-
tecture (55). It has been demonstrated that mosquito-borne
flaviviruses share an RNA stem loop structure (called SL
II) toward the 5′ end of the 3′UTR which has similarities
to SL IV of the 3′UTR and is important for sfRNA pro-
duction (52–54). RNA folding predictions of the 3′UTR of
tick-borne flaviviruses showed RNA structures with folds
highly similar to SL II and SL IV (respectively named SL
2 and SL 1 in the tick-borne viruses) for most tick-borne
flaviviruses, despite sequence differences to mosquito-borne
flavivirus 3′UTRs (Supplementary Figure S7).
To determine if the predicted LGTV and TBEV RNA
stem loop structures (Figure 5A and Supplementary Fig-
ure S7) give rise to sfRNAs, vertebrate and tick cells were
infected with LGTV (56) or transfected with TBEV repli-
con (24). Northern blot analysis detected TBEV and LGTV
RNA at the expected size of ∼0.4 kb (predicted SL 2,
LGTV: −447 nt; TBEV: −453 nt) (Figure 5A and B). In
addition, similar to WNV a lower band was observed. This
may be due to the presence and characteristics of two SL
Figure 5. Analysis of subgenomic flavivirus (sf)RNA in the 3′UTR of tick-
borne flaviviruses. (A) Structure model of SL 2 and SL 1 RNA stem loop
structures of TBEV and LGTV. (B) Expression of TBEV (TND/ME)
(top) and LGTV (bottom) sfRNA in replicon (top), non-transfected (con-
trol CTRL) or infected cells (bottom) was detected by northern blot anal-
ysis with 3′UTR specific DIG-PCR probes. (C) The effect of sfRNA on
RNAi in IDE8 cells was determined by co-transfection of FFluc, Rluc and
expression constructs for MBP-HdVr (MBP), LGTV 3′UTR or TBEV
3′UTR. Silencing was induced 24 hpt following addition of dsRNA to
the culture medium. At 48 hpt, relative luciferase activity (FFluc/Rluc)
was determined and normalized to cells treated with eGFP specific (ctrl)
dsRNA. The luciferase expression level measured with MBP-HdVr was
set at 1.0. The mean with standard error is shown for three independent
experiments performed in duplicate (one experiment)/triplicate (two ex-
periments). ∗ indicate significance by Tukey’s HSD (P ≤ 0.05). See also
Supplementary Figure S7.
structures [SL 1 and 2]. Moreover, there are differences be-
tween arthropod and vertebrate cells (Figure 5B) (52,53).
The RSS activity of these sfRNAs was investigated
next, after establishing successful plasmid transfections in
IDE8 cells (Supplementary Figure S6A). IDE8 cells were
co-transfected with plasmids encoding Firefly luciferase
(FFluc; reporter gene), Rluc (internal control), and plas-
mids expressing LGTV or TBEV 3′UTRs. Maltose binding
protein (MBP) sequence fused to the hepatitis delta virus
ribozyme (HDVr) was used as negative control RNA as the
3′UTRs plasmids also contain an HDVr. Subsequently, si-
lencing was induced by either FFluc-specific (dsFFluc) or
control (eGFP) dsRNA and luciferase activity determined.
Reduced silencing was observed in cells expressing 3′UTR
constructs compared to MBP-HDVr (Figure 5C). These re-
sults indicate that the 3′UTRs of LGTV and TBEV are able
to interfere with the tick siRNA pathway.
DISCUSSION
RNAi is known to be a major defense mechanism against
arboviruses in mosquitoes (10,11). Much less is known
about ticks. Here, we investigated the antiviral RNAi re-
sponse in I. scapularis-derived cells and viral counter-
defense strategies. Our analysis reveals tick Ago and Dcr
genes additional to those previously described (19). A sig-
nificant gene expansion in the Ago subfamily has occurred
in arachnids, compared to insects such as D. melanogaster
and A. aegypti. Our results characterize key differences be-
tween Ixodes and mosquito RNAi responses. The antivi-
ral activity of Ago-30, Ago-16 and Ago-68 (in case of vi-
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ral infection) is in line with previous reports showing that
mosquito/fly Ago-2 is involved in the antiviral RNAi re-
sponse and phylogenetic analysis indicates that Ixodes Ago-
30, Ago16 and Ago-68 are homologous to Ago-2 of in-
sects (57,58). The expansion of putative Ago-2 paralogs in
arachnids is different from other arthropods, which gen-
erally have one, or at most two, Ago-2 homologs. In con-
trast to Ago-16 and Ago-30, Ago-68 only shows antiviral
activity in case of virus infection, which may suggests its in-
volvement in limiting virus spread by pre-priming yet unin-
fected cells using systemic RNA silencing. Like mosquitoes,
ticks appear to have undergone an expansion of the Piwi
clade (Supplementary Figure S5C), though the expansion
is smaller and occurred independently, in addition to a
possible loss of Ago-3. We show that Dcr-90 is involved
in antiviral RNAi against replicon in contrast to Dcr-89
showing significant antiviral activity in case of virus. How-
ever, failure of consistent/ efficient knockdown of Dcr-
89 between experimental approaches and the borderline
increase/significance of Dcr knockdowns on virus infection
leaves it open whether or not a second Dcr protein is in-
volved and if there are differences between effects of Dcr
knockdowns on replicon and virus. Phylogenetic analysis,
dependent on the rooting, maps Dcr-89 in a cluster with
Dcr-2 proteins in insects. Dcr-2 is critical for the exogenous
antiviral siRNA pathway in Drosophila, and presents a lim-
iting factor for sufficient knockdown involving exogenous
RNAi (using dsRNA) in this organism (14). Dcr-89 could
act in a similar way in ticks, which may explain the lack of
consistent knockdown. Dcr-90 showed an antiviral effect in
IDE8 cells despite clustering with Dcr-1 proteins which have
not yet been reported as antiviral in flies or mosquitoes.
It cannot be excluded that potential antiviral functions of
some Ago/Dcr proteins we describe here may have been
missed due to inefficient knockdown of the transcript; how-
ever our results already show that mechanisms in ticks may
differ in detail from those present in insects.
A key feature of antiviral RNAi in mosquitoes is the pro-
duction of 21 nt viRNA molecules (10,11). The majority
of viRNAs in IDE8 cells are 22 nt in length [as reported
for viRNAs of the positive strand nodavirus in C. elegans
(45,46)]. The same observation was made if an RNAi re-
sponse was artificially induced by dsRNA. As the length of
the siRNAs or viRNAs is mostly dependent on the Dcr en-
zyme, this indicates a key difference between I. scapularis
and insect Dcr proteins. In insects, miRNA molecules differ
from siRNA molecules (22 versus 21 nt) as they are mostly
produced by Dcr-1. The antiviral effect of Dcr-90, which
clusters with insect Dcr-1 proteins, and the production of
22 nt viRNAs points to differences between the antiviral
RNAi pathways in I. scapularis and insects. Small RNAs of
22 nt were also found to be the major class of small RNA
molecules that map to the genome of I. scapularis.
Little is known about the dsRNA substrate for Dcr-2
and the origin of viRNAs. Findings by us and others sug-
gest that dsRNA replicative intermediates are Dcr-2 sub-
strates in mosquitoes and derived cell lines and show that
hot and cold spots of viRNAs are present along arbovirus
genomes/antigenomes (21,38,40–43). This is in agreement
with our results for SCRV and transfected dsRNA. In con-
trast, LGTV viRNAs map at highest frequencies to or
around the 5′ and 3′ termini. In contrast, similar regions
present in DENV and WNV are not particularly targeted
by the RNAi machinery in mosquitoes (41–43). It has to
be mentioned that recent work has shown that certain hot
and cold spot observations are due to cloning bias of the
small RNAs (59,60). The presence of small RNAs mapping
to the non-coding strand of SCRV with a similar frequency
as to the coding strand, supports the dsRNA genome as in-
ducer molecule even with cloning bias. The same dsRNA-
mediated induction may explain the bias of targeting the
5′ and 3′ genome termini of LGTV in IDE8 cells. A pre-
viously described replication-incompetent TBEV replicon
(C17Fluc NS5 GAA) (23) behaved similar as the corre-
sponding wild-type replicon in IDE8 cells with regards to
luciferase production over time [in contrast to BHK where
it shows reduction of luciferase production overtime as pre-
viously reported (23)] and production/ mapping of TBEV-
specific small RNAs (Supplementary Figure S8 and Table
2). This suggests replication of the GAA mutant either by
the viral replicase or other enzymes with complementing
or replicative activity present in the IDE8 cells. Therefore
such a mutant can unfortunately not be used to determine
whether the observed TBEV-specific small RNAs are pro-
duced from incoming single stranded RNA, dsRNA repli-
cation intermediates or partial dsRNA.
Differences in the number of cells targeted by replicon
or virus and the amount of virus/replicon RNA per cell
could explain the difference in production of overall LGTV-
specific small RNAs for replicon versus virus-infected IDE8
cells. Infection by full-length virus may also hide and limit
the antiviral RNAi response in IDE8 cells more efficiently
than replicon RNA which misses the coding sequences for
structural proteins. Besides, the presence of structural pro-
teins and nucleotide sequence (and thus changes in overall
length of the viral RNA) may explain the observation that
distribution of replicon viRNA versus virus shows some
difference. Despite these differences though, LGTV viR-
NAs share common characteristics (bias for 22 nts viRNAs
and targeting areas around the 5′ and 3′ genome termini)
which are different to flavivirus-specific viRNAs reported
in mosquitoes (41–43).
The detection of LGTV-specific viRNAs indicates the
ability of the RNAi response to target the virus, raising the
question: how can the virus still replicate in tick cells? Plant
and ‘true insect’ viruses encode RSS proteins that interfere
with the antiviral RNAi to allow successful viral infection
(14,61). No arbovirus RSS protein is known, but an eva-
sion strategy has been suggested for the alphavirus SFV
(21) and the sfRNA molecules of mosquito-borne viruses
interfere with RNAi responses (22). The 3′UTRs of tick-
and mosquito-borne flaviviruses do not share high similar-
ity at the nucleotide level and exchanging these sequences
mostly leads to replication-deficient viruses (62–64). De-
spite this, bioinformatic modeling suggested a highly sim-
ilar secondary RNA structure profile in the 3′ UTR of
arthropod-borne flaviviruses, production and interference
with the RNAi response was shown of TBEV and LGTV.
WNV sfRNA is believed to mediate RSS activity by act-
ing as a competitive substrate for Dcr (22). In contrast to
WNV and DENV UTRs that do not appear to be specif-
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ically targeted by Dcr (41–43), the 3′ UTR of the LGTV
and TBEV replicon in IDE8 cells appears to be a target for
Dcr activities; along with the 5′ UTR it generates the highest
frequency of viRNAs. The sfRNA RSS activity probably re-
sults in less powerful activity than the known protein-based
RSS of insect viruses. Expression of an RSS protein by al-
phaviruses results in reduced mosquito survival (40,65). Us-
ing a weak suppressor such as sfRNA may allow for suf-
ficient levels of replication needed for successful transmis-
sion.
Taken together, our findings define details of the tick an-
tiviral RNAi response and its interference by tick-borne ar-
boviruses. They show several important differences in an-
tiviral RNAi between different classes of arbovirus vec-
tors (Arachnida versus Insecta) and broaden our knowledge
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The exogenous siRNA pathway is important in restricting arbovirus infection in mosquitoes. Less
is known about the role of the PIWI-interacting RNA pathway, or piRNA pathway, in antiviral
responses. Viral piRNA-like molecules have recently been described following infection of
mosquitoes and derived cell lines with several arboviruses. The piRNA pathway has thus been
suggested to function as an additional small RNA-mediated antiviral response to the known
infection-induced siRNA response. Here we show that piRNA-like molecules are produced
following infection with the naturally mosquito-borne Semliki Forest virus in mosquito cell lines.
We show that knockdown of piRNA pathway proteins enhances the replication of this arbovirus
and defines the contribution of piRNA pathway effectors, thus characterizing the antiviral
properties of the piRNA pathway. In conclusion, arbovirus infection can trigger the piRNA pathway
in mosquito cells, and knockdown of piRNA proteins enhances virus production.
INTRODUCTION
Arboviruses are unique in that they must naturally replicate
in both their invertebrate vector and vertebrate host and
are therefore subjected to the selective pressure of very
different antiviral responses. One of the major antiviral
responses in invertebrates is the RNA silencing pathway or
RNA interference (RNAi). It has been shown that the RNAi
pathway, in particular the exogenous small interfering
(si)RNA pathway, is able to inhibit and restrict arbovirus
infections in whole mosquitoes or mosquito cells (Blair,
2011; Donald et al., 2012). The exogenous RNAi pathway is
induced by virus-derived dsRNA that is recognized by a
Dicer protein, Dcr-2, and is processed into 21 bp-long
virus-derived siRNAs, also called viRNAs. After viRNAs are
incorporated and unwound in the RNA-induced silencing
complex (RISC) that harbours Argonaute 2 (Ago 2) as a
catalytic domain, one strand of the viRNA is retained and
used as a guide to find complementary viral RNA, which is
then degraded. Until recently, it was believed that the anti-
viral response in invertebrates is only attributed to the
exogenous siRNA pathway. Recently, however, the PIWI-
interacting RNA (piRNA) pathway has also been suggested
to display antiviral activity. piRNA molecules differ from
siRNAs in several aspects; they are produced by a Dicer-
independent pathway; have a broader size range of
25229 nt; are associated with proteins of the PIWI clade
and have a so-called ‘ping-pong’ signature due to their
production pathway, which is represented by a bias for U at
position 1 in antisense piRNAs and A at position 10 in
sense piRNAs (Saito & Siomi, 2010; Senti & Brennecke,
2010; Siomi et al., 2010, 2011; van Rij & Berezikov, 2009).
In Drosophila melanogaster, it has been shown that PIWI
proteins are mainly expressed in germline cells and are
thought to protect the germline from transposable
elements by targeting the transcribed RNA of active
transposons. However, PIWI proteins have also been
detected in somatic cells (Brennecke et al., 2007).
Although their induction pathway is still not completely
understood, two mechanisms have been proposed to
describe piRNA biogenesis. Primary piRNA molecules are
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antisense to the genomic regions of transposons and derive
from long precursor ssRNA that targets transposon-derived
sense RNA. Upon cleavage, they give rise to secondary
piRNA molecules that are mostly sense with an A10 bias.
Secondary piRNAs are incorporated into Argonaute 3 (Ago
3) protein, which uses these piRNAs to find complement-
ary antisense RNA, which again results in the production of
primary-type piRNAs. This so-called ping-pong mech-
anism results in the generation of anti-sense primary
piRNA molecules with a U1 bias. Primary piRNA
molecules have mostly been found to form complexes
with Aubergine (Aub) and PIWI proteins (Saito & Siomi,
2010; Senti & Brennecke, 2010; Siomi et al., 2010, 2011; van
Rij & Berezikov, 2009).
The detection of virus-specific piRNA molecules in
drosophila ovary somatic sheet (OSS) cells was the first
report suggesting that the piRNA pathway targeted viruses
in insects (Wu et al., 2010). More recently, virus-specific
piRNA molecules have been reported in aedine mosquitoes
for chikungunya virus (CHIKV) (Togaviridae, Alphavirus)
(Aedes albopictus and Ae. aegypti) and dengue virus
(DENV) (Flaviviridae, Flavivirus) (Ae. aegypti), and their
derived cell lines can become infected with Sindbis virus
(SINV) (Togaviridae, Alphavirus), La Crosse virus (LACV)
(Bunyaviridae, Orthobunyavirus), Rift Valley fever virus
(RVFV) (Bunyaviridae, Phlebovirus) and Schmallenberg
virus (SBV) (Bunyaviridae, Orthobunyavirus) (Hess et al.,
2011; Léger et al., 2013; Morazzani et al., 2012; Schnettler
et al., 2013; Vodovar et al., 2012). It is not known whether
these virus-specific piRNA molecules actually mediate any
antiviral activities or which proteins of the piRNA pathway
are important for this response. The PIWI protein clade
shows an expansion in aedine mosquitoes compared
to drosophila, which is consistent with a role besides
transposon targeting. Ae. aegypti encode seven Piwi
proteins (Piwi 1, AAEL008076; Piwi 2, AAEL008098; Piwi
3, AAEL013692; Piwi 4, AAEL007698; Piwi 5, AAEL013233;
Piwi 6, AAEL013227; Piwi 7, AAEL006287) and one Ago 3
protein (AAEL007823), compared to D. melanogaster, which
only encodes one of each of Piwi, Ago 3 and Aub (Campbell et
al., 2008a).
Although expression of some of the PIWI proteins has been
recently reported in Ae. aegypti-derived Aag2 cell lines
(Vodovar et al., 2012) and in the head and thorax of Ae.
albopictus (Morazzani et al., 2012), nothing is known about
their involvement in antiviral activity. If the piRNA
pathway acts as an antiviral response, then it would be
expected that silencing proteins involved would have a
positive effect on arbovirus replication as observed for the
Ago 2 protein, which is known to be involved in the
siRNA-based antiviral RNAi response (Campbell et al.,
2008b; Sánchez-Vargas et al., 2009). To test this hypothesis,
we investigated the importance of piRNA-related proteins
on viral infection. Re-analysis of previous deep-sequencing
data from mosquito-borne Semliki Forest virus (SFV)
(Togaviridae, Alphavirus) infection of U4.4 (derived from
Ae. albopictus) or Aag2 (derived from Ae. aegypti) cells (Siu
et al., 2011) revealed the presence of piRNA-like small
RNAs mapping mainly to a section of the SFV genome,
which decreased in Aag2 cells following knockdown for all
Piwi/Ago 3 proteins. Silencing of PIWI 4 protein increased
SFV replication and production but did not decrease the
presence of SFV-specific piRNA-like molecules, confirming
that the piRNA pathway does indeed display antiviral
activity and that Piwi 4 possibly acts as an antiviral effector
protein in this pathway.
RESULTS
SFV-specific piRNA-like molecules in aedine cell
lines
To determine whether the piRNA pathway specifically
targets SFV in mosquito cells, we first investigated if these
cells produce viral-specific piRNA-like molecules following
infection. We re-analysed data previously obtained from
deep sequencing of Aag2 and U4.4 cells infected with SFV
[RNA isolation 24 h post-infection (p.i.)]; deep sequencing
by using the Illumina Solexa platform as described in
Methods (Siu et al., 2011) and this time also mapped small
RNAs greater than 26 nt in length to the SFV genome. As
previously reported, the major species of virus-specific
small RNA molecules were viRNAs 21 nt in length (Siu
et al., 2011); however, small RNAs mapping to SFV in the
range of 25–29 nt could be observed for both cell lines (Fig.
1a). Most of these small RNA molecules mapped to the
sense orientation of the SFV in the 59 end of the
subgenomic RNA and had a bias for A at position 10, a
characteristic of secondary piRNAs (Fig. 1b and c). Besides,
the 59 ends of these complementary SFV-specific RNAs
were most frequently separated by 10 nt, a feature of
piRNAs produced by the ping-pong mechanism (Fig. 1d)
This is consistent with what has previously been reported
for SINV, CHIKV and SBV-specific piRNA-like RNAs
(Morazzani et al., 2012; Schnettler et al., 2013; Vodovar
et al., 2012). Having demonstrated the production of
piRNA-like RNAs in our mosquito cell infection systems,
we proceeded to investigate piRNA pathway functionality
by determining the effect of Piwi/Ago 3 silencing on SFV
replication.
Expression and knockdown of PIWI transcripts in
Aag2 cells
Given the lack of genomic information for Ae. albopictus,
these experiments were performed in Ae. aegypti-derived
Aag2 cells. To produce dsRNA molecules specifically
targeting single PIWIs or Ago 3, primers were designed
to amplify unique regions of these genes by RT-PCR. Ago 2
depletion was taken as a positive control as it has been
previously reported to be involved in the antiviral siRNA
pathway (Campbell et al., 2008b; Sánchez-Vargas et al.,
2009; van Rij et al., 2006), and Ago 1 was a negative control
that is known to be involved in the microRNA pathway.
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Fig. 1. Aag2 and U4.4 cells produce both viRNAs and piRNA-like RNAs following SFV infection. (a) Size distribution of small
RNA molecules mapping to the SFV genome or anti-genome in Ae. aegypti (Aag2) or Ae. albopictus (U4.4); RNA was isolated
at 24 h p.i. Red and green indicate small RNAs mapping to the genome and anti-genome, respectively. (b) Relative nt frequency
and conservation per position of 25–29 nt small RNAs mapping to the genome and anti-genome of SFV in Aag2 and U4.4 cells
are indicated. Sequence is represented as DNA. The overall height of the nt represents sequence conservation. (c) Frequency
distribution of 28 nt small RNA molecules to the SFV genome or anti-genome in Aag2 and U4.4. The y-axis shows the
frequency of the 28 nt small RNAs mapping to the corresponding nt position of the x-axis (SFV genome length). Positive
numbers represent the frequency of small RNAs mapping to the genome and negative numbers those mapping to the anti-
genome. (d) Frequency map of 24–30 nt small RNAs mapping to the opposite strand of SFV4. Probabilities of
complementarities of the sense and antisense SFV-specific small RNAs were mapped along the small RNAs (position 0
represents the first nt).
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First, the primers were tested for their specificity to amplify
unique regions of the Piwi/Ago 3 mRNAs. As previously
reported (Vodovar et al., 2012), we amplified Piwi 4, 5, 6
and 7, as well as Ago 3. Piwi 1–3 are highly homologous,
making unique primer design difficult. Primers amplifying
parts shared by either Piwi 1, 2 and 3 or only 2 and 3 were
successful, as well as Piwi 2 and 3 alone; however, attempts
to amplify a unique region of Piwi 1 were unsuccessful
(Fig. 2a). Sequencing of the PCR products confirmed their
origin. Before, silencing the Piwi and Ago 3 with the
dsRNA produced by in vitro transcription, transfection
efficiency of dsRNA in Aag2 was assessed and optimized
using internally labelled fluorescent dsRNA molecules. A
maximum of 28.6 % positive cells was observed (Fig. S1a,
available in JGV Online). Cells were transfected with 100 ng
dsRNA, either Piwi specific (1/2/3, 2/3, 2, 3, 4, 5, 6, 7 and Ago 3)
or control (eGFP specific), at 24 h post-seeding using
Lipofectamine 2000. Silencing of target transcripts was
determined by semi-quantitative reverse transcriptase PCR
(RT-PCR) 24 h post-transfection (p.t.), and several experi-
ments were quantified in relation to control dsRNA using
actin as a loading control (Fig. 2c). Aag2 cells treated with
dsRNA specific for Piwi 1/2/3, 2/3, 4, 5, 6 and Ago 3 showed a
10–42 % reduction in target transcripts compared to controls
treated with eGFP dsRNA. Similar results were observed for
Piwi 2, 3 and 7 (Fig. 2b, c). A cell viability assay (cellTiter-Glo,
Promega) was performed on all dsRNA-treated cells to
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Fig. 2. Expression and knockdown of piRNA-related transcripts in Aag2 cells. (a) Detection of Piwi (1/2/3, 2/3, 2, 3, 4, 5, 6, 7)
and Ago 3 transcripts in Ae. aegypti-derived Aag2 cells by RT-PCR using oligo-dT primers for reverse transcription, and gene-
specific primers for PCR. no RT represents the PCR product derived from samples lacking the superscript III enzyme. (b)
dsRNA-based silencing of Piwi (1/2/3, 2/3, 2, 3, 4, 5, 6 and 7), Ago 3, Ago 1 and Ago 2 transcripts or cells transfected with
eGFP-specific control dsRNA (ctrl) were detected in Aag2 cells by RT-PCR using gene-specific primers. Actin PCR product
was used as a control. (c) Quantification of mRNA knockdowns using ImageJ software (National Institutes of Health). Graph
shows the mean expression of five repeats normalized to actin expression and relative to eGFP-dsRNA controls. Error bars
show standard errors of means.
Antiviral activity of the piRNA pathway
http://vir.sgmjournals.org 1683
viability, but no deleterious effect was observed (data not
shown).
Effect of Piwi/Ago 3 knockdown on SFV
replication
Next, the effect of Piwi/Ago 3 silencing on SFV replication
was investigated and compared to the knockdowns of Ago 1
and 2. dsRNA transfections in Aag2 cells were repeated, and at
24 h p.t., these cells were infected with the reporter alphavirus
SFV4(3H)-RLuc [expressing Renilla luciferase (RLuc) as a
replication marker] (Fig. 3a). Infections were performed at an
m.o.i. of 0.1 (Fig. 3b, c), and RLuc activity was determined
48 h p.i. Significantly higher luciferase activity was detected
in cells treated with Piwi 4-specific dsRNA compared
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Fig. 3. Piwi/Ago 3 proteins inhibit SFV replication in Aag2 cells. (a) Schematic representation of SFV4 encoding Renilla
luciferase (RLuc) as reporter (flanked by duplicated nsP2-protease cleavage sites at the nsP3/4 junction) as part of the viral
non-structural polyprotein; SFV4(3H)-RLuc virus. (b) Aag2 cells transfected with dsRNA against Piwi (1/2/3, 2/3, 4, 5 and 6),
Ago 3 or eGFP-specific dsRNA (control) were infected with SFV4(3H)-RLuc 24 h p.t. at an m.o.i. of 0.1. The mean of four
independent experiments performed in triplicate are shown with standard errors (* represents p,0.05, t-test). (c) As (b) with
dsRNA specific against Piwi (2, 3, 4 and 7), Ago 2, Ago 1 or eGFP-specific dsRNA (control). Luciferase activity was measured
48 h p.i., and the means with standard errors are shown for three independent experiments performed in triplicate (* represents
p,0.05, t-test). (d) SFV titre (p.f.u. ml”1) in supernatant of Piwi 4-, Ago 1- or Ago 2-silenced cells versus control (eGFP dsRNA)
infected with an m.o.i. of 0.1 was determined 48 hp.i. by plaque assay. The means of three independent experiments performed
in triplicate are shown with standard errors (* represents p,0.05, t-test).
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2/3- and Piwi 1/2/3-specific dsRNA showed an increase in
RLuc activity, although Piwi 4-specific dsRNA had a stronger
effect (Fig. 3b). Knockdown of Ago 1 had no effect on
luciferase expression compared to Ago 2 knockdowns, which
exhibited the highest increase in luciferase activity (Fig. 3c).
In addition, plaque assays performed with supernatant from
dsRNA-transfected (eGFP, Piwi 4, Ago 1 and Ago 2) and
SFV4(3H)-RLuc-infected cells (m.o.i. of 0.1) showed higher
virus titre in cells treated with Piwi 4 or Ago 2 dsRNA (Fig.
3d). To ensure that the observed increase of RLuc activity in
cells transfected with Piwi 4-specific dsRNA was not due to
off-target effects of the dsRNA, experiments were repeated
with two additional Piwi 4-specific dsRNA molecules (Piwi 4-
2 and Piwi 4-3), resulting in similar RLuc activity (Fig. S1b).
Overall, these results show that silencing Ago 2 and some
Piwi, in particular Piwi 4, in Aag2 cells enhances SFV
replication and virion production.
Effect of PIWI/Ago 3 knockdown on the
production of SFV-specific piRNA-like molecules
Deep-sequencing experiments were performed to deter-
mine in more detail if Piwi 4 is needed for the production
of SFV-specific piRNA-like molecules or rather acts as an
effector molecule using the produced SFV-specific piRNA-
like molecules to target the viral RNAs. Knockdown of all
Piwi/Ago 3 proteins was performed to determined that any
of these proteins are needed for the production of SFV-
specific piRNA-like molecules. First, we established that the
same cells could be targeted by dsRNA transfection and
SFV infection using internally labelled fluorescent dsRNA
and immunostaining for SFV nsP3 (Fig. S1a). Next, cells
were transfected either with a combination of dsRNA
molecules (targeting Piwi 1-3, 4, 5, 6, 7 and Ago 3) or Piwi
4-specific dsRNA alone, followed by SFV4 infection at an
m.o.i. of 10. Cells transfected with eGFP-specific dsRNA
were used as control. At 24 h p.i., total RNA was isolated,
small RNAs were sequenced and the frequencies and SFV
genome location of small RNAs were determined. All
samples showed the presence of 21 nt SFV-specific small
RNAs with a similar frequency to the genome and anti-
genome; however, their frequency differs depending on the
transfected dsRNAs, giving the highest number in cells
transfected with a combination of piRNA/Ago 3-specific
dsRNA, followed by Piwi 4-specific dsRNA, with control
eGFP-specific dsRNA giving the lowest frequency. In
addition, SFV-specific small RNAs of length 26–30 nt with
a peak at 27 nt, mapping mainly to the sense orientation,
could be observed in cells transfected with eGFP-specific
control dsRNA and Piwi 4-specific dsRNA. Similar
molecules were also present in cells transfected with a
combination of Piwi/Ago 3-specific dsRNA but at a much
lower frequency. These molecules have all the piRNA-
specific features described for the previously identified
SFV-specific small RNA molecules: characterized by an A10
bias in the sense molecules, a U1 bias in the antisense
molecules (Fig. 4a, b) and separation of 10 nt of the 59ends
of the complementary small RNAs (Fig. S2b). As already
observed for the other SFV-specific piRNA-like molecules,
they mainly map to the 59 end of the subgenomic RNA
(Fig. 2a). To further characterize the response of SFV
replication in these knockdown cells, the experiments were
repeated following infection with the SFV4(3H)-RLuc
reporter virus. Cells transfected with a combination of
Piwi/Ago 3-specific dsRNA molecules, lacking Piwi 4
dsRNA, were also included. Increase in RLuc activity
compared to control cells could be observed for all
knockdowns; however, the strongest increase was present
in cells with Piwi 4 knockdown followed by knockdown of
all Piwi/Ago 3. Interestingly, cells transfected with a
combination of Piwi/Ago 3-specific dsRNA but lacking
Piwi 4-specific dsRNAs resulted in the lowest RLuc increase
(Fig. 4c). Overall, these results support the involvement of
Piwi/Ago 3 for the production of the SFV-specific piRNA-
like molecules and suggest that Piwi 4 acts as an effector
protein that targets the virus but is not needed for the
production of SFV-specific piRNA-like molecules.
Can dsRNA molecules induce piRNA production
Knockdown experiments of Ago 3 performed in Anopheles
gambiae suggests that at least some of the PIWI pathway
proteins are also involved in the exogenous dsRNA-
induced silencing response (Hoa et al., 2003). In addition,
recent experiments in aedine mosquitoes infected with
transgenic CHIKV expressing the dsRNA-binding protein
B2 suggest that dsRNA molecules are an inducer of the
piRNA pathway (Morazzani et al., 2012), as is known for
the exogenous siRNA pathway. To investigate if dsRNA on
its own can be processed into piRNA-like molecules, we
transfected Aag2 or U4.4 cells with dsRNA molecules
derived from the eGFP sequence. Subsequently, RNA was
isolated 24 h p.t., followed by sequencing and mapping of
small RNAs to the eGFP target sequence as described
above. As expected, small RNAs of 21 nt in size that
mapped to the sense or antisense orientation and along the
eGFP sequence were observed as the majority, indicating
induction of the exogenous RNAi pathway (Fig. 5a, b).
Some small RNAs in the 25–29 nt range mapping to the
eGFP input sequence were identified; however, no specific
sequence logo identifying them as piRNA-like molecules
was detected (data not shown). This suggests that ssRNA
(for example from virus replication) is needed for the
production of piRNA molecules but does not rule out a
link between the siRNA and piRNA pathways.
DISCUSSION
Until now, antiviral RNA silencing activities in mosquitoes
have mainly been reported for the exogenous siRNA
pathway. The identification of piRNA-like virus-specific
RNA molecules in drosophila OSS (Wu et al., 2010),
mosquitoes and mosquito-derived cells against different
arboviruses suggested a contribution of the piRNA
pathway in the antiviral response (Hess et al., 2011; Léger
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et al., 2012; Morazzani et al., 2012; Schnettler et al., 2013;
Scott et al., 2010; Vodovar et al., 2012). However, this role
has not been experimentally proven. The piRNA pathway is
known to target transposons and thereby ensures genome
stability, especially in germline cells. As some arboviruses
have been reported to be vertically transmitted (Anderson
et al., 2012; Mulyatno et al., 2012), an antiviral response by
the piRNA pathway in germline cells may constitute an
antiviral mechanism to inhibit vertical transmission or
limit virus replication in developing embryos. On the other
hand, a putative piRNA pathway in somatic tissues could
add another layer to small RNA-based antiviral responses
controlling arboviral infection. The finding that SFV-
produced piRNA-like small RNA molecules in Ae. aegypti-
and Ae. albopictus-derived cell lines is in accordance with
recently published work showing similar results for
CHIKV, SINV, LACV and SBV (Morazzani et al., 2012;
Schnettler et al., 2013; Vodovar et al., 2012). The
observation that the knockdown of some PIWI proteins
in Aag2 cells has a positive effect on SFV infection supports
the hypothesis that the piRNA pathway and possibly the
viral-specific piRNA-like small RNAs have an antiviral
function in these cells. A similar result has been previously
reported in anopheline mosquitoes. Indeed, A. gambiae
showed an increase in O’nyong-nyong virus (Togaviridae;
Alphavirus) following Ago 3 knockdown (Keene et al.,
2004). We extend this finding to aedine mosquitoes and
highlight the additional contribution of Piwi 4. The fact
that virus-specific piRNA-like small RNA molecules are
not specific to Ae. aegypti but can also be found in infected
Ae. albopictus, coupled with the expression of all piRNA


















































































































Fig. 4. Piwi/Ago 3 proteins are involved in the production of SFV-specific piRNA-like molecules in Aag2 cells. (a) Size
distribution of small RNA molecules mapping to the SFV genome or anti-genome in Aag2 transfected with eGFP-specific
control dsRNA, a combination of Piwi/Ago 3 dsRNA (Piwi 1/2/3, 2/3, 2, 3, 4, 5, 6, 7 and Ago 3) or Piwi 4-specific dsRNA,
followed by SFV4 infection; RNA was isolated at 24 h.p.i. Red and green indicate small RNAs mapping to the genome and anti-
genome, respectively. (b) Relative nt frequency and conservation per position of 25–29 nt small RNAs mapping to the genome
and anti-genome of SFV in Aag2 prior to transfection with the above-mentioned dsRNA molecules. Sequence is represented as
DNA. The overall height of the nucleotide represents sequence conservation. (c) Aag2 cells transfected with different
combinations of dsRNA (all Piwi/Ago 3: Piwi1/2/3, 4, 5, 6, 7 and Ago 3; all Piwi 4: Piwi1/2/3, 5, 6, 7 and Ago 3; Piwi 4 or
dsRNA control: eGFP specific) were infected with SFV4(3H)-RLuc 24 h p.t. at an m.o.i. of 0.1. The means of three independent
experiments performed in triplicate are shown with standard errors (* represents p,0.05, t-test).
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and thorax) (Morazzani et al., 2012), indicates that the
‘antiviral’ piRNA pathway is probably not specific to Ae.
aegypti but could possibly be present in Ae. albopictus as well.
It is not known if the same is true for drosophila. Viral-
specific piRNAs have been described in drosophila OSS (Wu
et al., 2010), but it is not known if they have any antiviral
activity in these cells. In addition, no viral-specific piRNAs
have been reported in somatic tissue or derived cells of
drosophila until now, which is in contrast to aedine
mosquitoes and their derived cells (Hess et al., 2011; Léger
et al., 2012; Morazzani et al., 2012; Schnettler et al., 2013;
Vodovar et al., 2012). This could be due to the differences in
PIWI pathway protein expression between drosophila and
Ae. aegypti (Campbell et al., 2008a). However, knockdown of
Piwi in drosophila results in increased WNV production
similar to that observed in Ago 2 knockdowns (Chotkowski
et al., 2008), which would also support an antiviral activity of
the piRNA-related pathway in drosophila. More research is
needed to determine the possible antiviral activity of piRNAs
in drosophila and whether this is restricted to ovary cells or is
found in all somatic tissue, and to determine the precise
differences between these pathways in aedine mosquitoes and
drosophila.
We do not know how the antiviral piRNA pathway is
induced in aedine mosquitoes, although previous observa-
tions have suggested a dsRNA molecule as the inducer
(Morazzani et al., 2012). This would suggest crosstalk
between the siRNA and piRNA pathways. A similar result
has been reported for A. gambiae-derived cells, which show
a decrease in dsRNA-induced reporter gene expression
following Ago 3 knockdown (Hoa et al., 2003), indicating
such crosstalk even in non-aedine mosquitoes. However,
the lack of piRNA-like molecules produced in the case of
dsRNA transfection alone (Fig. 5) suggests the need for
ssRNA (active viral replication) to induce piRNA production.
The inhibitory effect observed by the expression of the
dsRNA-binding RNAi suppressor B2 by CHIKV on the
production of viral-specific piRNAs suggests that this is a
secondary effect as dsRNAs are replication intermediates
required for ssRNA production (Morazzani et al., 2012). The
observation that most piRNAs map to the coding strand
region of the 59 end of the SFV subgenomic mRNA, SINV or
CHIKV (Morazzani et al., 2012; Vodovar et al., 2012) suggests
that perhaps particular transcripts or genome regions are
preferentially targeted. In this case, viral-specific dsRNA,
either due to the sequence or structural features such as
dsRNA, could be the inducer of the piRNA pathway.
Characterization of the viral-specific piRNA-like molecules
suggests a ping-pong production mechanism; however,
knockdown of Ago 3, which is known to be important for
the ping-pong mechanism in drosophila, did not result in an
increase of SFV replication. It could be possible that the
observed viral-specific piRNA-like molecules are produced in












































































Fig. 5. Transfected dsRNA feeds into the siRNA but not the piRNA pathway. (a) Size distribution of small RNA molecules
mapping to the input eGFP sequence following transfection of eGFP-derived dsRNA (720 nt) into Ae. aegypti (Aag2) or Ae.
albopictus (U4.4)-derived cells. RNA was isolated at 24 h p.t.. Red and green colour maps show the coding strand and non-
coding strand of the input dsRNA, respectively. (b) Frequency distribution of 21 nt small RNA molecules to the eGFP coding
strand (positive) or non-coding (negative) strand in Aag2 and U4.4. The y-axis shows the frequency of the 21 nt small RNAs
mapping to the corresponding nt position of the 720 nt eGFP-specific dsRNA of the x-axis.
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drosophila, or that the obtained knockdown of Ago 3 was not
sufficient.
To date, it is not definitively known if the viral-specific
piRNA-like molecules in mosquitoes and derived cell lines
are really produced through the piRNA pathway using
PIWI and Ago 3 proteins, although their ping-pong
signature highly suggests this production pathway. In
addition, piRNA production models were shown in
drosophila using at least two PIWI family proteins for
the production of primary and secondary piRNA mol-
ecules, but knockdown experiments only showed a strong
effect on SFV production for Piwi 4. The low frequency of
SFV-specific piRNA-like molecules found in cells with
knockdown of all Piwi and Ago 3 proteins strongly
supports their involvement in the production of these
molecules. However, the lack of decrease in SFV-specific
piRNA-like molecules in Piwi 4 knockdowns and the
increase in SFV replication and production suggest an
effector role of this PIWI-clade Ago protein by using the
SFV-specific piRNA-like molecules to target the virus. The
observed increase in SFV replication in both Piwi 4 and all
Piwi/Ago3 knockdown cells compared to control dsRNA
could also explain the increase of 21 nt viRNAs in these
cells. In addition, the increase in SFV-specific piRNA-like
molecules in combination with a higher SFV replication
again suggests that Piwi 4 is not needed for SFV-specific
piRNA-like production, but rather it is used to target and
thereby silence the virus.
Together, these results show that arbovirus replication is
able to trigger the piRNA pathway and that silencing of
piRNA-related proteins reduces viral-specific piRNA-like
molecules and enhances viral replication and production,
suggesting an antiviral response by the piRNA pathway.
Both the piRNA and exogenous siRNA pathways may act in
combination to control viral infections in mosquito cells.
Future research is needed to determine the viral inducer
molecule of the piRNA pathway and map the involvement of
each Piwi/Ago 3 protein in detail. We cannot exclude that
some Piwi-clade proteins that are important in viral piRNA-
like production have been missed due to either inefficient
knockdown or the need of combinational knockdowns, but
our results already suggest Piwi 4 as an effector protein.
Besides, the proposed linkage between the siRNA and
piRNA pathways has yet to be investigated, and it is not yet
known if the piRNA and siRNA pathways are restricting
different parts of the viral infection (acute versus persistent
infection) in mosquitoes. Experiments in the exogenous
RNAi pathway knockout cell lines, such as C6/36 (Brackney
et al., 2010; Scott et al., 2010), suggest that the piRNA
pathway may still be able to control viral infection to some
extent on its own; however, further studies are required to
fully assess interaction between the pathways.
METHODS
Cells, plasmids and virus. Ae. albopictus-derived U4.4 and Ae.
aegypti-derived Aag2 cells were maintained in L-15 medium
supplemented with 10 % FCS and 10 % tryptose phosphate broth at
28 uC. Amplification and titration of SFV (strain SFV4) and the
SFV4(3H)-RLuc reporter virus and infection of U4.4 and Aag2 cells
were performed in a similar way as previously described; infections
were performed at growth temperature (28 uC) (Siu et al., 2011).
Briefly, viruses were grown in BHK-21 cells in Glasgow minimum
essential medium (GMEM) with 5 % FCS and 10 % tryptose
phosphate broth at 37 uC with 5 % CO2. Virus purified from the
supernatant or virus present in supernatant was titrated by plaque
assay on BHK-21 cells using an Avicell (0.6 %)/MEM overlay with 2 %
FCS. Infection of mosquito cells was performed in L-15 medium with
10 % FCS and 10 % tryptose phosphate broth for 1 h at 28 uC,
followed by a washing step with PBS and overlay with media.
Reverse transcription and PCR. RT-PCR was performed with total
RNA (500 ng) isolated using TRIzol (Invitrogen), Superscript III and
oligo-dT primer, according to the manufacturer’s protocol. Piwi/Ago
3 transcripts were detected and amplified by PCR (2 ml of the cDNA
reaction) using primers containing T7 RNA polymerase promoter
sequences (Table S1). For the detection of the transcripts, 40 rounds
of PCR using KOD polymerase were performed in contrast to 35
rounds for semi-quantitative PCR using GoTaq polymerase. The
eGFP-derived PCR product was produced by using eGFP-C1
(Clontech) as a template. PCR products were gel-purified and used
for dsRNA production or first cloned into the pJet blunt 1.2 vector
(Fermentas) and sequenced.
In vitro dsRNA transcription. dsRNA molecules for Piwi/Ago 3 and
eGFP were produced with a T7 RNA polymerase in vitro transcription
kit (Megascript RNAi kit, Ambion) using a PCR product as a
template, followed by column purification. Internally fluorescently
labelled eGFP-specific dsRNA was produced in the same way but
using fluorescein-labelled rNTP mix (Roche) following the manu-
facturer’s protocol, and purified by ethanol precipitation. Primer
sequences are indicated in Table S1.
Cell viability assay. Viability of cells transfected with dsRNA molecules
was determined using a CellTiter-Glo luminescent cell viability assay
(Promega) following the manufacturer’s recommendations.
Luciferase assay. Luciferase activities were determined using a Dual
Luciferase assay kit (Promega) on a GloMax luminometer following
cell lysis in Passive Lysis Buffer.
Transfection. Aag2 cells (1.76105 per well) were seeded in 24-well
plates, 24 h before transfection. Piwi/Ago 3 transcripts were silenced
by the transfection of 100 ng dsRNA per well (Piwi specific or 400 nt
eGFP) at 24 h post-seeding with Lipofectamine 2000 (Invitrogen),
following the manufacturer’s protocol. At 24 h p.t., cells were either
harvested to isolate RNA for RT-PCR or infected with SFV4(3H)-
RLuc at the indicated m.o.i. Supernatant from infected cells (m.o.i. of
0.1) was used to determine virus titre by plaque assays on BHK-21
cells. In addition, luciferase expression was measured 48 h p.i. as
described above.
Small RNA isolation and sequencing. Small RNA sequencing was
carried out by ARK-Genomics (The Roslin Institute, University of
Edinburgh) and The GenePool (University of Edinburgh) using the
Illumina Solexa platform. Approximately 56105 U4.4 cells and
66105 Aag2 cells per well were transfected in a 6-well plate with 1 mg
eGFP-derived dsRNA (720 nt) or left untreated.
For the infection experiments, Aag2 cells were transfected with 1 mg
Piwi 4 or eGFP dsRNA or 200 ng each Piwi1-3, 4, 5, 6, 7 and Ago 3
dsRNA using Lipofectamine 2000. At 24 h p.t., cells were infected
with SFV4 at an m.o.i. of 10. At 24 h p.t. or p.i., RNA was isolated
using 1 ml TRIzol (Invitrogen) per well, followed by purification,
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sequencing and analysis as previously described (Schnettler et al.,
2013).
Immunostaining. Aag2 cells were fixed in formaldehyde and
permeabilized by 0.3 % Triton/PBS for 30 min, followed by a wash
with PBS. Cells were pre-incubated with CAS-Block for 1 h at room
temperature, followed by incubation with CAS-Block diluted SFV
nsP3-specific antibody (1 : 500) (Siu et al., 2011) for 90 min at room
temperature. After three washing steps with PBS, an anti-rabbit
antibody conjugated with Alexa Fluor 543 diluted in CAS-Block
(1 : 1000) was incubated for 60 min at room temperature. Following
further washing steps with PBS, cells were dried and mounted with
DAPI-containing hard set Vectashield mounting medium (Vector
Laboratories), and fluorescence was detected on a Zeiss LSM Meta
microscope.
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Comparative genome analysis of Salmonella Enteritidis
PT4 and Salmonella Gallinarum 287/91 provides
insights into evolutionary and host adaptation
pathways
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Zahra Abdellah,1 Karen Brooks,1 Inna Cherevach,1 Tracey Chillingworth,1
John Woodward,1 Halina Norberczak,1 Angela Lord,1 Claire Arrowsmith,1 Kay Jagels,1
Sharon Moule,1 Karen Mungall,1 Mandy Sanders,1 Sally Whitehead,1
Jose A. Chabalgoity,5 Duncan Maskell,6 Tom Humphrey,7 Mark Roberts,8
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& Co. KG, 27472 Cuxhaven, Germany; 4School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington,
Leicestershire LE12 5RD, United Kingdom; 5Department of Biotechnology, School of Medicine, Universidad de la Republica,
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We have determined the complete genome sequences of a host-promiscuous Salmonella enterica serovar Enteritidis PT4
isolate P125109 and a chicken-restricted Salmonella enterica serovar Gallinarum isolate 287/91. Genome comparisons
between these and other Salmonella isolates indicate that S. Gallinarum 287/91 is a recently evolved descendent of S.
Enteritidis. Significantly, the genome of S. Gallinarum has undergone extensive degradation through deletion and
pseudogene formation. Comparison of the pseudogenes in S. Gallinarum with those identified previously in other
host-adapted bacteria reveals the loss of many common functional traits and provides insights into possible
mechanisms of host and tissue adaptation. We propose that experimental analysis in chickens and mice of S.
Enteritidis–harboring mutations in functional homologs of the pseudogenes present in S. Gallinarum could provide
an experimentally tractable route toward unraveling the genetic basis of host adaptation in S. enterica.
[Supplemental material is available online at www.genome.org. The genome sequence data from this study have been
submitted to EMBL under accession nos. AM933172 and AM933173.]
Zoonotic pathogens, particularly those associated with veteri-
nary animals in the human food chain, are some of the most
important causes of infectious diseases in humans. Pathogens
associated with zoonotic infections exhibit a promiscuous phe-
notype in that they maintain the ability to colonize and poten-
tially cause infections in more than one host species. In contrast,
some pathogenic agents are significantly host restricted, or
adapted, and are normally only able to cause disease in one host.
Salmonella enterica is a single bacterial species that includes ex-
amples of both promiscuous and host-adapted pathotypes. Iso-
lates from serovars such as S. enterica serovar Typhimurium and S.
Enteritidis predominantly retain the ability to infect more than
one mammalian host, including humans, whereas serovars such
as S. enterica serovars Typhi and S. Gallinarum are restricted to
humans and chickens, respectively. The ability to transmit be-
tween and within particular host populations is centrally impor-
tant in dictating the epidemiology of infections and the emer-
gence of new diseases.
Before the mid-1980s, S. Enteritidis was regarded as an S.
enterica serovar of minor public health significance, but subse-
quently this serovar became dominant in terms of human food
poisoning in many parts of the world (Rodrigue et al. 1990).
National and international legislation regarding the reporting of
disease incidence, improved hygiene and biosecurity (Barrow
9Corresponding author.
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2000), and vaccination have contributed to controlling S. Enter-
itidis levels in poultry and consequently in man in Europe, but
levels of infection remain significant. Most recent isolates of S.
Enteritidis are regarded as promiscuous in the sense that they can
cause infections in mice, retain the ability to colonize the tissues
of chickens, and cause gastroenteritis in man.
S. Gallinarum, the causative agent of fowl typhoid, is a pre-
dominantly avian-restricted serovar (Shivaprasad 2000). Interest-
ingly, in common with the human-restricted serovar S. Typhi,
the chicken-adapted S. Gallinarum causes an invasive typhoid-
like disease. Thus, here host adaptation appears to have co-
evolved with loss of the intestinal lifestyle and the acquisition of
the ability to cause systemic infection. S. Gallinarum still causes
a disease of worldwide economic significance, and although it
has been largely controlled in countries with strong health con-
trol policies, largely through serology-based test and slaughter
schemes, it remains a problem elsewhere. Multi locus enzyme
electrophoresis analyses of isolates of S. Enteritidis and S. Galli-
narum indicate that, together with isolates of S. Dublin and S.
Pullorum, they form a related strain cluster that share the same
lipopolysaccharide-based O structure (O-1, 9, 12 characteristic of
serogroup D). The nonmotile S. Gallinarum and S. Pullorum were
previously suggested to have split independently from a motile
ancestor related to S. Enteritidis (Li et al. 1993; McMeechan et al.
2005). Nonmotility in S. Gallinarum has been partially attributed
to mutations in the flagellin subunit gene fliC gene (Kilger and
Grimont 1993), which would normally express the phase 1 g, m
antigens characteristic of S. Enteritidis. Nonmotility may en-
hance the ability to invade systemically from the gut by avoiding
the TLR-5-induced pro-inflammatory responses of the host (Kai-
ser et al. 2000; Iqbal et al. 2005).
Here we report the full genome sequences of representative
isolates of S. Enteritidis and S. Gallinarum and provide a detailed
comparative genomic analysis of the two serovars. These data
have been used to provide insight into the biology, mechanisms
of host/tissue adaptation, and evolutionary relationships of these
important pathogens.
Results and Discussion
General features of the S. Enteritidis PT4 strain P125109
and S. Gallinarum strain 287/91 genomes
The complete genome sequences of the promiscuous S. Enteriti-
dis PT4 strain P125109 (hereafter S. Enteritidis PT4; EMBL acces-
sion no. AM933172) and the highly host-adapted chicken patho-
gen S. Gallinarum strain 287/91 (hereafter S. Gallinarum 287/91;
EMBL accession no. AM933173) were determined and annotated.
The main features are summarized in Table 1 and Figure 1, where
they are compared with S. Typhimurium strain LT2 (hereafter S.
Typhimurium LT2) (McClelland et al. 2001). The most striking
feature of the analysis is the predominant similarity and synteny
of core regions of the genomes, including many of the Salmonella
pathogenicity islands (SPI). Indeed, this comparative analysis
highlights an extremely close relationship between the genomes
of S. Enteritidis and S. Gallinarum, suggesting the latter is a direct
evolutionary descendent of the former. However, in comparison
to S. Enteritidis PT4, S. Gallinarum 287/91 harbors a significantly
higher number of predicted pseudogenes. Although the number
of pseudogenes in S. Enteritidis PT4 is slightly higher than re-
ported for S. Typhimurium LT2, it is in line with levels described
in other broad host range enteric pathogens such as Yersinia en-
terocolitica (Thomson et al. 2006). In contrast, the number of
pseudogenes in S. Gallinarum 287/91 is closer to that of the
human-restricted S. Typhi CT18 (204 pseudogenes) (Parkhill et
al. 2001) and S. enterica serovar Paratyphi A (173 pseudogenes)
(McClelland et al. 2004).
Whole-genome comparisons of S. Enteritidis PT4
and S. Typhimurium LT2
Initially, the genome of S. Enteritidis PT4 was compared with
that of S. Typhimurium LT2, a well-characterized and fully se-
quenced S. enterica isolate. S. Enteritidis PT4 and S. Typhimurium
LT2 are both representatives of serovars able to cause enteritis in
a broad range of hosts and produce murine typhoid, but they also
show significant phenotypic differences, including serovar type.
An alignment of the genome of S. Enteritidis PT4 with that of S.
Typhimurium LT2 revealed colinearity except for an inversion
about the terminus in S. Typhimurium LT2 (Fig. 1) (McClelland
et al. 2001), with >90% of coding sequences (CDS) forming an
extensive core gene-set (Figs. 2, 3). The average nucleotide iden-
tity between the shared orthologs is 98.98% compared with
99.7% between those of LT2 and a second fully sequenced S.
Typhimurium strain SL1344 (data not shown). The genes that are
only present either in S. Enteritidis PT4 or S. Typhimurium LT2
form 6.4% and 9.6% of their respective genomes (Fig. 3). The
majority of S. Enteritidis PT4 unique CDS are in clusters from >3
kb up to >40 kb, but there are very few indels of <3 kb (Fig. 2;
Table 2). We refer to these nonshared gene clusters as regions of
difference (ROD). CDS present in S. Enteritidis PT4 but absent
from S. Typhimurium LT2 are dominated by prophage-related func-
tions, although other functional classes are represented (Fig. 3).
Table 1. General properties of S. enterica serovar genomes
S. enterica serovars
Serovar Enteritidis Typhimurium Gallinarum Typhi
Strain P125109 (PT4) LT2 287/91 CT18
Size 4,685,848 4,857,432 4,658,697 4,809,037
Percent G + C content (%) 52.17 52.22 52.20 52.09
No. of CDS 4318 4451 4274 4599
Coding density 85.5% 86.8% 79.9% 87.6%
Average gene size 953 947 939 958
rRNA operons 7 7 7 7
tRNA 84 85 75 78
Pseudogenesa 113 25 309 204
aTaken from original publications (see text).
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Gene sets common to both S. Enteritidis PT4
and S. Typhimurium LT2
Within the core genes, there are many of the functions associated
with virulence and host interactions and include SPIs and fim-
brial operons. With the exception of SPI-6, SPI-9, and SPI-10, the
other SPIs in S. Enteritidis PT4 are closely related to their equiva-
lents in S. Typhimurium LT2 (Fig. 2) (McClelland et al. 2001). Of
the three SPIs that vary, S. Enteritidis PT4 SPI-10 only encodes the
sef fimbrial operon, consistent with this region being mosaic in
isolates of different serovars (Edwards et al. 2000; Collighan and
Woodward 2001; Bishop et al. 2005). The SPI-9 CDS SE2609,
encoding a large repetitive exported protein, appears intact in S.
Enteritidis PT4 unlike the ortholog, STM2689, in S. Typhimurium
LT2. The SPI-6 region of S. Enteritidis PT4 is 22 kb in size com-
pared with 47 kb in S. Typhimurium LT2. SPI-6 varies markedly
in size in all the other sequenced Salmonella, including S. Typhi
(McClelland et al. 2001, 2004; Parkhill et al. 2001; Chiu et al.
2005). Of the other known SPIs, SPI-8, SPI-7, and SPI-15 are ab-
sent from S. Enteritidis PT4 (Parkhill et al. 2001; Vernikos and
Parkhill 2006). Conversely, SPI-17 is present in S. Enteritidis PT4
but absent from S. Typhimurium LT2. The S. Enteritidis PT4
SPI-17 is a degenerate prophage encoding CDS known to be
involved in O-antigen conversion in other systems (Vernikos and
Parkhill 2006).
S. Enteritidis PT4 harbors 13 fimbrial clusters, 10 of which
are highly conserved in S. Typhimurium LT2 with orthologous
genes sharing >97% nucleotide identity and inserted at the same
sites in both genomes (Fig. 1; Table 2). The only exceptions to
this are safA, safB, and stdA, where the S. Enteritidis PT4 and S.
Typhimurium LT2 orthologs show 81%, 87%, and 89% nucleo-
tide identity, respectively. The S. Enteritidis PT4 fimbrial clusters
not found in S. Typhimurium LT2 include a novel cluster we
have termed peg, which is inserted at the same location as the S.
Typhimurium LT2 stc operon and is so far restricted to S. Enter-
itidis, S. Gallinarum 287/91, and S. Paratyphi A. The peg fimbrial
proteins show 58%–64% identity with their predicted functional
equivalents in the S. Typhimurium LT2 stc cluster (Table 2). Of
the remaining fimbrial clusters, ste is absent from S. Typhimu-
rium LT2, but there is a deletion remnant of the ste major pilin
subunit remaining at the analogous site (S. Typhimurium LT2;
positions 3,102,016–3,102,150 bps). Fimbrial operon stj is pres-
ent in S. Typhimurium LT2 and replaces a gene of unknown func-
tion still present in S. Enteritidis PT4 (SEN4331A). Thus, in common
Figure 1. Global comparison between S. Typhimurium, S. Enteritidis, and S. Gallinarum. ACT comparison (http://www.sanger.ac.uk/Software/ACT)
of amino acid matches between the complete six-frame translations (computed using TBLASTX) of the whole-genome sequences of S. Typhimurium LT2
(LT2), S. Enteritidis PT4 (PT4), and S. Gallinarum 287/91 (GAL). Forward and reverse strands of DNA are shown for each genome (light gray horizontal
bars). The red bars between the DNA lines represent individual TBLASTX matches, with inverted matches colored blue. The position of all the fimbrial
operons in these three genomes are marked as colored boxes positioned on the forward and reverse strands of DNA. Analogous fimbrial operons are
colored the same. The boxes of fimbrial operons that include pseudogenes are crossed with a white line. Other genomic features are only shown if they
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with other promiscuous salmonellae, S. Enteritidis PT4 harbors
multiple functional fimbrial operons (Townsend et al. 2001).
In addition to the gene remnants found for the ste fimbrial
operon S. Enteritidis PT4, RODs ROD17, ROD25, ROD34,
ROD35, and ROD37 (Table 2) that fall outside of the core
gene-set also have discernable remnants in S. Typhimurium LT2
or are conserved in other S. enterica and so are likely to have been
present in a precursor of S. Enteritidis PT4, shared with S. Typhi-
murium LT2, and subsequently deleted from S. Typhimurium
LT2.
Figure 2. Circular representation of the S. Enteritidis PT4 chromosome. From the outside in, the outer circle 1 marks the position of regions of
difference (mentioned in the text) and is detailed in Table 2. Circle 2 shows the size in base pairs. Circles 3 and 4 show the position of CDS transcribed
in a clockwise and anti-clockwise direction, respectively (for color codes see below); circle 5 shows the position of S. Enteritidis PT4 pseudogenes. Circles
6 and 8 show the position of S. Enteritidis PT4 genes that have orthologs (by reciprocal FASTA analysis) in S. Typhimurium strain LT2 (all CDS colored
green) and S. Gallinarum strain 287/91 (all CDS colored blue), respectively. Circles 7 and 9 show the position of S. Enteritidis PT4 genes that lack
orthologs in (by reciprocal FASTA analysis) in S. Typhimurium strain LT2 (all CDS colored pink) and S. Gallinarum strain 287/91 (all CDS colored gray),
respectively. Circle 10 shows the position of S. Enteritidis PT4 rRNA operons (red). Circle 11 shows a plot of G + C content (in a 10-kb window). Circle
12 shows a plot of GC skew ([G  C]/[G + C]; in a 10-kb window). Genes in circles 3 and 4 are color-coded according to the function of their gene
products: dark green, membrane or surface structures; yellow, central or intermediary metabolism; cyan, degradation of macromolecules; red, infor-
mation transfer/cell division; cerise, degradation of small molecules; pale blue, regulators; salmon pink, pathogenicity or adaptation; black, energy
metabolism; orange, conserved hypothetical; pale green, unknown; and brown, pseudogenes.
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Gene sets only present in S. Enteritidis PT4 but not S.
Typhimurium LT2
By analyzing the genetic context of the S. Enteritidis PT4 specific
RODs, we distinguish between those likely to have been acquired
independently from those that may have been deleted from S.
Typhimurium LT2 (discussed above). Examples of likely acquisi-
tions include SPI-17, ROD4, ROD9, ROD13, ROD21, ROD22,
ROD28, ROD40, SE14, and SE20 (Table 2). RODs unique to S.
Enteritidis PT4 include potentially mobile genomic islands, clus-
ters of genes encoding metabolic functions and prophage-like
elements, as well as a variable assortment of fimbrial operons
already described (summarized in Table 2).
Genomic islands
ROD21 is the only S. Enteritidis PT4 genomic island not found in
S. Typhimurium LT2 and has features characteristic of mobile
genetic elements (Table 2). ROD21 shares significant structural
conservation with conserved genomic loci present in a range of
bacteria. These islands all display an unusual G + C profile,
whereby regions conserved between islands show a higher G + C
content compared with the variable island-specific regions (Fig.
4) (Williamson and Free 2005; this study). Surprisingly, most of
the ROD21-related islands encode paralogs of H-NS (hnsB) and/or
an H-NS antagonist, hnsT (Williamson and Free 2005; Navarre et
al. 2006; Doyle et al. 2007). These paralogs may play a role in
relieving any potential fitness burden associated with sequester-
ing H-NS to these low G + C DNA elements (Doyle et al. 2007).
Of the other S. Enteritidis PT4-specific RODs, ROD13 en-
codes five CDS displaying sequence similarities and synteny with
genes associated with the uptake and catabolism of the hexonate
sugar acid L-idonate encoded by the gntII locus of Escherichia coli
(Table 2) (Bausch et al. 1998). Although the substrate for this
system is unclear, it is known that colonic mucus contains sev-
eral sugar acids that represent an important source of nutrients
and that E. coli mutants unable to utilize them are unable to
colonize the mouse large intestine (Sweeney et al. 1996). More-
over, genes involved in the transport of gluconate and related
hexonates are up-regulated in S. Typhimurium in macrophage,
suggesting that they may also be an important source of carbon
for intracellular bacteria (Eriksson et al. 2003).
The S. Enteritidis PT4 RODs also include loci that are highly
variable in the salmonellae and, for ROD40, between the wider
Enterobacteriaceae. ROD40 locus encodes a Type I restriction/
modification system and is analogous to the variable E. coli immi-
gration control region (ICR) (Raleigh 1992; Titheradge et al. 1996).
Prophage
Prophage are known to drive diversity in S. enterica, and thus, it
is not surprising that many S. Enteritidis PT4–specific RODs are
prophage-like elements, including SE10, SE12, SE12A,
SE14, and SE20 (Fig. 2; Table 2) (Thomson et al. 2004; Cooke
et al. 2007). All these prophage regions
are related and carry the same cargo
genes as prophage found previously in
other S. enterica (see Table 2), including
genes encoding type three secretion sys-
tem (TTSS) effector proteins—sseK3,
sspH2, gogA, sseI, and sopE; the PhoPQ-
activated genes pagK and pagM; as well as
sodCI encoding a Cu/Zn superoxide dis-
mutase known to be an important colo-
nization factor for S. Typhimurium
(Stanley et al. 2000; Figueroa-Bossi et al.
2001; Mmolawa et al. 2003; Thomson et
al. 2004). Of the six prophage-related re-
gions, only SE20 appears intact and
probably represents a recent insertion
event, whereas remnants of SE12A are
also present at the same location in S.
Typhimurium LT2 and probably repre-
sent the most ancient phage insertion
that has been maintained in these two
Salmonella lineages. However, the num-
ber of remnants and intact cargo genes
found on the S. Enteritidis PT4 prophage
highlights the importance of these ele-
ments for gene sampling and increasing
the overall diversity and even patho-
genic potential of salmonellae.
Whole-genome sequence of S.
Gallinarum 287/91 and comparisons
with S. Enteritidis PT4 and S.
Typhimurium LT2
One of the striking features of the S. Gal-
linarum 287/91 genome is the high simi
Figure 3. Distribution of orthologous CDS in S. Enteritidis PT4, S. Typhimurium LT2, and S. Galli-
narum 287/91. The Venn diagram shows the number of genes unique or shared between two other
S. enterica serovars (see Methods). The associated pie charts show the breakdown of the functional
groups assigned for CDS in relevant sections of the Venn diagram. Color code for the pie charts is as
follows: (1) hypothetical proteins, (2) conserved hypothetical proteins, (3) chemotaxis and motility, (4)
chromosomal replication, (5) chaperones, (6) protective responses, (7) transport and binding proteins,
(8) adaptations to atypical conditions, (9) cell division, (10) macromolecule degradation, (11) synthesis
and modification of macromolecules, (12) amino acid biosynthesis, (13) biosynthesis of cofactors,
prosthetic groups and carriers, (14) central intermediary metabolism, (15) small-molecule degrada-
tion, (16) energy metabolism, (17) fatty acid biosynthesis, (18) nucleosides and nucleotide biosynthe-
sis and metabolism, (19) periplasmic/exported/lipoproteins, (20) ribosomal proteins, (21) laterally
acquired (including prophage CDS), (22) pathogenicity and virulence, (23) general regulation, and
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larity with S. Enteritidis PT4 compared with S. Typhimurium LT2
(Figs. 3, 5). The average nucleotide identities of orthologs shared
between S. Gallinarum 287/91 and S. Enteritidis PT4 were higher
(99.7%) than those found in LT2 (98.93%). Another obvious fea-
ture is the massive accumulation of pseudogenes in S. Gallina-
rum 287/91 compared with S. Enteritidis PT4 and S. Typhimu-
rium LT2. The genome of S. Gallinarum 287/91 is slightly smaller
than S. Enteritidis PT4, carries significantly fewer tRNA genes
(Table 1), and is colinear except for a single inversion (817 kb;
about the rRNA operons) and translocation of a region (49 kb)
located between two different rRNA operons (Figs. 1, 5).
The number of CDS unique to S. Gallinarum 287/91 (76) or
shared exclusively between S. Gallinarum 287/91 and S. Typhi-
murium LT2 (16) was small and predominantly phage-associated
(Figs. 3, 5). Moreover, genes from both of these categories all fell
within regions (SPI-6, ROD9, ROD42, and SG12) that are present
in S. Enteritidis PT4 but appear to be in the process of being lost.
Consequently, these genes are unlikely to be recent acquisitions
by S. Gallinarum 287/91.
Of the 130 CDS specific to S. Enteritidis PT4, compared
with S. Gallinarum 287/91, those associated with ROD4 and
prophages SE10, SE14, and SE20 (82 CDS) appear to be re-
cent acquisitions with no evidence of them ever being present in
S. Gallinarum 287/91(Fig. 3; Table 2). Of the remaining 48 CDS
in this category, 21 were located on loci (ROD15, ROD18, and
ROD30) (Table 2) almost entirely deleted from S. Gallinarum 287/
91. The others were located on shared loci such as ROD14 and
SPI-6 that are degenerate in both serotypes, compared with S.
Typhimurium LT2. The functions that these RODs encode in S.
Enteritidis PT4 are summarized in Table 2.
Thus, we provide compelling genetic evidence that S. Enter-
itidis and S. Gallinarum are recently diverged clones. On this
conclusion, we have plotted the most parsimonious explanation
for the observed gene flux following the divergence of S. Typhi-
murium LT2, S. Enteritidis PT4, and S. Gallinarum 287/91
(Fig. 6).
Functional gene loss and pseudogene formation
In addition to the large scale deletion, there is further evidence of
reductive evolution in S. Gallinarum 287/91 in the form of 309
putative pseudogenes that carry frameshifts or premature stop
codons or that are remnants of genes present in other bacteria.
Remarkably, this represents ∼7% of the total coding capacity of
the genome and includes genes from many functional categories,
including metabolism and virulence (for a full list, see Supple-
mental Table 1).
Figure 4. Comparison of the ROD21 locus of S. Enteritidis with related genomic islands. ACT comparison (http://www.sanger.ac.uk/Software/ACT)
of amino acid matches between the complete six-frame translations (computed using TBLASTX) of ROD21 compared with related loci uropathogenic
E. coli strain CFT073 (UPEC), Erwinia carotovora sbsp. atroseptica strain SCRI1043 (two loci: ECA1 and ECA2), and Photorhabidus luminescens,sbsp.
laumondii TT01 (PHL; see Methods). The red bars spanning between the genomes represent individual TBLASTX matches. CDS are marked as colored
boxes positioned on the horizontal gray DNA bars: (orange) genes conserved in two or more of the genomic islands; (light green) variable genes of
unknown function; (dark pink) hnsB; (dark blue) hnsT; (light pink) integrase; (dark green) type IV pilin-associated genes; (red) plasmid-related mobility
functions; (salmon pink) transposase-related genes; (yellow) tRNA genes; (light blue)repeats. The G + C profile for the UPEC loci is shown above. The
scale is marked in base pairs.
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S. Gallinarum 287/91 has lost several pathways, which are
likely to narrow the spectrum of substrates available for use as
sources of carbon and energy. These include malS encoding a
periplasmic alpha-amylase required for growth on long chain
maltodextrins (Schneider et al. 1992), those affecting the catabo-
lism of (D)-glucarate (gudD) and the mutation in the hyaF gene
(within the hydrogenase 1 [hya] gene cluster).
S. Gallinarum 287/91 also possesses multiple mutations in
genes within all three operons required for the breakdown 1,2-
propanediol: ttr, cbi, and pdu operons directing tetrathionate res-
piration; coenzyme B12 biosynthesis (B12; cobalamine); and 1,2-
propanediol degradation, respectively (Supplemental Table 1)
(Roth et al. 1996). 1,2-Propanediol is an important source of en-
ergy for S. Typhimurium, and cbi mutants are significantly at-
tenuated in their ability to grow in macrophages (Klumpp and
Fuchs 2007). Consequently, for most of the salmonellae, the abil-
ity to degrade propanediol is the likely selective pressure main-
taining the cbi and ttr genes, and the loss of function of any of
Figure 5. Circular representation of the S. Gallinarum 287/91 chromosome. For a full description of this figure, see legend to Figure 2. The exception
is that circle 5 shows the position of S. Gallinarum 287/91 pseudogenes. Circles 6 and 8 show the position of S. Gallinarum 287/91 genes which have
orthologs (by reciprocal FASTA analysis) in S. Typhimurium LT2 (all CDS colored green) or S. Enteritidis PT4 (all CDS colored blue), respectively. Circles
7 and 9 show the position of S. Gallinarum 287/91 genes that lack orthologs in (by reciprocal FASTA analysis) in S. Typhimurium strain LT2 (all CDS
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these three pathways was probably the precursor to the degen-
eration of the others in S. Gallinarum 287/91. Mutations within
the cbi, pdu, and ttr genes was also a feature of the S. Typhi CT18
genome (Table 3), suggesting that these mutations may be char-
acteristic of more invasive Salmonella serotypes.
Uniquely among the Salmonella, S. Gallinarum 287/91 and
S. Pullorum are unable to make glycogen (Supplemental Table 2)
(McMeechan et al. 2005). The genome sequence data revealed
that mutations in the glycogen biosynthetic pathway are exten-
sive in S. Gallinarum 287/91, including glgA, glgB, and glgC,
which are responsible for all steps in biosynthesis. Although the
significance of these mutations are not clear, they may explain in
part the poor survival of this bacterium outside of the host (Mc-
Meechan et al. 2005).
Several of the identified S. Gallinarum 287/91 pseudogenes
lie in amino acid catabolic or biosynthetic pathways. Salmonella
encodes three pathways for arginine degradation (Reitzer 2003),
and S. Gallinarum 287/91 carries mutations in two of these:
There are deletions or frameshifts in the genes of the arginine
N-succinyltransferase (AST) (astA) and arginine deiminase (ADI)
(arcA) pathways, respectively. S. Gallinarum 287/91 also carries a
mutation in speC encoding the ornithine decarboxylase, making
the one remaining intact arginine catabolic pathway, arginine
decarboxylase pathway (ADC), an essential biosynthetic route for
putrescine. The mutation in speC is also likely to explain the
inability of S. Gallinarum to decarboxylate ornithine, a defining
feature of this Salmonella serovar (Supplemental Table 2) (Crich-
ton and Old 1990).
Pseudogenes potentially involved in virulence
and host adaptation
S. Gallinarum 287/91 is defined as being nonmotile. S. Gallina-
rum 287/91 carries 50 genes associated with motility and che-
motaxis, distributed over three loci. Of these, five genes, present
in two loci, carry mutations that explain
the nonmotile phenotype, including
cheM, flhA, flhB, flgK, and flgI (Supple-
mental Table 1).
Of the 13 fimbrial operons detected
in S. Enteritidis PT4, the std fimbrial op-
eron is not present in S. Gallinarum 287/
91 (see ROD30 above). The remaining 12
S. Gallinarum 287/91 fimbrial operons
are identical to those in S. Enteritidis PT4
except for the mutations in genes within
operons sti, stf, saf, stb, peg, lpf, sef, and
sth (see Supplemental Table 1). The level
of pseudogene formation within these
12 fimbrial gene clusters (16%) is over
twice that of the genome average (7%).
Only operons fim, bcf, csg, and ste re-
main undisrupted on the S. Gallinarum
287/91 chromosome (summarized in
Fig. 1). However, both S. Enteritidis and
S. Gallinarum carry fimbrial operons on
their virulence plasmids. The S. Enteriti-
dis virulence plasmid carries five genes—
pefA, pefB, pefC, pefD, and pefR—highly
conserved with those of S. Typhimurium
LT2 (Woodward and Kirwan 1996). The
pef operon is not present on the S. Gal-
linarum 287/91 plasmid; in its place are
three intact fimbrial genes displaying sequence similarity with
those of the E. coli K88 fimbrial gene cluster (Rychlik et al. 1998).
This fimbrial operon represents the only evidence of S. Gallina-
rum 287/91 having acquired new functions since the split from S.
Enteritidis. It would be interesting to know if any isolates of S.
Enteritidis carry such a fimbrial operon and whether this is a
common characteristic of all S. Gallinarum strains. Significantly,
the host-adapted S. Typhi harbors novel fimbrial genes, includ-
ing Type IV pili associated with the acquisition of mobile ele-
ments (Pickard et al. 2003), and like S. Gallinarum 287/91, there
is an elevated level of mutation in fimbrial genes (14% compared
with the genome average of 4.4%), again suggesting parallel
paths toward host adaptation (Table 3).
Salmonella can express several paralogous TTSS effector pro-
teins, which show a degree of functional redundancy, for ex-
ample, sopE and sopE2 (Friebel et al. 2001). Other effectors related
by sequence include pipB and pipB2, and sifA and sifB. S. Galli-
narum 287/91 has lost one of each of these parlogous pairs.
Other S. Gallinarum 287/91 TTSS effector genes that carry muta-
tions include sopA, which has been implicated in S. Typhimuri-
um–induced intestinal inflammation (Zhang et al. 2006). Using
an antibody against the C-terminal portion of SopA, we detected
a secreted protein of the expected size in S. Enteritidis PT4 but
not S. Gallinarum 287/91 (data not shown), consistent with the
location of a stop codon prior to the mAb-binding region in S.
Gallinarum SopA predicted by the genome sequence (Supple-
mental Table 2). SopA influences Salmonella-induced enteritis,
and taken together with the attrition of other Type III secreted
effectors, this may partially dictate the differential virulence of
the serovars in mammalian hosts.
As well as additional pseudogenes associated with cell inter-
actions, again like S. Typhi, S. Gallinarum 287/91 carries muta-
tions in genes also associated with shedding (shdA and ratB), drug
resistance, DNA restriction/modification, and protective re-
Figure 6. Line diagram to represent the whole-genome differences of S. Enteritidis PT4, S. Typhi-
murium strain LT2, and S. Gallinarum strain 287/91. A summary of the observed loss and gain of RODs
described in Table 2. The diagram is based on the assumption that following the divergence of PT4 and
LT2 from a common ancestor PT4 and GAL have subsequently diverged. Branches are not intended to
infer phylogenetic distance. Evidence that a locus was once present in LT2, PT4, or GAL (see legend to
Figure 1) but has subsequently been deleted from that genome is marked by the suffix *, $, or £,
respectively. Brackets indicate the name for locus in GAL. Parentheses indicate the name for locus in
PT4. Dotted arrows mark the position in the pseudo-tree at which that ROD(s) appears
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sponses (Supplemental Table 1). The majority of S. Enteritidis
isolates can produce a biofilm, of which cellulose is a key com-
ponent. While mutations in biofilm production may not mea-
surably affect virulence, they are significantly less resistant to
chemical and mechanical stress. Consequently, this is likely to be
an adaptation by Salmonella to survival in the environment but
has also been suggested to prolong retention in the gut (Solano et
al. 2002). We have shown experimentally that S. Gallinarum
287/91 is unable to make cellulose, and this is likely to be ex-
plained by a mutation in bcsG (Supplemental Table 2). This is
consistent with the reduced ability of S. Gallinarum to colonize
the gut compared with S. Enteritidis.
Conclusions
The data presented in this report provide several clear messages,
some of which may be experimentally tractable. Comparative
analysis of the genomes of S. Enteritidis PT4 and S. Gallinarum
287/91 shows that representative strains of these two S. enterica
serovars are highly related and that S. Gallinarum may be a direct
descendant of S. Enteritidis. Importantly, S. Enteritidis is promis-
cuous, being able to colonize and infect multiple hosts, including
chickens, cattle, mice, and humans, in addition to producing
murine typhoid. Whereas S. Gallinarum is highly restricted to
causing a typhoid-like disease in avian species, it is relatively
noninfectious in other hosts, including mice, and does not colo-
nize the gut of animals. Thus, we suggest that there is an experi-
mental opportunity to use genetic approaches to define the ge-
netic basis of host restriction by directly comparing the patho-
genicity of strains of S. Enteritidis and S. Gallinarum in murine
and chicken models.
Previous genome analyses on host-restricted salmonellae
has involved human-restricted serovars, including S. Typhi and S.
Paratyphi, limiting experimental tractability. Nevertheless ge-
nome comparisons of host-restricted/adapted S. enterica serovars,
and indeed of other pathogens, indicate that loss of gene func-
tion may be a common evolutionary mechanism through which
host adaptation occurs. Gene loss not only may limit the inter-
host promiscuity of the pathogen but also is likely to restrict the
potential pathogenicity in the host to a more limited set of in-
teractions. We hypothesize that gene loss may be a mechanism of
targeting the invading pathogen preferentially to particular tis-
sues or host cells and avoiding the potential stimulation of non-
specific inflammation. An example here would be the loss of
flagella or fimbriae, which can mediate attachment and invasion
of cell surfaces and may activate pattern recognition molecules.
Table 3. Summary of the common traits identified among the functions of genes lost independently by S. Typhi CT18 and S. Gallinarum
287/91
Process/pathway S. Gallinarum 278/91a S. Typhi CT18b
Cell interactions slrP, sopA, sifB, sspH2, sinH, pipB2, pagK, bigA sopD2 (STY0971), sopA (STY2275),
sopE2 (STY1987), sseJ (STY1439a),
cigR (STY4024), misL (STY4030),
marT (STY4027), sivH (STY2767),
slrP (STY0833), bigA (STY4318)
Fecal shedding shdA, ratB shdA (STY2755), ratB (STY2758), sivH (STY2767)
Fimbriae std, stiC, stfF, safC, stbC, pegC, lpfC, sefD, sefC,
sthB, sthA, sthE
bcfC (STY0026), fimI (STY0590), steA (STY3084),
safE (STY0333), stgC (STY3920),
ushA (STY0539), sefA (STY4836a)
sefD (STY4839), sefR (STY4841),
sthC (STY4938), sthE (STY4938)
Flagella/motility cheM, flhB, flhA, flgK, flgI fliB (STY2166)
Type I restriction modification hsdR, hsdM hsdM (STY4833)
Type III restriction modification
Restriction enzyme StyLT1 mod res (STY0389)
Cobalamine biosynthesis pocR, cobD, cbiD, cbiC, cbiO cbiM (STY2226), cbiK (STY2229), cbiJ (STY2231)
Propanediol utilization pduG, pduO pduN (STY2254)
Metal/drug resistance and transport
Copper cusA, cusS cusA (STY0610), cusS (STY0609a)
Nickel/cobalt rcnAcusA, cusS rcnA (STY3169)
Nickel nxiArcnA nxiA (STY2901)
Acriflavin acrFnxiA acrE (STY3569), acrF (STY3570)
Tetrathionate respiration ttrB, ttrC ttrS (STY1735)
Trehalose degradation/synthesis treC treA (STY1924)
Hydrogenase I hyaF hyaB2 (STY1525), hyaA (STY1319)
Ornithine catabolism speC speC (STY3270), speF (STY0739)
Amino acid catabolism
L-serine/L-threonine tdcG tdcC (STY3426)
Cellulose biosynthesis bcsG bcsC (STY4184)
Surface polysaccharide
LPS O-chain gtrB gtrB (STY2627b)
LPS core rfaZ (waaZ) wcaK(STY2311), wcaD (STY2324), wcaA (STY2328)
Alternative terminal electron acceptors
Dimethyl sulfoxide reductase dmsA2, dmsA1 dmsA2 (STY4503), dmsB2 (STY4506)
Trimethylamine N-oxide (TMAO) torS torR (STY3954), torC (STY3955)
Carbon source
D-Glucarate uptake and degradation gudD gudP (STY4097)
Maltodextrin and Maltose associated malS, malY, malX malY (STY1657a), malX (STY1657)
aFor systematic gene identifiers and a description of function, see Supplemental Table 1.
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In addition, gene loss can influence the ability of the pathogen to
survive in the external environment or even in stressful situa-
tions within the host. Table 3 provides a list of some of the
common traits identified among the functions of genes lost in-
dependently by S. Typhi and S. Gallinarum. Some of the overlaps
are striking, including the loss of common TTSS effectors and
genes involved in common metabolic processes such as cobala-
mine and propanediol utilization, tetrathionate respiration,
sugar uptake and utilization, hydrogenase activity, cellulose pro-
duction, ornithine decarboxylase activity, and electron transport
acceptor function. Some of these common traits have also been
noted to have changed in representatives of gut adapted (Y. en-
terocolitica) versus systemic (Y. pestis) yersiniae, and again in this
system, gene loss may be involved in the adaptation from a gut
to a systemic lifestyle. We believe that further studies analyzing
the contribution of pseudogenes and their functional alleles to
host adaptation and tissue specificity and, in particular, the par-
allel but overlapping degradative evolutionary pathways fol-
lowed by different organisms adapting to different hosts will lead
to significant understanding of the mechanisms of host adapta-
tion and host restriction and could be applicable to the less trac-
table human-adapted organisms, such as S. Typhi.
Methods
Bacterial strains
S. Gallinarum strain 287/91 was isolated from an outbreak of
fowl typhoid in brown egg–laying hens by A. Berchieri, Univer-
sity of Sao Paulo, Jaboticabal, Brazil. It is highly virulent (>90%
mortality) in susceptible breeds of chickens (P. Barrow and A.
Berchier, unpubl.). It was chosen in preference to the well-
characterized strain 9 (Smith 1955) because of the length of labo-
ratory passage of the latter strain. S. Enteritidis phage type 4 (PT4)
strain P125109 was isolated from an outbreak of human food-
poisoning in the United Kingdom that was traced back to a poul-
try farm. The strain is highly virulent in newly hatched chickens
and is also invasive in laying hens, resulting in egg contamina-
tion (Barrow 1991; Barrow and Lovell 1991). Biochemical tests
for carbohydrate catabolism were performed using api 50 CH
according to manufacturer’s instructions (BioMerieux).
Growth and sequencing of S. Enteritidis PT4
and S. Gallinarum 287/91
Methods for sequencing S. Enteritidis PT4 and S. Gallinarum 287/
91 were identical unless stated. A single bacterial colony was
picked from Congo Red agar and grown overnight in BAB broth
with shaking at 37°C. Cells were collected, and total DNA (10 mg)
was isolated using proteinase K treatment followed by phenol
extraction. The DNA was fragmented by sonication, and several
libraries were generated in pUC18 using size fractions ranging
from 1.0–2.5 kb.
The whole genome sequenced to a depth of 9 coverage
from M13mp18 (insert size 1.4–2 kb) and pUC18 (insert size 2.2–
4.2 kb) small insert libraries using dye terminator chemistry on
ABI3700 automated sequencers. End sequences from larger insert
plasmid (pBACe3.6, 12–30 kb insert size) libraries were used as a
scaffold.
The sequence was assembled, finished, and annotated as
described previously (Parkhill et al. 2000), using the program
Artemis (Berriman and Rutherford 2003) to collate data and fa-
cilitate annotation.
The genomes have been submitted to EMBL under the fol-
lowing accession numbers: S. Enteritidis PT4 genome,
AM933172; S. Gallinarum 287/91 genome, AM933173.
In silico genome analysis
The genome sequences of S. Typhimurium strain LT2 (McClel-
land et al. 2001), S. Enteritidis PT4, and S. Gallinarum 287/91
were compared pairwise using the Artemis Comparison Tool
(ACT) (Carver et al. 2005). Subsequences taken from the genomes
of uropathogenic E. coli strain CFT073 (Welch et al. 2002), Er-
winia carotovora sbsp. atroseptica strain SCRI1043 (Bell et al.
2004), and Photorhabidus luminescens,sbsp. laumondii TT01
(Duchaud et al. 2003) were compared with ACT as above and
used to construct Figure 4.
Pseudogenes had one or more mutations that would ablate
expression; each of the inactivating mutations was confirmed by
subsequently rechecking the original sequencing data and where
necessary were resequenced.
Orthologous gene sets were identified by reciprocal FASTA
searches. Only those pairs of homologous CDS were retained for
further analysis where the predicted amino acid identity was
40% over 80% of the protein length. These genes were then
subject to manual curation using gene synteny to increase the
accuracy of this analysis. This strategy was applied to pairwise
comparisons of the genomes of S. Typhimurium strain LT2, S.
Enteritidis PT4, and S. Gallinarum 287/91.
Cellulose production assay
For preparation and use of Calcofluor plates, Calcofluor white
stain was obtained from Sigma as a 0.1% w/v solution. This was
added to L-agar at a final concentration of 200 µg/mL as recom-
mended by Solano et al. (2002). Bacterial cultures were inocu-
lated and then left at room temperature for 48 h.
Colony fluorescence was examined by holding the plate
over a 366-nm UV transilluminator. Controls used included E.
coli C600 (negative control) and S. typhimurium SL1344 (positive
control). Colony fluorescence was scored quantitatively using
the controls as standards.
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Salmonella enterica is an animal and zoonotic pathogen of worldwide importance and may be classified into
serovars differing in virulence and host range. We sequenced and annotated the genomes of serovar Typhi-
murium, Choleraesuis, Dublin, and Gallinarum strains of defined virulence in each of three food-producing
animal hosts. This provides valuable measures of intraserovar diversity and opportunities to formally link
genotypes to phenotypes in target animals.
Salmonella enterica causes salmonellosis in humans and
other warm-blooded animals. Over 2,600 serovars have been
classified according to the reactivity of antisera to somatic
lipopolysaccharide and flagellar antigens and are broadly
grouped on the basis of host range and disease presentation.
The molecular basis of the differential virulence and tropism of
serovars remains ill defined (20). An understanding of such
processes is required to develop strategies for disease control
and to predict the threat posed by isolates from animals.
The extent to which currently sequenced strains are typical
of the wider serovar is open to question. We report the se-
quencing and annotation of four strains representing serovars
that produce significant illness in food-producing animals: S.
Typhimurium strain ST4/74 (11), originally isolated from a calf
with salmonellosis in the United Kingdom (17) and the parent
of the widely used mouse virulent hisG auxotroph SL1344 (10);
S. Choleraesuis var. kunzendorf strain SCSA50, a field isolate
from a case of swine typhoid in the United Kingdom (3); S.
Dublin strain SD3246, a Vi-negative isolate from a calf with
systemic salmonellosis in the United Kingdom (24); and S.
Gallinarum SG9, first described to cause fowl typhoid in orally
dosed chickens by Smith in 1955 (19). Crucially, the virulence
of each strain has been reciprocally compared in calves, pigs,
and chickens (3, 4, 6, 14, 15, 16, 17, 24, 25, 26, 27), fulfilling
Koch’s postulates and enabling strain genotypes to be linked to
phenotypes in target hosts.
Sequencing and annotation. 36 cycle paired-end sequencing
was carried out on an Illumina GAIIx, yielding between 80 and
150X coverage. SOAPdenovo (13) was used to generate de
novo contigs, and reads aligned to a reference using Novoalign
(Novocraft, Selangor, Malaysia). S. Typhimurium 4/74 reads
were assembled on the genome and large plasmid of
strain SL1344 (http://www.sanger.ac.uk/Projects/Salmonella/).
S. Choleraesuis SCSA50 reads were assembled on the genome
of strain SC-B67 (7) and its virulence plasmid (28). S. Dublin
SD3246 reads were assembled on the genome of strain
CT_02021853 (accession no. CP001144). S. Gallinarum SG9
reads were assembled on the genome of strain 287/91 (22). The
de novo and reference contigs were combined using MUMmer
(12) and Gap4 (5).
Sequences were annotated using GenoPipe (http://genopipe
.bioinfo-portal.cdac.in/) and a combination of gene prediction
software (1, 8, 18, 21). Manual curation followed to enhance
the annotation, including pseudogene prediction and assign-
ment of start sites. Genes with unsuitable names for submis-
sion were searched against SwissProt (23), and genes with a
large degree of overlap were checked for domains (2, 9) and
hits in SwissProt. If no domains or matches were found, the
gene was removed from the annotation.
Intraserovar comparisons indicated that the complete S.
Typhimurium 4/74 genome contained just eight single-nucle-
otide polymorphisms (SNPs) relative to SL1344, consistent
with the shared history of the strains and high-quality sequenc-
ing and assembly. The hisG allele varied between the strains as
expected (10).
Nucleotide accession numbers. Sequences were deposited
in GenBank and assigned the following accession numbers;
S. Typhimurium 4/74 (CP002487-CP002490), S. Cholerae-
suis SCSA50 (CM001062 to CM001063), S. Dublin SD3246
(CM001151 to CM001152), and S. Gallinarum SG9
(CM001153 to CM001154).
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Abstract
With the development of ultra-high-throughput technologies, the cost of sequencing bacterial genomes has been
vastly reduced. As more genomes are sequenced, less time can be spentmanually annotating those genomes, result-
ing in an increased reliance on automatic annotation pipelines. However, automatic pipelines can produce inaccurate
genome annotation and their results often require manual curation. Here, we discuss the automatic and manual
annotation of bacterial genomes, identify common problems introduced by the current genome annotation process
and suggests potential solutions.
Keywords: bacteria; genomics; annotation; automatic; errors
BACKGROUND
Prokaryotic genomics has seen an explosion in the
number of genome projects, driven by the advent
of next generation sequencing (NGS), resulting in
a huge reduction in the time and money investment
per project [1]. Microbial genome annotation often
consists of running an automatic annotation pipeline
followed by manual curation of the results [2].
Most annotation pipelines use homology methods
to transfer information from a closely related refer-
ence genome to the new sequence. Automatic pipe-
lines can lead to the introduction and propagation of
poor annotation and errors, and it is the purpose of
the manual curation step to catch and remove these.
However, as it is now possible to sequence multiple
microbial genomes in a single day at low cost using a
single sequencing machine [3], it is no longer feasible
to manually curate the annotation of all sequenced
genomes. Fully-automatic annotation pipelines,
while essential to the modern microbial genomicist,
may introduce and propagate inconsistent and incor-
rect gene annotations.
High-quality annotation goes beyond applying
gene prediction software and transferring the anno-
tation from the genome’s closest relative. We have to
include features other than coding sites (CDS), such
as ribosomal-binding sites (RBSs), termination sites
and conserved motifs/domains. Not only do these
features give a fuller annotation they actually can
rectify errors from earlier parts of the annotation pro-
cess. For example, predicting RBS and termination
sites will give a much clearer idea of a gene’s true
location rather than using gene prediction alone.
Luckily, there are many software tools for the pre-
diction of these features [4–8].
Transferring annotation purely based on the
closest annotated relative does have its limitations.
When we consider the reason the new strain has
been sequenced, often it will be to identify how
this strains differ genetically to its close relatives.
This is paradoxical because we are trying to find
the differences between these strains but using a simi-
larity based method to annotate it. Potential areas of
interest may not be annotated because they are not in
the reference genome.
With this surge in sequencing, we will also see an
increase in the number of annotated genomes sub-
mitted to the public databases. Sequence databases
have introduced more stringent requirements for
submitters meaning that running an annotation
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pipeline alone is not enough to ensure acceptance of
the genome annotation [9, 10]. There has also been a
surge in other next generation techniques such as
RNA-seq, incorporating experimental methods
gives a better indication of a protein’s role and
whether it is functional. These annotations would
be more accurate because they are based on actual
experiment data rather than homology. Currently
genomes can include evidence tags stating how the
annotation was assigned, however, they are often
omitted from the process. Including evidence quali-
fiers gives the user an idea of the reliability of the
reference genome. The concept of assigning a level
of quality to annotation is not novel, but is seldom
used [11, 12].
This article discusses some of the current steps for
prokaryotic genome annotation and offers a guide to
some of the common problems that are encountered
during automatic annotation. It goes on to identify
the limitations of reference genomes and why choos-
ing the closest relative is not always the best option.
We also discuss the rules of the public sequence data-
bases, and go on to suggest possible next steps toward
a more accurate, comprehensive annotation with
minimal propagation of errors.
Annotation of bacterial genomes
Here we describe a very general process used for
bacterial genome annotation (Figure 1). A more
thorough review can be found in Stothard and
Wishart [2]. In many cases there is a closely related
strain/serovar available which has already been
sequenced and annotated. Most annotation pipelines
employ gene prediction software, the most common
of which is GLIMMER [13]. This uses a reference
set of sequences to train a model and then utilizes
that model to predict coding regions in the genome
of interest. Many other ab initio gene prediction
algorithms exist and these are reviewed by Do and
Choi [14]. Alternatively, gene finding can be per-
formed by extrinsic methods, identifying open read-
ing frames directly from comparisons to protein
databases [15, 16].
Once coding regions have been identified, they
are aligned either to a reference genome annotation
or the entirety of UniProt [17] using fast sequence
alignment tools (e.g. FASTA [18] or BLAST [19]),
the top hits are accepted as homologs and the anno-
tation is transferred across for genes displaying high
similarity. Other features such as tRNAs and rRNAs
may then added using other prediction software [20].
A range of automatic bacterial annotation pipe-
lines have been published, including web-based
systems such as RAST [21], BASys [22], WeGAS
[23] and MaGe/Microscope [24]; and systems to be
locally installed, such as AGeS [25], DIYA [26] and
PIPA [27]. There is also MICheck [28] which checks
annotated sequences for syntactic errors. All of these
systems carry out the basic process outlined above,
with various additions to check for errors or add
additional information. It is worth noting that in
order to submit to a genome repository that the
annotation needs to be in a compatible format
(e.g. .tab or .asn). Some pipelines do not output in
this manner as they are designed to either hold the
annotation online or for in-house analysis [22, 23].
Further processing may therefore be necessary before
submission to a public database.
Other feature types
For acceptance to databases such as GenBank or
EMBL, only gene, CDS and structural RNA features
Figure 1: A generic process for bacterial genome
annotation.











need to be added [9, 10]. However, many other
features should be added. This section gives a
broad overview of some of the other features and
how they can be predicted; a comprehensive guide
is available [29].
Gene prediction software sometimes assigns the
wrong start/termination sites. Glimmer for example
assigns the start site as the most upstream start codon
[5]. By searching for RBS, one can infer and reassign
the start site; RBSFinder does this by looking for
motifs such as the Shine-Dalgarno sequence pattern
[5]. For termination sites, TransTerm searches for
rho-independent transcription terminators to assign
the correct termination site [6]. As well as correcting
start/termination sites these features should be added
to the annotation, using the tags ‘RBS’ and ‘termin-
ator’ respectively.
Regions of conservation within proteins such as
motifs and domains should be added to the annota-
tion after the gene finding step. There are many
databases which store protein families such as
ProSite, PRINTS and Pfam [4, 7, 8]. InterproScan
can perform searches against a range of domain/
motif databases [30]. Hits to motif/domain databases
should be assigned the qualifier ‘db_xref’ within the
corresponding CDS feature [9, 10].
Areas of horizontal gene transfer (HGT) such
as pathogenicity islands and prophage can be pre-
dicted by looking at asymmetries in codon compos-
ition and the GC content as these will often differ
between areas of HGT and the rest of the genome
[31]. They are often associated with the presence
of integrases, transposases and IS elements [31].
Software tools exists to predict these [32, 33], and
these are reviewed and compared by Langille, et al.
[34]. There are clear guidelines for annotating
phage, this should be assigned under the ‘source’
feature with the name of the bacteriophage in
the ‘organism’ qualifier and the type of sequence
in ‘mol_type’ (usually genomic DNA). There is
no specific annotation tag for other GIs so these
should be annotated as miscellaneous features. The
mobile genetic elements themselves use the ‘mobile_
element’ tag.
Sequence repeats such as ‘clustered regularly inter-
spaced short palindromic repeats’ (CRISPRs) and
other tandem repeats are of biological interest. For
example, they can be used to understand the bacter-
ial defense mechanism [35] and to distinguish be-
tween closely related strains [36]. Software tools
exist [37, 38] and databases such as MICdb store
predicted microsatellites as well as offering a predic-
tion tool for user inputted sequence [39].
Identifying a protein’s cellular localization can be
indicative of function and this can be used in the
identification of drug targets. There are many meth-
ods of prediction including homology and keywords
[40], amino acid composition [41–43] and a mixture
of these [44], Gardy and Brinkman [45] have per-




In an ideal world this would be the end of the
annotation process. The fact that homology is the
basis for these pipelines means that many genomes
currently available may have been annotated using
old, out of date genomes as a reference which in turn
have been annotated based on even older more out
of date genomes. The misannotations and errors may
perpetuate throughout each new genome, ultimately
propagating into secondary databases such as UniProt
[17] and KEGG [46], and domain-specific databases
such as PATRIC [47].
The public sequence databases have recognized
the need for controlling this replication of errors
and provide validation software for checking
the standard of one’s annotation prior to submission
[9, 10]. This section looks at common errors that are
the product of automated annotation and tries to
address methods of overcoming these.
Inconsistent annotation
Many bacterial genera now have multiple species
and strains with complete genomes, representing
a fantastic resource for comparative genomics.
However, each genome is annotated separately, by
a range of different groups using different protocols,
and this introduces inconsistencies. One particular
problem is that of split/fused genes and domains;
Kummerfield and Teichman [48] found that, of
7116 distinct domain architectures examined across
131 archaeal, bacterial and eukaryotic genomes, 47%
showed evidence of gene fusion/fission events. An
example of this is the eutM/eutN locus in Salmonella.
Figure 2 shows six different models that have been
used to annotate this region in the 17 RefSeq records
for Salmonella at time of publication. In Salmonella
typhi CT18 (NC_003198) and Salmonella typhi Ty2
(NC_004631) there is a single ORF of 690 bp











annotated as eutN (Figure 2A). The protein
sequence maps to two domains in PFAM, a BMC
domain (PF00936) and a EutN_CcmL domain
(PF03319). In all other Salmonella genomes in
RefSeq, stop codons within this region split the
gene, and the domains, in two. In one genome
(NC_012125) the region has been annotated as a
single long pseudogene of 690 bp (Figure 2B); a fur-
ther four genomes annotate two intact gene/CDS
features, eutM and eutN, each 300 bp in length
(Figure 2C). A further three genomes are annotated
with one pseudogene, a 291 bp ORF equivalent to
the eutM gene in Figure 2C, and one intact gene, a
288 bp ORF labeled as eutN (Figure 2D). A further
two genomes annotate two ORFs, 291 bp and
300 bp in length respectively, both annotated as
pseudogenes (Figure 2E), equivalent to the eutM
and eutN genes in Figure2C. Finally, one genome
(NC_006511) includes two intact genes, but has
reversed the order of eutM and eutN (Figure 2F).
The various ways in which the eutN and eutM
genes have been annotated represents a problem for
further genome annotation. We cannot know,
simply from the genome sequences alone, whether
this locus represents a single long gene that has been
split in two, or two shorter genes that have become
fused. All six models represent different interpret-
ations of a locus that is highly conserved at the nu-
cleotide level across Salmonella species, and any novel
genome that is compared to just one of those models
will have annotation heavily influenced by that
model. For example, if a novel genome is compared
only to genomes represented by Figure 2B (two
short ORFs annotated as a single long pseudogene)
the interpretation will be very different than if the
genome were compared to Figure 2C (two short
ORFs annotated as two separate intact genes).
Predicting domains directly, rather than genes,
using tools such as PfamAlyzer [49], may help in
regions with split genes. In the case of eutM/eutN
in Salmonella, a domain search would identify two
intact domains in all cases; however, the question
of whether or not those domains come from the
same or separate genes would remain unresolved.
We are left with two different versions of the eutN
gene from Salmonella in the public databases, one of
690 bp containing two domains, and one of 290 bp
with one domain.
The only way to annotate this region correctly
in silico would be to compare any new genome to
each of the six different models. It is difficult to im-
agine a set of rules that could be given to an auto-
matic annotation pipeline to interpret correctly the
evolution of this region and apply that interpretation
to a newly sequenced genome. To truly get the full
story we would need to look at experimental data
(such as RNA-Seq data) to see what the patterns of
expression are.
In the eutN/eutM example above, we see a case
where genes of vastly differing lengths have been
Figure 2: The six different models present across 17 RefSeq entries for Salmonella species for the eutM/eutN
locus. Green indicates normal gene/CDS features, lighter grey indicates gene features annotated as pseudogenes.
(A) A single intact gene of 690bp; (B) a single pseudogene of 690bp; (C) two short intact genes 300bp in length;
(D) one pseudogene and one intact gene, each 300bp in length; (E) two pseudogenes, each 300bp in length; and
(F) two intact genes with the order reversed.











given the same gene name in different genomes; in
contrast to this, it is also possible for orthologous
genes to be assigned different gene names. Figure 3
shows a syntenic block of genes annotated in
Escherichia coli K12 MG1655 (NC_000913) and E. coli
O157:H7 Sakai (NC_002695). These two regions
are more than 97% identical at the nucleotide
level; however, the annotation differs considerably.
While E. coliK12MG1655 contains features with gene
names araA, araB and araC, the equivalent features in
E. coli 0157:H7 Sakai do not have those gene names
and have been assigned uninformative locus tags.
Further information is available for the features
with only locus tags, including their involvement
in arabinose metabolism, however, the gene names
remain absent. At the far right of the gene block, two
orthologous features exist, both with gene names,
however, this time the problem is that they are dif-
ferent: thiB in K12 MG1655 and tbpA in 0157:H7
Sakai. A simple search of the NCBI gene database
(search term ‘thiB AND Escherichia coli [Organism]’
versus search term ‘tbpA AND Escherichia coli
[Organism]’) reveals that both features code for a
thiamin(e) transporter subunit, but the gene is
given the gene name tbpA in over 30 E. coli species,
whereas it is given the name thiB in only one.
Luckily, the thiB feature in K12 MG1655 lists tbpA
as a ‘synonym’. Finally, in the centre of the image,
K12MG1655 contains a feature with the gene name
yabI, whereas its ortholog in 0157:H7Sakai only has a
locus tag. This is an example of a y-gene, which we
discuss in greater detail in the ‘Hypothetical proteins’
section.
The major issue here is that not only do differ-
ent genomes annotate orthologous genes differ-
ently, and provide inconsistent information; they
also contain differing amounts of information.
This means that, when annotating a new genome,
it is essential to choose a reference genome that
contains the most accurate and up-to-date infor-
mation, and that it is also preferable to compare
any new genome to multiple references such that
inconsistent annotations can be identified and
resolved.
Spelling mistakes
There are 128 proteins in UniProt that contain
the word ‘syntase’, an incorrect spelling of the
word ‘synthase’. To put this into context,
the RefSeq entry for RhizobiumetliCFN42 (accession
NC_007761) assigns the function ‘dihydrofolate
syntase’ to gene folC. This has propagated into
other databases such as UniProt (accession:
Q2KE79), KEGG (accession: RHE_CH00024),
and xBASE (accession: RHE_CH00024). If a user
was to visit any of these databases and search
for ‘dihydrofolate synthase’ the misspelled entries
would be omitted from the search results. Large
scale detection and correction of spelling mis-
takes in public databases is a difficult task, and so
there is a reliance on the submitter to correct
these. Automatic annotation pipelines simply copy
and propagate what is there already. Spelling mis-
takes may be highlighted by the validation software
provided by the public databases during submission,
however, an alternative correct spelling isn’t offered,
making it difficult to amend the mistakes without
manual intervention.
This can be solved by writing rules to find spelling
mistakes [16]. However, this approach is limited to
spelling mistakes which are explicitly written in the
code. A solution may exist beyond biological sci-
ence. The search engine Google upon receiving
the input ‘syntase’ automatically states ‘Did you
mean: synthase’. There are programming languages
which have classes or plugins to produce such ‘did
you mean’ results [50, 51].
Figure 3: A syntenic block of genes showing inconsistent gene name annotations in E.coli K12 MG1655 and E. coli
0157:H7 Sakai.











‘Same gene name, different product
name’
This issue occurs when two features, either within
or between genomes, are assigned the same short
gene name yet different product names. The NCBI
validation software specifically highlights when this
occurs intra-genomically with the description ‘Same
gene name, different product name’ [9, 10]. In
the current set of 2696 microbial genome and plas-
mid sequences in RefSeq, we detected 23,843 genes
with at least two different product names (see http://
www.ark-genomics.org/genomeannotation.html for
the full list). The most extreme example of this is
gene ‘tnp’ which has 151 different product names
(‘tnpA’ has a further 97). A more manageable
example can be seen in Table 1. The ‘int’ gene has
a total of 12 different product names across 17
Salmonella RefSeq entries. These product names con-
tain huge variation in terms of information content.
When using an automatic annotation pipeline, there
is a danger that if the top hit is to an entry labeled
‘Hypothetical protein’, then you will capture far
less information than if your top hit is to ‘phage
integrase family site specific recombinase’. In order
to correctly annotate this gene in a new genome, it is
necessary to take into account all of these product
names in the annotation process. It is difficult to im-
agine a set of text-mining rules that could efficiently
interpret the range of annotations and assign the
most suitable one to a new gene.
Hypothetical proteins
The term ‘hypothetical protein’ often refers to a
gene that has been predicted by software but
which finds no homolog of known function in the
databases, and which has no known functional
domain. There are currently 53 035 proteins whose
product name contains both words in UniProt
(search term: ‘name:hypothetical AND name:pro-
tein’) and there are a further 5 178 212 proteins in
UniProt that contain the words ‘uncharacterized’
and ‘protein’ (search term: ‘name:uncharacterized
AND name:protein’). These may be real genes
with no known function or they may be artifacts
of the gene prediction process.
Many bacterial genes of unknown function are
assigned y-gene names based on their orthologous
location in E. coli K-12 [52]. The letters denote the
location in terms of minutes around a circular
genome. This gene annotation has propagated
throughout many strains and species of bacteria,
losing the relevance and context of its name as the
genes are not all in the same relative location to
the original annotation in E. coli K-12. For example
the yabF gene has a known function, ‘glutathione-
regulated potassium-eflux system ancillary protein’.
The gene name yabF is completely meaningless in
all genomes other than the original and actually has
a synonym kefF. With that in mind annotators
should use more informative gene names as a pref-
erence, choosing alternative gene names over the
original y-gene annotation.
Often there are features which are only ortholo-
gous to other hypothetical features and do not
contain any domains. These could either be regions
with no functionality, a relic of the feature prediction
software or the domains present have not been
discovered yet. Whether or not to include them
is often a decision made by the annotation team
and varies between groups. Thus, many artifactual
Table 1: Different product names assigned to features with the gene name ‘int’ across 17 different
RefSeq entries for Salmonella species
Gene name Product name Accession
int bacteriophage integrase NC_003198, NC_004631, NC_015761
int Gifsy-1 prophage Int NC_006905
int hypothetical protein NC_006905
int Integrase NC_003198, NC_004631, NC_006511, NC_012125
int integrase (fragment) NC_003198
int phage integrase family site specific recombinase NC_006905
int putative cytoplasmic protein NC_006905
Int Putative integrase NC_003384
int putative integrase protein NC_006905
int putative P4-type integrase NC_006905
int putative phage integrase protein NC_006905
int site-specific recombinase, phage integrase family NC_012125











‘hypothetical proteins’ may be annotated, published
and disseminated into the public databases, rein-
forcing the annotator’s belief that their new gene
predictions do indeed have homologs in other
species. It would be more informative to actually
state in the annotation a score for each feature.
This will allow users to make informed assessments
of the features and programmers to easily parse
genomes to handle hypothetical proteins based on
their quality of hits. Gilks, et al. [12] discuss the
possibility of assigning scores based on the source
of annotation.
There are arguments for and against keeping
these proteins in the annotation. If they are indeed
a misannotation by the gene prediction software they
should be removed as they will perpetuate through
secondary and tertiary databases as a recognized
protein awaiting functional discovery. Searching for
conserved domains or motifs in databases such as
Pfam or InterPro can give an indication of whether
a hypothetical protein is functional but this has pit-
falls too. The fact that a protein has a domain
hit doesn’t necessarily convey its function. Pfam
[8], for example, contains over 3000 ‘domains of
unknown function’, or DUFs, representing over
20% of known families [53] and as more novel gen-
omes are sequenced the number of new DUFs
will increase. A hit to a DUF does not inform us
of a feature’s function, but as they are areas of high
conservation they indicate a potential region of
biological interest.
Through computational methods alone there
are no means to conclusively determine whether a
genomic region is functional. With that in mind
conserved features of unknown function should be
kept because in the future they may be recognized as
a true region of interest; however, they should
be annotated differently to discriminate them from
features with stronger evidence. Evidence tags are
available but they are often not present, and are
not a prerequisite for submission to GenBank or
Embl. Evidence qualifiers such as how the feature
was predicted (e.g. glimmer, blast, homology) and
what entries it hits in a given database provide a
clear audit trail for anyone who wants to assess the
quality of a particular annotation. The type of data
source used, that is, whether it is manually curated or
automated should be stated, providing the user with
a clear method of judging the annotation. As experi-
mental data becomes more ubiquitous evidence tags
should play a larger role in annotation.
Experimental methods such as RNA-Seq [54] and
Signature Tagged Mutagenesis (STM) [55] may help
to identify regions of functionality. RNA-Seq data
can help delineate and quantify areas of transcription,
and overlaying this expression data on the genome
may help biologists to identify pseudogenes and the
true locations of features. STM can help identify the
function of genes by monitoring the phenotype of
single-gene mutants.
The most important point is that one’s annotation
is only ever as good as the reference data sources.
In terms of publicly available genome sequences
the quality is varied. It is worth actually looking at
the annotation and assessing the quality. Choosing a
genome because it is the closest relative will give the
most homologous features but might not give the
best quality annotation.
Combining additional data with the original
annotation gives scientists a new way of viewing
the genome. Experimental data could be able to
solve the eutM/eutN problem described above; for
example, RNA-Seq data would show which areas
of the genome are actively transcribed and STM
may indicate whether knocking out either of the
genes alters the phenotype of the mutant.
Distinguishing orthologs from paralogs
The definition of orthologous and paralogous
genes is of great importance when annotating
novel genomes. Whereas ‘homology’ refers to
genes that simply share a common origin, ‘orthology’
refers to genes that arise by speciation and ‘paralogy’
refers to genes that arise by duplication. Figure 4
shows some of the processes that can lead to, and
define, orthologs and paralogs. Beginning with a
single ancestral, a gene duplication event occurs to
create two paralogous genes. After a speciation
event, there are two different organisms that both
contain the paralogous genes from the gene duplica-
tion event. Gene 1a in Organism 1 has three homo-
logs after the speciation event. Gene 1a in Organism
1 and Gene 1a in Organism 2 are orthologs as they
have only been separated by the speciation event.
Gene 1a in Organism 1 and Gene 1b in Organism
1 are in-paralogs, as they have only been separated
by the gene duplication event. Finally, Gene 1a in
Organism 1 and Gene 1b in Organism 2 are
out-paralogs, as they have been separated by the
gene duplication and the speciation event.
These processes are not only crucial in defining
evolutionary relationships, but also functional











relationships, as orthologs tend to retain similar func-
tions, whereas paralogs tend to diverge over time to
perform different functions (reviewed in ref. [56]).
Therefore, when transferring functional annotation
from a sequenced genome to a novel genome, it is
essential that orthologs are accurately defined. There
are several computational approaches which can be
used to accurately define orthologs (reviewed in ref.
[57]). Phylogenetic tree-based approaches attempt to
reconstruct the evolutionary relationship between
gene sequences and thus define orthologs and para-
logs; however, it may be impractical to construct a
phylogenetic tree for every gene in a newly sequence
genome. An alternative is the ‘bidirectional’ or ‘re-
ciprocal’ best-hit approach [58], usually determined
by comparing the top-ranking matches found by a
search algorithm such as BLAST or FASTA [18, 19].
Gene Synteny, the conservation of local gene order,
can also help distinguish orthologs from paralogs in
closely related genomes. However, it is important to
note that a number of processes can lead to the
breakdown of absolute gene synteny, resulting in
genuine orthologs having a different gene order.
These processes include gene duplication or fusion
events, local rearrangements (insertions/deletions)
and translocations. It is important that we model
these processes to allow the correct identification of
orthologs in complex cases, and the MaGe [24]
system attempts to do this. Finally, it has been
observed that orthologs exhibit a greater level of
protein domain architecture conservation than para-
logs [59]. In practice, it may be essential to use a




Many scientists go through the process of annotation
with the final aim of submitting to a genome data-
base such as GenBank or EMBL. In order to realize
this goal there are many rules which need to be
followed [9, 10] and often validation software is pro-
vided to verify one’s annotation. These rules
are imposed to ensure a better standard of genome
annotation, however, they do mean that often the
output of an automatic annotation pipeline must be
manually checked and altered prior to publication.
Many of the issues described in the ‘Limitations of
the Annotation Process’ section may be identified
as potential problems and the submitter is provided
with long lists of features that represent these. They
must be checked, and either altered or justified. In
addition to those mentioned above, there are others
described below.
CDS nomenclature
There are many words which may be unacceptable
in protein names, such as ‘binding’, ‘domain’, ‘like’,
‘motif’, ‘gene’ and ‘homolog’. Submitters may be
Figure 4: A diagram displaying the processes that can lead to, and define, orthologs and paralogs.Gene duplication
and speciation events create complex evolutionary relationships between genes.











encouraged to change these: for example ‘bac-
teriophage replication gene’ can be changed to ‘bac-
teriophage replication protein’ and ‘peptidyl-tRNA
hydrolase domain protein’ can be changed to
‘peptidyl-tRNA hydrolase protein’; a note may be
added to state that the feature contains the afore-
mentioned domain. These rules add complications
if the submitter wants to fully automate the process
of annotation. As a rule of thumb, if a predicted
coding region has homologs in SwissProt these are
the best protein names to transfer across and running
the validation software after using SwissProt initially
can greatly reduce the number of suspect names.
As an aside, ‘probable’ and ‘predicted’ are not flagged
up by the validation software but ‘putative’ is the
preferred alternative.
Some CDSs have the same protein name as the
protein next to them, which can be the sign of either
a disrupted gene or a valid gene duplication event. It
can also be because the protein name is very general
such as ‘hypothetical protein’ or ‘inner membrane
protein’. These features may be flagged up by the
validation software and, if they are not pseudogenes,
need a note stating that they overlap a CDS with the
same protein name.
CDS gene names that appear more than once in
a genome and have different proteins names to
one another (e.g. Table 1) may also be identified as
potential errors. These may be brought to the
submitter’s attention who often has to use their dis-
cretion and knowledge to assign gene names cor-
rectly. This can be as simple as performing a
similarity search and seeing which gene names are
associated with the hits.
Problems with coding regions
The NCBI validation software flags up all instances
where a coding region completely contains another
coding region on the opposite strand. The submitter
is asked to check these coding regions and decide
whether these are true features. If the coding
region only hits hypothetical proteins and doesn’t
contain any domains, it may be either removed or
demoted to a miscellaneous feature.
FUTURE
Gold standard genomes
RefSeq is one attempt to standardize and improve the
quality of genome annotation; however, as we have
shown, problems persist. With the implementation
of stricter rules for submission we should see an
increase in annotation quality. While genomes of
varying quality are available there should be a
means for scientists to see the quality of any given
annotation. Evidence qualifiers such as how the
feature was predicted and what entries in a given
database the feature sequence hit, including the
database version and date, would provide a clear
audit trail for anyone who wants to assess the quality
of a particular annotation. The type of data source
used, that is, whether it is manually curated or auto-
matically generated should also be stated, providing
the user with a clear method of judging the
annotation.
Out of the 1851 publicly available completed
bacterial genomes 102 have a version number of
0.2 or higher [60]. This means that the submitting
group have revisited the original sequence and
changed it. The fact that the sequences have been
changed is indicative of a higher quality sequence.
This, however, does not reflect the quality of the
annotation. It is possible to look at the revision his-
tory of genomes within GenBank, this will give users
an idea of changes on a genome by genome basis, no
small feat when there are 1851 genomes available. In
the literature there have been several papers which
have revisited and reannotated genomes, these
include strains of E. coli, Campylobacter jejuni and
Mycobacterium tuberculosis [61–63]. In terms of what is
currently available these genomes are likely to be the
closest to realizing ‘gold standard genome
annotation’.
Janssen, et al. [11] calculated the number of publi-
cations per gene for all completed genome to calcu-
late a Species Knowledge Index (SKI) for each
genome. They showed that, in bacteria, there is a
pronounced bias toward certain organisms namely
E. coli, Pseudomona aeruginosa and Bacillus subtilis. With
this in mind perhaps there should be a focus
to annotate genomes with a high SKI to the highest
level possible as there is such an abundance of experi-
mental data available. These can then be used as gold
standard genomes for annotations of other species.
As we learn more about genes and protein func-
tion it becomes clear that a simple protein name is
inadequate. Some proteins are multi-functional, per-
forming different tasks depending on the context it
is expressed in. We can say that a protein has a
one-to-many relationship with function, meaning
that assigning a protein name based on the first func-
tion associated with it can be misleading and











inaccurate. The Gene Ontology (GO) may provide a
more flexible way of describing a range of func-
tions explicitly and concisely, and GO annotations
natively include evidence qualifiers. However, GO
terms are not frequently included as part of the initial
annotation of bacterial genomes. The EBI offer
UniProtKB-GOA Proteome Sets [64], GO annota-
tions for all completely sequenced genomes in the
public domain, however, these are not included with
or clearly linked to the original genome submission.
The development and use of GO annotations
is encouraged and these should be included in
genome annotation efforts.
Improving automated annotation
The pipelines currently on offer do not take many of
the pitfalls outlined above into account, meaning
that a lot of manual effort is required to correct
errors and inconsistencies. It is easy to imagine
adjustments to current pipelines that take into
account certain aspects (e.g. common spelling mis-
takes) but not others (e.g. correctly interpreting
pseudogenes). Realistically, completely removing
the manual stage of annotation would be imprudent,
however, improving current automated pipelines
may greatly reduce the time spent manually checking
the annotation.
New data types
There have been a flood of new genome-wide data
types in the post-genomic era, for example micro-
array and RNA-Seq data, many of which can assist
with genome annotation. However, these are often
large, unwieldy, come in a variety of different for-
mats and can be hard to integrate with one another.
Allowing scientists to visualize this data alongside
genome annotation can be hugely powerful [65];
however, genome annotation is often kept in specific
flat file formats where integrating non-text data is
virtually impossible. Secondary and tertiary databases
may include additional data alongside the original
genome annotation [20], but these ‘data warehouse’
approaches employ copies of the original data
which can become out-of-date and out-of-synch
with the original data. The advent of bioinformatics
web services [66] may allow new systems that query
data live over the internet, ensuring the latest data is
displayed.
CONCLUSION
Advances in sequencing technologies are allowing
researchers to sequence microbial genomes at a
huge rate. It is becoming harder to devote time to
manually annotate these genomes, leading to a rise in
automatic annotation pipelines. However, due to a
range of problems, the output of these automatic
annotation pipelines is unsuitable for publication.
Some changes can be made to improve this output;
however, it is difficult to envisage an end to manual
checking and curation.
Additional data from post-genomics experiments
can help improve genome annotation; however, a
line has to be drawn regarding what data should be
included in the annotation and what should be in
separate databases. Tools and services need to be de-
veloped which offer scientists a means of viewing
genome annotation augmented with other experi-
mental data. This will empower the user to make
meaningful judgments on the quality of annotation
and the relevance of a particular region to their
research.
For the foreseeable future bacterial annotation re-
quires both automated and manual steps. Offering
users a measure of quality for the whole genome
and individual genes will allow user to make an in-
formed choice regarding reference genomes and
transferring annotation between genomes. Using
GO terms would improve protein description and
reduce syntactic errors.
Key Points
 Advances in sequencing technology now allow modern
researchers to rapidly sequencemultiple bacterial genomes.
 Automatic annotation pipelines that work via comparison to a
reference database can introduce and propagate errors.
 Manual checking and curation of annotation is essential tomain-
tain a high quality.
 Additional data-sources from post-genomic experiments can
assist in the annotation process.
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Abstract
Background: Salmonella enterica is a facultative intracellular pathogen of worldwide importance.
Over 2,500 serovars exist and infections in humans and animals may produce a spectrum of
symptoms from enteritis to typhoid depending on serovar- and host-specific factors. S. Enteritidis
is the most prevalent non-typhoidal serovar isolated from humans with acute diarrhoeal illness in
many countries. Human infections are frequently associated with direct or indirect contact with
contaminated poultry meat or eggs owing to the ability of the organism to persist in the avian
intestinal and reproductive tract. The molecular mechanisms underlying colonisation of poultry by
S. Enteritidis are ill-defined. Targeted and genome-wide mutagenesis of S. Typhimurium has
revealed conserved and host-specific roles for selected fimbriae in intestinal colonisation of
different hosts. Here we report the first systematic analysis of each chromosomally-encoded major
fimbrial subunit of S. Enteritidis in intestinal colonisation of chickens.
Results: The repertoire, organisation and sequence of the fimbrial operons within members of S.
enterica were compared. No single fimbrial locus could be correlated with the differential virulence
and host range of serovars by comparison of available genome sequences. Fimbrial operons were
highly conserved among serovars in respect of gene number, order and sequence, with the
exception of safA. Thirteen predicted major fimbrial subunit genes were separately inactivated by
lambda Red recombinase-mediated linear recombination followed by P22/int transduction. The
magnitude and duration of intestinal colonisation by mutant and parent strains was measured after
oral inoculation of out-bred chickens. Whilst the majority of S. Enteritidis major fimbrial subunit
genes played no significant role in colonisation of the avian intestines, mutations affecting pegA in
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two different S. Enteritidis strains produced statistically significant attenuation. Plasmid-mediated
trans-complementation partially restored the colonisation phenotype.
Conclusion: We describe the fimbrial gene repertoire of the predominant non-typhoidal S.
enterica serovar affecting humans and the role played by each predicted major fimbrial subunit in
intestinal colonisation of the primary reservoir. Our data support a role for PegA in the
colonisation of poultry by S. Enteritidis and aid the design of improved vaccines.
Background
Non-typhoidal serovars of Salmonella enterica are an
important cause of food-borne diarrhoeal illness in
humans worldwide. Using active surveillance data from a
catchment area of 44.5 million people, the FoodNet net-
work has estimated that there are 1.4 million cases of
human non-typhoid salmonellosis in the United States
per annum, leading to 15,000 hospitalisations and 400
deaths [1]. Over the past three decades S. enterica serovar
Enteritidis has emerged as a significant cause of such
infections [2]. The consumption of undercooked poultry
meat and eggs is a major risk factor for S. Enteritidis infec-
tion [3] and the phage types circulating in humans are
commonly found in broilers [4] and layers [5]. The inci-
dence of S. Enteritidis infection in humans declined mark-
edly following the implementation of control strategies,
including vaccination for poultry, regulations on storage
and preparation of food and improved education [6].
Despite such measures, S. Enteritidis remains the most
prevalent cause of non-typhoidal salmonellosis in many
countries, including the United Kingdom http://
www.hpa.org.uk/infections/topics_az/salmonella/
data.htm, and improved vaccines are needed to achieve
further reductions in the burden of human disease.
It is well established that S. Enteritidis is able to persist in
the intestinal and reproductive tract of poultry in the
absence of clinical signs [7]; however the molecular mech-
anisms mediating colonisation of these sites are ill-
defined. Further, it is unclear why some S. enterica serov-
ars are associated with enteric disease in a broad range of
healthy out-bred adult hosts (e.g. Enteritidis and Typh-
imurium), whereas others are host-restricted or -specific
and associated with severe systemic disease (e.g. Galli-
narum in poultry and Typhi in humans). Targeted and
genome-wide mutagenesis of the broad host range serovar
Typhimurium has indicated that it uses both conserved
and host-specific factors to colonise the intestines of
chickens, cattle, pigs and mice [8-14]. Among the factors
that influence intestinal colonisation are fimbriae; pro-
teinaceous surface appendages that mediate interactions
between bacteria and host cells.
Of the thirteen fimbrial loci predicted to be encoded by
the S. Typhimurium genome, lpf, fim, bcf, stb, stc, std, sth
and csg have been implicated in virulence in mice
[11,13,15-17]. Screening of a library of signature-tagged
mutants of S. Typhimurium indicated that pathogenicity
island (SPI)-6-encoded saf fimbriae may play a host-spe-
cific role in ileal colonisation of pigs [14], whereas the
stbC, csgD and sthB fimbrial genes were implicated in col-
onisation of the avian gut [12]. Separately Ledeboer et al
described a role for lpfA-E, pefC, csgA and fimH, but not
sthD or bcfF, in biofilm formation on chicken intestinal
mucosa cultured ex vivo [18]. Relatively few studies have
probed the role of fimbriae in colonisation of poultry by
S. Enteritidis. Allen-Vercoe and Woodward reported that a
S. Enteritidis mutant lacking fimD, csgA, pefC, lpfC and
sefA colonised the caeca at comparable levels to the parent
strain following oral dosing of 1 or 5 day-old chicks [19]
and was similarly invasive [20] and adherent to chicken
gut explants [21]. Furthermore, single mutants lacking
fimA, csgA or sefA exhibited no significant defect in colo-
nisation of chick caeca and were excreted in the faeces at
comparable levels to the parent [22,23]. Although roles
for S. Enteritidis fimbriae in intestinal colonisation of
poultry have so far been lacking, Type I fimbriae [24] and
curli [25] have been implicated in egg contamination.
In the recent publication of the complete genome
sequence of S. Enteritidis strain P125019 [26] we have
defined the full repertoire of fimbrial loci and identified a
unique fimbrial operon, peg, present in S. Gallinarum, S.
Enteritidis and also S. Paratyphi. The peg operon displays
60–70% sequence conservation with the stc operon of S.
Typhimurium and is located in the same relative position.
The peg operon belongs to the γ clade of fimbriae and is
predicted to be assembled via the chaperone usher path-
way [27].
The work herein examined the fimbrial gene conservation
in the published genomes of other S. enterica serovars and
also searched for traits associated with phase variation.
Isogenic S. Enteritidis mutants with insertions in the
major fimbrial subunit of each of the fimbrial operons
were constructed using lambda Red recombinase-medi-
ated linear recombination [28] followed by P22/int trans-
duction. Mutant phenotypes were then evaluated and
confirmed using an established chicken colonisation
model.
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Methods
In silico analysis of fimbrial loci
The complete genome sequences of S. enterica serovar
Enteritidis strain P125109 [26], S. Gallinarum strain 287/
91 [26], S. Typhimurium SL1344 and S. Typhimurium
DT104 were produced by the Pathogen Sequencing Unit,
Wellcome Trust Sanger Institute, UK http://
www.sanger.ac.uk/Projects/Salmonella/. Published
genome sequences were obtained from the National
Center for Biotechnology Information (NCBI) and are
described with their RefSeq-curated accession numbers; S.
Typhimurium LT2 NC_003197 [29], S. Typhi CT18
NC_003198 [30], S. Typhi Ty2 NC_004631 [31] and S.
Choleraesuis SC-B67 NC_006905 [32]. Fimbrial gene
sequences were identified from the primary literature and
databases via NCBI Entrez and the genome sequences
were visualised and compared using Artemis and Artemis
Comparison Tool ACT [33,34]. Direct and indirect repeat
sequences were searched for as described [35]. A Perl
script was written to isolate and visualise S. Enteritidis
fimbrial operons and is available from the authors on
request.
Bacterial strains and plasmids
S. Enteritidis phage type 4 strain P125109 (NCTC 13349)
was isolated from a poultry-associated outbreak in the UK
and is naturally nalidixic acid resistant. A spontaneous
nalidixic acid resistant derivative of S. Enteritidis S1400
[19] was selected by standard methods and it exhibits
wild-type growth and chick colonisation phenotypes
(data not shown). Strains were cultured in Luria-Bertani
(LB) medium supplemented with antibiotics at the fol-
lowing concentrations where appropriate: nalidixic acid
(Nal, 20 μg ml-1), novobiocin (1 μg ml-1), ampicillin (100
μg ml-1) and chloramphenicol (25 μg ml-1). Plasmids
pCP20 [36], pKD3 and pKD46 [28] were obtained from
the E. coli Genetic Stock Centre, Yale University. Plasmids
pCR4Blunt-TOPO (Invitrogen, Paisley, UK) and
pACYC177 [37] were used for cloning in E. coli K-12 strain
TOP10F' (Invitrogen, Paisley, UK).
Construction and validation of major fimbrial subunit 
mutations
Primers were designed to amplify the pKD3-encoded
chloramphenicol resistance cassette, including 40 bp
homology extensions from the 5' and 3' of each predicted
major fimbrial subunit gene (Table 1). The extensions
were designed such that the region between the start and
stop codon of each major fimbrial subunit gene would be
replaced by the chloramphenicol resistance cassette. PCR
products were purified and electroporated into S. Enteri-
tidis harbouring the helper plasmid pKD46, following
induction of the Red recombinase with 10 mM L-arab-
inose at 30°C as previously described [28]. Recombinants
were selected on LB-agar containing chloramphenicol and
cured of pKD46 by culture at 37°C in the absence of amp-
icillin. Mutations were confirmed at the expected position
in the genome by PCR with primers specific to the chlo-
ramphenicol resistance cassette and primers flanking each
major fimbrial subunit gene (Table 2). Mutations were
also confirmed by Southern blotting with HindIII-
digested genomic DNA from wild-type and mutant strains
using the cat gene as a probe. Attempts were made to
transduce each mutation using bacteriophage P22/int
into an archived strain to reduce the likelihood that phe-
notypes are the result of second site defects. For unknown
reasons, three mutations could not be transduced, there-
fore the original recombinant was compared relative to
the parent strain. Growth kinetics of all mutants were
determined by diluting an overnight culture of S. Enteri-
tidis wild-type or mutant strain 1:1000 in LB medium and
measuring the absorbance at 600 nm every 30 minutes for
24 hours using a Bioscreen-C real-time spectrophotome-
ter (Thermo®, Helsinki, Finland).
FLP recombinase-mediated excision of the 
chloramphenicol resistance cassette
To remove the chloramphenicol resistance cassette from
the ΔpegA::cat mutant and create a predicted non-polar
mutation, the temperature-sensitive plasmid pCP20 was
introduced and expression of FLP recombinase induced
by culture at 42°C in the absence of antibiotic selection as
described [28]. FLP-mediated recombination between
flippase recognition target (FRT) sites flanking the pKD3-
derived chloramphenicol resistance cassette was con-
firmed by PCR using primers flanking pegA. Excision of
the chloramphenicol cassette was predicted to result in an
84 nucleotide in-frame scar between the pegA start and
stop codons. The second codon in the scar is a stop codon,
however pegA is not predicted to be translationally cou-
pled to the 3' gene and therefore polar effects are not
anticipated at the level of transcription or translation.
Trans-complementation of the pegA::cat mutant
The pegA coding sequence was amplified by PCR from S.
Enteritidis P125109 genomic DNA using Pfu proof-read-
ing DNA polymerase (Promega, Madison, USA) with
primers pegA-for and pegA-rev containing ClaI restriction
endonuclease cleavage sites. The pegA amplicon was
ligated into pCR4Blunt-TOPO via topoisomerase I and
transformed into chemically-competent E. coli TOP10 F'
cells as described by the manufacturer (Invitrogen, Pais-
ley, UK). A recombinant was verified by PCR with pegA-
specific primers and digestion with ClaI. The ClaI frag-
ment containing pegA was then sub-cloned into
pACYC177 using T4 DNA ligase. Recombinant plasmids
with the insert in the sense (ppegAfwd) and antisense (ppe-
gArev) orientation relative to the kanamycin resistance
gene promoter of pACYC177 were isolated and electropo-
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The primers were designed to mutate the major fimbrial subunit by lambda Red recombinase-mediated integration of linear PCR products. Forward 
and reverse primers were used to amplify the pKD3-derived chloramphenicol cassette and contain 40 bp homology extensions 5' and 3' of the 
target gene.
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Table 2: Primer combinations used to validate each fimbrial mutation.
Primer combination Predicted amplicon size (bp) Sequence (5'-3')
bcfAFOR + C1 633 TGCACTATCCGCAACGATATATTT
bcfAREV + C2 507 TAAAATACGCTTTCGCGATCGGTCGGT
csgAFOR + C2 173 CAAGGAGCAATAAAGTATGCATAATTT
csgAREV + C1 302 CAGCAGTTGTAGTGCAGAAACAGTCGCATA
lpfAFOR + C2 867 TTAGTTACGCGCTGTGTCAA
lpfAREV + C1 288 ATCCAATACCCACCTCTATACACTCCA
fimAFOR +C1 807 AACCTCAGATCGCACCTGCTGC
fimAREV + C2 429 ATGCCGACATGACGCCAGACC
sefAFOR + C1 373 CTATTAATGGGGATGTTGTGTAA
sefAREV + C2 946 CTAATAATCTCTTATAATTTC
safAFOR + C1 701 TGAGACTCTCTCATTGGAGCGCT
safAREV + C2 597 AATTGAGGTCAAGGGTCGCGCC
stbAFOR + C2 887 TTAATGGTGGGGGACATCGTA
stbAREV + C1 295 TTATTTTTACCACTCCATAAGCACGAA
pegAFOR + C2 179 CACAAGCCAGGCATAATGCAATCATC
pegAREV + C1 377 ACATTGCGATAACTTCCTGTCTATGAGAA
stdAFOR + C2 587 GCTGTACCGTACCTGACTGTC
stdAREV + C1 714 TGTTTTTAAATTTCATCCGCGAAG
steAFOR + C1 739 TACGACAACGCCTATATAATA
steAREV + C2 600 AGCAGCGTGGAGTGTCCCAGGTCAGC
stfAFOR + C1 283 CATATAAACATGGGGTATTGATGA
stfAREV + C2 155 GGCTGGCATCATCTTTAACA
sthAFOR + C1 584 GCGTTGATTTTGTTAATGC
sthAREV + C2 704 GAAAGCTCACGATTTGAGATCAAC
stiAFOR + C2 385 TTTGGCCGACAACACACTATG
stiAREV + C1 661 GTAAATCAGCTTAAATTCCG
C1 - TTATACGCAAGGCGACAAGG
C2 - GATCTTCCGTCACAGGTAGG
Primers are specific to the flanking regions of the specified fimbrial gene (FOR or REV) or the chloramphenicol resistance cassette (C1 – forward or C2 – 
reverse).
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rated into S. Enteritidis P125109 ΔpegA::cat with selection
for ampicillin resistance.
Experimental animals
Inoculation of chickens with S. Enteritidis wild-type,
mutant and trans-complemented strains was conducted
according to the requirements of the Animal (Scientific
Procedures) Act 1986 (PPL 30/1998) with the approval of
the local Ethical Review Committee. Specific pathogen-
free out-bred Rhode Island Red chickens were reared at
the Institute for Animal Health and housed in group cages
in bio-secure accommodation. Birds were fed a vegetable-
based diet (Special Diet Services, Manea, Cambridgeshire,
UK) with access to water ad libitum. To reduce inter-ani-
mal variation, chickens were orally dosed on the day of
hatch with 0.1 ml Salmonella-free adult gut flora cultured
as described [38]. Owing to constraints of space, the phe-
notype of each fimbrial mutant could not be simultane-
ously evaluated relative to the parent. Rather, 4 groups of
15 birds were accommodated per room with 3 groups
each receiving a different fimbrial mutant strain and one
group the corresponding parent strain. Approximately 1.5
× 108 colony-forming units (CFU) of stationary phase LB-
grown Salmonella were given by oral gavage at 18-days-
old. Inocula were confirmed to be comparable by retro-
spective plating of serial dilutions to selective media. Five
birds from each group were sacrificed by cervical disloca-
tion at 3, 7 and 10 days post-inoculation and the liver,
spleen, caecal contents, caecal wall, ileal contents and ileal
wall were recovered aseptically and diluted 1:10 in phos-
phate-buffered saline for homogenisation. A rotary blade
was used to homogenise the samples and serial ten-fold
dilutions were plated on brilliant green agar containing
novobiocin and nalidixic acid. As each sample was diluted
1:10 for homogenisation and 20 μl of this was plated in
triplicate, the theoretical limit of detection by direct plat-
ing is log10 2.2 CFU/g. For some samples bacterial counts
were below the limit of detection by direct plating and
therefore enrichment was used. The homogenized sample
was incubated overnight at 37°C in a final concentration
of 1 × selenite broth before being plated on brilliant green
agar plates supplemented with nalidixic acid and novo-
biocin. This results in a qualitative rather than a quantita-
tive count but was given an arbitrary figure of log10 1 CFU/
g as the sample diluted 10-1 must have contained at least
one viable organism. Owing to the difficulty separating
caecal contents from the mucosa, the total caecal load is
presented as a measure of colonisation of this site. This
represents the mean viable count of S. Enteritidis in caecal
content and mucosa samples, including biological and
technical replicates.
To confirm the role of pegA in intestinal colonisation of
chickens by S. Enteritidis, P125109 wild-type, ΔpegA::cat
mutant, ΔpegA mutant, ΔpegA::cat [ppegAfwd] and
ΔpegA::cat [ppegArev] were given by oral gavage to ten 18-
day-old Rhode Island Red chickens as above. Post mortem
examinations were performed at 1 and 3 days post-inocu-
lation (n = 5 per time interval) and bacteria at enteric and
systemic sites enumerated. Plasmid stability in the
absence of antibiotic selection in vivo was evaluated by
plating selected samples to media containing nalidixic
acid with or without ampicillin.
Statistical analysis
Counts of viable bacteria were log10 transformed and a
generalised linear model was constructed using the least
square means ± standard error of the mean (Statistical
Analysis System version 9, SAS Institute, Cary, NC, USA).
The significance of differences between test and control
groups was determined by an F-test with data taken as
repeated measurements. P values < 0.05 were considered
significant.
Results
In silico analysis of S. Enteritidis P125109 fimbrial loci
Fourteen predicted fimbrial loci of the sequenced S. Enter-
itidis phage type 4 strain were identified [26]. Thirteen
fimbrial loci are predicted to be encoded on the genome,
whereas the P125109 pef operon is plasmid-encoded and
highly similar to that of S. Typhimurium LT2 and S. Chol-
eraesuis SC-B67. As S. Enteritidis pef was previously
reported to play no significant role in colonisation of 1-
and 5-day-old chicks [19], we elected to focus this study
on chromosomally-encoded loci. Additional file 1 shows
the predicted organisation of each fimbrial operon of
strain P125109, together with %G+C content of the locus
and the location and e-values of Pfam subunit, usher and
chaperone domains.
The analysis of the Pfam domains failed to identify a
major fimbrial subunit in csg and saf, consistent with the
prediction that they give rise to atypical fimbriae. The csg
operon is not predicted to encode proteins with usher or
chaperone domains, consistent with assembly of Csg fim-
briae via a nucleator-dependent pathway [39]. The saf
operon consists of a chaperone and usher domain. The
adhesive component is formed by the main structural
subunit whose sequence has been shown here to be
highly variable and it is not located at the tip as with other
chaperone/usher assembled fimbriae [40]. The saf fim-
briae are composed of flexible linear multi-subunit fibers
connected by short fibers or linkers which allow flexibility
in the final structure [40].
The conservation and organisation of fimbrial loci in the
genomes of sequenced strains of S. enterica was analysed
using the Artemis Comparison Tool. This revealed differ-
ences in the number and location of fimbrial loci between
the strains as well as the presence of predicted truncations
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and pseudogenes (Figure 1). At the nucleotide level, 56 of
71 fimbrial genes examined possessed ≥ 95% identity
(Additional file 2). These include all of the genes of the
fimbrial operons sti, stb, fim, csg and lpf, implying that
their function may be conserved.
S. Enteritidis P125109 shares 10 of its 13 fimbriae with
the sequenced S. Typhimurium strains. The S. Enteritidis
ste, sef and peg operons are absent from the sequenced
serovar Typhimurium strains, whereas the latter posses stc
and stj operons that we do not find in P125109 (Figure 1).
We previously reported that the percentage of fimbrial
genes that are pseudogenes in S. Gallinarum is greater
than the genomic mean [26]. In addition we found here
that the host-specific strains S. Typhi CT18 and S. Typhi
Ty2 (data not shown) possessed the highest number of
predicted fimbrial pseudogenes (based on the presence of
at least one stop codon in the predicted coding sequence).
The percentage of fimbrial genes that are pseudogenes in
S. Typhi CT18 and S. Typhi Ty2 is 14% and 16% respec-
tively, whereas the genomic mean of pseudogenes is
4.4%. In contrast the broad host-range serovars Enteritidis
and Typhimurium LT2, DT104 and SL1344 appeared to
contain an intact repertoire of fimbriae (data not shown)
and the host-restricted serovar Choleraesuis maintained
an intermediate number of predicted functional fimbrial
genes. No single fimbrial locus could be correlated with
host-specificity; however as has previously been suggested
it is plausible that the loss of fimbrial genes in host-spe-
cific and -restricted serovars is associated with the narrow-
ing of the niches they may occupy [26,29,30].
Fimbrial genes in some bacteria are subject to phase vari-
able (on-off) expression that may be mediated via recom-
bination (e.g. FimBE-mediated inversion of the fimA
promoter in E. coli [41]), epigenetic regulation dependent
on Dam methylation (e.g. control of Pap pili in uropath-
ogenic E. coli [42]) or slipped-strand mis-pairing between
homo- or hetero-polymeric tracts (e.g. assembly and mat-
uration of Neisserial pilin reviewed in [43]). In Salmonella,
evidence exists for phase variable expression of Type I fim-
briae [44-46] and long-polar fimbriae [47]. Further, epige-
netic regulation of the pef genes in S. Typhimurium by
Dam methylation has been described [48] and expression
of std fimbrial genes has been observed to be repressed in
a S. Typhimurium Dam methylase mutant [49,50].
We searched S. Enteritidis fimbrial loci for traits associ-
ated with phase variation. Genes with homology to
known recombinases were not detected within or proxi-
mal to fimbrial loci. Putative transposase and integrase
genes associated with DNA mobility were observed prox-
imal to the saf, sef and fim operons. Direct or inverted
repeat sequences that may serve as substrates for recombi-
nation were not detected. A pattern-matching search was
carried out for the Dam methylase target sequence GATC
within and proximal to P125109 fimbrial operons. This
identified hundreds of potential targets (Additional file
3), including those predicted to be methylated in the S.
Typhimurium pef cluster [48]. Where S. Typhimurium
strains SL1344 and LT2 possess GATC sites at -98, -110
and -212 relative to the start of pefB, S. Enteritidis
P125109 possessed only the sites at -110 and -212, but an
additional site at +47 in pefB that is absent in the two
Typhimurium strains (Additional file 3a, grey shaded
area). Three potential Dam methylation target sites were
also identified upstream of the std operon (-88, -97 and -
110) in S. Enteritidis P125109. This density of GATC sites
is higher than random distribution would predict and cor-
relates with the Dam-dependent repression of the std
genes as detected by microarray analysis [49] and using
antibody against StdA [50] (Additional file 3a, purple
shaded area). Predicted Dam methylase targets were also
identified upstream of the sef, sti and stf operons in S.
Enteritidis P125109 (Additional file 3). Hundreds of
homopolymeric tracts comprising 4 or more A or C resi-
dues were identified within fimbrial loci. Several con-
served hetero-polymeric tracts were identified using a
variable tandem repeat pattern finder, however only one
was present in a fimbrial gene (ten repeated 6-mers (GAC-
CAT) within stdA).
Construction of S. Enteritidis major fimbrial subunit 
mutants
Amplicons for the 13 chromosomally-encoded predicted
major fimbrial subunit genes of S. Enteritidis P125109,
were produced in order to delete each one via lambda Red
recombinase-mediated linear recombination. Despite
repeated attempts, pKD46 failed to mediate homologous
recombination of linear amplicons in S. Enteritidis
P125109 under conditions suitable for other S. enterica
strains. However all 13 genes were successfully disrupted
in the S. Enteritidis phage type 4 strain S1400nalR, which
is known to efficiently colonise the avian intestines
[19,20]. Ten of the major fimbrial subunit gene deletions
(marked by insertion of a chloramphenicol resistance cas-
sette between the predicted start and stop codons) were
successfully transduced into S. Enteritidis P125109 using
bacteriophage P22/int. Transductants of S. Enteritidis
P125109 or the archived S1400nalR strain were not iso-
lated for three of the mutated fimbrial constructs
(ΔsafA::cat, ΔfimA::cat and ΔsteA::cat). All of the success-
fully recovered isogenic mutants were verified by PCR and
no growth defects were detected in batch culture (data not
shown).
Screening of S. Enteritidis fimbrial subunit mutants in a 
chick colonisation model
Although P125109 is known to colonise the intestines of
streptomycin pre-treated mice [51], no data existed on the
colonisation dynamics of the sequenced S. Enteritidis
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Schematic representation of the repertoire and relative genomic location of fimbrial loci in the published genomes of S. enterica serovarsFigure 1
Schematic representation of the repertoire and relative genomic location of fimbrial loci in the published 
genomes of S. enterica serovars. Each coloured box represents a distinct fimbrial locus encoded in the sense (top) or anti-
sense (bottom) orientation. Boxes of the same colour on both strands represent divergently transcribed operons. A diagonal 
line through the box indicates that at least one gene in the operon is a predicted pseudogene. The repertoire of S. Typhimu-
rium and S. Typhi is representative of other sequenced strains of the same serovar. All genomes are aligned relative to their 
predicted origin. Not to scale.
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strain P125109 in chickens. A pilot experiment was there-
fore performed to evaluate the magnitude and duration of
colonisation of enteric and systemic sites at intervals post-
oral inoculation and to gain an assessment of inter-ani-
mal variation. Following oral gavage of 18-day-old out-
bred specific pathogen-free Rhode Island Red chickens
birds with 1.5 × 108 CFU, the caecal contents and mucosa
were colonised by 4–5 log10 CFU/g of strain P125109 at
days 1, 3 and 7 post-infection (n = 5 per time interval;
Additional file 4). Bacterial colonisation of the ileum and
translocation to the liver and spleen was detected, with
recoveries at around the limit of detection at 2–3 log10
CFU/g by days 3 and 7 (Additional file 4).
Each fimbrial mutant was separately inoculated into
groups of 15 Rhode Island Red chickens at 18 days-of-age
and bacteria enumerated at enteric and systemic sites at 3,
7 and 10 days-post inoculation relative to the correspond-
ing parent strain. As the caeca are a key site of bacterial
persistence in the avian gut [52,53], (Additional file 4)
and attenuation of defined and random Salmonella
mutants is reliably detected at this site [12], the total cae-
cal load is presented here as a measure of intestinal colo-
nisation, representing the mean of the caecal wall and
mucosa bacterial counts. We cannot preclude the possibil-
ity that some fimbriae mediate a specific tissue tropism
that was not detected herein. Recoveries of viable bacteria
from the liver and spleen were often close to the limit of
detection by direct plating in chickens infected with wild-
type strains (Additional file 4) and mutant strains (data
not shown). Where adequate bacteria were recovered to
permit a statistical analysis, no significant differences were
observed at these sites. Figure 2 shows the caecal colonisa-
tion kinetics of stb,peg, std, stf, sth, sti, bcf, csg, lpf and sef
major fimbrial subunit mutants of S. Enteritidis P125109
relative to the parent strain. The caecal loads of fim, saf
and ste major fimbrial subunit mutants of S. Enteritidis
strain S1400nalR relative to the parent are shown in Figure
3.
The S. Enteritidis P125109 ΔstbA::cat fimbrial mutant was
recovered from the chicken caeca at lower levels than the
wild-type at all intervals post-inoculation (Figure 2A),
with differences becoming significant by days 7 and 10 (P
= 0.0081 and P = 0.03, respectively). This is consistent
with the attenuation of a S. Typhimurium stbC mutant in
chick caeca detected by signature-tagged mutagenesis
[12]. The ΔpegA::cat mutant of S. Enteritidis P125109 was
significantly impaired in colonisation of the caeca at days
3 and 7 post-inoculation compared with the wild-type (P
= 0.0006 and P = 0.0002 respectively), although recover-
ies by day 10 were comparable (Figure 2B). The P125109
ΔbcfA::cat mutant, was recovered in significantly lower
numbers than the parent strain at day 7 (P = 0.04), but not
at other times (Figure 2G) and the S1400nalR ΔsteA::cat
mutant was recovered in significantly lower numbers than
the parent but only at day 10 (P = 0.0034; Figure 3C). No
other fimbrial mutations significantly influenced the
course of caecal colonisation at the 95% confidence inter-
val.
Confirmation of the role of PegA in colonisation of 
chickens by S. Enteritidis
Figure 2B implies a role for PegA in the colonisation of the
chicken caeca. However, the ΔpegA::cat mutation was
transduced from S1400nalR into P125109 prior to analy-
sis in chickens and a theoretical possibility exists that
other traits proximal to the pegA gene were transferred that
resulted in attenuation. To address this, we analysed the
phenotype of the original S1400nalR ΔpegA::cat mutant
relative to the parent and sought to restore the mutant to
the wild-type level of colonisation by plasmid-mediated
trans-complementation using the same experimental
design as above. As with the ΔpegA::cat mutant of
P125109 (Figure 2B) an approximate 2 log10 CFU/g
reduction in the total caecal load of the S1400nalR
ΔpegA::cat mutant was detected at days 3 and 7 post-inoc-
ulation relative to the parent strain (Figure 4; P = 0.0135
and P = 0.0088, respectively). However, as with the
ΔpegA::cat mutant of strain P125109, no significant differ-
ence was detected by day 10 post-inoculation.
The chloramphenicol resistance cassette was excised from
the P125109ΔpegA::cat fimbrial mutant to determine if
polar effects on the expression of 3' genes may explain the
attenuation observed. This addresses the possibility that
pegA may not be involved in colonisation per se, but that
downstream genes participate in the expression of surface
structure(s) that may include distally-encoded fimbrial
subunits. Excision was achieved by transient expression of
flippase recombinase as described in the Methods. The
total caecal loads of both the S. Enteritidis P125109
ΔpegA::cat andΔpegA mutant were approximately two
orders of magnitude lower than the parent strain at 1 and
3 days post-oral inoculation of chickens (Figure 5). No
significant difference existed between the caecal loads of
the ΔpegA::cat and ΔpegA mutants (P values 0.27 and 0.64
at 1 and 3 days post-inoculation, respectively); however in
both cases a highly significant reduction in caecal load
was detected for each mutant relative to the parent strain
(P values < 0.0001 at 1 day post-infection), consistent
with previous findings.
A pACYC177-derived plasmid was created in which the S.
Enteritidis P125109 pegA gene was cloned in the same ori-
entation as the kanamycin promoter (ppegAfwd), or in the
antisense orientation (ppegArev). This replicon was
selected for trans-complementation as it did not impair
the virulence of S. Typhimurium in mouse co-infection
studies [54]. Introduction of ppegArev into the S. Enteri-
BMC Microbiology 2008, 8:228 http://www.biomedcentral.com/1471-2180/8/228
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Total caecal load of S. Enteritidis P125109 wild-type and major fimbrial subunit mutant strains at 3, 7 and 10 days post-oral in culation of 18-day-old out-bred Rhode Island Red chickensFigure 2
Total caecal load of S. Enteritidis P125109 wild-type and major fimbrial subunit mutant strains at 3, 7 and 10 
days post-oral inoculation of 18-day-old out-bred Rhode Island Red chickens. Blue lines with diamonds denote the 
wild-type strain and pink lines with squares denote the fimbrial mutants. The dashed line indicates the theoretical limit of 
detection by direct plating (2.2 log10 CFU/g). The data reflect the mean ± standard error of the mean from five birds at each 
time interval. F-tests of the difference in recovery of wild-type and mutant strains at each time interval were performed and P 
values < 0.05 are marked with an asterisk.
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tidis P125109 ΔpegA mutant resulted in total caecal
counts that were not significantly different to the ΔpegA
fimbrial mutant at both 1 and 3 days post-oral inocula-
tion of chickens (P = 0.24 and P = 0.07, respectively).
However, recoveries of the ppegArev-bearing strain were
lower than for the ΔpegA::cat mutant alone at both time
points, indicating that plasmid carriage may exert a slight
fitness cost. The ΔpegA mutant harbouring ppegArev was
significantly attenuated compared to the parent strain at 1
and 3 days post-inoculation (P values < 0.0001). In con-
trast, introduction of the pACYC177-derived plasmid
containing pegA in the sense orientation into the ΔpegA
mutant partially restored the ability of the mutant strain
to colonise the caeca at both time points relative to the
wild-type strain (P = 0.0005 and P = 0.02 at 1 and 3 days
post-inoculation, respectively) and to the ΔpegA fimbrial
mutant (P = 0.0014 and P = 0.0005 at 1 and 3 days post-
inoculation, respectively). Plating of tissue homogenates
to media with or without ampicillin indicated that the
plasmid was stably maintained in the absence of antibi-
otic selection in vivo. Taken together these data confirm
that pegA plays a role in caecal colonisation of the avian
intestines by S. Enteritidis.
Discussion
S. Enteritidis phage type 4 is an important zoonotic path-
ogen and the factors mediating persistence in the avian
reservoir are ill-defined. Toward an understanding of the
Total caecal load of S. Enteritidis S1400nalR wild-type, ΔfimA::cat, ΔsteA::cat and ΔsafA::cat mutant strains at 3, 7 and 10 days p st-oral inoculation of 18-day-old out-bred Rhode Island Red chick nsFigure 3
Total caecal load of S. Enteritidis S1400nalR wild-type, ΔfimA::cat, ΔsteA::cat and ΔsafA::cat mutant strains at 3, 
7 and 10 days post-oral inoculation of 18-day-old out-bred Rhode Island Red chickens. Blue lines with diamonds 
denote the wild-type strain and pink lines with squares denote the fimbrial mutants. The dashed line indicates the theoretical 
limit of detection by direct plating (2.2 log10 CFU/g). Samples positive only by enrichment culture were given an arbitrary value 
of 1 log10 CFU/g since at least one viable organism must have been present. The data reflect the mean ± standard error of the 
mean from five birds at each time interval. F-tests of the difference in recovery of wild-type and mutant strains at each time 
interval were performed and P values < 0.05 are marked with an asterisk.
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molecular mechanisms by which S. Enteritidis colonises
the chicken gut, the role of fimbriae was examined as
these influence the carriage, virulence and tropism of
other members of the Enterobacteriaceae. From the raw
genome sequence of S. Enteritidis P125109, 13 intact
chromosomal fimbrial loci were predicted. By comparing
the sequence and distribution of the fimbrial loci with the
published genomes of other S. enterica serovars in silico,
no single locus correlated with host specificity. Microarray
studies have indicated that a remarkable degree of conser-
vation of fimbrial gene content exists among 26 S. Enteri-
tidis isolates from varied geographical locations, hosts
and years [55] and between strains of other broad host
range serovars [56,57]. However, sequencing of such loci
is required to determine if subtle differences in gene func-
tion exist.
Systematic mutagenesis of each major fimbrial subunit
gene and screening in a chicken model revealed that the
majority of major fimbrial subunits played no significant
role in colonisation of the caeca (P values greater than
0.05). The absence of roles for S. Enteritidis Fim, Csg, Lpf
and Sef fimbriae confirms previous reports that mutants
lacking these fimbriae singly or in combination exhibit no
significant defect in colonisation of chicks [19,20,22].
Conversely, the present study supports a role for Stb fim-
briae in colonisation of the avian intestines by Salmonella
that was suggested by the isolation of an S. Typhimurium
stbC mutant by screening a library of signature-tagged
mutants for attenuation in chicks [12]. The same screen of
random mutants also identified attenuating mutations in
sthB and csgD, however roles for sthA and csgA were not
observed herein and studies with defined non-polar
mutants and trans-complemented strains will be required
to establish if the sth and csg loci play a conserved or sero-
var-specific role in colonisation of chickens. Owing to the
relatively short-term nature of the studies reported here,
we cannot preclude the possibility that the fimbrial subu-
nits examined may play a role in longer-term persistence
in the avian intestines or indeed tropism for the reproduc-
tive tract and egg, and further studies will be required to
investigate this.
For the first time, we have shown that S. Enteritidis
P125109 and S1400nalR mutants of the novel Peg fim-
brial operon show statistically significant attenuation in
chickens that can be partially restored by plasmid medi-
ated trans-complementation. A mutant in which the polar
effects of the deletion of pegA are not predicted at the tran-
scriptional or translational level was also attenuated; fur-
ther implying that the phenotype of pegA insertion
mutants is not due to altered expression of downstream
genes. The inability of the ppegAfwd plasmid to fully restore
colonisation to wild-type levels may reflect differences in
the expression level of the fimbrial subunit in vivo and/or
the fitness cost of maintaining the plasmid since recover-
ies of the ΔpegA::cat mutant bearing pegA on pACYC177 in
the antisense orientation were slightly lower than for the
mutant alone.
Assays with cultured cells did not indicate any significant
role for pegA in adherence to primary chick kidney cells,
HD11 avian macrophage-like cells or HEp-2 human
laryngeal epithelial cells (data not shown) and there was
no correlation between in vitro and in vivo results, regard-
less of the fimbriae examined. However, this is not unex-
pected as many fimbriae are known to be poorly
expressed during culture in laboratory media [58], but are
induced in bovine and murine intestinal lumen [58,59]
and serve as antigens in mice [59].
Although there is attenuation of the S. Enteritidis pegA
mutant, the pegC gene encoding a putative chaperone is a
pseudogene in the sequenced strain of the poultry-
adapted serovar S. Gallinarum, which implies that the
possession of the entire fimbrial operon is unlikely to be
a prerequisite for chicken colonisation. It should be noted
that the tissue distribution of S. Enteritidis and S. Galli-
Total caecal load of S. Enteritidis S1400nalR wild-type and ΔpegA::cat fimbrial muta  strains at 3, 7 nd 10 days post-oral inocul ti n of 18-day-old out-bred Rhode Isl nd RechickensFigure 4
Total caecal load of S. Enteritidis S1400nalR wild-type 
and ΔpegA::cat fimbrial mutant strains at 3, 7 and 10 
days post-oral inoculation of 18-day-old out-bred 
Rhode Island Red chickens. Blue lines with diamonds 
denote the wild-type strain and pink lines with squares 
denote the fimbrial mutant. The dashed line indicates the 
theoretical limit of detection by direct plating (2.2 log10 CFU/
g). The data reflect the mean ± standard error of the mean 
from five birds at each time interval. F-tests of the difference 
in recovery of wild-type and mutant strains at each time 
interval were performed and P values < 0.05 are marked with 
an asterisk.
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narum is markedly different in age-matched healthy out-
bred birds, with S. Gallinarum causing severe systemic
disease with little enteric involvement whereas S. Enteri-
tidis colonises the gut to a high level [7].
The absence of significant roles for S. Enteritidis fimbrial
loci in isolation may reflect redundancy or the existence of
compensatory mechanisms, whereby the loss of single
fimbriae may modulate expression of other fimbriae or
colonisation factors. In a murine model deletions in the S.
Typhimurium lpf, pef, fim and csg operons only moder-
ately impaired virulence when tested individually,
whereas a mutant containing all four deletions exhibited
a 26-fold increase in the median lethal dose and reduced
ability to colonise the intestinal lumen [15]. Further stud-
ies with S. Enteritidis strains harbouring multiple fimbrial
mutations may be warranted. Transcriptome analysis of
the expression of fimbrial genes in the mutant strains
described herein may indicate whether cross-talk and
compensation mechanisms exist, provided probes are
used that discriminate between fimbrial transcripts in the
absence of cross-hybridisation.
Conclusion
S. Enteritidis phage type 4 possesses thirteen chromo-
somally-encoded fimbrial loci, from which the predicted
major fimbrial subunits of the majority can be deleted
without significantly impairing caecal colonisation of
chickens. Our data support the involvement of Stb fim-
briae, previously suggested by screening of signature-
tagged mutants of S. Typhimurium in poultry, and reveal
for the first time that PegA influences caecal colonisation
of chickens by S. Enteritidis. Since StbA and PegA serve as
antigens in mice and vaccination with a cocktail of puri-
fied fimbrial subunits is partially protective in a murine
model [59], further studies are required to evaluate the
efficacy of subunit or live-attenuated vaccines that exploit
the data presented here for control of zoonotic S. enterica
serovars in poultry.
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Conservation of the nucleotide sequences of S. Enteritidis strain 
P125019 genes across sequenced strains of other S. enterica serovars. 
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Plasmid-mediated trans-complementation of the ΔpegA::cat mutant of S. Enteritidi  P125109 at 1 and 3 days post-or l inoculation of 18-day-old out-bred Rh e Isl nd Red chick-ensFigure 5
Plasmid-mediated trans-complementation of the 
ΔpegA::cat mutant of S. Enteritidis P125109 at 1 and 3 
days post-oral inoculation of 18-day-old out-bred 
Rhode Island Red chickens. Total caecal load of the wild-
type and mutant strain were compared to those of the 
P125109 ΔpegA::cat insertion mutant and ΔpegA strains in 
which pegA was introduced on plasmid pACYC177 in either 
the forward or reverse orientation relative to the promoter 
of the kanamycin resistance gene. The data represent the 
mean total caecal load ± standard error of the mean from 
five birds at each time interval for each strain. The dashed 
line indicates the theoretical limit of detection by direct plat-
ing (2.2 log10 CFU/g). F-tests of the difference in recovery of 
wild-type and mutant strains at each time interval were per-
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Salmonella enterica Serovar Typhimurium Colonizing the Lumen of
the Chicken Intestine Grows Slowly and Upregulates a Unique
Set of Virulence and Metabolism Genes
P. C. Harvey, M. Watson,† S. Hulme,‡ M. A. Jones,‡ M. Lovell,‡ A. Berchieri, Jr.,§
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The pattern of global gene expression in Salmonella enterica serovar Typhimurium bacteria harvested from
the chicken intestinal lumen (cecum) was compared with that of a late-log-phase LB broth culture using a
whole-genome microarray. Levels of transcription, translation, and cell division in vivo were lower than those
in vitro. S. Typhimurium appeared to be using carbon sources, such as propionate, 1,2-propanediol, and
ethanolamine, in addition to melibiose and ascorbate, the latter possibly transformed to D-xylulose. Amino acid
starvation appeared to be a factor during colonization. Bacteria in the lumen were non- or weakly motile and
nonchemotactic but showed upregulation of a number of fimbrial and Salmonella pathogenicity island 3 (SPI-3)
and 5 genes, suggesting a close physical association with the host during colonization. S. Typhimurium bacteria
harvested from the cecal mucosa showed an expression profile similar to that of bacteria from the intestinal
lumen, except that levels of transcription, translation, and cell division were higher and glucose may also have
been used as a carbon source.
Salmonella enterica serovars Typhimurium and Enteritidis
are the two S. enterica serovars most frequently associated with
human food poisoning, with 1.4 million cases reported in the
United States in 1999 (26) and an estimated 192,703 cases in
the European Union in 2004 (4). Poultry and poultry products
are generally considered to be major sources of human infec-
tion (3, 65). Healthy adult chickens generally show no clinical
disease following oral infection with these serovars (6, 70).
Infection of birds more than a few days old with S. Typhimu-
rium or S. Enteritidis results in asymptomatic cecal coloniza-
tion with persistent shedding of organisms, resulting in carcass
contamination at slaughter and entry into the human food
chain. The ecology of colonization of birds of this age is com-
plex (21). In contrast, infection within a few hours of hatching,
as can occur in hatcheries, when the chicken is immunologi-
cally immature and possesses a rudimentary gut flora, not only
results in massive multiplication in the alimentary tract but can
also result in severe systemic disease in the bird (6, 73).
Although intestinal colonization is central to entry into the
human food chain, either through carcass contamination or by
preceding systemic infection and subsequent egg contamina-
tion, the mechanism whereby S. enterica serovars colonize and
interact with the host in the early stages of infection is still
poorly understood. Screening of randomly generated mutant
libraries of S. Typhimurium and more targeted studies have
provided some insight into the bacterial genes required for
colonization of chickens which are several weeks old and pos-
sess a gut flora. Type I and other fimbriae, including those
encoded by the stb, csg, and sth operons (22, 31, 59), are
thought to be involved in attachment of Salmonella and Esch-
erichia coli bacteria to the mucosal layer or even to epithelial
cells. Lipopolysaccharide is also thought to be involved, but it
is unclear how (20, 59, 82). Additionally, global regulatory
genes and a number of metabolic functions, including serine
and citrate utilization, together with heat shock conditions,
appear to contribute to the process in adult birds (59). Al-
though some of the genes identified indicate that a close as-
sociation with the gut mucosa is important in Salmonella col-
onization, the metabolic behavior of bacteria in the gut of
newly hatched chickens is still poorly understood. Microbial
behavior under these circumstances is very different from that
in older birds. Viable numbers of Salmonella bacteria coloniz-
ing the cecum are much higher in younger than in older birds,
and the interactions between the bacteria may more closely
resemble those in stationary-phase broth cultures (100), where
competition for nutrients under the prevailing redox condi-
tions is at least known to be involved. Some studies also indi-
cated the importance of proton-translocating proteins in colo-
nization (44, 100; S. Muhammad, M. A. Jones, and P. Barrow,
unpublished). Other factors, including some secreted pro-
teins, contribute in different hosts, but it is again unclear
how (52, 59, 82).
The numerical predominance of Salmonella bacteria in the
ceca of young chicks following experimental infection allows
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effective analysis of the bacteria in the absence of other organ-
isms, and gene transcription pattern analysis at the genome
level is thus possible. A whole-genome array derived from S.
Typhimurium was used to investigate gene expression of the
virulent avian phage type 14 strain S. Typhimurium F98 (70,
82, 100), harvested directly from chick ceca and compared with
expression patterns from bacteria grown in broth in vitro. This
approach, at least with Campylobacter jejuni, has demonstrated
successfully that expression profiles under these conditions do
resemble those observed in older, fully colonized birds (92).
MATERIALS AND METHODS
Chick colonization and sample collection. One hundred chickens from a
brown-egg commercial laying line (Lohmann) were hatched in prefumigated
incubators. Chickens were housed in fumigated cages and handled with sterile
gloves to avoid contamination. One hundred chicks were infected orally within
12 h of hatching (to avoid the development of gut flora) by gavage with 0.1 ml of
an S. Typhimurium F98 (70, 82, 100) culture grown for 16 h in LB broth at 37°C
in a shaking incubator (150 rpm) and diluted to contain 107 CFU/ml. Only sterile
water was provided, since the yolk sac is not fully resorbed for up to 3 to 4 days,
providing sufficient food for the experimental period. At 16 h postinfection, the
birds were killed individually and the cecal contents were removed immediately
from the exposed ceca by syringe and mixed with Tri Reagent (Sigma). The cecal
contents from seven of the birds were collected separately and stored on ice to
be used for viable count estimations. The cecal contents from each group of
birds, mixed with Tri Reagent, were pooled prior to extraction and purification.
The purified RNA was further treated with DNase I and cleaned using RNeasy
mini columns (Qiagen) and then concentrated further by RNA precipitation
using 3 M sodium acetate. RNA was used only when the quality and concentra-
tion were optimal, as determined by spectrophotometer (Pharmacia). The ex-
periment was repeated three times. Viable count estimations were made by
plating decimal dilutions on MacConkey agar to allow the presence of any
contaminating colonies among the predominant non-lactose-fermenting Salmo-
nella bacteria to be detected. In the three experiments, the numbers of Salmo-
nella bacteria were between 8.95 and 10.20 log10, and lactose fermenters or other
colony types were not detected (2 log10 per g).
Patterns of in vivo gene expression were compared with those of bacteria
grown in vitro. For these controls, total RNA was extracted in the same way from
three cultures of S. Typhimurium F98, in which 2 ml of an overnight LB broth
culture was inoculated into 200 ml of prewarmed LB broth and incubated with
shaking (150 rpm) for 3 h at 37°C. Cultures were pretreated with RNA Protect
(Qiagen) before being centrifuged at 5,000  g for 10 min at 20°C prior to RNA
extraction.
Harvesting of Salmonella from the mucosal wall. In addition to harvesting the
cecal contents, material was taken from the cecal mucosa for analysis by mi-
croarray. Samples were extracted by emptying the ceca with gentle pressure and
then opening the walls of the ceca lengthwise and shaking the cecal walls in RNA
Protect (Qiagen) to release bacteria from the surface. RNA from the ceca and
from the washings from the mucosal wall was isolated using standard cleanup
procedures, and samples from the same experiments were pooled. RNA from
both samples was amplified using a MessageAmp II-bacteria kit (Ambion) per
the manufacturer’s instructions. RNA quality and concentration were deter-
mined with a spectrophotometer (Pharmacia). Gene expression was compared
with that of the luminal samples.
Microarray hybridization. The S. Typhimurium array was printed as described
previously (25). Total bacterial RNA was isolated from chicken ceca and from in
vitro cultures grown in LB broth. The DNase-treated total in vivo- and in vitro-
grown RNA was converted to fluorescently labeled cDNA using indirect labeling
techniques (2, 25). Briefly, 15 g of the total RNA samples from chick cecal
contents was reverse transcribed (SuperScript II; Invitrogen) in the presence of
1 l of deoxynucleoside triphosphates (dNTPs) (2.5 mM concentration each of
dATP, dCTP, and dGTP and 1 mM concentration of dTTP [Amersham]), 1.5 l
of aminoallyl-dUTP (Sigma), and 30 g of pd(N6) (Amersham) in a total volume
of 12 l. This mixture was incubated overnight at 42°C before the reaction was
stopped, and the mixture was cleaned with 450 l of water in triplicate using
Microcon units (YM-30; Millipore).
Two cDNA probes were labeled with 100 mg of Cy3 (in vivo lumen sample) or
Cy5 (in vitro or in vivo mucosal sample) (monofunctional dyes; Amersham). The
Cy3- and Cy5-labeled probes were combined and cleaned using a QIAquick PCR
purification kit (Qiagen). The probe was dried in a speed vacuum before it was
resuspended in a total volume of 25 l of hybridization buffer (3 SSC [1 SSC
is 0.15 M NaCl plus 0.015 M sodium citrate], 25 mM HEPES, yeast tRNA, 50
Denhardt’s solution, 10% [wt/vol] SDS), heated for 2 min, and then cooled in the
dark. The probe was applied directly to the array with a clean coverslip placed on
top. The probe was hybridized for 16 h at 63°C in a humidified slide chamber
(Telechem, Inc., CA). The slide was postprocessed as described previously (25).
Slides were scanned using a commercial laser scanner (GenePix 4000A; Axon
Instruments, MDS, Sunnyvale, CA).
Data analysis. Fluorescence intensities of the signal and background were
calculated for each spot using image analysis software (GenePix Pro 3.0; Axon
Instruments). Three biological replicates each of both the in vitro-grown RNA
and the in vivo-harvested RNA were compared. The data were analyzed using
the Limma package (71). The data were first normalized within arrays using the
Loess method (72) and then normalized between arrays in order to scale the log
ratios to have the same median absolute deviation (MAD) across arrays (95). A
linear model was then fitted for each spot across the series of arrays. The
resulting P values were adjusted according to the false-discovery-rate method of
Benjamini and Hochberg (8). Functional annotations were linked to the genes
from the NCBI file NC_003197.ptt (http://www.ncbi.nlm.nih.gov/nuccore
/16763390).
RT-PCR. The data were validated by quantitative reverse transcriptase PCR
(qRT-PCR) of 15 genes which were differently regulated in the lumen samples to
confirm gene expression ratios (87). Primers (Table 1) and fluoroprobes were
designed using Primer Express software (PE Applied Biosystems) and purchased
from Sigma-Genosys Europe Ltd. (Cambridge, United Kingdom). One-step
qRT-PCR was performed in triplicate by using a mix of 2 ng/l DNase-treated
total RNA, gene-specific primers (50 nM) and probes (100 nM), and reverse
transcriptase qPCR master mix (RT-QPRT-032X; Eurogenetic, EGT Group,
Belgium). The concentrations of primers and template in each reaction mixture
were determined by construction of a standard curve, starting with 200 ng total
RNA and 500 nM primer and using 10-fold dilutions from 101 to 105. Three
total RNA samples were analyzed in triplicate in PCRs, and three replicate
values were used to generate the standard curves. Amplification and detection of
specific primers were performed using the ABI Prism 7700 sequence detection
system (PE Applied Biosystems, Warrington, United Kingdom). The cycle pa-
rameters were as follows: an initial cycle of 48°C for 30 min and 95°C for 10 min
and then 40 cycles of 95°C for 15s and 60°C for 1 min. The results were expressed
in terms of threshold cycle value, the cycle at which the change in the reporter
dye passes a significant threshold value above background. The fold changes in
gene expression calculated from the qRT-PCR data were converted to log2
values and plotted against the changes calculated from the array data, which had
also been log2 converted.
Creation of mutants. Insertion mutants using kanamycin or streptomycin/
spectinomycin resistance cassettes were prepared as single mutants using stan-
dard procedures detailed elsewhere (82, 83, 100). Briefly, oligonucleotide prim-
ers were used to amplify upstream and downstream fragments, which were then
joined together by an additional overlap extension PCR using the same two
fragments as a template. This allowed the introduction of a KpnI site in the
middle of the combined fragment and an XhoI and BglII (or, in the case of the
cobS and cbiA mutants, XbaI) site at each end. This construct was incorporated
into the suicide vector pDM4 (54), and the Kmr GenBlock insertion was intro-
duced into the KpnI site. Spectinomycin and streptomycin (Spc-Str) resistance
insertions were made in the same way. The cassette was in pHP45Spc (H.
Krisch, Département de Biologie Moleculaire, Université de Genèva, Switzer-
land). A single-base-pair change generated a BamHI site in the middle of the
fragment that enabled an Spc-Str resistance cassette to be inserted after base 406
of the open reading frame (ORF), and XbaI sites were incorporated into each
end of the fragment for cloning into pDM4. Oligonucleotide primers are shown
in Table 1. These pDM4 derivatives were maintained in E. coli strain SM10pir
(83) and were introduced into the recipient Salmonella strains by conjugation.
Transconjugants were isolated on selective medium supplemented with either
streptomycin or kanamycin (25 g/ml), and their sensitivities to chloramphenicol
were then tested to identify those that resulted from a recombinational double-
crossover event that had not incorporated any pDM4 DNA. The mutation was
transduced into a fresh culture using P22 HT int (5). Transductants were checked
by PCR using primers from the 3 end of the cassette and the 5 end of the
structural gene, which generated a single DNA fragment in each of the mutants
but not in the parent strain.
Double mutants were prepared with the creation of the additional mutation in
a single mutant background using the alternative resistance cassette.
Assessment of colonization ability. Colonization was checked in specific-
pathogen-free (SPF) day-old Light Sussex chickens obtained from the Poultry
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Production Unit, Institute for Animal Health. Birds were maintained in cages at
33°C with water and received no food prior to oral inoculation.
Colonization ability was assessed in two ways. First (100), groups of 10 chick-
ens were inoculated orally within 24 h of hatching with 0.1 ml of an undiluted
broth culture of the strain (mutant or parent of nalidixic acid-resistant [Nalr] S.
Typhimurium F98) to be tested. They were then given access to a vegetable
protein-based diet (SDS, Manea, Cambridgeshire, United Kingdom). Twenty-
four hours later, 3 birds were killed and the numbers of bacteria of the inoculated
strain in the ceca were enumerated. The remaining 7 birds were inoculated orally
with 0.1 ml of a 1:1,000 dilution of a broth culture of an Spcr mutant of the parent
F98 strain. Three days later, all birds were killed and the numbers of bacteria of
both strains in the cecal contents were counted on brilliant green containing
either sodium nalidixate (20 g/ml) and novobiocin (1 g/ml) or spectinomycin
(50 g/ml) (Sigma).
TABLE 1. Oligonucleotide primers used for mutant production
Gene Oligonucleotide sequences of primersa Enzyme Resistance cassette
















































a Underlining and boldface indicate enzyme sites.
VOL. 79, 2011 SALMONELLA GENE EXPRESSION IN CHICKEN INTESTINE 4107
Second, at 1 day of age, groups of 20 chickens were inoculated orally with 0.1
ml of an overnight LB broth culture of cecal contents obtained from healthy,
adult SPF chickens to prevent the development of systemic disease. They were
then given access to feed, as described above. Twenty-four hours later, the
chickens were infected orally with 108 CFU of either a spontaneous Nalr mutant
of S. Typhimurium F98 or a Nalr mutant with a single or double insertion
mutation in selected genes in 0.1 ml of LB broth. At 1, 2, and 3 weeks after
inoculation, cloacal swabs were taken from each bird and plated in a standard
manner (6) on brilliant green agar containing sodium nalidixate (20 g/ml) and
novobiocin (1 g/ml) to obtain a semiquantitative enumeration of the bacteria
excreted.
Virulence assays. Selected mutants of S. Typhimurium F98 were tested for
their virulence for newly hatched Rhode Island Red chickens. The mutations
were transferred by P22 transduction (5) to strain 4/74, which is virulent for mice
(SL1344) (83), for assessment of virulence in BALB/c mice. Virulence was
assessed by oral inoculation of groups of 20 newly hatched chickens with 0.1 ml
or of 10 BALB/c mice with 50 l of a broth culture diluted to contain 106 CFU
in this volume. Morbidity and mortality were recorded over a 3-week period.
Signs in chickens included anorexia and a disinclination to drink, standing with
head and wings lowered, and caked feces around the vent. Mice became unsteady
and had a “starry” coat. These signs are generally predictive of severe disease and
death, and animals with signs of disease were killed humanely. Animals showing
signs typical of salmonellosis were killed humanely, and their livers were cultured
on MacConkey agar. Differences in mortality were analyzed by a 2 test.
Microscopy of cecal contents. Eight newly hatched chickens were inoculated
orally with 0.1 ml of a 1/1,000 dilution of an overnight LB broth culture of S.
Typhimurium within 8 h of hatching. Eighteen hours later, all birds were killed
and cecal contents were harvested into universal bottles and stored at 4°C. They
were diluted 1:100 in phosphate-buffered saline (PBS) and observed within 1 to
2 h by phase microscopy. The number of bacterial cells that showed evidence of
division, expressed as a proportion of the total, was counted for each sample.
Bacteria which were attached or had a visible septum were regarded as in the
process of division. Motility and general cell shape were also observed.
Microarray data accession numbers. Raw data have been deposited in GEO
(http://www.ncbi.nlm.nih.gov/pubmed/11752295), platform GPL6439 (http:
//www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc	GPL6439), and series GSE10337
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc	GSE10337).
RESULTS
Transcription profile from within the cecal contents. RNA
extracted from S. Typhimurium bacteria from the luminal con-
tents of the ceca of day-old chicks was compared to that from
the in vitro cultures. The genes were grouped by clusters of
orthologous groups of proteins (COGs) classification and are
shown in Fig. 1. This overarching classification indicated major
changes resulting from adaptation to the cecal environment.
Overall, 17% of the 4,457 S. Typhimurium coding sequences
(CDS) present on the array showed changes in expression
during infection. Of these, 282 CDS were upregulated more
than 2-fold, including genes associated with amino acid, car-
bohydrate, coenzyme, and lipid transport. A total of 464 CDS
were downregulated more than 2-fold, including genes associ-
ated with cell cycle regulation, translation, and DNA replica-
tion. Total RNA was extracted from five noninfected birds to
determine if the cecal contents alone produced a cross-reac-
tion with the array; no cross-reaction was detected (data not
shown).
Genes which showed statistically significant differential ex-
pression between in vivo and in vitro conditions (2-fold change,
P  0.05) were considered to be of interest. The genes with
increased and decreased levels of expression which fulfilled
this criterion are listed in Tables 2 and 3, respectively.
Compared with in vitro-grown luminal bacteria, significant
changes were observed in genes associated with the following
factors. (i) Relating to cell division, 12 genes associated with
recombination, gene regulation, transcription, and chromo-
some replication, including hupA, himA, ygiE, and dnaX, were
downregulated in vivo, compared to in vitro-grown bacteria. In
addition, seven genes involved in cell division (including
ftsEKX) were downregulated. There was a significant reduction
in expression of 32 genes associated with translation, including
rplB to rplW, rpsAGJSP, and rpmBIJ, following analysis of gene
expression within the lumen of the cecum. Genes associated
with DNA repair (including dcm, encoding DNA cytosine
methylase, recC, and sbcC) were upregulated.
(ii) Regarding energy sources, the prpBCDE locus, but not
prpR, its regulator, was significantly upregulated in the lumen.
A number of genes in the pdu operon were upregulated, par-
ticularly the latter part, pduK-pduV. However, there was no
associated upregulation of the cob or cbi genes. The btuF gene
was found to be expressed, indicating utilization of an external
source of cobalamin. Increased expression of genes in the eut
(ethanolamine degradation) operon (eutPQTDMN) was de-
tected. The low redox environment of the lumen is indicated by
the significant upregulation of ttrABC, although phs and asr
gene products were not significantly upregulated. Other genes
associated with respiration with oxygen as the terminal elec-
tron acceptor, including cydA, cyoCD, nuoEFIJ, frd, and napC,
were downregulated.
(iii) Regarding carbohydrates, a number of different loci
involved in the utilization of carbohydrates showed different
levels of up- and downregulation. Expression of melA was
significantly upregulated in the lumen, although the changes in
expression of melB and melR were not statistically significant.
Four of the 11 genes (yiaM, yiaN, lyxK, sgbH) required for the
catabolism of L-ascorbate to D-xylulose were upregulated. The
gene encoding trehalose phosphate synthase, otsA, was also
upregulated in the lumen, as were some unidentified genes,
FIG. 1. Comparison of S. Typhimurium genes expressed in the
lumens of newly hatched chicks with those expressed in in vitro-grown
bacteria, classified according to COGs. Black bars, cecal contents;
white bars, in vitro. The classified genes were found to be significantly
different, with a 
2-fold change in expression and a P value of less than
0.05. COGs classification abbreviations: C, energy production and con-
version; D, cell cycle control, mitosis, and meiosis; E, amino acid
transport and metabolism; F, nucleotide transport and metabolism; G,
carbohydrate transport and metabolism; H, coenzyme transport and
metabolism; I, lipid transport and metabolism; J, translation; K, tran-
scription; L, replication, recombination, and repair; M, cell wall/mem-
brane biogenesis; N, cell motility; O, posttranslational modification,
protein turnover, and chaperones; P, inorganic ion transport and me-
tabolism; Q, secondary metabolites biosynthesis, transport, and catab-
olism; R, general function prediction only; S, function unknown; T,
signal transduction mechanisms.
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TABLE 2. S. Typhimurium genes of interest which were upregulated during colonization of the cecal lumen, compared to gene expression in
broth culturesa





Not in COGs STM1144 csgA Major curlin subunit precursor 3.9 0.002
STM1601 ugtL Putative exported protein 2.9 0.02
STM1602 sifB Secreted effector 3.4 0.01
STM1384 ttrC Tetrathionate reductase complex subunit C 2.3 0.03
STM0550 fimY Putative regulatory protein 3.1 0.01
STM1143 csgB Minor curlin subunit precursor 4.2 0.04
STM3758 fidL Putative inner protein 2.2 0.04
Amino acid transport and
metabolism
STM0878 potG Putrescine transporter 5.6 0.03
STM2992 argA N--acetylglutamate synthase 4.6 0.03
STM4296 adi Catabolic arginine decarboxylase 4.4 0.047
STM1094 pipD Pathogenicity island-encoded protein D 4.1 0.05
STM4105 metF 5,10-Methylenetetrahydrofolate reductase 3.6 0.03
STM3965 metE 5-Methyltetrahydropteriryltriglutamate-homocystein S-methyltransferase 2.2 0.04
STM3086 speA Arginine decarboxylase 3.6 0.02
STM0887 artJ Arginine transport system component 2.4 0.02
STM2055 pduU Polyhedral body protein 3.7 0.05
STM2056 pduV Propanediol utilization protein 2.8 0.01
STM2469 eutP Putative ethanolamine utilization protein 3.5 0.0006
STM2468 eutQ Putative ethanolamine utilization protein 3.0 0.007
STM0877 potF Putrescine transporter 2.5 0.05
STM0878 potG Putrescine transporter 5.6 0.03
Carbohydrate transport and
metabolism
STM1928 otsA Trehalose-6-phosphate synthase 4.3 0.03
STM4298 melA -Galactosidase 3.2 0.04
STM3674 lyxK L-Xylulose kinase 2.0 0.047
STM3675 sgbH Putative 3-hexulose-6-phosphate isomerase 3.1 0.02
STM0018 Putative exochitinase 3.0 0.014
STM1560 Putative -amylase 2.9 0.008
STM3254 Putative fructose-1-phosphate kinase 2.7 0.009
STM3671 Putative transporter 3.0 0.02
Energy production and
conversion
STM0369 prpC Putative citrate synthase 6.0 0.004
STM1383 ttrA Tetrathionate reductase complex subunit A 4.6 0.03
STM2057 pduW Propionate kinase 3.4 0.02
General function STM0370 prpD 2-Methylcitrate dehydratase 7.1 0.001
Inorganic ion transport STM2862 sitB Putative ATP-binding protein 2.8 0.04
STM0206 butF Putative periplasmic cobalamin-binding protein 2.6 0.01
STM2863 sitC Putative permease 2.3 0.05
Lipid STM0371 prpE Putative acetyl-CoA synthetase 3.5 0.003
Motility STM0339 stbB Putative fimbrial chaperone 2.8 0.01
STM0195 stfA Putative fimbrial subunit 3.4 0.02
STM4593 sthB Putative fimbrial usher protein 2.6 0.05
STM0198 stfE Putative minor fimbrial subunit 3.1 0.02
STM0199 stfF Putative minor fimbrial subunit 3.7 0.03
STM0200 stfG Putative minor fimbrial subunit 3.5 0.02
Replication STM2150 stcC Putative outer membrane protein 2.3 0.04
STM0395 sbcC ATP-dependent dsDNA exonuclease 2.9 0.01
STM1992 dcm DNA cytosine methylase 3.4 0.01




STM2046 pduK Polyhedral body protein 4.1 0.03
STM2054 pduT Polyhedral body protein 2.6 0.04
STM2047 pduL Propanediol utilization protein 3.5 0.03
STM2465 eutM Putative detox protein 2.4 0.02
STM2464 eutN Putative detox protein 2.4 0.02
Transcription STM3964 metR metE/metH regulator 2.2 0.03
STM3756 rmbA Putative cytoplsmic protein 3.1 0.04
STM0552 fimW Putative fimbrial protein 3.0 0.02
Translation STM1909 argS Arginine tRNA synthetase 2.0 0.04
Function unknown STM1088 pipB Secreted effector protein 5.5 0.01
STM3764 mgtC Mg2 transport protein 2.5 0.05
STM0884 Putative inner membrane protein 4.8 0.04
a Genes selected as genes of interest showed a 
2-fold increase in expression levels and a P value of 0.05.
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TABLE 3. S. Typhimurium genes of interest which were downregulated during colonization of the cecal lumen, compared with
expression in broth culturesa





Not in COGs STM2770 fljA Phase 1 flagellin repressor 2.5 0.03
STM2304 pmrD Polymyxin resistance protein B 6.02 0.005
Amino acid transport and
metabolism
STM dsdA D-Serine deaminase 6.65 0.0036
STM3244 tdcB Threonine dehydratase 4.9 0.01
STM3240 tdcG L-Serine deaminase 2.6 0.03
Carbohydrate transport and
metabolism
STM2433 crr Glucose-specific IIA component 10.78 0.026
STM4231 lamB Maltoporin precursor 4.4 0.04
STM2190 mglB Galactose transport protein 5.6 0.001
STM0684 nagB Glucosamine-6-phosphate deaminase 2.5 0.05
STM0685 nagE N-Acetylglucosamine-specific enzyme IIABC 2.1 0.04
STM2431 ptsH Phosphohistidinoprotein-hexose phosphotransferase 9.00 0.014
Cell cycle STM3569 ftsX Putative cell division protein 3.3 0.008
STN3570 ftsE Putative cell division ATPase 3.3 0.03
STM0960 ftsK Cell division protein 3.5 0.02
Energy production and
conversion
STM2320 nuoJ NADH dehydrogenase I chain J 2.3 0.03
STM2321 nuoI NADH dehydrogenase I chain I 2.4 0.03
STM2255 napC Periplasmic nitrate reductase 3.0 0.02
STM0440 cyoD Cytochrome o ubiquinol oxidase subunit IV 3.4 0.04
STM4340 frdD Fumarate reductase membrane anchor polypeptide 3.6 0.05
STM2325 nuoE NADH dehydrogenase I chain E 4.1 0.03
STM2324 nuoF NADH dehydrogenase I chain F 3.5 0.05
STM0441 cyoC Cytochrome o ubiquinol oxidase subunit III 6.96 0.013
STM0740 cydA Cytochrome d terminal oxidase polypeptide subunit I 6.33 0.0062
General function STM4361 hfq Host factor I 10.08 0.0005
STM1751 hns DNA-binding protein HLP-II 8.73 0.0033
Cell motility STM1959 fliC Flagellin 14.89 0.00055
STM1171 flgN Putative FlgK/FlgL export chaperone 7.79 0.007
STM1920 cheW Chemotaxis docking protein 7.26 0.0027
STM1183 flgK Flagellar hook-associated protein 1 2.3 0.02
STM4533 tsr Methyl-accepting chemotaxis protein 3.9 0.03
STM1915 cheZ Chemotactic response protein 4.0 0.02
STM2771 fljB Phase 2 flagellin 4.0 0.01
STM1921 cheA Chemotaxis sensory histidine protein kinase 4.0 0.02
STM1174 flgB Flagellar basal body rod protein 4.2 0.05




STM1339 himA Integration host factor alpha subunit 3.9 0.013
STM3185 yqiE ADP-ribose pyrophosphatase 3.6 0.007
STM0484 dnaX DNA polymerase III tau/gamma subunits 3.1 0.01
STM4170 hupA DNA-binding protein HU-alpha 6.36 0.00079
Signal transduction mechanisms STM1916 cheY Chemotaxis regulator 6.62 0.01
Transcription STM0900 Putative helicase 12.5 0.002
STM2875 hilD Invasion protein regulatory protein 10.3 0.008
STM1172 flgM Anti-FliA factor 7.71 0.011
STM2867 hilC Invasion regulatory protein 5.89 0.014
STM3245 tdcA Transcriptional activator 3.0 0.005
STM1956 fliA Sigma 28 3.0 0.025
Translation STM3728 rpmB 50S ribosomal subunit protein L28 5.92 0.02
STM3440 rplC 50S ribosomal subunit protein L3 2.1 0.04
STM3437 rplB 50S ribosomal subunit protein L2 2.22 0.02
STM3425 rplF 50S ribosomal subunit protein L6 2.6 0.02
STM3414 rplQ 50S ribosomal subunit protein L17 3.3 0.01
STM3438 rplW 50S ribosomal subunit protein L23 2.9 0.01
Continued on following page
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including STM0018, STM1560, and STM3254, classified as
having a role in carbohydrate utilization. Interestingly, there
was significant downregulation in glucose utilization genes,
including crr and ptsH and genes involved in N-acetylgluco-
samine utilization, such as nagBE. The genes lamB and mglB
were also downregulated.
(iv) With respect to amino acid utilization, there was a sig-
nificant level of upregulation of expression of metE, metF, and
metR, and upregulation of adiA, speA, argA, and argS indicated
that arginine was being utilized by bacteria in the lumen. In-
terestingly, there was a significant upregulation in the expres-
sion of the potFGHI operon (putrescine transport) within the
lumen. tdcAB, the transcriptional activator, and tdcB, involved
in threonine utilization, were downregulated. In addition, dsdA
and tdcG, involved in serine utilization, were also downregu-
lated.
(v) For the bacterial surface, the majority of genes involved
in flagellum production were downregulated in the lumen,
including flgM, flgN, flgK, flgB, fliC, fljB, and fliA. There was
also significant downregulation of chemotaxis genes cheAWZ,
tcp, and tsr. Several fimbrial genes were significantly upregu-
lated, including stfAEFG, stbB, stjB, stcC, sthB, csgA, and csgB.
Parts of the fim operon, fimY and fimW, were also upregulated.
(vi) With respect to virulence factors, a small number of
genes from Salmonella pathogenicity island 1 (SPI-1) were
significantly upregulated, including sitBC, sipD, and spaS. The
sit genes encode a part of an ABC transport system for the
uptake of iron into the periplasmic space, indicating a potential
function in colonization (94, 101). Two genes from SPI-1, hilC
and hilD, were significantly downregulated in expression. Both
of these genes are involved in the transfer of environmental
signals to the central virulence gene regulator, HilA (23). This
result is surprising, given the predicted effect of downregulat-
ing HilA. No significant change was observed for hilA expres-
sion, and a number of genes in SPI-1 were upregulated. This
strongly suggests that in the lumen of the gut, a number of
different factors are acting on the regulation of HilA. Little
change in expression was detected within SPI-2 and SPI-4.
Within SPI-3, mgtC, rmbA, and fidL and the colonization-
associated genes shdA and misL, and in SPI-5, pipB, were
found to be upregulated in the lumen. While a role for mgtC
has been described for growth in low-magnesium environments
(58), the requirement for pipB, rmbA, and fidL expression may
represent redundant gene expression from the same island.
There also seems no obvious reason for pipB expression to be
required, as it is involved in intracellular kinesin binding (37).
Validation by quantitative RT-PCR. To validate the mi-
croarray results, RT-PCR was carried out on 15 selected genes
showing different levels of expression within the lumen. The
data for the 15 genes (Fig. 2) gave an r2 value of 0.53, which
was a good fit (P 	 0.0019). The slope (2.27) indicated higher
values by RT-PCR than by microarray.
Transcription profile from the mucosal wall. Patterns of
gene expression in RNA extracted from S. Typhimurium bac-
teria from the washings of the cecal mucosa were compared to
the data arising from the RNA harvested from the cecal lumen
of day-old chicks. The genes were grouped by COGs classifi-
cation and are shown in Fig. 3. A total of 33 genes were
significantly (change of 2-fold, P  0.005) upregulated at the
TABLE 3—Continued





STM3430 rplN 50S ribosomal subunit protein L14 3.2 0.008
STM3422 rplP 50S ribosomal subunit protein L16 3.3 0.01
STM4393 rpsR 30S ribosomal subunit protein S18 2.2 0.03
STM3441 rpsJ 30S ribosomal subunit protein S10 2.5 0.02
STM0981 rpsA 30S ribosomal subunit protein S1 3.2 0.03
STM3447 rpsG 30S ribosomal subunit protein S7 3.6 0.03
STM3448 rpsL 30S ribosomal subunit protein S12 3.7 0.045
STM3436 rpsS 30S ribosomal subunit protein S19 3.9 0.012
STM3419 rpmJ 50S ribosomal subunit protein X 3.6 0.02
STM1335 rpmI 50S ribosomal subunit protein L35 3.9 0.01
Translocation STM3321 yhbH Putative sigma N modulation factor 16.11 0.0049
Function unknown STM2390 yfcZ Putative cytoplasmic protein 9.52 0.0051
STM3995 yihD Putative cytoplasmic protein 6.99 0.00041
STM2697 Phage tail-like protein 6.87 0.003
STM4088 yiiU Putative cytoplasmic protein 6.26 0.0017
a Genes selected as genes of interest showed a 
2-fold change in expression levels and a P value of 0.05.
FIG. 2. Correlation between microarray and real-time RT-PCR ex-
pression values. Log2-transformed expression values for 15 genes from
total bacterial RNA extracted from day-old-chick cecal contents in
triplicate. The best-fit linear regression line is shown together with the
r2 value and the calculated slope equation.
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mucosa, and 16 genes were significantly downregulated (Ta-
bles 4 and) 5.
Potentially significant changes in the mucosa, compared with
luminal bacteria, were observed in genes associated with the
following factors. (i) Relating to carbohydrate transport and
metabolism, genes associated with glucose utilization were sig-
nificantly upregulated at the mucosa, including gmhA, ptsH,
and crr. A phosphotransferase suppressor of ompF was down-
regulated at the mucosal wall.
(ii) Regarding amino acid transport and metabolism, only
one gene, yhiP, encoding a putative peptide transport protein,
was significantly upregulated at the mucosa. However, three
genes were significantly downregulated, including two encod-
ing ABC transporter proteins and carB.
(iii) With respect to energy production and conversion, the
cytochrome b562 gene, cybC, was significantly upregulated at
the mucosal wall. Four genes, pduDUW and ybhP, plus a gene
coding for a tetratricopeptide repeat protein were significantly
downregulated.
(iv) With respect to cell division and transcription, three
genes associated with cell division were upregulated, namely,
ftsA, yhdE, and mreB. Four genes associated with transcription
were also upregulated (including rpoN and yciT).
(v) Regarding translation and posttranslational modifica-
tion, two genes, tpx and sspA, were significantly upregulated at
the mucosal wall, as was rpsM, which encodes a 30S ribosomal
subunit protein. However, only one gene, the ribosome stabi-
lization factor gene yfiA, was downregulated significantly.
(vi) Interestingly, pipB was upregulated at the mucosal wall.
ugtL, which provides resistance to antimicrobial peptides, was
also upregulated.
It is appreciated that the number of genes showing changes
in expression at the mucosa is very small compared with that of
the bacteria in the lumen and that the overall patterns of
expression in the two populations were almost identical.
Microscopy of bacteria from the mucosa. Phase-contrast
microscopy of the cecal lumen and cecal mucosa from the
above-described samples was used to estimate the numbers of
dividing bacteria in these two sites in the cecum. Samples taken
from eight chickens indicated that the percentage of dividing
bacteria was higher at locations close to the mucosal wall than
within the lumen (Fig. 4). There was no difference in bacterial
cell size. No bacterial cells from the lumen showed evidence of
motility (directional movement) in 10 microscopic fields, sup-
porting the results of the gene expression studies above.
Colonization of chickens. Assessing the contribution to in-
testinal colonization of genes which were upregulated in the
intestine was difficult in newly hatched chickens, since even
serovars such as Salmonella enterica serovar Choleraesuis,
which is unable to colonize the alimentary tract of adult birds,
are nevertheless able to multiply in the guts of newly hatched
chickens. We therefore decided to use a competition assay in
which selected mutants are assessed for their ability to exclude
a superinfecting parent strain inoculated 24 h later (100). This
method is preferred to an assay in which both strains are
inoculated simultaneously, because it allows an assessment of
whether the mutant is utilizing the same nutrients under sta-
tionary-phase redox conditions as the parent strain which will
compete with it. Our experience is that mutants which are
sometimes noninhibitory in our assay are nevertheless fre-
quently able to grow to equally high numbers as the parent
strain when inoculated simultaneously (P. Barrow, M. Lovell,
and M. A. Jones, unpublished results). Mutants were selected
because the genes were relatively highly upregulated (metF,
csgA, argA, and potG) or because they were linked metaboli-
cally (ttrS, ttrB, pduA, and eut). At the time of challenge, all
mutants tested (metF, csgA, ttrS, ttrB, pduA, eut, argA, and
potG) colonized the gut well, judging from the counts in the
ceca of three birds killed at the time of challenge (Table 6).
When the birds were killed 3 days after challenge, most mu-
tants were still colonizing well, with the mean cecal count
ranging from 7.03 to 7.71 log g1. Only the argA, pduA, ttrS,
and potG mutants were found in low numbers. Despite this, all
the mutants tested were able to exclude the parental challenge
strains, with 6 of the 7 birds killed having challenge counts of
2 log, whereas the mean count of the challenge strain in birds
which had not been previously inoculated with another strain
was 5.11 (range, 4 to 7.20).
Because pdu, ttr, and btu genes were all upregulated in the
intestine, and because these genes are all related to the anaer-
obic catabolism of 1,2-propanediol and ethanolamine, mutants
with inactivated ttr, pdu, eut, or btu genes, and also cob and cbi
operons, were tested for their ability to colonize the guts of
1-day-old chickens which had received gut flora preparations.
The patterns of fecal excretion are shown in Fig. 5. The great-
est reductions in fecal excretion from that of the parent strain
were seen with the pduA, ttrB, and cbiA genes and the cobS
btuB double mutant. Statistical significance was assessed using
the 2 test. Statistically significant reductions in colonization
were observed only with the ttrB mutant (P  0.01). Additional
FIG. 3. Comparison of S. Typhimurium genes expressed at the
mucosal wall with those expressed in the lumens of newly hatched
chicks, classified according to COGs. Black bars, lumen; gray bars,
mucosal wall. The classified genes were found to be significantly dif-
ferent, with a 
2-fold change in expression and a P value of less than
0.05. COGs classification abbreviations: C, energy production and con-
version; D, cell cycle control, mitosis, and meiosis; E, amino acid
transport and metabolism; F, nucleotide transport and metabolism; G,
carbohydrate transport and metabolism; H, coenzyme transport and
metabolism; I, lipid transport and metabolism; J, translation; K, tran-
scription; L, replication, recombination, and repair; M, cell wall/mem-
brane biogenesis; N, cell motility; O, posttranslational modification,
protein turnover, and chaperones; P, inorganic ion transport and me-
tabolism; Q, secondary metabolites biosynthesis, transport, and catab-
olism; R, general function prediction only; S, function unknown; T,
signal transduction mechanisms.
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reductions which were less significant were observed with pduA
(P 	 0.03) and cobS (P 	 0.1) mutants.
None of these mutations produced any significant attenua-
tion in the virulence of S. Typhimurium for mice or newly
hatched chickens. Signs of severe systemic disease were ob-
served in 8 to 10 of the 10 inoculated mice and in 15 to 20 of
the 20 inoculated chickens, regardless of whether the strain
was the virulent parent or a mutant strain (P 	 0.25). Pure,
heavy growth of Salmonella was obtained by culturing the livers
of animals which were killed humanely.
DISCUSSION
The results here demonstrate that extensive transcriptional
changes occur following infection of day-old chicks with S.
Typhimurium, with many genes being downregulated in ex-
pression, indicating decreased metabolic activity from that of
the broth culture. Those genes which were upregulated reflect
a degree of adaptation to the luminal environment.
To study gene expression in Salmonella during colonization
of chickens, the most appropriate model is generally regarded
TABLE 4. S. Typhimurium genes upregulated at the mucosal walla





Amino acid transport and
metabolism
STM3592 yhiP Putative peptide transport protein 2.08 0.049
Carbohydrate transport and
metabolism
STM0310 gmhA Phosphoheptose isomerase 2.06 0.037
STM1558 Putative glycosyl hydrolase 2.13 0.017
STM2431 ptsH Phosphohistidinoprotein-hexose phosphotransferase 2.29 0.017
STM2433 crr Glucose-specific IIA component 2.4 0.036
Cell cycle control, mitosis, and
meiosis
STM0132 ftsA ATP-binding cell division protein 2.37 0.019
STM3371 yhdE Putative inhibitor of septum formation 2.26 0.0198
STM3374 mreB Rod shape-determining protein 2.13 0.014
Cell motility STM1177 flgE Flagellar hook protein 2.64 0.03
Cell wall/membrane biogenesis STM0124 murF D-Alanine-D-alanine ligase 2.09 0.044
Energy production and
conversion
STM4439 cybC Cytochrome b562 2.06 0.03
Function unknown STM0119 yabB Putative cytoplasmic protein 2.28 0.042
STM1088 pipB Secreted effector protein 2.35 0.016
STM3347 yhcB Putative periplasmic protein 2.42 0.037
General function prediction
only
STM1581 yddE Putative phenazine biosynthetic protein 2.02 0.045
STM2580 era GTPase 2.09 0.028
STM2969 ygdH Putative nucleotide binding 3.18 0.012
Inorganic ion transport and
metabolism
STM4324 cutA Putative periplasmic divalent cation tolerance protein 2.3 0.02
Not in COGs STM0471 ylaC Putative inner membrane protein 2.06 0.003
STM1059 ycbW Putative cytoplasmic protein 2.71 0.03
STM1092 Putative cytoplasmic protein 2.32 0.024
STM1601 ugtL Putative membrane protein 2.1 0.04
STM2983 orfX Putative lipoprotein 2.09 0.01
Nucleotide transport and
metabolism




STM1682 tpx Thiol peroxidase 2.79 0.038
STM3342 sspA Stringent starvation protein A 2.23 0.041
Transcription STM1704 Putative regulatory protein 2.73 0.022
STM3320 rpoN Sigma 54 2.09 0.022
STM3515 yciT Transcriptional activator 2 0.026
STM4318 Putative acetyltransferase 2.198 0.019
Translation STM3418 rpsM 30S ribosomal subunit protein S13 2.73 0.026
a Genes selected as genes of interest showed a 
2-fold increase and a P value of 0.05.
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to be animals that are 2 to 6 weeks old and that have estab-
lished gut floras which would be more dominant numerically
than the colonizing pathogen. The constraints imposed by
studying gene expression by microarray meant that experi-
ments had to be performed in newly hatched chickens to avoid
false-positive signals from the presence of numerically domi-
nant flora components, such as E. coli. This model reflects the
situation that occurs during infection in newly hatched chick-
ens which does take place within hatcheries. Despite the short-
comings of this approach, the patterns of expression were
closer to our preconceptions than we imagined. Similarly, pat-
terns of global gene transcription in Campylobacter jejuni in a
similar model were found to resemble those in older birds with
gut floras (92), and other similar models (e.g., a streptomycin-
treated mouse) have been used with E. coli with success (15,
44, 45).
The requirement for a large number of chickens to generate
sufficient RNA also meant that bacteria present in the ceca of
different birds would also likely have been present at different
stages of the growth cycle, depending on whether the ceca were
full, had just emptied, or were freshly filled (P. Barrow, un-
FIG. 4. Percentage of bacteria showing evidence of cell division out
of the total number of bacteria observed by phase microscopy from the
cecal lumens (white bars) or cecal mucosae (black bars) of 8 chickens
infected orally with S. Typhimurium when less than 24 h old and killed
24 h later.
TABLE 5. S. Typhimurium genes downregulated at the mucosal walla





Amino acid transport and
metabolism
STM0067 carB Carbamoyl-phosphate synthase large subunit; putative
ABC transporter
2.9 0.035
STM1255 Periplasmic binding protein 2.49 0.044
STM2055 pduU Polyhedral body protein 2.097 0.031
STM1257 Putative ABC transporter protein 2.03 0.006
STM3594 prlC Oligopeptidase A 2.09 0.0496
Carbohydrate transport and
metabolism





STM2120 asmA Suppressor of OmpF assembly mutants 2.12 0.049
Energy production and
conversion
STM2057 pduW Propionate kinase 2.1 0.006
PSLT027 ccdA Antidote 2.14 0.045
STM0813 ybhP Putative cytoplasmic protein 2.09 0.025
STM2007 Tetratricopeptide repeat protein 2.33 0.034
Not in COGs STM0903 Putative chaperone 2.79 0.003
STM2041 pduD Propanediol dehydratase medium subunit 2.58 0.04
STM3688 Putative cytoplasmic protein 2.16 0.0499
Replication, recombination,
and repair
STM4168 nfi Endonuclease V 2.22 0.011
Transcription STM3773 Putative transcriptional regulator 2.07 0.019
Translation STM2665 yfiA Ribosome stabilization factor 2.75 0.01
a Genes selected as genes of interest showed a 
2-fold change in expression levels and a P value of 0.05.
TABLE 6. Viable counts of test (Nalr) and challenge (Spc) mutants
of S. Typhimurium F98 in the ceca of newly hatched chickens
in a competition assaya
Mutation
Viable count ofb:
Test strain Challenge strain
postmortemAt time of challenge Postmortem
metF 8.32, 8.42, 8.59 7.17 (6.60–7.82) 2 (2–2)
csgA 8.40, 7.64, 8.04 7.79 (7.18–8.18) 2 (2–2)
ttrS 7.73, 6.30, 7.08 6.95 (6.00–7.79) 2 (2–2.85)
ttrB 7.93, 8.43, 9.11 7.74 (7.00–8.00) 2 (2–2)
pdu 8.08, 8.04, 8.00 6.60 (6.00–7.65) 2 (2–5.2)
eut 8.2, 8.88, 9.00 7.59 (7.18–7.68) 2 (2–2)
argA 7.11, 7.88, 7.28 6.00 (6.00–6.90) 2 (2–2.78)
potG 7.90, 7.83 6.95 (6.70–7.28) 2 (2–2)
Parent 8.80, 8.18, 8.28 7.00 (6.60–8.57) 2 (2–2)
None 2, 2, 2 2 (2–2) 4.3 (4.00–7.82)
a Ten chickens were inoculated with the test strain. Three chickens were killed
to enumerate this strain 24 h later at the time of challenge. All chickens were
killed 3 days later to enumerate both strains in the ceca.
b Viable counts at time of challenge are presented for all three chickens.
Viable counts postmortem of all other chickens are the means and ranges.
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published). This potential variation had implications for mea-
suring the expression of genes associated with logarithmic ver-
sus stationary-phase growth, but it did not appear to have a
profound effect, judging from the patterns of expression ob-
served.
Although we measured luminal gene expression, we were
aware that the ceca contained heterogeneous environments, as
indicated by the differing rates of cell division in the lumen and
close to the mucosa. This was supported by differences in
expression levels in genes associated with cell division, tran-
scription, and translation. What was perhaps more surprising
was that so few other genes were affected. The metabolic and
virulence profiles from the bacteria harvested from the lumen
fairly well reflected those from the mucosa, where most of the
cell multiplication was taking place. This was reassuring. The
small number of changes in expression at the mucosa from that
of the luminal contents suggested that the two populations
were very similar, but it offers some insight into the lifestyle of
the bacteria close to the mucosa. The involvement of genes (crr
and gmhA) in the uptake and metabolism of glucose, galactose,
or mannose suggests that sialic acid from host cell membranes
would likely act as a potential carbon source for bacteria close
to the mucosa.
The data presented were also validated by the similar
changes in expression observed in selected genes tested by
RT-PCR, as has been found by other authors (2, 92).
The reduced level of cell division within the lumen, indicated
by microscopy, together with the reduced expression of genes
associated with cell division, transcription, and translation, sug-
gests a greatly reduced rate of metabolism and growth at this
site. There is a direct dependence of transcription and trans-
lation rates and gene doses on bacterial growth rates (49, 53),
in addition to the dependence on total RNA quantity and
ribosomal proteins (35, 47). The relationship between cell
growth rates and expression of genes associated with cell divi-
sion is less clear, since a key gene associated with the formation
of the Z ring, ftsZ, is expressed independently of growth rate
(88). The ftsEKX genes interact and form part of the divisome.
Although functionality of several fts genes is not required for
cell growth, as indicated by continued filamentous growth in fts
mutants, ftsE mutants do show reduced growth rates, which
can be suppressed at high osmolarities (18). Despite the ap-
parent low rate of cell division and the shortage of nutrients in
the lumen, there was evidence that propionate, 1,2-propane-
diol, and ethanolamine acted as important carbon sources.
This was less apparent at the mucosal wall, where the pduDUW
genes were significantly downregulated and the main source of
nutrients was unclear, although there was some evidence for
use of glucose in this niche but not in the lumen (see below).
Interestingly, expression of SspA, stringent starvation protein
A, was upregulated at the mucosal wall. This protein in E. coli
was found to be induced during stationary phase and starvation
for carbon, amino acids, nitrogen, and phosphate (34). It is
thought to act as a global regulator. Its expression suggests that
the bacteria were experiencing conditions of starvation, and
though most bacterial multiplication is occurring close to the
mucosa, this itself is not an ideal or static environment and it
indicates the complexity of the environmental niches in the gut.
Within the lumen, degradation of 1,2-propanediol appeared
to be occurring, although this generally requires endogenous
adenosyl cobalamin (coenzyme B12) biosynthesis. The pdu
genes are contiguous and coregulated with cobalamin biosyn-
thetic genes (cob and cbi) (49, 66). However, in the current
experiments, there was no significant upregulation of the cob
or cbi operons within the lumen. Some vitamin B12 is thought
to be present in egg yolk (17) and would be present in the gut
of newly hatched chickens, as the yolk sac is not fully resorbed
for 3 to 4 days. This could be scavenged by BtuF (85), and BtuF
in Salmonella is a periplasmic binding protein with a high
affinity for vitamin B12 which was expressed within the lumen.
FIG. 5. Numbers of chickens, expressed as a percentage, which were excreting the inoculated mutant of a nalidixic acid-resistant derivative of
S. Typhimurium F98 at 1 week (white bars), 2 weeks (gray bars), and 3 weeks (black bars) after oral inoculation of chickens possessing gut floras.
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Genes involved in the catabolism of ethanolamine, which is
derived in part from host cells and membranes, are encom-
passed in the eut operon (67, 75). The eutT gene encodes an
adenosyltransferase, which is used to activate EutR, and in
turn triggers transcription of the operon (68). Two of the
genes, eutM and eutN, partially encode a metabolosome with
the products of eutSLK, which encode the shell proteins of the
metabolosome (74). The role of this structure was proposed to
be to concentrate low levels of ethanolamine catabolic en-
zymes (10). The eutD gene encodes a phosphotransacetylase,
which acts as a safety valve to minimize flux variations in a
system which converts ethanolamine into acetyl coenzyme A
(acetyl-CoA). The roles of eutP and eutQ remain unclear,
though they were significantly upregulated in the cecal lumen.
Tetrathionate is one of the electron acceptors of choice for
the utilization of ethanolamine and 1,2-propanediol (64) in the
absence of oxygen. Other genes associated with respiration,
including cydA, cyoCD, nuoEFIL, frd, and napC, were down-
regulated, suggesting that an anaerobic environment is present
in the cecal lumen. This is in contrast to the findings of Jones
et al. (44) showing that cytochrome bd oxidase was required for
colonization of the streptomycin-treated mouse intestine by E.
coli. These models are not strictly comparable, since the strep-
tomycin-treated mouse will retain some gut flora, whereas
there was virtually none in this series of experiments. In addi-
tion, we have found a degree of host specificity related to the
likely route of respiration during intracellular Salmonella in-
fection in chickens and mice (83) and the redox conditions
implied therein. Tetrathionate is reduced to thiosulfide and
further to H2S with the products of ttr, phs, and asr genes. It is
likely that the tetrathionate results, in part, from material from
the yolk sac, which is rich in sulfur. The role of sulfur-based
electron acceptors in respiration in the gut has been shown
recently by Winter et al. (90), who demonstrated that in mice
with acute intestinal infection, reactive oxygen is released,
which generates thiosulfate to be used as an electron acceptor.
The model used here involved birds in which, at the time of
harvesting, no inflammation was visible. It seems likely that
during a more established infection when inflammation and
gut damage will also occur, similar events are likely to take
place.
Expression of ackA, encoding acetate kinase, which balances
acetate and acetyl coenzyme A production, and an alternative
phosphate donor acetyl phosphate, was upregulated 2-fold. A
significant role of substrate-level phosphorylation in chickens
is further supported by the poor colonization ability of ackA
and pta mutants (P. Barrow and M. A. Lovell, unpublished
findings).
The results from in vivo studies with mutations affecting the
complex interactions between propanediol and ethanolamine
as carbon sources, tetrathionate as the electron acceptor, and
cobalamin as a cofactor were ambiguous, probably indicating
the degree of redundancy in these nutrients as carbon sources.
Thus, although the pduA mutant, like the other mutants, was
fully inhibitory in the competition assay, it colonized the gut
less well in these birds and also colonized the birds with the
floras less well, albeit with a reduction of marginal significance.
The eutS mutant colonized the gut well, again indicating the
degree of redundancy in carbon source availability in this com-
plex niche. Thus, although genes may be upregulated, indicat-
ing metabolic activity, their mutation will divert metabolic ac-
tivity to other catabolic pathways. Both the ttrB and ttrS
mutants colonized less well in this assay, with only the ttrB
being significantly reduced. The picture is confused by the fact
that the double mutants with a btuB mutation colonized well,
whereas the single cobS and cbiA mutants colonized less well,
although not significantly so. The interaction between pro-
panediol utilization with tetrathionate and with cobalamin is
highly complex, and much of the nature of these interactions in
vivo remains to be determined.
The breakdown of propionate occurs via the 2-methylcitrate
cycle using the prpBCDE locus (33), encoding the propionate-
degrading enzymes and carrying prpR, a transcriptional regu-
lator (38) which was previously thought to act as a sensor for
2-methylcitrate, an intermediate of the breakdown pathway
(60, 61, 81). Although cobB expression was also thought to be
required (79), there was no significant difference between ex-
pression in vivo and in vitro. The absence of cobB expression
may be compensated for by expression of pduW, which encodes
propionyl coenzyme A, a precursor of 2-methylcitrate, and
which was upregulated 4-fold. The prpE mutant showed no
reduction in colonization ability from that of the parent strain
(tested in a different assay; results not presented). However,
given the other energy sources available to Salmonella within
the lumen, this was not unexpected.
D-Glucose is taken up and concomitantly phosphorylated
either by the glucose-specific enzyme II (EII) transporter or by
the phosphoenol-pyruvate-dependent transporter (97). The
phosphoryl group is transferred to glucose through enzyme I
(encoded by ptsI) and the phosphohistidine carrier protein
(encoded by ptsH) to sugar-specific EII, which consists of two
subunits, crr and ptsG. At the mucosal wall, glucose may be a
more important carbon source, with upregulation of ptsH and
crr, though expression of ptsI and ptsG was not significant.
However, in the cecal lumen, we think that a number of other
carbohydrates may also have been utilized, most significantly
melibiose and L-ascorbate, suggesting, with the downregulation
of crr and ptsH, that glucose was not an available source. The
breakdown of melibiose utilizes two genes, melA (-galactosi-
dase) and melB (transporter), and their expression is stimu-
lated by MelR (77). Expression of melA was significantly up-
regulated in the lumen, although expression of melB and melR
was not statistically significant. With the high levels of expres-
sion of melA, it suggests either that this compound may already
have been present in the cell or that the product of the melA
gene was being used to break down a second carbohydrate
source.
Four of the 11 genes required for the catabolism of L-ascor-
bate to D-xylulose, which enters the pentose phosphate path-
way, were upregulated. Generation of internal trehalose also
appears to occur in the lumen, with the upregulation of otsA.
This would fit with a model where the bacteria in the lumen are
growing slowly or are under stress, as the trehalose operon is
induced under these conditions in an RpoS-dependent manner
(76, 84). Trehalose has been demonstrated to play a role in cell
protection against stressful environmental conditions, such as
osmotic stress and heat shock, and was proposed to have a role
in survival but not virulence (39).
Several other sources of carbohydrates were not utilized in
the lumen, including maltose and galactose, as indicated by
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downregulation of lamB (30) and mglB, respectively. Again,
this is in contrast to the findings of Jones et al. (45), which
showed that maltose was important for E. coli colonization of
the mouse intestine. These authors also found, in contrast to
our previous findings, that glycogen was a significant carbon
source (57). These results indicate the different responses in
terms of gene expression and metabolism to colonizing differ-
ent hosts, as recognized by Chang et al. (15) and as is found in
those genes responsible for respiration during systemic Salmo-
nella infection in chickens or mice (83).
Bacteria from the ceca demonstrated a requirement for me-
thionine with significant levels of expression of metE, metF,
with which metH forms the folate branch of the methionine
pathway, and metR. The MetR protein acts as an activator for
the transcription of metE, metA, metF, and metH (93). Homo-
cysteine functions as a coregulator for MetR-mediated regu-
lation and has a positive effect on the expression of metE,
which encodes a transmethylase, and metF, which encodes
5,10-methylenetetrahydrofolate reductase but has a negative
effect on metA and metH. The methylation of homocysteine,
the final reaction prior to formation of methionine, is carried
out via the vitamin B12-independent enzyme MetE (94). Genes
involved in the utilization of other amino acids, including thre-
onine (tdcB) and serine (dsdA and tdcG), were downregulated
in the cecal lumen. The downregulation of tdcA, the transcrip-
tional activator of the tdc operon, suggests that there is little
requirement for threonine or serine within the lumen. There
was also a significant downregulation of genes involved in the
biosynthesis of glycine and one-carbon units (gcvH and gcvP),
suggesting that these amino acids were not essential for growth
and survival in the lumen.
The environment within the chick cecum was thought to be
very weakly acidic, at pH 6.5 to 7 depending on diet, in addi-
tion to being anaerobic. Several mechanisms of survival of
Salmonella under acidic conditions have been well docu-
mented (27, 29), although it is fairly certain that this pH would
not induce a strong acid tolerance response. Three acid-resis-
tant (AR) mechanisms have been identified in Escherichia coli,
including AR1, which involves RpoS and cyclic AMP (cAMP)
enabling cells to resist a pH as low as 2.5 (28). The AR3 system
involves an arginine decarboxylase and has recently been iden-
tified in Salmonella and expressed under anaerobic conditions
(48). S. Typhimurium DT104 was found to induce an arginine-
dependent AR response involving transcriptional activation of
adiA and adiC genes by adiY (48). In the present study, ex-
pression of adiA and speA was detected at high levels in vivo,
suggesting that Salmonella was degrading arginine to agama-
tine. Upregulation of the transcriptional regulator adiY and of
speB, which converts agmatine to putrescine, was not detect-
able in the ceca. However, Salmonella was actively generating
arginine, as indicated by the upregulation of argA and argS, and
scavenging arginine, as indicated by expression of artJ, which
encodes a binding protein for arginine. Interestingly, Salmo-
nella expressed significant levels of genes from the potFGHI
operon, which encodes an ATPase-binding, putrescine-specific
uptake system. Polyamines have been found to increase sur-
vival in extremely acidic and other inimical environments (96).
Whether these data indicate low pH at the microenvironmen-
tal level or resistance to another factor inimical to metabolism
in a gross environment where the pH is close to neutral re-
mains to be determined. Mutation of argA did not alter colo-
nization ability or survival in day-old chicks, although a role for
speA in the colonization of 2-week-old chickens was suggested
by Morgan et al. (59).
Mutation of potG did not alter colonization of day-old
chicks. Similarly, Morgan et al. (59) found that mutation of
potH did not reduce colonization ability. This suggests that the
potFGHI operon was not functioning to transport putrescine
into the cell but may have been playing an alternative role.
As the evidence suggested an environment where oxygen
concentrations were very low, a 3-fold increase in dcm, asso-
ciated with DNA repair, was unexpected. Heithoff et al. (36)
reported previously that dam mutants were virulent in mice,
but the role of cytosine methylation (dcm) was unclear. It is
important in the regulation of biological processes in plants
and animals, but the role of dam in the methylation of adenine
is more important. However, the results here suggest that in
chicks, dcm may contribute to the survival of Salmonella within
that environmental niche. Given the probably low oxygen con-
tent of the cecal lumen, suggested by the downregulation of
cydA, cyoCD, nuoEFIJ, and frd, the expression of recC was
unexpected. The protein encoded by this gene functions to
repair damage to DNA caused by host-synthesized com-
pounds. Mutations in recA and recBC were found to be highly
sensitive to oxidative compounds synthesized by macrophages
and avirulent in mice (11). Similarly, the expression of sbcC
was unexpected. The protein encoded by this gene acts to
restore recombination and to resist DNA damage. It suggests
that radical oxygen molecules, which could be damaging to the
chromosome, may exist within the lumen. Interestingly, expres-
sion of tpx was detected at the mucosal wall, suggesting a
gradient of oxygen across the cecum itself. Bacteria protect
themselves from reactive oxygen species with a range of anti-
oxidant defense enzymes, including thiol peroxidase. It was
found that tpx acts as a lipid peroxidase to inhibit bacterial
membrane oxidation and acts as a principle antioxidant for E.
coli during anaerobic growth (14). It is possible that tpx may be
functioning in a similar way here. Again, the recent work by
Winter et al. (90) is relevant here, since it indicates that the
release of reactive oxygen species into the gut results from
inflammation. Although there was no indication of any gross
inflammatory response here, the induction of proinflammatory
cytokines by invading bacteria is a rapid event (46) and begins
to be apparent by 16 to 24 h postinfection of newly hatched
chickens (91). This process would undoubtedly have started in
the gut of the chickens examined here.
Bacteria in the lumen displayed poor motility compared to
in vitro-grown bacteria, as demonstrated by phase-contrast mi-
croscopy. The lack of motility is further supported by the
downregulation of a number of genes involved in flagellar
structure and function in the cecal lumen. The majority of the
genes involved in the process were downregulated in the lu-
men, including two regulatory genes, flgM and flgN, which act
to regulate gene expression. flgM acts as anti-sigma factor 28,
which binds sigma factor 28 until the completion of the hook-
basal body unit (2). flgN has two roles (1): it acts as a sensor for
late gene expression in flagellar assembly by promoting expres-
sion of flgM translation, and it is associated with hook-associ-
ated proteins to inhibit its translation on flagellar completion.
The first hook-filament junction protein, encoded by flgK, was
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downregulated, as was flgB, which forms part of the rod protein
(95). Interestingly, fliC and fljB, which encode flagellin, were
downregulated, as was fljA, which acts as a negative regulator
for fliC expression (95). This suggests that no flagellin was
produced in the chick lumen and, with the lack of expression of
chemotaxis genes (cheAWZ, tcp, tsr), suggests that there is no
major chemoattractant in the lumen which Salmonella bacteria
would move toward. The downregulation in expression of tcp
and tsr (41) suggests that neither citrate (tcp) nor serine (tsr) is
present in the lumen. Stecher et al. (74) have shown that
motility increases closer to the mucosa in the inflamed mouse
intestine, although flagellation was less important in the non-
inflamed gut. We did not look at motility at the mucosa, but
there would certainly not have been any gross inflammation
during the short period of the experiments here.
Up to 13 different fimbrial operons have been suggested to
be elaborated by Salmonella (40, 56). Some fimbrial genes are
only expressed in particular environments (24). Within the
chick lumen, several fimbrial genes were expressed, including
stfAEFG, stbB, stjB, stcC, and sthB, suggesting that they may
have a role in colonization or survival outside the host. The stf
operon was found not to be essential for colonization by Clay-
ton et al. (16). Morgan et al. (59) suggested that stbC and sthB
contributed to colonization of older chickens. Genes required
for biosynthesis of thin, curled fimbriae (csgB and csgA) were
upregulated in the lumen as in macrophages (24). These are
thought to have a role in adhesion, becoming associated with
extracellular matrix, and are known to have a role in patho-
genesis in E. coli (31). They appeared to play little role in our
in vivo model.
The fim operon, encoding type 1 fimbriae, was downregu-
lated in the lumen due to the upregulation in the expression of
two regulatory genes, fimY and fimW. The role of the fimY
gene in S. Typhimurium remains unclear, though it is essential
for fimbrial production and acts as a coactivator with fimZ
(79). fimW acts as a negative regulator and interacts with fimZ-
mediated activation of fimA expression (78).
Salmonella pathogenicity islands (SPI) contain genes which
confer virulence-associated functions upon the host bacterium,
often mediated by secreted proteins. In Salmonella, many
pathogenicity islands and other gene clusters have been well
characterized, and expression of a number of genes from the 5
major islands has been detected. A small number of genes
from SPI-1 were upregulated, including sitBC, which encodes
an iron uptake system (101). The sitABCD operon is induced
under iron-deficient conditions and is thought to play a role in
iron acquisition in mice (42, 98). Interestingly, hilC and hilD
are downregulated in the lumen. These genes encode tran-
scriptional activators, which can bind to hilA and induce ex-
pression of three operons within SPI-1, namely, inv-spa, prg-
org, and sic-sip (23). The high levels of repression of hilD
suggest that expression of SPI-1 is inhibited, though expression
of sipD and spaS was detected. hilD also plays a role in medi-
ating the activities of SPI-1 and SPI-2 (12). The role of SPI-1
genes, and secreted proteins in general, in colonization in
day-old chicks has not been widely investigated and is of con-
siderable interest. Most SPI-1 genes were found not to be
required for colonization of the cecal lumen of older birds by
Morgan et al. (59), although they were required for coloniza-
tion of the intestinal mucosa of calves. Recently, Jones et al.
(43) found that SPI-1 did not play an essential role in systemic
infection in 1-day-old birds. A subset of SPI-2 genes, including
ttrAC, ssaBCDMSU, and sseC, were upregulated significantly in
the lumen. Interestingly, gene expression was detected
throughout SPI-2, though most of the changes were not signif-
icant. Regulation of expression of SPI-2 genes is thought to
involve OmpR-EnvZ and PhoP-PhoQ (9), but none of the
genes encoding these proteins showed significant alterations in
their levels of expression. Again, Morgan et al. (59) found very
few of these genes to be required for colonization of older
birds. Interestingly, Wigley et al. (89) found in day-old chick-
ens that SPI-1 contributed to and SPI-2 was essential for the
virulence of Salmonella enterica serovar Pullorum in newly
hatched chicks, where gut colonization does represent an early
phase of the infection process in this infection model (73).
In SPI-3, mgtC was upregulated, along with rmbA and fidL.
The mgtC gene forms a part of the mgtBC operon, which is
positively regulated by magnesium, although the exact role of
mgtC has not yet been clearly defined. This gene does not have
a role in magnesium uptake, though it may have a role in
long-term survival in macrophage cell lines (58), suggesting
that mgtC may have a similar role here. Statistically nonsignif-
icant increases in expression were also observed with mgtA and
mgtB. No genes were expressed from SPI-4, and no role in
colonization of chickens was observed by Morgan et al. (59).
However, in SPI-5, pipB, whose role is unclear, was found to be
upregulated in the lumen and at the mucosal wall. These au-
thors also found that pipB contributed to colonization of older
chickens (59). Although its role is unclear, it has a link with
SPI-2 since this SPI is required for its secretion (50), though
here those genes were not significantly upregulated.
It is worth noting that expression of ugtL was upregulated at
the mucosal wall. This gene is required for resistance to the
antimicrobial peptides maginin 2 and polymyxin B (69). Within
the lumen, magnesium limitation appears to be occurring, but
it is interesting that a defense peptide is being expressed by
Salmonella, suggesting that a rapid response by the host to
infection is occurring.
The exact role for secreted proteins in colonization is un-
clear. Older work (82) supported the hypothesis that cecal
colonization, of chickens at least, by Salmonella was largely a
physiological characteristic, since there seemed little ecological
advantage in adhesion to the mucosa in an organ where the
rate of flow of chyme was very low. However, the identification
of some SPI genes in colonization (59, 82) suggested that
colonization, as a virulence trait, might not be as straightfor-
ward as originally thought. More recent information indicated
that a T cell-mediated response, rather than secretory antibod-
ies, was central to immune clearance of S. Typhimurium from
the chicken gut (7), suggesting that a close association with the
mucosa may indeed be involved. The upregulation of fimbrial
genes (59) supports this assertion.
The microscopic observations indicated a higher rate of cell
division in the mucosa than in the lumen of the cecum. This
was supported by the increased expression at the mucosa of
ftsA, a gene involved in cell division which acts to anchor the
protofilaments of bacterial tubulin, encoded by ftsZ, to the
membrane (62). However, the presence of ftsA alone is not
sufficient for the Z ring to form, and zipA (32) and other
downstream genes required were not expressed at significant
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levels at the mucosal wall. On the other hand, further support
for active cell division occurring close to the mucosa comes
from expression of mreB. The protein encoded by mreB has
been found responsible for the rodlike shape of Salmonella
bacteria (19). Recent work (86) suggests that the MreB protein
directs the incorporation of new peptidoglycan into the wall,
though the presence of ftsZ is required to direct the insertion.
In addition, yhdE, which inhibits the formation of the septum,
was expressed (12), suggesting that the cells were elongating
after cell division at the point of sample collection. The MreB
protein also contributes, it is thought, to chromosomal segre-
gation (51).
These preliminary data suggest that S. Typhimurium bacte-
ria in the cecal lumens of newly hatched chickens show down-
regulation of genes associated with transcription, translation,
and cell division, all required for growth, whereas there was
some expression of genes associated with cell division in bac-
teria harvested closer to the mucosa. It seems likely that con-
centrations of oxygen or of other electron acceptors and a
variety of nutrients would be present closer to the mucosa than
to the lumen, so these findings are not surprising. They are
supported by earlier results with E. coli colonization of the
mouse intestine, where there was evidence for most microbial
growth taking place close to the mucosa (63), and our micro-
scopic findings support this. The data suggest that several en-
ergy and carbohydrate sources are utilized which are different
from those used in late-log-phase nutrient broth cultures, in-
cluding propionate, ethanolamine, and 1,2-propanediol. Or-
ganisms in the lumen were poorly motile and showed a down-
regulation of genes associated with chemotaxis, though no
genes associated with motility were identified or expressed at
the mucosa. From our colonization studies, it was clear that
several genes associated with propanediol catabolism under
anaerobic conditions were involved in colonization, although
the picture is obviously complex. However, in the light of
previous findings where very few genes made great changes
when tested as single mutations (16, 100), coupled with the
degree of metabolic redundancy in enteric bacteria, this per-
haps should not be surprising. This indicates that the coloni-
zation phenotype is a multifactorial characteristic with the
main site of metabolic and other physiological activity close to
the mucosa.
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Abstract
Background: The integration of genomic information with quantitative experimental data is a key
component of systems biology. An increasing number of microbial genomes are being sequenced,
leading to an increasing amount of data from post-genomics technologies. The genomes of
prokaryotes contain many structures of interest, such as operons, pathogenicity islands and
prophage sequences, whose behaviour is of interest during infection and disease. There is a need
for simple and novel tools to display and analyse data from these integrated datasets, and we have
developed ProGenExpress as a tool for visualising arbitrarily complex numerical data in the context
of prokaryotic genomes.
Results: Here we describe ProGenExpress, an R package that allows researchers to easily and
quickly visualize quantitative measurements, such as those produced by microarray experiments,
in the context of the genome organization of sequenced prokaryotes. Data from microarrays,
proteomics or other whole-genome technologies can be accurately displayed on the genome.
ProGenExpress can also search for novel regions of interest that consist of groups of adjacent
genes that show similar patterns across the experimental data set. We demonstrate
ProGenExpress with microarray data from a time-course experiment involving Salmonella
typhimurium.
Conclusion: ProGenExpress can be used to visualize quantitative data from complex experiments
in the context of the genome of sequenced prokaryotes, and to find novel regions of interest.
Background
The genomes of prokaryotic organisms contain many
structures that may be involved in pathogenicity, includ-
ing a variety of operons, pathogenicity islands and
prophage sequences. Operons are sets of adjacent genes in
bacteria that form a single transcriptional unit, and many,
such as those coding for flagella [1] or fimbriae [2], have
been implicated in pathogenicity. Pathogenicity islands
are distinct regions of the genome that confer virulence
upon the host, and are found in many pathogens of
humans, animals and plants, and at least ten pathogenic-
ity islands have been identified in Salmonella alone [3].
Prophage sequences represent the chromosomes of bacte-
riophage integrated as part of the genome of the bacterial
host, and have also been implicated in pathogenicity in
several species [4].
In order to study the behaviour of these elements, it is
essential to integrate information about the genome struc-
ture of an organism with quantitative measurements
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produced by post-genomic technologies, such as those
from microarray or proteomics experiments. This integra-
tive biology approach is a key feature of systems biology.
Studying the behaviour of these genomic elements, and
other groups of adjacent genes, during infection and dis-
ease may reveal important information about the molec-
ular mechanisms underlying pathogenicity.
Several microbial genome viewers have been developed
which allow quantitative data to be displayed on the
genome. The Microbial Genomes Viewer [5] offers a
good online solution, however users must install a
browser plug-in and may not be comfortable transmitting
data over the internet. GenoMap [6] can be used to create
plots of microarray data on microbial genomes, and is
available as Tcl/TK source code. Genome2D [7] also offers
good visualisation of quantitative data on microbial
genomes, but is limited to the Windows operating system.
Finally, GenomeViz [8] has recently been released, which
offers much functionality, including visualisation of
quantitative data, genome alignments and GC content.
However this software is currently limited to unix-based
systems. All of the above solutions are limited in two
respects. Firstly, the quantitative values are represented as
a colour-scale, which reduces the accuracy of the data and
which may present problems in comparing one colour to
the next. Secondly, the above tools can only display a sin-
gle value for each gene, which precludes the visualisation
of more complex data, such as a time-course experiment.
Implementation
ProGenExpress is released as a package for R. R is a freely
available, open-source statistical package [9] that is widely
used in the biological community. R has very powerful
statistical and graphical capabilities, and many add-on
packages are freely available. The bioconductor project
[10,11] provides a huge number of add-on packages for R,
covering a wide range of biological data analysis applica-
tions, and the implementation of ProGenExpress in R pro-
vides seamless integration with many of these packages.
ProGenExpress is written in the native R language and has
been fully tested on both windows and linux. R is availa-
ble for windows, linux, unix and MacOS (including
MacOS X).
Results and discussion
ProGenExpress has been written to allow researchers to
quickly and simply visualize the behaviour of bacterial
genomic regions of any size during experiments using
whole genome technologies, such as microarray or pro-
teomics experiments. For information relating to the
genome organisation of prokaryotes, ProGenExpress
includes functions for downloading and reading both
NCBI .ptt files, which describe the location of protein cod-
ing genes in bacteria in a tabular format, and include links
to the COGs database [12], and whole genome RefSeq
entries [13]. For the quantitative experimental data, Pro-
GenExpress can use the objects created by many of the
packages from the bioconductor project [10,11], or data
imported into R from text files, SQL databases and Excel.
There are currently 225 completed prokaryotic genomes
in RefSeq [15] that ProGenExpress can read, and though
the utility of ProGenExpress is demonstrated here using
microarray data, any kind of numerical data that can be
linked to the genes of prokaryotic organisms can be dis-
played using ProGenExpress. Where measures of the sta-
tistical significance of the data points for each gene are
available, these can be passed to the plotting functions of
ProGenExpress, with the result that those genes that are
not significant will be plotted in white and those that are
significant will be plotted in their normal plotting colour.
The genome is represented as two barplots, one for each
strand. Each gene has a number of bars equal to the
number of experimental data sets included, allowing
time-course or complex strain/treatment experiments to
be plotted. Distance between the bars for each gene is rep-
resentative of intergenic distance. Slices of the genome can
be selected either by base range, gene synonym or gene
name. Both horizontal and vertical plots are possible, and
bars can be coloured either by numerical value or by
COGs [12] functional category.
The software is demonstrated here using microarray data
from Eriksson et al [14]. This data set consists of gene
expression measurements from intracellular Salmonella
typhimurium at 4, 8 and 12 hours post murine macrophage
infection. Gene expression values were calculated as the
relative expression level of test RNA to that of RNA from
bacteria grown in vitro, and the data has been centred and
normalised according to Eriksson et al [14]. Data from
Erikson et al is available as a spreadsheet [14]. This spread-
sheet was pre-processed to contain only columns for gene
synonym, gene name and relative expression level of test
RNA to control RNA on a log 2 scale for each of the three
time points. The spreadsheet was saved as tab-delimited
text and read in to R using the read.table() function. The S
typhimurium genome and plasmid sequences were read
in to R using the read.ptt() function, with RefSeq files
NC_003197.ptt and NC_003277.ptt respectively. The
microarray data was linked to the gene location data using
the linkem.avg() function. Images of the microarray data
on both the entire genome and the plasmid were then
generated using the plotrange() and plotrange.vertical()
functions in conjunction with jpeg(), an internal R func-
tion. The results were viewed in Internet Explorer. Finally,
the find.region() function was used to find regions of
interest as described below.
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Figure 1 shows the expression of all genes on Salmonella
typhimurium LT2 plasmid pSLT, coloured by COGs func-
tional category. The majority of the genes on this plasmid
are up-regulated at all three time-points, implying a role
for this plasmid during macrophage infection. Figure 2
displays a smaller region of the genome containing the fli
operon, with all genes in the operon displaying similar
expression profiles. Erikksson et al [14] found 919 genes
to be significantly differentially expressed, and that meas-
ure of statistical significance has been incorporated into
Figure 2. Significant genes are coloured normally, whereas
those that are not significant are white. All but three of the
14 genes in the operon are shown to be significantly dif-
ferentially expressed, suggesting that the whole operon is
differentially expressed and that perhaps the measure of
statistical significance used is too stringent. Finally, Figure
3 is a vertical plot of Salmonella pathogenicity island II
(SPI-II), showing that most genes on this island are up-
regulated at all three time-points. This island encodes a
type III secretion system, and has been shown to be
required for systemic infection by facilitating replication
of intracellular bacteria within membrane-bound Salmo-
nella-containing vacuoles [3].
ProGenExpress can also search for operons and other
regions of interest by looking for clusters of genes that are
close together and which display similar patterns in the
experimental data. Using this facility, we identified over
200 potential regions of interest in Salmonella typhimurium
consisting of four genes or more, including several known
operons and potential unannotated operons. Figure 4
shows a region of the genome containing a group of six
genes that has been found using ProGenExpress. The
genes have no assigned gene name, have either an
unknown or putative/predicted function, are close
together on the genome and have similar expression pro-
files across the three time-points. We believe these genes
may represent an unannotated operon.
ProGenExpress has several advantages over existing soft-
ware. The package seamlessly integrates with the biocon-
ductor project and the many packages available in R for
microarray analysis, including limma, marray and affy,
and is available for both Windows and Linux, amongst
others. Both horizontal and vertical plots are possible,
and an unlimited number of data points for each gene can
be plotted, allowing for the visualization and analysis of
Gene expression measurements for Salmonella typhimurium plasmid pSLTFigur  1
Gene expression measurements for Salmonella typhimurium plasmid pSLT. Gene expression measurements for the 
pSLT plasmid of Salmonella typhimurium. The genome is represented as two barplots, one for each strand. Each gene has three 
bars representing expression at 4 h, 8 h and 12 h post macrophage infection. Gene expression measurements (y-axis) are 
ratios of test RNA to control RNA on the log 2 scale. Bars are colour-coded according to the COGs [12] functional category. 
Distance between genes is relative and representative of intergenic distance. This image clearly shows that the majority of 
genes on the plasmid are up-regulated during macrophage infection.
BMC Bioinformatics 2005, 6:98 http://www.biomedcentral.com/1471-2105/6/98
Page 4 of 7
(page number not for citation purposes)
complex time course or strain/treatment experiments.
Furthermore, the bar-plots display numerical data
accurately, and do not rely on a colour-scale to depict val-
ues. Finally, the ability to search integrated genomic and
post-genomic data sets for clusters of genes which behave
similarly represents an opportunity for the discovery of
novel genomic elements involved in pathogenicity.
Conclusion
We describe ProGenExpress, an open-source R package
which allows researchers to quickly and easily visualise
quantitative data from arbitrarily complex experiments in
the context of the genome of sequenced prokaryotes. Pro-
GenExpress can also be used to search for genomic regions
which may represent coherent functional units. We show
how ProGenExpress can be used to visualise microarray
data from a time-course experiment on the genome of Sal-
monella typhimurium, and to find unannotated genomic
regions that may be involved in pathogenicity. Future
plans for the software include the ability to read data from
ensembl databases, and the development of visualisation
Gene expression measurements for flagella biosynthesisFigur  2
Gene expression measurements for flagella biosynthesis. Gene expression measurements for the fli operon from Sal-
monella typhimurium. The genome is represented as two barplots, one for each strand. Each gene has three bars representing 
expression at 4 h, 8 h and 12 h post macrophage infection. Gene expression measurements (y-axis) are ratios of test RNA to 
control RNA on the log 2 scale. Distance between genes is relative and representative of intergenic distance. The fli operon is 
involved in flagella biosynthesis and this image clearly shows that the entire operon is strongly down-regulated during macro-
phage infection. Significantly differentially expressed genes are coloured red or green, whereas non-significant genes are col-
oured white. All but three of the 14 genes in the operon are significantly differentially expressed.
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Gene expression measurements for Salmonella pathogenicity island IIFigur  3
Gene expression measurements for Salmonella pathogenicity island II. Gene expression measurements for Salmo-
nella Pathogenicity Island II (SPI-II) from Salmonella typhimurium. The genome is represented as two barplots, one for each 
strand. Each gene has three bars representing expression at 4 h, 8 h and 12 h post macrophage infection. Gene expression 
measurements (y-axis) are ratios of test RNA to control RNA on the log 2 scale. Distance between genes is relative and rep-
resentative of intergenic distance. This island has been linked to pathogenicity, and encodes a type III secretion system. It is 
required for systemic infection and intracellular pathogenesis by facilitating replication of intracellular bacteria within mem-
brane-bound Salmonella-containing vacuoles [3]. Here we can clearly see that the majority of genes in the island are strongly 
up-regulated during macrophage infection.
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tools for eukaryotic genomes. Software updates and new
releases will be available from the project home page.
Availability and requirements
• Project Name: ProGenExpress
• Project Home Page: http://progenexpress.sf.net
• Operating Systems: Windows, Linux, Unix
• Programming Language: R
• Other Requirements: R version 2.0 or above
• License: GNU GPL
Authors' contributions
MW developed and tested the software in full.
List of abbreviations
COG: Cluster of Orthologous Groups
SPI-II: Salmonella pathogenicity island II
A putative operonFig re 4
A putative operon. Gene expression measurements from a genomic region of Salmonella typhimurium. The genome is repre-
sented as two barplots, one for each strand. Each gene has three bars representing expression at 4 h, 8 h and 12 h post macro-
phage infection. Gene expression measurements (y-axis) are ratios of test RNA to control RNA on the log 2 scale. Distance 
between genes is relative and representative of intergenic distance. The image shows six genes that have been identified by 
ProGenExpress as potentially interesting. The genes are very close together on the genome and display similar expression pat-
terns, and therefore could represent an as yet unannotated operon. The genes have synonyms STM4257 – STM4262 and cur-
rently have no confirmed function.
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Whole-genome shotgun metagenomics experiments produce DNA sequence data from
entire ecosystems, and provide a huge amount of novel information. Gene discovery
projects require up-to-date information about sequence homology and domain structure
for millions of predicted proteins to be presented in a simple, easy-to-use system.There is
a lack of simple, open, flexible tools that allow the rapid sharing of metagenomics datasets
with collaborators in a format they can easily interrogate. We present Meta4, a flexible
and extensible web application that can be used to share and annotate metagenomic gene
predictions. Proteins and predicted domains are stored in a simple relational database, with
a dynamic front-end which displays the results in an internet browser. Web services are
used to provide up-to-date information about the proteins from homology searches against
public databases. Information about Meta4 can be found on the project website1, code is
available on Github2, a cloud image is available, and an example implementation can be
seen at http://www.ark-genomics.org/tools/meta4
Keywords: metagenomics, database, web service, gene discovery, bioinformatics
INTRODUCTION
Whole-genome shotgun (WGS) metagenomics can be defined
as the application of high-throughput sequencing technologies
to whole environmental samples, enabling scientists to assay
the genomes of all organisms within a particular ecosystem, be
it the human gut microbiome (Yatsunenko et al., 2012), per-
mafrost (Mackelprang et al., 2011), or the Sargasso Sea (Venter
et al., 2004). One of the aims of such endeavors is to discover
novel enzymes that may have be of use to the biotechnol-
ogy industry (Cowan et al., 2005), and metagenomics has been
identified as a major mechanism for increasing the “sequencing
space” from which to discover new biocatalysts (Cowan et al.,
2004).
Whole-genome shotgun metagenomics experiments routinely
produce hundreds of gigabases of sequencing data. A generalized
analysis pipeline for such data is to (i) assemble the genomic data
de novo; (ii) predict genes and proteins on the resulting contigs
and scaffolds; (iii) assign domains and function to those proteins;
(iv) interpret those findings within the biological context. It is
not unusual for such studies to generate several million novel
genes/proteins – Venter et al. (2004) reported over 1.2 million
novel genes, and Hess et al. (2011) reported over 2.5 million puta-
tive genes, 27755 containing a domain of interest: those relevant
to biomass degradation.
Metagenomic assembly poses specific problems over and above
those of single genome assembly. The attempt to simultaneously
assemble thousands of different genomes often results in large and
1http://www.ark-genomics.org/bioinformatics/meta4
2https://github.com/mw55309/meta4
complex assembly graphs. These require more memory to create
and query, and also often require extra information in order to find
true paths through the graphs. Ray Meta (Boisvert et al., 2012) is
a massively distributed metagenome assembler that uses message
passing, whereas Pell et al. (2012) reduce memory requirements
using a bloom filter and use kmer connectivity to improve the
assembly process. Other tools attempt to partition the assembly
graph – Meta IDBA using graph connectivity (Peng et al., 2011)
and MetaVelvet using both coverage and connectivity (Namiki
et al., 2012). Finally, MetAMOS (Treangen et al., 2013) is a metage-
nomics pipeline that combines a number of published tools for
metagenomic analysis.
Once the raw metagenomic reads have been assembled into
contigs and scaffolds, the next stage is an attempt to predict the
location of genes. Here again, metagenomics poses particular
problems when compared to single bacterial genome annotation
(recently reviewed in Richardson and Watson, 2013). Specifi-
cally, traditional bacterial gene predictors use models trained on a
single, related genome; as with metagenomics we sequence thou-
sands of genomes simultaneously, this is no longer appropriate.
A number of tools have been published for metagenomic gene
prediction, including MetaGeneAnnotator (Noguchi et al., 2008),
Orphelia (Hoff et al., 2009), FragGeneScan (Rho et al., 2010), and
Glimmer-MG (Kelley et al., 2012). Yok and Rosen (2011) propose
a combination of tools.
Once genes have been annotated, domains can be assigned
to protein-coding genes using traditional approaches, such as
HMMER (Eddy, 2009) searches of domain databases such as Pfam
(Punta et al., 2012), and the use of tools such as InterProScan
(Mulder and Apweiler, 2007).
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After raw reads from metagenomics experiments have been
assembled and annotated, researchers are left with a very large
and rich dataset which can be difficult to query and share. Tools
that allow multiple users to browse and query such datasets, either
privately within a consortium, or as part of a public collaboration,
remain under-developed. It is essential that simple, open, and
flexible tools are provided to allow scientists to easily access the
outputs of metagenomic gene discovery projects. Here we describe
Meta4, a web application that is easy to install, that should work
on any standard LAMP (Linux, Apache, MySQL, PHP) server,
and which allows users to search and browse large collections of
metagenomic gene predictions in a user-friendly web interface. In
addition, Meta4 makes use of web services to provide up-to-date
annotation.
There are a few existing tools for organizing and analyzing
metagenomic data on the web; however, despite being feature-rich,
many are closed systems. The integrated microbial genomes and
metagenomes (IMG/M) system (Markowitz et al., 2012) allows
comprehensive analysis of genomes and metagenomes sequenced
at the Joint Genome Institute (JGI). However, the system is not
open-source, it is not possible to download the code and create
a local installation, the software is only extensible by the authors
and it is not easy to integrate your own data – one must e-mail
the authors and request integration. Similarly, the Community
cyberinfrastructure for Advanced Microbial Ecology Research and
Analysis (CAMERA; Sun et al., 2011) is a workflow-based, feature-
rich website for metagenomic analysis; however, the same issues
remain in that it is not open-source, it is only extensible by
the authors, it is not possible to create a local installation, and
users must e-mail the authors to request integration of their data.
Luckily, the metagenomics RAST server (MG-RAST; Meyer et al.,
2008), a very popular and comprehensive tool for metagenomic
data analysis, is far more open, with users encouraged to submit
their own data, and the code is available on github3. However,
even the authors admit, local installations of the tool are difficult,
they advise against it, and no support for such an undertaking is
available4.
All three tools are feature- and function-rich, and aim to be
complete systems for the assembly, annotation, and comparison
of multiple metagenomic samples. One problem with systems such
as IMG/M and CAMERA is an inability for users to maintain data
privacy; once data is uploaded to these systems, it is available for
the public to see. MG-RAST does have the option to submit to a
private queue, but this is a low priority queue. As such, these tools
are not designed for the simple task of sharing large amounts of
data quickly and simply. Meta4 is not designed to compete with
these tools in terms of functionality; rather, it is a simple tool
allowing the rapid sharing of metagenomic results that is easily
extensible by the addition of web services. It is possible to set up
a Meta4 database in less than 30 min on a simple Linux server
such as an Amazon EC2 micro instance. Meta4 is a lightweight
tool, completely open-source, easy to install locally and easy to
add additional functionality through web services.
3https://github.com/MG-RAST/
4http://blog.metagenomics.anl.gov/mg-rast-v3-2-faq/#local_install
Meta4 was developed on an Amazon EC2 micro instance
using a CloudBioLinux (Afgan et al., 2012) image. All code
is available via Github. An example Meta4 database can be
queried at http://www.ark-genomics.org/tools/meta4 containing
an assembly of the Hess et al. (2011) data.
MATERIALS AND METHODS
The overall structure of Meta4 is shown in Figure 1. Central to the
system is the Meta4 MySQL database, which stores information
on samples, assemblies, gene predictions, and protein domain
information. The choice to store some basic annotation in the
database itself allows users to query the available gene predictions
on domains of interest. Without such annotation, it would be very
difficult for users to filter the large numbers of gene predictions
in metagenomic datasets. We have chosen to store information
on protein domains, rather than the results of homology searches
(e.g., BLAST), as often domain searches are more sensitive to dis-
tant homology. Information can be loaded into the database from
common formats using the database loading scripts, including
GFF3 (gene predictions) and fasta (contigs and scaffolds). A web
form is provided that allows users to query the database and infor-
mation is presented in two ways: firstly, data extracted directly
from the Meta4 database is presented in the browser; secondly,
data extracted from the Meta4 database is provided to a range of
web services, and the results of those web services presented in
the browser. This allows for the latest, live, up-to-date annotation
to be displayed for each gene prediction, and is a key feature of
Meta4.
INTERFACE AND WEB SERVICES
The dynamic web interface is written in Perl/CGI and should run
on any apache web-server with minimal setup. The user is pre-
sented with a form including several parameters for search and
retrieval of genes/proteins within the database. The results are
FIGURE 1 |The overall structure of Meta4, which shows the
relationship between the MySQL database, the data loading scripts,
the web interface, external web services, and the users.
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returned as an HTML table, and consist of two parts – those that
return information stored in the database, and those returned
from web services.
We have implemented three web services in Meta4. The first
uses the EBI’s SOAP wublast interface (McWilliam et al., 2009),
querying Uniprot (Magrane and Consortium, 2011) with a pro-
tein sequence retrieved from the database. The top 10 results
are returned and these represent the most up-to-date homology
information for that protein within Uniprot.
The second uses the Uniprot REST web service (Jain et al.,
2009). Domains associated with a particular protein are extracted
from the database and used as input to search Uniprot. In this
way, known proteins with a similar domain structure to that being
queried are returned and presented to the user. Users are then able
to see the protein name and species of similar proteins, and can
click through to the Uniprot entry.
The third uses the EBI’s InterproScan (Mulder and Apweiler,
2007) SOAP interface (McWilliam et al., 2009), querying up to
14 separate protein domain databases with a protein sequence
retrieved from the database. The image and text returned also
represent the most up-to-date information publicly available for
the domains predicted within the query protein.
DATABASE STRUCTURE
The Meta4 MySQL database models the following specific entities
and their relationships:
(i) Sample: information about a specific biological sample that
has been sequenced. In reality we imagine most researchers
will store this information in some other database [e.g., a
laboratory information management system (LIMS)], but
this table allows metagenomic data to be linked to specific
samples.
(ii) Assembly: information about a de novo assembly of data from
a biological sample. This allows for multiple different assem-
blies of the same sample. The parameters of the assembly can
be stored as tag = value pairs in an assembly_param table.
(iii) Contig: models the contigs that are output as the result of an
assembly. We do not explicitly differentiate between contigs
and scaffolds. In this instance, a contig simply describes a
single, contiguous sequence obtained from a metagenomic
assembly.
(iv) Gene prediction: information on the genes predicted on any
given contig, including the location on the contig, and the
DNA and protein sequence.
(v) Domain database: contains information on the domain
database used and allows each gene prediction to have hits
to multiple domain databases [e.g., PROSITE (Sigrist et al.,
2010) and Pfam (Punta et al., 2012)] or multiple versions of
the same domain database.
(vi) Protein domain: information on the domains within each
domain database.
(vii) Domain match: storage of the link between gene predictions
and protein domains, including location of the match, bit
score and e-value.
Crucially, this structure allows multiple assemblies of the same
biological sample, as it is common to carry out multiple genome
assemblies using different software and parameter sets (which can
be flexibly stored in the assembly_param table). Domain matches
from multiple databases may also be stored.
CODE STRUCTURE AND DEVELOPMENT
We have implemented the Meta4 data model in MySQL with an
interface written in Perl and Perl CGI. The code has been tested
on CloudBioLinux (Afgan et al., 2012) and a local Scientific Linux
server, and should work on any standard LAMP server. The github
repository contains the following folders:
(i) sql: SQL for creating the MySQL database.
(ii) examples: example files used to create a simple instance of
Meta4.
(iii) scripts: perl scripts to load information and data into a Meta4
database.
(iv) cgi_scripts: perl CGI scripts that provide an interface to query
the data within a Meta4 database.
A README file is included in the distribution which gives
accurate instructions on how to create a Meta4 database that is
accessible via a web browser. If the import scripts are run with no
parameters, simple instructions are printed to the terminal.
Meta4 is released under an open-source license and we wel-
come active participation in the project. Whilst Meta4 is suitable
for release and publication in its current form, there are many
ways in which Meta4 could be developed. For example, currently
users must import data using Linux command-line scripts, rather
than a graphical user interface (GUI); also, we present scripts to
import data from the output of pfam_scan.pl5, and we welcome




We have created an example Meta4 database and the results can
be browsed at http://www.ark-genomics.org/tools/meta4. Briefly,
we downloaded data from Hess et al. (2011) (SRA accession
SRA023560) and assembled the reads using SOAPdenovo (Li
et al., 2010). Open-reading frames greater than 200 bp in length
were extracted as putative genes. Pfam-A domains were anno-
tated using pfam_scan.pl5. As the experiment was designed to
find novel biomass degrading genes, we encourage users to enter
“glyco_hydro” into the “Name” field and click “Submit.”
BROWSING GENE PREDICTIONS
Meta4 allows users to browse information on particular gene pre-
dictions. An example screenshot of such information can be seen
in Figure 2. Basic information such as the gene name, description,
and sequence lengths are extracted from the database. Protein
domains annotated within the database are also extracted, and
presented as both a table and an image. Furthermore, the actual
gene and protein sequences are presented, and formatted cor-
rectly. Afterward, live information is presented from the three
web services. Firstly, proteins with the same domain structure are
extracted from Uniprot, and presented as a table. Secondly, the top
10 BLAST hits against Uniprot/TREMBL are presented. In this
way, users are able to see similar proteins in Unprot by domain
5ftp://ftp.sanger.ac.uk/pub/databases/Pfam/Tools/PfamScan.tar.gz
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FIGURE 2 | Screenshot of the Meta4 results interface, showing information extracted from the Meta4 database, and information from web services
(marked as “live” in the table).
structure and by sequence homology, and can click through to
the relevant entries. Finally, results from the InterProScan web
service are presented, both as an image and as text. As InterProScan
searches 14 different domain databases, we are able to view more
information here than the simple domain information stored in
the Meta4 database. A key advantage of Meta4 is that informa-
tion and annotation about the protein in question is served to the
user in real time, and therefore represents the most up-to-date
information possible.
WEB INTERFACE
The web interface has been tested on Firefox (Windows, Linux,
Android), Safari (Windows, Mac), Opera (Windows, Android),
Konqueror (Linux), Chrome (Windows), the Android native
browser, and Internet Explorer (Windows). All features work
on all browsers, except Internet Explorer 8 (Windows). Our
implementation of the EBI’s InterproScan web service produces
an in-line image using the data URI (uniform resource iden-
tifier) scheme, and we understand Internet Explorer 8 to have
a 32 Kb limit for these. This is fixed in Internet Explorer
version 9.
AMAZON EC2 CLOUD IMAGE
An Amazon Machine Image (AMI) is available (EU-WEST: ami-
46687f32). The AMI is based on Ubuntu Precise 12.04 (64 Bit)
with additional dependencies installed, including Meta4. We
have loaded the example data packaged with Meta4, and the
system is available from the cgi-bin of the installed Apache2
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The role of Meta4 is to allow bioinformaticians to share the results
of metagenomic assembly and annotation with collaborators, and
to provide those collaborators with a simple web-based interface
with which to query and browse the data. It is not intended to
compete with tools that aim to assemble, annotate, and function-
ally or taxonomically compare multiple metagenomic datasets;
rather, it is a simple web application that can be used to search and
browse large amounts of information quickly, and retrieve genes
and proteins that may be of interest for further studies.
The key advantages of Meta4 are:
(i) Simplicity: Meta4 is incredibly simple and can be installed
in minutes on a standard LAMP server, either using the
git repository or by using the Amazon EC2 image. A new
Meta4 instance can be created rapidly from standard formats
using the scripts provided. In addition, Meta4 is completely
open-source.
(ii) Use of web services: by using web services, Meta4 ensures the
latest annotation results are delivered to users. In contrast,
other systems store pre-computed results which can rapidly
become out-of-date. By using web services, it is easy to extend
the functionality of Meta4.
(iii) Separation of data delivery from data analysis: existing web-
based systems combine assembly and annotation with results
presentation. By separating the search/browse function from
data analysis, Meta4 allows bioinformaticians to use an assem-
bly and annotation pipeline of their choice, and still share
their results with collaborators through a user-friendly web
interface.
(iv) Access control: often when one submits data to a public web-
server, a commitment is made to make the data publicly
available. Meta4 can be set up on a private intranet in minutes,
ensuring data privacy; alternatively, cloud Meta4 instances can
be limited to specific IP addresses. Thus Meta4 allows both
public and private sharing of data.
Managing the large amounts of data from WGS metagenomics
projects is a challenge and there is a need for simple tools that
enable scientists to access and query the results. We present Meta4,
a simple database for the storage of proteins and their domains
predicted from metagenomics experiments. Meta4 is lightweight,
easy to install and deploy, and can handle large amounts of data.
The system presents information to scientists in a format they
understand via a web interface. Meta4 is easily extensible through
the addition of web services, and despite not being as feature-
rich as some existing systems, benefits from being open-source,
lightweight and easy to install and deploy. The use of web ser-
vices means that the data served to users is as up-to-date as the
underlying primary database, which is an advantage over large
data warehouses whose data may become out-of-sync with the
primary data source. Meta4 is available under an open-source
license at http://www.ark-genomics.org/bioinformatics/meta4.
Despite the increasing number of published algorithms for
metagenomic assembly and annotation, the complexity of the
problem is such that errors are common. Attempts must be made
to assess the quality of metagenomic assemblies prior to annota-
tion, especially to ensure inappropriate joins are not made during
the contig and scaffold production steps. Metagenomic assemblies
are often highly fragmented, and this can affect gene prediction
and protein domain annotation. Once specific protein targets have
been identified from metagenomic datasets, we recommend a
manual annotation step to ensure the gene location (start and
end) and protein domain structures are correctly defined.
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Analysis of pathogen-detection microarray data<p>DetectiV is a tool for analyzing pathogen-detection microarray datasets that allows simple visualisation, normalisation and significance testing.</p>
Abstract
DNA microarrays offer the possibility of testing for the presence of thousands of micro-organisms
in a single experiment. However, there is a lack of reliable bioinformatics tools for the analysis of
such data. We have developed DetectiV, a package for the statistical software R. DetectiV offers
powerful yet simple visualization, normalization and significance testing tools. We show that
DetectiV performs better than previously published software on a large, publicly available dataset.
Rationale
One of the key applications of metagenomics is the identifica-
tion and quantification of species within a clinical or environ-
mental sample. Microarrays are particularly attractive for the
recognition of pathogens in clinical material since current
diagnostic assays are typically restricted to the detection of
single targets by real-time PCR or immunological assays. Fur-
thermore, molecular characterization and phylogenetic anal-
ysis of these signatures can require downstream sequencing
of genomic regions. Many microarrays have already been pro-
duced with the aim of characterizing the spectrum of micro-
organisms present in a sample, including detection of known
viruses [1-5], assessment of bioterrorism [6,7] and monitor-
ing food quality [8].
However, the use of DNA microarrays for routine applica-
tions produces many challenges for bioinformatics. Firstly,
probe selection is a difficult and time consuming process.
There are a huge number of diverse species in nature, of
which we have sequence information for only a tiny fraction.
This makes it difficult to find oligonucleotides, either alone or
in combination, that uniquely identify species of interest. Oli-
gos may have homology to multiple species, which results in
a complex and noisy hybridization pattern. Secondly, each
nucleic acid sample tested will typically contain a mixture of
DNA and RNA from the organism of interest, the host and
from a variety of contaminants, which may all contribute to
the resulting microarray profile. Furthermore, this may be
complicated by the presence of multiple, possibly related,
pathogen species, making it difficult to separate patterns due
to cross-hybridization from a true positive result.
Urisman et al. [9] have previously reported E-Predict, a com-
putational strategy for species identification based on
observed microarray hybridization patterns. E-Predict uses a
matrix of theoretical hybridization energy profiles calculated
by BLAST-ing completely sequenced viral genomes against
the oligos on their array, and calculating a free energy of
hybridization. Observed hybridization profiles are then com-
pared to the theoretical profiles using a similarity metric, and
a p value calculated using a set of experimentally obtained
null probability distributions. E-Predict has been shown to
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produce useful results in a number of situations. However, at
present, E-Predict does not contain any tools for visualiza-
tion, and requires extensive customization and calculation
before it is applicable to new arrays. Also, E-Predict is only
available as a CGI script for Unix/Linux platforms.
We present DetectiV, a package for R [10] containing func-
tions for visualization, normalization and significance testing
of pathogen detection microarray data. R is a freely available
statistical software package available for Windows, Unix/
Linux and MacOS, meaning DetectiV is a platform independ-
ent solution. DetectiV uses simple and established methods
for visualization, normalization and significance testing.
When applied to a publicly available microarray dataset,
DetectiV produces the correct result in 55 out of 56 arrays
tested, an improvement on previously published methods.
When applied to a second dataset, DetectiV produces the cor-
rect result in 12 out of 12 arrays.
Implementation
DetectiV is implemented as a package for R, a powerful, open-
source software package for statistical programming [10].
Many packages for R already exist for the analysis of biologi-
cal datasets, including microarray data, and the bioconductor
project [11] is just one example of a group of such packages.
As it is implemented in R, DetectiV easily integrates with
many of the packages available for microarray analysis,
including limma [12], marray [11] and affy [13].
DetectiV is written in the native R language and uses standard
functions within R. As R is available on Microsoft Windows,
Unix (including linux) and MacOS, DetectiV represents a
platform independent solution for the analysis of pathogen-
detection microarray data.
The flow of information through DetectiV is shown in Figure
1. The basic dataset required is a matrix of data, with rows
representing probes on the array, and columns representing
measurements from individual microarrays. This dataset is
easily produced from data structures created by limma [12],
which includes functions for reading in many common micro-
array scanner output formats, and affy [13], which provides
functions for reading in affymetrix data. Commonly,
researchers will have an additional file of information giving
details about each probe. In the case of pathogen detection
arrays, this file will most often contain the type, species,
genus and other classification data for the pathogen to which
each probe is designed. It should be noted that there may be
more than one entry in this file for each probe; for example, if
a given probe is thought to hybridize to multiple pathogens.
In text format, these may be read in using the native
read.table command, or in excel format using the RODBC
library.
Once these two datasets are in R, DetectiV prepares them for
analysis using the prepare.data function. This function joins
the array data to the probe information data based on a
unique ID. The researcher may choose to subtract local back-
ground if appropriate. The default at this stage is to average
over replicate probes, again based on a unique ID. This will
result in a single value for each unique probe for each array.
The data will have one or more columns of extra information
from the annotation file, and these columns will be used to
group the data for further analysis.
Researchers will wish to visualize their data in order to com-
pare the hybridization signals for the probes recognizing the
different pathogen signatures. DetectiV provides a function
called show.barplot for this. The output from prepare.data is
passed to the function, along with the name of the column
containing the variable by which the data will be grouped,
referred to here as group. An example in pathogen detection
data may be species, genus, family, and so on. The data are
sorted into unique groups as defined by the unique values of
group. A barplot is drawn, with one bar per unique probe.
Probes from the same group are drawn together. Each group
is represented by a unique background color, enabling the
user to easily visualize the different groups. An example out-
put is shown in Figure 2. This sample comes from Urisman et
al [9] and represents data from a virus detection microarray
hybridized with amplified RNA from nasal lavage, positive for
respiratory syncytial virus by direct fluorescent antibody
(DFA) test. The group chosen here is virus family. It is quite
clear from this image that there is a virus from the family Par-
amyxoviridae present in the sample, demonstrated by the
high bars associated with that family.
These images are often very large, and so DetectiV offers the
ability to subset the data before plotting by using the get.sub-
set function. Figure 3 shows a similar barplot using a subset
of the data: only those oligos representing species that belong
to the Paramyxoviridae family. It is clear from this image
that those oligos representing different groups/species of res-
piratory syncytial virus have the highest intensity, as we
would expect, although there is cross-hybridization with oli-
gos for human metapneumovirus (another paramyxovirus in
the same sub-family: Pneumovirinae).
DetectiV may also carry out normalization and significance
testing. For this, there is the function normalise. Here, the
aim of normalization is to represent the data in relation to a
negative control. The idea is that if the values for each probe
are divided by the negative control and then the log2 taken,
then the data should be normally distributed, and each group
should have a mean of zero (providing a pathogen is not
present). Traditional statistical tests can then be used to test
if any group of probes is significantly different from zero.
DetectiV offers three methods of normalization, each using a
different 'type' of negative control, and these are summarized
in Table 1.
http://genomebiology.com/2007/8/9/R190 Genome Biology 2007,     Volume 8, Issue 9, Article R190       Watson et al. R190.3
Genome Biology 2007, 8:R190
Flow of information, and steps taken, when analyzing pathogen detection microarray data using DetectiVigure 1
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GSM40814 by familyFigure 2
GSM40814 by family. Example barplot from DetectiV showing data from a virus detection microarray. The sample included amplified RNA from nasal 
lavage, positive for respiratory syncytial virus by DFA. Oligos have been averaged over replicates and grouped according to virus family. Each unique oligo 
is represented by a single bar. Each virus family has a unique background color. The y-axis is raw intensity.
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GSM40814 Paramyxoviridae by speciesFigure 3
GSM40814 Paramyxoviridae by species. Example barplot from DetectiV showing data from a virus detection microarray. The sample included amplified 
RNA from nasal lavage, positive for respiratory syncytial virus by DFA. Only oligos representing species from the Paramyxoviridae family are shown. 
Oligos have been averaged over replicates and grouped according to virus species. Each unique oligo is represented by a single bar. Each virus species has 
a unique background color. The y-axis is raw intensity.
0 5,000 10,000 15,000 20,000 25,000
Avian paramyxovirus 6
Bovine parainfluenza virus 3




Human parainfluenza virus 1 strain 
Human parainfluenza virus 2
Human parainfluenza virus 3













R190.6 Genome Biology 2007,     Volume 8, Issue 9, Article R190       Watson et al. http://genomebiology.com/2007/8/9/R190
Genome Biology 2007, 8:R190
The median method calculates the global median value for
each array. It should be noted that this method assumes that
most probes will not hybridize to anything. If this assumption
is false then this method should not be used. However, if the
assumption holds, then the median is a good representation
of that value we would expect to see from probes that have not
hybridized to anything.
The control method relies on specific negative controls having
been spotted on the array. The researcher may then choose
one of these controls, and the mean value is calculated for that
control for each of the arrays. The mean control value for each
array is then used as a divisor for each probe on their respec-
tive arrays.
Finally, the array method utilizes an entire control array or
channel. In this instance, an entire array is chosen to be the
negative control, and all probe values are divided by their
respective elements from the control array. An obvious exam-
ple for a control array may be RNA from a known uninfected
animal. The control array therefore has a value for each spe-
cific probe representing that value we would expect to see if
that specific probe has not hybridized to anything.
In all instances, after taking the log2, groups of probes that
have not hybridized to anything should be normally distrib-
uted and have mean zero. We can therefore split the probes
into groups and perform a t-test for each one. DetectiV does
this using the do.t.test function. The normalized (or raw) data
are split into groups as defined by the unique values of a user
defined annotation column. Providing each group has more
than two probes, a t-test is performed to test the difference of
the observations from zero. The average value is also calcu-
lated. The output is a table, sorted by p value.
Methods and data analysis
The data used were downloaded from the Gene Expression
Omnibus (GEO) [14], accession number GSE2228. The array
platform for this data is GEO accession GPL1834, and
includes over 11,000 oligos representing over 1,000 viral and
bacterial species [4].
The dataset itself consists of 56 arrays including 15 independ-
ent HeLa RNA hybridizations, 10 independent nasal lavage
samples positive for respiratory syncytial virus, 7 independ-
ent nasal lavage samples positive for influenza A virus, a
serum sample positive for hepatitis B virus, a nasal lavage
sample positive for both influenza A virus and respiratory
syncytial virus, and culture samples of 11 distinct human rhi-
novirus serotypes.
Both DetectiV and E-Predict [9] have been used to analyze the
data. For DetectiV, the data were not corrected for local back-
ground. Missing, negative and zero values were set to a
nominal value of 0.5. Intensities were averaged across repli-
cate probes. Median normalization was then carried out, fol-
lowed by a t-test grouping the data by virus species. Probes
representing actin, GAPDH and Line_Sine were filtered from
Table 1
DetectiV normalization methods
Method Normalized statistic Terms
Median Where  is the value for probe i on array j and  is the median value for all probes on array j
Control Where  is the value for probe i on array j and  is the mean value for control oligo c on array j
Array Where  is the value for probe i on array j and  is the value for probe i on control array/channel c
Explanation of the three normalized statistics offered by DetectiV.
log2 x xj
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j( ) x ji x j
log2 x cj
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Parameters used for input into E-Predict.
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the results. Results were first filtered such that groups had a
normalized log2 ratio greater than or equal to 1 (a ratio of two
to the control) and then sorted by p value. This method will be
referred to as DetectiV.
For E-Predict, default values for all parameters were used,
and are shown in Table 2. Data points were corrected for local
background, as per the examples in Urisman et al. [9]. E-Pre-
dict filters out 266 oligos by default, and this setting was kept.
In all cases, E-Predict carried out two iterations, although
only results from the first iteration are shown here. The best
performing method of interpreting the results was to take
those species with a p value ≤ 0.05 and sort by distance
(termed E-Predict.dist). Note that this is the method cited in
[9], example 3, used to demonstrate E-Predict's ability to
detect SARS.
Pathogen detection arrays have also been implicated in the
discovery of SARS. Urisman et al. [9] reported that although
their original platform did not contain oligos designed to
SARS, once the SARS genome had been published, it was pos-
sible to recalculate the energy matrix for E-Predict and find
that the energy profile for SARS was the top hit (after taking
those viruses with low p values and sorting by distance). We
have applied DetectiV to the same dataset (GEO accession
GSE546). To include oligos for SARS, we searched a database
of oligo sequences on the array with sequence NC_004718
from RefSeq using NCBI blast. There were 61 oligos on the
array that hit the SARS genome with greater than 80%
identity across an alignment of 20 bp or more. In the analysis,
these oligos were assigned as representative of two viruses:
their original virus and SARS. The data were median normal-
ized and a t-test carried out using DetectiV.
Finally, having established that DetectiV compares favorably
with previously published software, we have validated the
DetectiV software by applying it to a second dataset. The data
used were downloaded from the GEO [14], accession number
GSE8746. The array platform for this data is GEO accession
GPL5725, and consists of 5,824 oligos representing over 100
viral families, species and subtypes. The dataset itself consists
of 12 arrays, 4 hybridized with RNA from cell cultured foot-
and-mouth disease virus (FMDV) type O, 3 hybridized with
RNA from FMDV type A, 1 hybridized with RNA from a sheep
infected with FMDV type O, and 4 hybridized with cell-cul-
tured avian infectious bronchitis virus (IBV). Analysis using
DetectiV was carried out as described above.
Results and comparison
We present here results from two methods of analysis, termed
DetectiV and E-Predict.dist, as described above. There are 56
arrays in the dataset, the expected results of which are known.
Each array was hybridized with RNA containing a single
virus, except GSM40845, which was infected with both influ-
enza A and respiratory syncytial virus. We assigned a correct
result for each method if the top hit from the analysis was the
same as the known infectious agent or, if that agent was not
represented on the array, the top hit was a very closely related
virus. In the case of GSM40845, we report a correct result if
both viruses were at the top of the reported hits, to the exclu-
sion of other virus species (but not closely related strains).
Additional data file 1 gives the top hit for both analysis meth-
ods in all 56 arrays. As can be seen, DetectiV generated a cor-
rect result in 55 out of the 56 arrays. In comparison, the E-
Predict.dist method gave a correct result in 53 out of the 56
arrays. These results are discussed in greater detail below.
DetectiV
Full results for each of the arrays can be found on the DetectiV
website [15]. Within the 55 correct results, there are three
classes that require slightly different interpretation, examples
of which are GSM40806, GSM40810 and GSM40817. Results
for these arrays are given in Table 3.
Array GSM40806 was hybridized with amplified HeLa RNA,
and the top hit from DetectiV is human papillomavirus type
18, as expected. This virus has both the smallest p value and
largest mean normalized log ratio. There is also clear
Table 3
Typical results from DetectiV
GSM40806 GSM40810 GSM40820
Virus p value Mean Virus p value Mean Virus p value Mean
Human papillomavirus type 18 4.1E-10 6.8 Human rhinovirus sp. 9.9E-12 4.1 Human herpesvirus 5 5.3E-16 0.57
Human endogenous retrovirus 
K115
0.000016 4 Human rhinovirus A 2.3E-09 4.1 Respiratory syncytial virus 1.1E-09 4.26
Halovirus HF2 0.0017 2.1 Enterobacteria phage M13 2.2E-07 5.7 Human rhinovirus sp. 5.9E-08 0.75
Human papillomavirus type 45 0.002 3.3 Human rhinovirus 16 6.2E-07 3.5 Human rhinovirus B 1.4E-07 0.47
Subterranean clover stunt virus 0.0032 2.6 Human rhinovirus 1B 0.000001 3.5 Human rhinovirus A 6E-07 0.75
Top five hits from three microarrays showing typical results from DetectiV. All have been sorted by p value. GSM40806 and GSM40810 have been 
filtered such that mean ≥ 1.
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distinction between the top hit and the rest of the hits below;
there are orders of magnitude between the values for both the
p value and the mean normalized log ratio. The other hits in
the table are expected as a result of hybridization by the virus
and host RNA to non-specific probes on the array. However,
the clear distinction in both the p value and mean log ratio
identify human papillomavirus type 18 as the top, and only,
hit.
GSM40810 was hybridized with RNA containing human rhi-
novirus 28. There are 24 distinct groups of human rhinovi-
ruses represented on the array, including a group of oligos for
all members ('human rhinovirus sp.), one each for human rhi-
novirus A and B, and several groups for distinct serotypes.
Human rhinovirus 28 is not one of those serotypes specifi-
cally targeted by the array; however, as a serotype of the
human rhinovirus A species, we would expect the groups for
human rhinovirus sp. and human rhinovirus A to be preva-
lent amongst the results. As can be seen from Table 3, the top
hit from DetectiV is human rhinovirus sp., closely followed by
human rhinovirus A, the expected result. The reason we have
highlighted this array, however, is that the result for Entero-
bacteria phage M13 shows a higher mean normalized inten-
sity than any of the rhinovirus groups. This is representative
of a class of result from DetectiV whereby a virus group has a
higher mean normalized log ratio, but a larger p value, than
the top hit. Here, as in GSM40806, we see orders of magni-
tude between the p value for the top hit and that for Entero-
bacteria phage M13, which identifies human rhinovirus as
being the infectious agent, but in this case we cannot rely on
the mean normalized intensity. In this particular instance,
Enterobacteria phage M13 is represented by 10 oligos, all of
which have intensities far greater than the global median, but
which vary considerably between 982 and 18,864. These high
values may be due to hybridization with a cloning vector.
Finally, array GSM40817 was hybridized with respiratory
syncytial virus. The results are again shown in Table 3, but for
this array only, they have not been filtered on mean normal-
ized intensity. Human herpesvirus 5 has by far the smallest p
value of any of the virus groups; however, it also has a very
small mean normalized log ratio. The correct hit, respiratory
syncytial virus, has the second smallest p value, but has a
much larger mean normalized log ratio. This represents the
final class of result seen by DetectiV, where the correct virus
group does not have the smallest p value, but does have a
much larger mean normalized log ratio than those groups
that have smaller p values. The small p value of respiratory
syncytial virus combined with the large mean normalized log
ratio identifies respiratory syncytial virus as the only
infectious agent. In this instance, human herpesvirus 5 is
represented by 241 oligos, 167 of which are greater than the
global median, but all of which have intensities less than
1,000. This could be due to the oligos for human herpesvirus
5 having distant homology with the infectious agent or host
cell.
These three types of result are typical of DetectiV, and explain
why both the p value and the mean normalized log ratio must
be taken into account when interpreting the results. Thus, if
the results from DetectiV are filtered such that only viruses
whose mean normalized log ratio is ≥ 1, and then sorted by p
value, the three scenarios described here are accounted for,
and we obtain the correct result in 55 out of the 56 arrays.
The single incorrect result for DetectiV comes from
GSM40816, which reports human herpesvirus 7 as the top
hit, whereas the infectious agent was in fact respiratory syn-
cytial virus. The top five hits for this array using the DetectiV
method are shown in Table 4. As can be seen, bovine respira-
tory syncytial virus and respiratory syncytial virus are second
and third, respectively. Both respiratory syncytial virus and
bovine respiratory syncytial virus have higher mean values
than human herpesvirus 7, although the latter has a smaller p
value and a mean value that is above the cut-off of 1. Had the
results been filtered for p value ≤ 0.5 and then ordered by
average value, then the top hit would have been respiratory
syncytial virus; similarly, if a cut-off of 2 had been applied
instead of 1, a correct result would have been reported. How-
ever, across the entire dataset these methods of interpreting
the results perform worse than the DetectiV method
described above. It is worth noting here that for this array, E-
Predict gives the correct top hit.
E-Predict
The results from E-Predict follow similar patterns to those of
DetectiV. In most cases it is obvious which virus is the infec-
tious agent, either by examining the p value, the similarity or
both together. Full results can be seen on the DetectiV website
[15]. However, there are certain results reported by E-Predict
where it is impossible to obtain the correct result no matter
which combination of p value and similarity is used. These
arrays are arrays are GSM40809, GSM40821 and
GSM40847, and the top five results for these arrays can be
seen in Table 5.
GSM40809 was hybridized with RNA containing human rhi-
novirus 26. Again, this is a serotype not specifically targeted
by the array; however, as a serotype of human rhinovirus B we
Table 4
Incorrect DetectiV result
Virus p value Mean
Human herpesvirus 7 8.60E-06 1.7
Bovine respiratory syncytial virus 2.70E-04 2
Respiratory syncytial virus 3.30E-04 3.2
Ictalurid herpesvirus 1 1.50E-03 1.7
Human herpesvirus 6B 1.50E-03 1.8
Top five hits from the DetectiV method from array GSM40816. The 
sample for this array was found to contain respiratory syncytial virus by 
DFA.
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would expect the 'human rhinovirus sp.' and 'human
rhinovirus B' groups to be the top hits (this is the case for
DetectiV). However, E-Predict reports human enterovirus D
as having the smallest p value, and enterovirus Yanbian 96-
83csf as having the largest similarity. The top five hits
reported in Table 5 for this array all have similar p values and
similarity measures, and there is no way of sorting or filtering
the results such that human rhinovirus B becomes the top hit.
Without the a priori knowledge that human rhinovirus 26
was the infectious agent, it would be more likely to conclude
that a species of enterovirus was present in the sample. It is
no surprise that these viruses are being confused, as they are
related viruses from the Picornaviridae family. However,
DetectiV is capable of calling the correct result in this
instance, whereas E-Predict is not.
Array GSM40821 was infected with hepatitis B virus but E-
Predict reports orangutan hednavirus as having both a
smaller p value and a higher similarity. This is not that sur-
prising given that hepatitis B and orangutan hepadnavirus
are closely related; however, the fact remains that with no a
priori knowledge, the only logical conclusion from this result
would be that the infectious agent was orangutan hepadnavi-
rus. Again, DetectiV calls this array correctly.
Finally, array GSM40847 was hybridized with RNA contain-
ing human rhinovirus 87. Again, this is a serotype not specif-
ically targeted by the array, and is not present in the NCBI
taxonomy database [16] at the time of writing. We can there-
fore expect the 'human rhinovirus sp.' group to be high
amongst the results (in fact, it is the top result for DetectiV).
E-Predict reports human enterovirus B as having the smallest
p value and human echovirus 1 as having the largest similar-
ity. In fact, E-Predict does not report any rhinovirus oligos in
the first iteration at all, and it is only in the second iteration
that the group human rhinovirus A is reported as significant.
In the three cases outlined above, there is no clear way of dis-
tinguishing the incorrect virus from the correct one. There is
also no consistent method of sorting or filtering the results
that would give the correct results. In these three cases, E-
Predict is unable to distinguish closely related virus species
and serotypes. We have reported here the best performing
method of interpreting E-Predict results, whereby virus
groups with a p value ≤ 0.05 are sorted by distance. This
results in a success rate of 53 out of 56 arrays.
DetectiV and SARS
The top five hits from the analysis of the SARS dataset can be
found in Table 6. As can be seen, the top hit is SARS, with the
lowest p value and the highest mean normalized log ratio.
SARS is distinct from the other viruses, having a p value three
orders of magnitude lower than the second top hit.
Validation
Full results can be found on the DetectiV website [17]. The top
hit from DetectiV for each of the 12 arrays from GSE8746 can
be found in Table 7. As can be seen, DetectiV clearly identifies
the infectious agent in all 12 cases. DetectiV works for both
the cell-cultured samples and the infected sheep, and shows
the ability of the array to distinguish between different sub-
types of FMDV.
Discussion
Developing a quick and reliable test for the presence/absence
of thousands of bacterial and viral species in a single
experiment is an attractive proposition, and a function that
DNA microarrays are ideally suited to. Microarrays are
extremely high-throughput and relatively cheap. In the case
of pathogen detection, the aim must be to quickly and clearly
identify those pathogens present in a sample with high
confidence, keeping false positives and false negatives to a
minimum.
However, the data from such microarrays pose many prob-
lems. Firstly, oligos may not be unique to the species they are
designed to. For certain species it is impossible to find a large
number of oligos that are unique only to that virus that meet




Virus p value Similarity Virus p value Similarity Virus p value Similarity
Human enterovirus D 0.000043 0.258894 Orangutan 
hepadnavirus
0.002291 0.148865 Human enterovirus B 0.000014 0.386095
Human rhinovirus B 0.000045 0.267815 Hepatitis B virus 0.002376 0.147182 Human enterovirus A 0.000016 0.378912
Human enterovirus C 0.000052 0.254504 Woodchuck hepatitis B 
virus
0.002716 0.10964 Human echovirus 1 0.000022 0.414618
Enterovirus Yanbian 96-
83csf
0.000094 0.276873 Woolly monkey 
hepatitis B Virus
0.00284 0.128919 Enterovirus Yanbian 
96-83csf
0.000022 0.412299
Human echovirus 1 0.000134 0.253816 Arctic ground squirrel 
hepatitis B virus
0.003227 0.103357 Human enterovirus D 0.000026 0.296065
Top five results from the E-Predict.dist method for arrays GSM40809, GSM40821 and GSM40847. In all cases results are ordered by p value.
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for closely related species and strains. In such cases, the 'best'
oligos are added to the array, in the knowledge that multiple
viruses may hybridize to them. This leads to noisy signals
across multiple virus families, species and serotypes. Sec-
ondly, infected biological samples may contain many differ-
ent virus species and strains, making interpretation difficult.
Thirdly, it is known that certain oligos simply do not work,
even when the array is hybridized with the species that those
oligos were designed to. Without testing the array with each
virus, we are incapable at present of predicting which oligos
will work and which will not. With thousands of species per
array, many of which cannot be cultured in vitro, it is unfea-
sible to challenge arrays with every species. Finally, we of
course do not know, nor can we ever know, the complete
genome sequence of every virus we may encounter.
Therefore, though we think we have oligos unique to a species
or strain, that is only ever in the context of our knowledge at
the time of design, and they may not in fact be unique.
Despite these problems, many species detection arrays have
been developed [1-5]. However, reliable methods of data
analysis have been rare. Initial methods included visual
inspection of the array [4] and clustering [18], both of which
are subjective and time-consuming. To combat this, Urisman
et al. [9] have proposed a more robust method, E-Predict. E-
Predict utilizes a pre-calculated energy matrix for each oligo
on the array and uses a variety of normalization and similarity
metrics to calculate a p value and similarity for each virus.
The advantages of E-Predict are that it is quantitative, pro-
duces good results and is extensible, through the extension of
the energy matrix. The disadvantages of the software are a
lack of visualization tools, the need to customize parameters
for different array platforms and hybridization conditions,
and the availability of the software only as a CGI script on the
Unix/Linux platform.
We have developed DetectiV, a package for R containing vis-
ualization, normalization and significance testing functions
for pathogen detection data. DetectiV uses simple and well
established visualization and statistical techniques to analyze
data from pathogen detection microarrays. DetectiV offers a
powerful visualization option in the form of a barplot, ena-
bling researchers to quickly and easily identify possible infec-
tious agents. Data can then normalized to a negative control
Table 6
DetectiV results for SARS array
Virus p value Mean
SARS 8.43E-09 1.906095
Human herpesvirus 7 3.29E-06 1.292008
Simian retrovirus 2 4.27E-05 1.328653
Coliphage alpha3 6.08E-05 1.113462
Transmissible gastroenteritis virus 7.88E-05 1.463675
Top five results from the DetectiV method of analyzing array GSM8528 from GEO accession GSE546. The sample hybridized to the array contained 
the SARS virus.
Table 7
Top hit for GSE8746
Array RNA Top hit p value Mean
GSM216542 Amplified RNA from cell cultured FMDV type O FMDO 1.51E-25 2.296645
GSM217164 Amplified RNA from cell cultured FMDV type O FMDO 1.07E-45 3.513068
GSM217167 Amplified RNA from cell cultured FMDV type O FMDO 2.36E-48 3.446262
GSM217169 Amplified RNA from cell cultured FMDV type O FMDO 5.91E-30 2.827877
GSM217172 Amplified RNA from cell cultured FMDV type A FMDA 6.96E-30 3.560941
GSM217175 Amplified RNA from cell cultured FMDV type A FMDA 8.71E-14 1.553392
GSM217177 Amplified RNA from sheep infected with FMDV type O FMDO 1.12E-27 2.431874
GSM217180 Amplified RNA from cell cultured FMDV type A FMDA 2.97E-33 3.609092
GSM217183 Amplified RNA from cell cultured Avian IBV IBV 1.05E-21 5.262134
GSM217184 Amplified RNA from cell cultured Avian IBV IBV 3.49E-33 7.958662
GSM217186 Amplified RNA from cell cultured Avian IBV IBV 6.20E-33 7.827526
GSM217188 Amplified RNA from cell cultured Avian IBV IBV 1.44E-35 8.0118
The top hit from DetectiV for the 12 arrays from the GSE8746 dataset. DetectiV produces the correct result in all 12 cases.
http://genomebiology.com/2007/8/9/R190 Genome Biology 2007,     Volume 8, Issue 9, Article R190       Watson et al. R190.11
Genome Biology 2007, 8:R190
(be that a specific probe, array or the global median), trans-
formed by taking the log2 and then subjected to a t-test for
each species on the array. Oligos are allowed to represent any
number of viruses, and thus any analysis is easily extensible
by simply updating the list of which oligos represent which
species.
DetectiV requires minimal set up and configuration, requir-
ing only an additional file detailing which species each oligo
represents. In the majority of cases, these files will already
exist. It is then possible to apply DetectiV 'out of the box' to
any array data that is readable by R or bioconductor. DetectiV
requires no training, configuration or customization specific
to each array. DetectiV is available as a package for R on both
Windows and Linux/Unix, and as such may be considered
platform-independent.
In this study, DetectiV produced the correct result in 55 out of
56 arrays, by filtering for viruses with a mean normalized log
ratio greater than 1 and then sorting by p value. We make the
distinction here between biological and statistical signifi-
cance. A statistically significant result may be obtained by a
group of oligos that display intensities only marginally larger
than the negative control (in this case the global median
intensity). This is demonstrated by human herpesvirus 5 on
array GSM40820 (Table 3). However, we know that from a
biological perspective, we would expect to see intensities far
higher than the negative control, and that intensities only
marginally higher result from low homology between the
probe and the sample. We can therefore use the statistical sig-
nificance (p value) in combination with our idea of biological
significance (the mean normalized log ratio) to successfully
call the correct result in over 98% of the arrays.
In the majority of cases there is a clear difference in the p
value, the mean normalized log ratio, or both, between the
correct hit and subsequent hits, allowing for both automatic
and manual detection of true and false positives. However,
this does require careful interpretation. Both DetectiV and E-
Predict predict multiple, significant matches on all of the
arrays. When using DetectiV, it is only when looking for major
changes between the top hit and subsequent hits, in terms of
p value or mean log ratio, that it is possible to separate the
true positives from the false positives. In many cases, using
automatic rules will result in the correct result; however,
there will inevitably be borderline cases where human inspec-
tion of the results is required. This is all the more important
when considering the possible economic impacts of a false
positive for certain species. At present, the safest way to
employ such arrays, and their analysis methods, may be sim-
ply as a first step towards identifying infectious agents,
informing researchers about which viruses they should test
for using more conventional methods.
The results from the application of DetectiV to the SARS data-
set are encouraging. Here, oligos designed to SARS were not
present on the array. However, using a simple NCBI blast
search, it was possible to extend the range of viruses covered
by the array to include SARS - 61 existing oligos showing sig-
nificant homology to the SARS genome. On application of
DetectiV to the updated data, SARS was the top hit. Not only
does this offer the promise of being able to extend the cover-
age of the array without adding further oligos, it also suggests
that it is possible to detect viruses without having any unique
oligos. This may inform the oligo selection process - it may be
equally desirable to have multiple, non-unique oligos to rep-
resent a species as it is to have a few that are unique.
The results from the application of DetectiV to a second data-
set are also encouraging, with the correct result being the top
hit in all 12 cases. Of particular interest is the ability of the
array, and DetectiV, to distinguish not only between separate
viral species, but also between different subtypes of FMDV. It
should be noted that in order to apply DetectiV to a second
dataset from a completely different array to the first dataset,
the user only has to change the GEO accession number and
the number of arrays within that dataset. This compares favo-
rably with E-Predict, which would require a separate training
dataset from the second array, the calculation of a large and
complex sequence similarity matrix and the optimization of
several parameters.
There are a number of ways in which DetectiV may be devel-
oped. In terms of visualization, better browsing capabilities of
the barplots would be desirable, perhaps using a web-inter-
face. In terms of the analysis, we may borrow ideas from gene
expression arrays. For example, limma uses an empirical
Bayes method to shrink each gene's standard error towards a
common value, and has been shown to perform better than
standard statistical methods [12]. It may be that we can apply
a similar method here to shrink the standard error for each
virus species towards a common value, thus increasing
sensitivity. It may also be possible to apply multiple-testing
procedures to the resulting p values. The Bonferroni correc-
tion may be appropriate, in which the p values are multiplied
by the number of comparisons, or a more conservative
approach may be needed, such as that suggested by Ben-
jamini and Hochberg [19], in order to control the false discov-
ery rate.
In conclusion, DetectiV is a highly accurate tool for the anal-
ysis of pathogen detection microarray data, offering simple
but powerful visualization, normalization and significance
testing functions. DetectiV performs better than previously
published software on a publicly available microarray data-
set. DetectiV is available as a package for R, a platform-inde-
pendent statistical software package, and requires little
configuration or customization. It is released under the GNU
General Public License and may be downloaded from the
DetectiV website [20].
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ABSTRACT
Motivation: The Oxford Nanopore MinION device represents a unique
sequencing technology. As a mobile sequencing device powered by
the USB port of a laptop, the MinION has huge potential applications.
To enable these applications, the bioinformatics community will need
to design and build a suite of tools specifically for MinION data.
Results: Here we present poRe, a package for R that enables users to
manipulate, organize, summarize and visualize MinION nanopore sequ-
encing data. As a package for R, poRe has been tested on Win-
dows, Linux and MacOSX. Crucially, the Windows version allows users
to analyse MinION data on the Windows laptop attached to the device.
Availability and implementation: poRe is released as a package for
R at http://sourceforge.net/projects/rpore/. A tutorial and further infor-
mation are available at https://sourceforge.net/p/rpore/wiki/Home/
Contact: mick.watson@roslin.ed.ac.uk
Supplementary information: Supplementary data are available at
Bioinformatics online.
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1 INTRODUCTION
Relative to first- and second-generation sequencing technologies,
single-molecule sequencing is a new science, with only Helicos
(Bowers et al., 2009), Pacific Biosciences (Eid et al., 2009)
and Oxford Nanopore (ONT) being widely available. Even
within the field of single-molecule sequencing, ONT’s nanopore
sequencing technology represents a new paradigm; while both
Helicos’ and Pacific Biosciences’ sequencing technologies meas-
ure incorporation events into a second strand, ONT’s MinION
and GridION systems measure a single molecule of DNA as it
passes through a protein nanopore. In addition, the MinION
is the world’s first mobile DNA sequencer; it is powered by a
laptop’s USB port and measures 4 inches in length. Recently,
ONT opened up the MinION access programme, enabling
researchers to use the device for the first time.
The ultra-low-cost and mobile nature of the MinION device
opens up a huge number of applications. However, users of the
device are faced with a number of informatics challenges. Users
of the MinION must buy a high-specification Windows laptop,
and thus there is a need for Windows-based software to handle
the data. The MinION outputs binary files in the HDF5 format
(http://www.hdfgroup.org/HDF5/). These contain raw data from
the sequencer, which are then processed by a cloud-based base
caller called ‘metrichor’. The subsequent called sequence files are
also in HDF5 format (with the extension .FAST5). It is not un-
common for users to be presented with 30–50000 HDF5 files
(.fast5), with no software with which to access the data. Further-
more, data from all runs are stored in a single directory, with no
subdirectories, and users find themselves needing to manipulate
thousands of files manually, which takes time and is error prone.
We have developed poRe, a package for the statistical package
R (http://www.R-project.org/; R Core Team, 2014), which
enables users to manipulate MinION FAST5 files into run
folders, extract FASTQ, gather statistics on each run and plot
a number of key graphs, such as read-length histograms and
yield-over-time. Crucially, as a package for R, poRe is cross-
platform and has been tested on Windows, Linux and
MacOSX. The Windows version enables users to run poRe on
the MinION laptop itself, rather than copying the data to a
Linux server to process with Perl or Python. This key feature
brings users closer to true mobile DNA sequencing.
2 METHODS
2.1 Data format
The FAST5 HDF5 files contain a number of hierarchical groups, datasets
and attributes, and these are described in more detail in the
Supplementary Information.
2.2 Organization and run statistics
The first task users face is to organize a single MinION folder, which may
contain reads from many different runs. We provide the function
copy.runs() to help with this. The function reads all FAST5 files within
a user-defined directory and extracts both the unique run identifier
(‘run_id’) and the name and version of the base caller. Each read is
then copied to a user-defined destination folder, under subfolders defined
by the run_id and the name and version of the analysis. The latter is key,
as each raw read may be base called many times by different versions of
the metrichor base caller.
Embedded within each FAST5 file are a number of key statistics about
the reads. These can be extracted for all reads in a run by the function
read.fast5.info(). This returns a data frame with 24 columns of metadata
for each read. The function run.summary.stats() can be used to extract*To whom correspondence should be addressed.
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key summary statistics, such as maximum, minimum and mean read
lengths.
2.3 FASTQ and FASTA extraction
Once the data are organized, users may wish to extract FASTQ/A data.
This can be done using the extract.run.fastq() and extract.run.fasta()
functions. For each FAST5 read in a given directory, this function will
extract the template, complement and 2D FASTQ/A data where they
exist and write these to individual FASTQ/A files.
2.4 Data exploration
We provide a number of functions that allow users to explore the data
visually. Histograms of read length can be created using the
plot.length.histogram() function. This plots histograms for the template,
complement and 2D read lengths (Supplementary Fig. S1).
The plot.cumulative.yield() function can be used to plot cumulative
yield of the run over time, and sums up the template, complement and
2D read lengths over time in seconds since the analysis began
(Supplementary Fig. S2).
Finally, the MinION device consists of a number of channels, each of
which should contain a single nanopore. Users can count and plot the
number of reads per channel for a run, using plot.channel.reads(), and
sum and plot the yield per channel, using plot.channel.yield(). Both of
these can be potentially used to diagnose problems in particular areas of
the flowcell.
2.5 Extracting and plotting events
The raw data from the MinION are the information about the electronic
signal measured as each single molecule of DNA passes through the
protein nanopore. It is these data that are converted to sequence data
by the metrichor agent. However, the raw events data are also available
and can be extracted using the function get.events(). This will extract the
thousands of events for both the template and complement for a particu-
lar read. The events data may then be visualized using the plot.squiggle()
function (see Fig. 1).
3 DISCUSSION
We have written poRe, an R package that enables users to more
easily manipulate, summarize and visualize MinION nanopore
sequencing data. As a package for R, poRe is available for both
Windows and Linux, and crucially the Windows version will
allow data analysis on the mandatory Windows laptop on
which the MinION depends. In addition, R is now a popular
statistical package among biologists, who may feel comfortable
using poRe through the R user interface.
poRe is one of the first bioinformatics packages to offer this
necessary functionality. poretools (Loman and Quinlan, 2014), a
toolkit written in Python, offers similar functionality, although
each software has a different set of (overlapping) functions. A
table comparing feature sets is available in the Supplementary
Information. The cross-platform nature of poRe, its ease of
installation and poRe’s ability to organize folders of FAST5
files make poRe an important tool for users of the MinION
device.
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Fig. 1. An example output from the plot.squiggle function. Plotted are the events data extracted from a single read. The y-axis is the mean electronic
signal reported for the pore, and the x-axis is time in seconds
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ABSTRACT
Motivation: With the increasing use of post-genomics techniques
to examine a wide variety of biological systems in laboratories
throughout the world, scientists are often presented with lists of
genes that they must make sense of. A consistently challenging
problem is that of defining co-regulated genes within those gene
lists. In recent years, microRNAs have emerged as a mechanism for
regulating several cellular processes. In this article, we report on how
gene lists and microRNA targets data may be integrated to test for
significant associations between gene lists and microRNAs.
Results: We discuss CORNA, a package written in R and released
under the GNU GPL, which allows users to test gene lists for
significant microRNA–target associations using one of three separate
statistical tests, to link microRNA targets to functional annotation and
to visualize quantitative data associated with those data.




Experiments involving post-genomics technologies such as
microarrays, proteomics and systems biology often present scientists
with gene lists that they must attempt to make sense of. Several
software packages exist that allow scientists to assign functional
annotation to gene lists, and to assign statistical significance to
those associations. These include tools for associating genes with
biological ontologies (e.g. Falcon and Gentleman, 2007) and with
biological pathways (e.g. Salomonis et al., 2007).
A particular challenge is that of assessing which genes in a given
gene list are co-regulated. miRBase (Griffiths-Jones et al., 2006), a
database of all known microRNAs, has been created and there have
been several published software tools that attempt to predict the
targets of microRNAs (Brennecke et al., 2005). An excel-based tool
(Creighton et al., 2008) has been produced for linking microarray
data to microRNA targets information.
Here we describe CORNA, a package for R that allows scientists
to analyse gene lists in the context of microRNA–target predictions.
Methods exist to test for significant microRNA–target relationships
in gene lists, and to test for significant associations between
microRNAs and pathways and GO terms. The software is flexible
and can read data from public databases or from a scientists own
data files. CORNA is released as open-source under the GNU GPL.
∗To whom correspondence should be addressed.
2 FLOW OF INFORMATION
Central to the flow of information through CORNA is the gene
list from which the user may test for significant microRNA–target
associations. The user may also start with a microRNA, find genes
that are associated with that microRNA and then test that gene list
for significant associations with KEGG pathways or GO terms. The
user may also plot quantitative data associated with the targets of a
particular microRNA.
2.1 Inputs
CORNA exclusively uses R vectors and data frames. CORNA
includes functions for reading microRNA–target data directly from
miRBase and microRNA.org (Betel et al., 2008). There are also
helper functions to read gene and GO term data using biomaRt
(Durinck et al., 2005); microarray data directly from GEO (Barrett
et al., 2008); and pathway data directly from KEGG (Kanehisa et al.,
2004).
2.2 Methods
CORNA employs three complementary statistical methods for enrichments
analysis of relationships within lists of genes. These are the HyperGeometric
test, Fisher’s exact test and the χ2-test.
2.3 Outputs
If the user tests a gene list for significant microRNA associations, then the
output is an R data frame with one row per microRNA, the observed and
expected frequencies from sample and population, and the range of user-
selected P-values.
Where the user begins with a particular microRNA, the targets information
is used to create a gene list and that gene list is tested for enrichment of
pathways and GO terms.
There is also a range of plotting functions for plotting quantitative data
associated with microRNA targets.
3 EXAMPLE ANALYSIS
3.1 Using CORNA to test for enrichment of
microRNA–target relationships in a gene list
The list in this example, tsam, consists of 1000 ensembl transcript
ids; 940 of these were chosen at random, then 30 predicted
targets for two microRNAs were added. The example assumes that
the file ‘arch.v5.txt.mus_musculus.zip’ has been downloaded from
miRBase targets.
© 2009 The Author(s)
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The only two microRNAs with a significant adjusted P-values are
those used to bias the transcript list. The user may work with
genes simply by converting the transcript list to microRNA–gene
relationships using the BioMart2df.fun and corna.map.fun functions.
3.2 Using CORNA to test for KEGG pathways
associated with a microRNA list
The microRNA used in this example is ‘mmu-mir-155’, and we use


























We first convert the microRNA–transcript relationship to a
microRNA–gene relationship using the BioMart2df.fun and
corna.map.fun functions. We then find those genes predicted to be
targets of mmu-mir-155. The next stage is to use the KEGG2df.fun
function to obtain links between genes and pathways from KEGG
Table 1. Top five significant pathways from CORNA for mmu-mir-155
ID Description Expected Observation P-value
00190 Oxidative phosphorylation 5 12 0.002
00400 Phenylalanine etc. biosynthesis 0 3 0.003
00500 Starch and sucrose metabolism 2 6 0.012
05020 Parkinson’s disease 5 10 0.016
04010 MAPK signaling pathway 9 15 0.044
for Mus musculus. Finally, we set the sample to be only those genes
targeted by mmu-mir-155 that have a pathway link, and perform
hypergeometric and Fisher’s exact tests for the KEGG pathways
involved. The top five pathways can be seen in Table 1.
4 SUMMARY
With increasing use of large-scale post-genomics techniques,
scientists are often presented with lists of genes. MicroRNAs have
emerged as an important regulator of gene function. In this article,
we have shown that CORNA can be used to test for significant
associations between genes, microRNAs, pathways and GO terms.
CORNA can also be used to plot quantitative data associated with
microRNA targets. CORNA is flexible and can read data from public
databases or from a user’s own files. CORNAhas been tested on both
Microsoft Windows and Red Hat Linux. CORNA is released under
the GNU GPL and is available from http://corna.sf.net.
Funding: BBSRC (core strategic grant of the Institute for Animal
Health).
Conflict of Interest: none declared.
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Large-Scale Integration of MicroRNA and Gene Expression 
Data for Identification of Enriched MicroRNA–mRNA 
Associations in Biological Systems
Preethi H. Gunaratne, Chad J. Creighton, Michael Watson,  
and Jayantha B. Tennakoon 
Abstract
The discovery of microRNAs (miRNAs) revealed a hidden layer of gene regulation that is able to inte-
grate multiple genes into biologically meaningful networks. A number of computational prediction pro-
grams have been developed to identify putative miRNA targets. Collectively, the miRNAs that have been 
discovered so far have the potential to target over 60% of genes in our genome. A minimum of six con-
secutive nucleotides in the 5¢-seed (nucleotides 2–8) in the miRNA must bind through complimentary 
base pairing to the 3¢-untranslated (3¢-UTRs) of target genes. Given the small sequence match required, 
a given miRNA has the potential to target hundreds of genes and a given mRNA can have 0–50 miRNA 
binding sites. The low-throughput nature of the query design (gene by gene or miRNA by miRNA) and 
a fairly high rate of false positives and negatives uncovered by the limited number of functional studies 
remain as the major limitations. Programs that integrate genome-wide gene and miRNA expression data 
determined by microarray and/or next-generation sequencing (NGS) technologies with the publicly 
available target prediction algorithms are extremely valuable on two fronts. First, they allow the investiga-
tor to fully capitalize on all the data generated to reveal new genes and pathways underlying the biologi-
cal process under study. Second, these programs allow the investigator to lift a small network of genes 
they are currently following into a larger network through the integrative properties of miRNAs. In this 
chapter, we discuss the latest methodologies for determining genome-wide miRNA and gene expression 
changes and three programs (Sigterms, CORNA, and MMIA) that allow the investigator to generate 
short lists of enriched miRNA:target mRNA candidates for large-scale miRNA:target mRNA validation. 
These efforts are essential for determining false positive and negative rates of existing algorithms and 
refining our knowledge on the rules of miRNA–mRNA relationships.
MicroRNAs (miRNAs) are small ~22 nucleotide noncoding 
RNAs that have been predicted to target >60% of the genes in our 
genome to mediate posttranscription gene silencing (1, 2). The 
1.  Introduction
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key determinants for miRNA–mRNA target associations lie in the 
5¢-seed region (nucleotides 2–8) in miRNA and the 3¢-untranslated 
region (3¢-UTR) of mRNA targets (2). The miRNA–mRNA 
target association is catalyzed mainly by the action of Argonaute 
(Ago) family of proteins in the RNA-induced silencing complex 
(RISC) (3). Base pairing of at least six consecutive nucleotides 
within the 5¢-seed of the miRNA with the target site on the 
mRNA is reported to be required at a minimum. However, 
binding can occur through the entire length of the miRNA. 
miRNA–mRNA duplexes that form with perfect or near perfect 
complementarity have been shown to result in mRNA cleavage 
between nucleotides 10 and 11 (4) of the miRNA resulting 
ultimately in mRNA cleavage and decay (4, 5). By contrast, when 
binding occurs through imperfect complementarity, the mRNA 
target is generally kept intact and silencing occurs through trans-
lational repression (6).
With the advent of microarray and next-generation sequenc-
ing (NGS) technologies in the postgenome era, it is now possi-
ble to determine genome-wide miRNA–mRNA associations 
that are significant to specific cellular contexts or systems such as 
the immune system. A number of target prediction algorithms, 
which are primarily based on searches for matches between 
miRNA seed sequences and 3¢-UTRs of genes, have been devel-
oped and freely available (7). Such programs offer users the pos-
sibility of quickly searching for potential targets on a miRNA by 
miRNA basis or potential miRNAs on a gene-by-gene basis. 
However, these approaches are too cumbersome and do not 
offer optimal solutions to integrate the glut of microarray (gene 
and miRNA expression) and sequencing (mRNA-seq and 
miRNA-seq) data that is becoming available on a daily basis. 
More recently, several groups have written programs and soft-
ware packages to address this issue and offer solutions for the 
large-scale three-way integration of gene expression data, 
miRNA expression data and miRNA–mRNA target predictions 
(8). These programs offer the users the possibility of reaping the 
full benefit of these genome-wide studies. It is becoming increas-
ingly clear that miRNAs are very different from the traditional 
transcriptional repressors that we are familiar with. Overexpression 
and loss-of-function studies suggest that most miRNAs have 
only a limited influence on their target genes (approximately 
two- to ten-fold repression) on its own. It appears that the main 
role of miRNAs is to fine-tune gene expression by coordinately 
downregulating multiple genes within and across pathways to 
integrate them into meaningful networks in relation to specific 
cellular states. The question then is what is the impact of global 
shifts in miRNA profiles on the transcriptome and proteome of 
a given cellular state. Furthermore, when aiming to assess the 
role of a given miRNA in relation to a specific biological process, 
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it is essential to consider its impact on all of its targets. 
Consequently, programs that integrate expression data with tar-
get prediction data are vital to understand the role of miRNAs 
in the immune system. In this chapter, we examine in detail 
three programs that allow the large-scale integration of genome-
wide expression and miRNA target prediction data.
While classical northern blotting and quantitative real-time PCR 
continue as techniques used for gene expression studies of single 
or small sets of genes over the past two decades, high-throughput 
microarray-based techniques have been increasingly applied in 
this field to measure several thousands of genes at a time. 
Microarray technology was first described by Schena et al. in 
1995 (9). Over the years, DNA chip based technologies have 
widely demonstrated the power of this high-throughput parallel 
synthesis based method. Microarray DNA chips contain thou-
sands of probes arranged on a regular pattern. Microarrays pro-
duce quantitative gene expression data based on relative dye 
intensities corresponding to DNA hybridized to probes immo-
bilized on chips (10). A typical microarray-based experiment 
consists of preparing a DNA chip based on target DNAs, gener-
ating a hybridization solution containing a mixture of fluores-
cently labeled cDNAs, incubating fluorescently labeled cDNAs 
with DNA chip followed by data detection based on laser tech-
nologies, and finally computer assisted statistical testing and 
data analysis. To disseminate data analyzed by researchers for 
public use, microarray data can be stored in NCBI microarray 
data repository Gene Expression Omnibus (GEO) (http://
www.ncbi.nlm.nih.gov/geo) (11) using a standardized frame-
work, termed microarray markup language (MAML).
MAML employs a standard format to describe microarray 
experiment details, which include experimental design, array 
design, samples, hybridization procedures and parameters, images, 
quantitation, and controls.
Several commercial producers have introduced microarrays with 
different features. The microarrays available in the current market 
differ from one another in terms of the technologies utilized for 
fabrication and their probe design architecture. Some of the popu-
larly known commercial manufacturers are given below:
Affymetrix GeneChip (http://www.affymetrix.com). Affymetrix 
was one of the first microarrays to appear in the market (12). Unlike 
in the case of traditional microarrays where cloning libraries are used 
for probe design, Affymetrix employs an in silico light directed 
synthesizing technology to produce probes on a glass chip (10). 
2.  Materials
2.1. Gene Expression 
Data
2.1.1.  Microarrays
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Bypassing management of clone libraries and ability to synthesize 
highly ordered DNA oligomers in silico are the two distinct advan-
tages of the Affymetrix design.
Agilent (http://www.agilent.com) employs an inkjet-based 
method to print whole cDNA or oligos on chips (13). Chips pro-
duced by Agilent offer 60-mer probes compared to the 25-mer 
probes offered by Affymetrix (10).
Nimblegen (http://www.nimblegen.com/) (14) uses a digi-
tal light processor to synthesize microarrays, apart from their use 
in transcriptome analysis. NimbleGen chips containing specific 
sequences are used to capture large genomic fragments, which 
can be subject to further analysis using Nimblegens GS FLX 
sequencing system (10).
CombiMatrix (http://www.combimatrix.com) offers custom 
arrays generated by a powerful computer-directed semiconductor 
microelectrode based on chip synthesis method, which can be 
programmed to generate a given array of oligonucleotides on 
chips (15). Signal detection can be carried out by either laser 
scanning or electrochemical methods (10).
Illumina bead array (http://www.illumina.com) (16) con-
ventional microarrays are manufactured by spotting oligonucle-
otides on two-dimensional substrates (17). On the contrary, 
Illumina bead based arrays are produced by means of random 
assembly of bead pools on a patterned substrate (17). Illumina’s 
technology offers higher oligo densities on their chips and thus 
higher throughputs by virtue of the intrinsic size of the beads and 
patterned substrates compared to conventional chips.
While array-based technologies and applications continue to 
grow, a plethora of information would be available for researchers 
through GEO in future. This would be a very valuable tool to 
facilitate cross-reference samples, identify signatures associated 
with disease, personalize medicine, and most importantly provide 
a global view of all biological processes through a platform for 
systematic in depth analysis of DNA and RNA variation.
The overall approach of miRNA profiling through microarrays 
remains similar to the approach employed in microarrays for gene 
expression profiling. Mature miRNAs are isolated and purified 
from tissue or cell samples using classical Trizol-based isolation or 
commercially available kits. The purified fragment of RNA is 
enriched and labeled. Array probes are designed by using locked 
nucleic acid (LNA) or chemically modified oligos and spotted on 
microarrays. Hybridization is then carried out and signal intensi-
ties measured using a laser scanner. Finally, quantification and 
data analysis is carried out using computer software. Unlike in the 
case of mRNA arrays designing arrays for miRNAs is challenging 
in that arrays must be designed to discriminate between the 
mature miRNAs and their precursors, miRNA microarrays should 
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be capable of detecting subtle differences of even a single-base 
difference of mature sequences (18). Short sequence length of 
18–25 nt of mature sequences and wide range of melting tem-
peratures (Tm) of mature miRNAs are significant problems in 
miRNA microarray design (19). In spite of the challenges, several 
miRNA microarrays have been designed and are currently avail-
able commercially. Synthetic oligonucleotides or cDNA fragments 
are used in miRNA microarray probe design. More recently, syn-
thetic oligonucleotides with chemical modifications providing 
high molecular affinities facilitating hybridization have been 
employed. AT-rich probes are known to show lesser hybridization 
affinity compared to GC-rich probes (20). Higher degrees of 
sensitivity can be achieved by introduction of A/T analogs, which 
enhance overall duplex stability (21). Substitution of A and T with 
20-O-methyl-2,6-diaminopurine and 20-O-methyl-5-methyluridine, 
respectively, has shown two- to threefold increases in relative 
hybridization (22). LNAs first described by Wengel and coworkers 
in 1998 are a novel class of conformationally restricted oligonu-
cleotide analogs, which show high thermal stabilities toward 
complimentary RNA and DNA (23). Chemically engineered 
LNAs have nucleotide analogs containing a bridging methylene 
group between C4¢ and O2¢ of the ribose ring (24). High thermal 
stabilities of LNAs bound to complimentary nucleic acid facilitates 
the design of short probes with excellent mismatch discrimination. 
Some of the commercially produced miRNA microarrays are 
discussed next.
Agilent miRNA microarrays are produced using unique chemi-
cally unmodified probes. Chemically unmodified oligos are immo-
bilized on an array platform by means of a short stilt, and to the 
5¢ end of the anchored oligo a G residue is included and an 
extended hairpin attached, the 3¢ end of the sample miRNAs are 
labeled by means of a Cy molecule attached to a C residue. When 
sample is introduced, hybridization takes place and the 5¢ G resi-
due of the probe complimentary to the 3¢ Cy labeled C residue 
binds resulting fluorescence. The hairpin functions as a bridge 
connecting the 5¢ end of the anchored oligo and the 3¢ end of the 
hybridized miRNA. Agilent claims that the inclusion of the G 
residue to 5¢ end of the probe increases stability of binding to 
target miRNA and the hairpin destabilizes probe hybridization to 
larger nontarget RNAs and hence provides a higher degree of 
specificity. Agilent’s G44071A human miRNA microarray plat-
form uses sequences from Sanger miRNA database (miRBase) 
version 12 and is capable of detecting unique 866 human and 
89 viral miRNAs. Agilent also produces several arrays in the 
G44 series for human mouse and rat miRNAs, which use differ-
ent versions of the Sanger database ranging from version 9.1 to 
12.0 as the reference source for sequences. In Agilent miRNA 
2.2.1.1. Agilent miRNA 
Microarray (http://www.
home.agilent.com)
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arrays, 40–60 mer unmodified oligonucleotides are directly syn-
thesized on the array by Agilent’s proprietary SurePrint inkjet 
technology. A unique feature of Agilent’s technology is the use of 
end labeling instead of conventional polymerase based methods 
where sample nucleotide damage within the substrate has been an 
issue. End labeling is insensitive to nucleotide damage and is par-
ticularly advantageous when testing preserved or chemically 
treated samples. Agilent’s platform requires only small input 
amounts in the 100 ng range of total RNA due to the high-yield 
end labeling method. As the labeling method does not require 
size fractionation or amplification, undesired bias introduced 
from these two steps is eliminated (25).
Exiqon uses melting temperature (Tm) matched LNA probes in 
their miRNA microarray design. Exiqon’s miRNA microarrays 
are marketed under the name miRCURY LNA™. In addition to 
probes for miRBase sequences, which the Exiqon system uses as 
a reference for their microarrays, Exiqon arrays contain probes 
called mirPLUS™ capture probes, which target proprietary 
miRNAs that have been defined by Exiqon company through 
cloning and sequencing of human normal and diseased tissues. 
Through these proprietary sequence probes, scientists would be 
able to gain unique information about miRNAs, which have not 
been defined elsewhere. As of August 2009 in the Exiqon 
Web site, a typical miRCURY LNA™ was listed as being capable 
of capturing 854 mature human miRNAs, 80 mature viral 
miRNAs, and 428 mature Exiqon-defined human mirPLUS™ 
miRNAs (26).
Invitrogen offers the NCode™ Human miRNA Microarray Kit 
V3 and NCode™ Multi-Species miRNA Microarray Kit V2 as 
integrated miRNA profiling systems, which include reagents for 
RNA isolation labeling and array hybridization. As of the date of 
writing this chapter (30 August 2009), it was listed in the 
Invitrogen Web site that the Human miRNA Microarray Kit V3 
contains probe sequences targeting nearly all of the known human 
miRNAs in the Sanger miRBase as well as probe sequences for 
373 novel putative miRNAs. The Multi-Species version was listed 
as having probes for the Sanger miRBase Sequence Database, 
Release 9.0, for human, mouse, rat, Drosophila melanogaster, 
Caenorhabditis elegans, and Zebrafish. Each NCode™ microarray 
slide comes fully blocked and ready to use. In case where starting 
material has concentrations <500 ng total RNA or equivalent 
cells/tissue, Invitrogen provides a miRNA amplification kit called 
the NCode™ miRNA amplification system. Once the total RNA 
is extracted and ready for hybridization, labeling can be carried 
out using an NCode™. Rapid miRNA labeling system, which is 
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based on a poly-A tailing reaction on RNA molecules followed by 
ligation of dye labeled Alexa Flour™ DNA polymer by means of 
an oligoDT bridge. Invitrogen offers the choices of employing 
either preprinted or self-printed microarrays using NCode™ 
Human or multispecies microarray probes for experiments. 
Analysis of results can be performed by means of NCode™ pro-
filer software. Invitrogen also provides a range of reagents under 
the NCode™ name for verification and further analysis of results 
by qPCR (27).
With the LC Sciences mParaFlo microfluidic miRNA Microarray 
chips assays can be performed with a minimum of 5 mg total 
RNA (28). The mirVana Isolation Kit (Ambion) is recom-
mended. The small RNA (<300 nt) fraction is size fractionated 
with YM-100 Microcon Centrifugal Filter Device (Millipore) 
and 3¢-extended with a poly-A tail by poly-A polymerase. An 
oligonucleotide tag is ligated to the poly-A tail for subsequent 
fluorescent dye staining. This platform allows dual labeling 
using Cy5 and Cy3 tags to label two RNA samples to be com-
pared in dual-sample experiments. Hybridization is performed 
overnight on a mParaFlo microfluidic chip using a microcircula-
tion pump (Atactic Technologies). On the microfluidic chip, 
each detection probe consists of a chemically modified nucle-
otide “coding” segment complementary to target miRNA 
(from miRBase, http://microrna.sanger.ac.uk/sequences/) or 
other RNA (control or customer defined sequences) and a 
spacer segment of polyethylene glycol to extend the “coding” 
segment away from the substrate surface. The detection probes 
are synthesized in situ with photogenerated reagent (PGR) 
chemistry on a Digital Light Projector (Texas Instruments) 
based synthesis system (29). Flexible DNA chip synthesis is 
gated by deprotection using solution photogenerated acids. 
The hybridization melting temperatures are balanced by adjust-
ing length and chemical modifications of the detection probes 
(29). Hybridization is carried out in 100 mL 6× SSPE buffer 
(0.90 M NaCl, 60 mM Na2HPO4, 6 mM EDTA, pH 6.8) con-
taining 25% formamide at 34°C followed by a stringent wash at 
52°C. Hybridization images are collected with a laser scanner 
(GenePix 4000B, Molecular Device) and signal intensity val-
ues extracted using ArrayPro image processing software 
(MediaCybernetics). Data analysis is carried out by first sub-
tracting the background and then normalizing with a cyclic 
LOWESS filter (locally weighted regression). For two-color 
experiments, the ratio of two sets of detected signals (log2 
transformed and balanced) and p-values of the t-test are calcu-
lated; a p-value of less than 0.01 is used to select significantly 
differentially detected signal. Data classification is accomplished 
2.2.1.4. LC Sciences 
(http://www.lcsciences.
com)
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by hierarchical clustering based on average linkage and 
Euclidean distance metric, and visualized with TIGR’s Multiple 
Experimental Viewer (MeV) (30).
Quantile normalization on the channel values is used to 
normalize two-color data within each chip to make single channel 
values within and between arrays more comparable and to improve 
the multiarray data analysis. The single channel normalized values 
are used in subsequent data analysis. Construction of a dendrogram 
on the single channel values, both before and after normalization, 
is recommended to examine the effect of normalization on the 
treatment differences.
Completion of the human reference genome by the international 
human genome sequencing consortium and US-based Celera 
genomics was a cornerstone of human scientific endeavor. This 
achievement clearly paved way for a new exciting era of scientific 
research. The human genome sequencing project commenced in 
the year 1990; by 2000 a draft version of the human genome was 
made available and a completed version was released in the year 
2003. During the human genome sequencing project era, the 
two widely used technologies were the original enzymatic dide-
oxy sequencing method pioneered by Fred Sanger and colleagues 
(31) and the Maxam and Gilbert method, which was described 
during the same year (32). The chemical degradation based 
Maxam and Gilbert method was particularly used in cases that 
were not easily resolved by the popular Sanger technique (33). 
As the human genome project progressed, the need for fast 
automated sequencers became imminent and companies with 
commercial interests were quick to step in to make improvements 
to the Sanger-based technique. In spite of the advances made in 
the Sanger technique through introduction of automated capil-
lary sequencers, particularly the sample preparation steps, which 
involved cloning of sequences into bacterial artificial chromosomes 
(BACs) or yeast artificial chromosomes (YACs) and artifacts 
related to sample preparation remained obstacles of making 
Sanger-based sequencing a completely automatable high-throughput 
method. In view of this fact, several companies came up with 
novel sequencing technologies, which had massively parallel 
high-throughput capabilities enabling genome-scale analysis in a 
relatively short period of time. These sequencing technologies are 
termed NGS technologies. As of today, three platforms, namely 
Roche Applied Science 454 platform, the Illumina platform, and 
Applied Biosystems ABI SOLiD system are widely used in research 
laboratories. More recently, the Helicos single-molecule sequencing 
device, HeliScope was released to the market. A brief description 
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The 454 FLX pyrosequencer, which was released in 2004, was 
the first to be introduced to the market as an NGS (34). In 
pyrosequencing, each time a nucleotide gets incorporated to the 
nucleotide chain through a polymerizing reaction, pyrophosphate 
is released, and the released pyrophosphate leads to a series of 
downstream events, which results in the production of firefly 
luciferase (35). In the 454 system, DNA fragments are ligated 
with special adapters. One of the adapters facilitates binding of 
the DNA molecule to a bead. Beads containing single DNA frag-
ments are subject to emulsion PCR and followed by a denatur-
ation step. Initial amplification of sample DNA is necessary to 
generate sufficient signal strength in the sequence by synthesis 
step, which is subsequently carried out on beads containing cop-
ies of a given fragment immobilized on an optical fiber chip. In 
the 454 setup, each bead with its amplified fragment is individu-
ally addressable by a CCD camera at the fluorescence detection 
stage. In the sequence by synthesis stage, polymerase enzyme, 
primers, and a given labeled nucleotide of known identity are 
provided to each bead at a time, and the resultant fluorescence 
due to the pyrosequencing reaction is measured via the optical 
fibers equipped to a smart camera. By introducing labeled nucle-
otides of a given kind at each subsequent cycle of the polymerizing 
reaction, the nucleotides being incorporated to the growing 
fragment in each cycle can be detected by fluorescence measure-
ment, and the sequence of each fragment can be decoded and 
assembled using sophisticated computer software. The 454 system 
is capable of detecting sequences in the 400–500 bp range and 
generates around 100 MB of data in a single run. A newer 
improved version of the 454 FLX called Titanium would provide 
a data output of around 500 MB. High costs of operation and 
generally low reading accuracy in homopolar stretches have been 
cited as drawbacks of the 454 system (33).
The Solexa sequencers were first introduced to the market in the 
year 2006 (36) and Illumina acquired Solexa in the year 2007 
(33). The Solexa system is based on sequencing by synthesis 
method, which uses a technology called “Reversible termina-
tion”. The basic workflow of the Illumina platform involves five 
main stages. The initial step involves randomly fragmenting DNA 
and ligating adaptors to random fragments. The second step 
involves attaching DNA to a special glass slide and is followed by 
a third step, where solid-phase bridge amplification is carried out 
using unlabelled nucleotides. The fourth step involves denaturing 
amplified double-stranded DNA on the slide, and finally the fifth 
step involves carrying out a PCR using labeled nucleotides and 
photographing.
Unlike in the case of the 454 instrument where a single vari-
ety of nucleotide is incorporated in each cycle of the fluorescence 
2.2.2.1. The 454 
GenomeSequencer FLX 
Instrument (Roche Applied 
Science) (http://www.454.
com/)
2.2.2.2. The Illumina 
(Solexa) Genome Analyzer 
(http://www.illumina.com/)
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generating polymerizing step, the Illumina instrument introduces 
all four labeled nucleotides to the polymerizing reaction at once. 
However, due to a chemical modification of the nucleotides, each 
time a nucleotide gets incorporated into the growing DNA chain 
termination of polymerization occurs. At this stage, a smart CCD 
camera photographs fluorescence signals resulting from nucleotides, 
which got incorporated to each individually addressable amplified 
cluster of DNA fragments, which are generated at the bridge 
amplification stage. Once photographing of all clusters is com-
pleted, termination is reversed and another set of nucleotides are 
introduced, and once incorporation takes place, the reaction is 
terminated and clusters are photographed. Eventually all photo-
graphic data are analyzed and the sequences are assembled using 
computer software. The sequence read length achieved by this 
technology is around 35 bp, and an advantage of this system is its 
ability to generate huge amounts of data in a single run. The 
Illumina GA2 sequencers released in 2008 had the ability to 
generate around 1.5 GB of data in a single read setup and around 
3.0 GB of data using a paired run. The ability of the instrument 
to generate massive amounts of data having short sequence 
lengths has made this instrument particularly well suited for small 
RNA based research, which generally does not demand long 
sequence reads. With various modifications in sample preparation 
and the use of different reagents, the Illumina platform can be 
used in a versatile fashion for ChipSeq and Bisulfite sequencing 
experiments as well.
In contrast to the polymerase reactions used in 454 and Illumina 
methods, the Applied Biosystems SOLiD technology uses a liga-
tion-based reaction to incorporate fluorescent-labeled nucleotides 
in the sequencing step (37). However, the Solid system shares 
similarities with 454 and Illumina as it utilizes an adapter ligated 
library and emulsion PCR on magnetic beads at the sample prep-
aration stages. The overall work flow of the solid system can be 
summarized as follows. Initially, an emulsion PCR step is carried 
out on adapter ligated DNA fragments anchored to magnetic 
beads to provide sufficient fluorescence intensities during the 
detection step. The magnetic beads containing the amplified frag-
ments are then transferred to a flow cell slide where a ligation 
reaction is carried out. The ligation reaction uses a primer, which 
attaches to the 5¢ prime end of the adaptor that immobilizes DNA 
fragments on the magnetic bead. DNA ligase and specific 8 mers 
whose fourth and fifth bases are specifically encoded with attached 
fluorescent labels are introduced to the reaction. Fluorescent 
detection is followed after each extending ligation step. After liga-
tion and detection, a regeneration step in which the 8 mers 
including the fluorescent labels are removed is carried out and a 
primer corresponding to a single base displacement (n−1) from 
2.2.2.3. The Applied 
Biosystems ABI SOLiD 
System (http://www3.
appliedbiosystems.com/)
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the 3¢ end of the adapter attaching the DNA fragment is intro-
duced, and the ligation cycle is followed while the two encoded 
bases are read. Similar cycles are carried out starting with primers, 
which correspond to n−2, n−3, n−4, and n−5. In each cycle, the 
encoded two bases are interrogated and data stored. Finally, when 
all rounds of ligation have been completed, a computer builds the 
sequence by decoding the stored data as two base pair calls. A 
distinct advantage of this system is the use of two base pair encoding. 
As a result of two base pair encoding, it is possible to discriminate 
between base calling errors, true polymorphisms and single base 
deletions of the sequence by alignment against a high quality ref-
erence. The sequence length in the solid systems is defined in 
between 25 and 35 by the user. A sequencing run in a SOLiD 
system can yield 2–4 GB of DNA sequence data (35).
Information regarding the HeliScope instrument is available at 
http://www.helicosbio.com/ (38). There are also several other 
companies, which are in the process of manufacturing single- 
molecule based powerful sequencers employing state-of-the-art 
technologies. The following links provide information regarding 
these systems, which are either in the developmental phase or are 
ready to step into the market: VisiGen Biotechnologies (http://visi-
genbio.com/) (39), Pacific Biosciences (http://www.pacificbiosci-
ences.com/index.php) (40), Sequenom (http://www.sequenom.
com) (41), Oxford Nanopore Technologies, UK (http://www.
nanoporetech.com/) (42), BioNanomatrix (http://bionanomatrix.
com/) (43), and Complete Genomics company (http://www.
completegenomics.com/) (44).
The small RNA fraction is prepared for Illumina sequencing by 
the ligation of 5¢ and 3¢ RNA adapters according to Illumina’s 
small RNA protocol, which can be found in the link http://www.
illumina.com/downloads/rnaDGESmallRNA_Datasheet.pdf 
(45). Illumina’s small RNA adaptors are ligated to the 5¢ and 3¢ 
ends of size selected <30 nt RNA. Adapter-modified DNA frag-
ments will be enriched by PCR and further gel purified prior to 
sequencing. Small RNA sequencing for each sample is then per-
formed using the Illumina Genome Analyzer (GA-2) according 
to the manufacturer’s small RNA protocol. Typically, this proto-
col results in over 5–10 million small RNA sequence reads per 
sample per lane.
A number of high-throughput computational pipeline have been 
developed for analyzing small RNA sequence reads generated 
by NGS technologies including Illumina sequencing (46). Our 
pipeline is described in (46, 47). For each sample, all unique 
sequence reads with a minimum read count of 10 are aligned to a 
reference set of miRNAs. The reference set is adaptable and cur-
rently consists of the 678 human and 472 mouse mature miRNA 
2.2.2.4. Small RNA 
Sequencing
2.2.2.5. Bioinformatics 
Platform for Analyzing 
Small RNA Sequence 
Reads
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sequences found in the miRNA database (miRBase version 11.0) 
plus 227 miRNA predictions from Berezikov et al. (48). It has 
been observed that the flexibility of DICER processing of the 
precursor miRNA produces a variety of sequence fragments, 
which may be active (49). To account for this, we perform a local 
Smith–Waterman alignment of each unique sequence read against 
each of the mature miRNAs in the reference, allowing for a 3-base 
overhang on the 5¢ end and a 6-base overhang on the 3¢ end. The 
alignments are scored such that a matching or overhanging base 
counts as two points and mismatches as −1. Each unique sequence 
read, which achieves a per-base alignment score of 2 (i.e., a per-
fect match) is associated with each mature miRNA for which it 
achieved that score. The read counts of all redundantly aligning 
reads are equally apportioned to all mature miRNAs to which 
they align.
Each specimen is expected to generate multiple sequences that 
are not sufficiently similar to any known human miRNA. For 
this purpose, a number of algorithms have been developed to 
evaluate the likelihood that the unique sequence that does not 
align with a known miRNA is a putative novel miRNA. Our 
novel miRNA discovery pipeline is described in Creighton et al. 
(8, 47). First, all small RNA sequences that do not align with 
known miRNA precursors are mapped to the reference genome 
sequence of the species the small RNA is derived from (i.e., 
human, mouse, etc.). Each exact sequence match is fetched 
along with 100 bases flanking either side. These ~220-bp 
sequences are then tested for miRNA-like hairpin structure. The 
~220-bp putative precursor sequences are evaluated with the 
Vienna package (www.tbi.univie.ac.at/RNA/) (50). Each of 
the unique sequences that map to a larger hairpin structures is 
tested for the Ambros criteria, which states that “authentic” 
miRNA sequences must map to one arm of a single-loop hairpin 
with a minimum free energy less than −25 kcal/mol (51, 52). 
Hairpins with overly large or unbalanced loops and unique 
sequences that map to the loop of the hairpin are rejected. After 
folding the read plus flanking sequence, the sequence is trimmed 
down to include only the plausible precursor and then folded 
again to ensure that the precursor was not artificially stabilized 
by neighboring sequence. Sequences appropriately placed in 
miRNA-like hairpins are considered to be “putative mature 
miRNAs” (pmms). Strong conservation of the mature miRNA, 
significant (but possibly weaker) conservation of the hairpin arm 
opposite the mature miRNA, and little or no conservation of the 
hairpin loop are considered a positive sign. Poorly conserved 
sequences are also considered since not all known miRNAs are 
conserved. If both the mature miRNA sequence and the miRNA-star 
sequence are found among the sequences, this candidate is 
2.2.2.6. Identification 
of Novel MicroRNAs
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considered a definitive confirmed novel miRNA. If there is a 
substantial difference in abundance, the more abundant form is 
defined to be the mature miRNA and the less abundant form 
the miRNA-star sequence.
miRNA:mRNA target predictions for a number of different 
species are now available in public Web sites. We recommend 
the PicTar algorithm (http://pictar.bio.nyu.edu) (53), which 
uses predictions from Krek et al. (54); TargetScan algorithm 
(http://www.targetscan.org) (55), which uses predictions from 
Lewis et al. (56); and the miRanda algorithm (http://www.
microrna.org) (57). The Sigterms software currently uses all 
three algorithms, and CORNA software is adapted for miRanda 
predictions (58).
Currently available algorithms are diverse, both in approach 
and in performance and all have room for improvement (7). A 
comparative description of some of the better known algorithms 
and their features are given below.
TargetScan provides target predictions for mammalian/verte-
brates offering predictions with site conservation consideration as 
well as without site conservation consideration (55). In predict-
ing targets, the algorithm takes into account parameters such as 
stringent seed pairing, site number and factors influencing site 
accessibility. In the mode where site conservation is taken into 
account, there is an option to rank by preferential conservation 
instead of site context (7).
PicTar provides target predictions for a wider variety of clades 
including mammalian/vertebrate, fly, and worm (53). The factors 
taken into consideration in this algorithm are stringent seed pairing 
for at least one of the sites of the miRNA, site number, and overall 
pairing stability (59). PicTar takes into consideration site conserva-
tion for all cases and does not offer a feature where target predic-
tions can be done without taking conservation into account (7).
The miRanda algorithm is capable of making miRNA target pre-
dictions for mammal/vertebrate, fly, worm as well as additional 
species (56). In its criteria for target prediction, the algorithm 
takes into account site number, pairing to most of the miRNA, 
and moderately stringent seed paring (60).
The PITA algorithm is capable of predicting miRNA–mRNA 
targets for mammalian/vertebrate, fly, and worm clades with site 
conservation consideration as well as without site conservation 
consideration (61). In its model for target predictions, PITA uses 
predicted site accessibility and stability as well as moderately 
stringent base paring and the number of sites (62).
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Methods and software for integrating gene expression results 
with miRNA expression can help to maximally assess the role of 
miRNAs as integrators of genes into biologically meaningful 
networks. This is based on the fact that a given miRNA typically 
has predicted target sites in the 3¢-UTRs of hundreds of genes 
and a given mRNA has multiple binding sites for several differ-
ent miRNAs. In addition, genes that belong to specific pathways 
or networks are coordinately regulated. For all these reasons, it 
is essential that miRNA–mRNA association analyses are dealt 
with in the context of genome-wide changes in transcripts. The 
ultimate aim is to determine predicted miRNA–mRNA pairs 
that are correlated in expression in the context of a specific 
experiment. These could be the genes which are significantly 
differentially expressed when comparing two different biologi-
cal states or genes that remain correlated in a treatment time 
course.
Current insight suggests that miRNAs exert their biologic 
effects by posttranscriptionally targeting gene expression; it fol-
lows that low expression of a given miRNA in a given system 
should conceivably cause a concomitant reversal of expression 
patterns for in silico predicted gene targets. Given this, we could 
define a miRNA–mRNA functional pair as consisting of a miRNA 
being predicted to interact with a given mRNA, where the two 
are also anticorrelated with each other in terms of expression. 
Public gene targeting prediction databases usually provide Web 
interface, where the user can look up predicted miRNA–mRNA 
functional pairs for a specific miRNA or gene of interest. In cases 
where the number of genes of interest (e.g., a set of genes arising 
from an expression profiling experiment) is in the hundreds, a 
gene-by-gene approach to looking up miRNA–mRNA pairs 
becomes impractical. Below we describe public software tools 
designed to make the task of integrating lists of genes and 
miRNAs easier.
CORNA (63) is an open-source package for the free statistical 
software R (http://www.r-project.org) (64) and allows scientists 
to analyze gene lists in the context of miRNA target predictions. 
In particular, when a list of genes and a list of miRNA target 
predictions are given, CORNA will carry out enrichment analysis 
to determine whether the gene list is enriched for particular 
miRNA targets more than that can be expected by chance. For 
example, the input gene list can come from a significant gene list 
from a microarray experiment or a biological pathway. Further 
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between miRNAs, pathways, and gene ontology (GO) terms and 
to display quantitative data associated with miRNA targets. 
CORNA employs three complementary statistical methods for 
enrichments analysis of relationships within lists of genes: the 
HyperGeometric test, Fisher’s exact test, and the c2-test. Central 
to the flow of information through CORNA is the gene list, from 
which the user may test for significant miRNA target associa-
tions. The user may also start with a miRNA, find genes that are 
targeted by that miRNA, and then test that gene list for enrich-
ment of KEGG pathways or GO terms. The user may also plot 
quantitative data associated with the targets of a particular 
miRNA. CORNA exclusively uses R vectors and data frames and 
includes functions for reading miRNA target data directly from 
miRBase (65) and microRNA.org (60). There are also helper 
functions to read gene and GO term data using biomaRt (66); 
microarray data directly from GEO (67); and pathway data 
directly from KEGG (68). A comprehensive tutorial exists at 
http://corna.sf.net.
Like CORNA, the Sigterms package allows the user to obtain 
miRNA–mRNA relationships for an entire set of genes (69). While 
CORNA runs with R, Sigterms consists of a set of Excel macros. 
The user enters a set of selected genes into an Excel “Annotation” 
workbook, which represents the entire set of genes on the gene 
profiling platform. The Annotation workbook can contain miRNA 
target predictions from one of the three commonly used algo-
rithms (TargetScan, PicTar, and miRanda), as well GO annotation 
or other pathway information. Annotation workbooks for a given 
gene array platform representing human or mouse genes can be 
found at http://sigterms.sourceforge.net.
The user-provided list of genes is first entered into a 
Microsoft Excel document. The software will then look up the 
genes in the Annotation workbook to retrieve all miRNA–mRNA 
pairs for the given algorithm. For each miRNA, Sigterms com-
putes an enrichment statistic that determines if the set of genes 
that are differentially expressed in the context of an experiment 
have binding sites more than expected by chance for that par-
ticular miRNA. Sigterms outputs the entire set of miRNA–mRNA 
pairs into an Excel worksheet; the user can then filter this work-
sheet for the miRNAs of interest (e.g., those miRNAs that are 
anticorrelated in expression with the genes). For computing the 
one-sided Fisher’s exact tests for enrichment of a set of targets 
for a particular miRNA within the set of genes, the reference 
gene set determined by the complete probe set on a given array 
is used. To account for multiple testing of miRNAs, Monte 
Carlo simulation testing is performed using a 100 randomly 
generated gene sets. For a given gene set and a given target 
3.2. Sigterms  
(http://sigterms.
sourceforge.net)
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prediction database, the number of miRNAs having a nominal 
significant p-value (p < 0.05) for target enrichment is computed 
for each of the 100 random tests. To calculate FDR, the average 
number of miRNA associations less than or equal to the given 
nominal p-value for the 100 random tests is used. The ultimate 
goal is to identify predicted targets within the gene set, that are 
enriched or overrepresented, which could help to implicate roles 
for specific miRNAs and miRNA-regulated genes in the system 
under study.
MMIA (which stands for “MicroRNA and mRNA integrated anal-
ysis”) is a Web-based application meant to provide a “one-stop” 
combined analysis of the miRNA/mRNA input data for various 
pathway-associated gene sets (70). The user inputs mRNA expres-
sion data as a tab-delimited text file along with either a miRNA 
expression data table or a list of top expressed miRNAs. Given the 
user-defined statistical cutoff values, MMIA defines the differen-
tially expressed genes and miRNAs from the data. Using miRNA 
prediction algorithms (TargetScan, PITA, and PicTar), MMIA 
then matches the upregulated or overexpressed genes with the 
downregulated or underexpressed miRNAs, and vice versa. MMIA 
can also generate heat maps of the data and search mRNA–miRNA 
pairs for pathway-related gene set enrichment. The MMIA software 
offers a convenient way for users to upload and analyze their data, 
though less flexible in how the analysis is carried out, as compared 
to CORNA or Sigterms.
Programs such as CORNA, Sigterms, and MMIA provide 
investigators without substantial bioinformatics support means 
by which they could make optimal use of their gene and miRNA 
expression data. The aim is to generate a list of miRNA–mRNA 
associations that are significantly correlated in the experiment 
of interest. The goal is to provide short lists of miRNA–mRNA 
pairs to be validated by direct biochemical assays, which establish 
that the miRNA–mRNA pair occurs in a duplex and coimmu-
noprecipitates in Argonaute complexes (71) and functional 
assays that demonstrate that the 3¢-UTR of the mRNA is 
responsive to the cognate miRNA in luciferase or GFP reporter 
systems (72).
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The zebra finch is an important model organism in several fields1,2
with unique relevance to human neuroscience3,4. Like other song-
birds, the zebra finch communicates through learned vocaliza-
tions, an ability otherwise documented only in humans and a
few other animals and lacking in the chicken5—the only bird with
a sequenced genome until now6. Here we present a structural,
functional and comparative analysis of the genome sequence of
the zebra finch (Taeniopygia guttata), which is a songbird belong-
ing to the large avian order Passeriformes7. We find that the over-
all structures of the genomes are similar in zebra finch and
chicken, but they differ in many intrachromosomal rearrange-
ments, lineage-specific gene family expansions, the number of
long-terminal-repeat-based retrotransposons, and mechanisms
of sex chromosome dosage compensation. We show that song
behaviour engages gene regulatory networks in the zebra finch
brain, altering the expression of long non-coding RNAs,
microRNAs, transcription factors and their targets. We also show
evidence for rapid molecular evolution in the songbird lineage of
genes that are regulated during song experience. These results
indicate an active involvement of the genome in neural processes
underlying vocal communication and identify potential genetic
substrates for the evolution and regulation of this behaviour.
As in all songbirds, singing in the zebra finch is under the control of
a discrete neural circuit that includes several dedicated centres in the
forebrain termed the ‘song control nuclei’ (for an extensive series of
reviews see ref. 8). Neurophysiological studies in these nuclei during
singing have yielded some of the most illuminating examples of how
vocalizations are encoded in the motor system of a vertebrate
brain9,10. In the zebra finch, these nuclei develop more fully in the
male than in the female (who does not sing), and they change markedly
in size and organization during the juvenile period when the male
learns to sing11. Analysis of the underlying cellular mechanisms of
plasticity led to the unexpected discovery of neurogenesis in adult
songbirds and life-long replacement of neurons12. Sex steroid
hormones also contribute to songbird neural plasticity, in part by
influencing the survival of new neurons13. Some of these effects are
probably caused by oestrogen and/or testosterone synthesized within
the brain itself rather than just in the gonads14.
Song perception and memory also involve auditory centres that
are present in both sexes, and the mere experience of hearing a song
activates gene expression in these auditory centres15. The gene res-
ponse itself changes as a song becomes familiar over the course of a
day16 or as the context of the experience changes17. The act of singing
induces gene expression in the male song control nuclei, and these
patterns of gene activation also vary with the context of the experi-
ence18. The function of this changing genomic activity is not yet
understood, but it may support or suppress learning and help integ-
rate information over periods of hours to days19.
The chicken genome is the only other bird genome analysed to
date6. The chicken and zebra finch lineages diverged about 100 million
years ago near the base of the avian radiation7. By comparing
their genomes we can now discern features that are shared (and thus
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Los Angeles, California 90056, USA. 5Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK. 6EMBL-EBI, Wellcome Trust Genome
Campus, Hinxton, Cambridge CB10 1SD, UK. 7MRC Functional Genomics Unit, University of Oxford, Department of Physiology, Anatomy and Genetics, South Parks Road, Oxford OX1
3QX, UK. 8Howard Hughes Medical Institute, Department of Neurobiology, Box 3209, Duke University Medical Center, Durham, North Carolina 27710, USA. 9Department of
Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon 97239, USA. 10Department of Biology & Biochemistry, University of Houston, Houston, Texas 77204,
USA. 11Department of Bioinformatics, Institute for Animal Health, Compton Berks RG20 7NN, UK. 12Department of Biosciences, University of Kent, Canterbury, Kent CT2 7NJ, UK.
13Instituto Universitario de Oncologia, Departamento de Bioquimica y Biologia Molecular, Universidad de Oviedo, 33006-Oviedo, Spain. 14Crown Human Genome Center, Department
of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel. 15Institute for Systems Biology, 1441 North 34th Street, Seattle, Washington 98103-8904, USA.
16Department of Biological Sciences, Louisiana State University, 202 Life Sciences Building, Baton Rouge, Louisiana 70803, USA. 17Department of Biochemistry & Molecular Genetics,
University of Colorado Health Sciences Center, Mail Stop 8101, Aurora, Colorado 80045, USA. 18University of Washington, Genome Sciences, Seattle, Washington 98195, USA.
19Department of Animal & Plant Sciences, University of Sheffield, Sheffield S10 2TN, UK. 20The Roslin Institute and Royal (Dick) School of Veterinary Studies, Edinburgh University,
EH25 9OS, UK. 21Freie Universitaet Berlin, Institut Biology, Takustr.6, 14195 Berlin, Germany. 22Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics,
IhnestraBe 73 14195 Berlin, Germany. 23Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, Massachusetts 02138, USA. 24Monsanto Company, 800
North Lindbergh Boulevard, St Louis, Missouri 63167, USA. 25Neuroscience Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.
Vol 464 | 1 April 2010 | doi:10.1038/nature08819
757
Macmillan Publishers Limited. All rights reserved©2010
generally characteristic of birds), and features that are most conspi-
cuously different between the two lineages—some of which will be
related to the distinctive neural and behavioural traits of songbirds.
We sequenced and assembled a male zebra finch genome using
methods described previously6,20. A male (the homogametic sex in
birds) was chosen to maximize coverage of the Z chromosome. Of
the 1.2 gigabase (Gb) draft assembly, 1.0 Gb has been assigned to 33
chromosomes and three linkage groups, by using zebra finch genetic
linkage21 and bacterial artificial chromosome (BAC) fingerprint maps.
The genome assembly is of sufficient quality for the analysis presented
here (see Supplementary Note 1 and Supplementary Table 1). A total
of 17,475 protein-coding genes were predicted from the zebra finch
genome assembly using the Ensembl pipeline supplemented by
Gpipe gene models (Supplementary Note 1). To extend further the
characterization of genes relevant to brain and behaviour, we also
sequenced complementary DNAs from the forebrain of zebra finches
at 50 (juvenile, during the critical song learning period) and 850
(adult) days post-hatch, mapping these reads (Illumina GA2) to
the protein-coding models (Supplementary Note 1). Of the 17,475
protein-coding gene models we find 9,872 (56%) and 10,106 (57%)
genes expressed in the forebrain at these two ages (90.7% overlap),
respectively. In addition to evidence for developmental regulation,
these reads show further splice forms, new exons and untranslated
sequences (Supplementary Figs 1 and 2).
To address issues of large-scale genome structure and evolution, we
compared the chromosomes of zebra finch and chicken using both
sequence alignment and fluorescent in situ hybridization. These ana-
lyses showed overall conservation of synteny and karyotype in the two
species, although the rate of intrachromosomal rearrangement was
high (Supplementary Note 2). We were also surprised to see genes of
the major histocompatibility complex (MHC) dispersed across several
chromosomes in the zebra finch, in contrast to the syntenic organiza-
tion of both chicken and human MHCs (Supplementary Note 2).
We assessed specific gene losses and expansions in the zebra finch
lineage by constructing phylogenies of genes present in the last
common ancestor of birds and mammals (Supplementary Note 2
and Supplementary Fig. 3). Both the zebra finch and the chicken
genome assemblies lack genes encoding vomeronasal receptors, casein
milk proteins, salivary-associated proteins and enamel proteins—not
surprisingly, as birds lack vomeronasal organs, mammary glands and
teeth. Unexpectedly, both species lack the gene for the neuronal
protein synapsin 1 (SYN1); comparative analyses suggest that the loss
of SYN1 and flanking genes probably occurred in an ancestor to
modern birds, possibly within the dinosaur lineage (Supplementary
Note 2, Supplementary Table 2 and Supplementary Fig. 4). Both zebra
finch and chicken have extensive repertoires of olfactory receptor-like
sequences (Supplementary Note 2 and Supplementary Fig. 5), pro-
teases (Supplementary Table 3), and a rich repertoire of neuropeptide
and pro-hormone genes.
Compared to mammals, zebra finch has duplications of genes
encoding several proteins with known neural functions, including
growth hormone, (Supplementary Fig. 3), caspase-3 and b-secretase
(Supplementary Table 3). Two large expansions of gene families
expressed in the brain seem to have occurred in the zebra finch
lineage after the split from mammals. One involves a family related
to the PAK3 (p21-activated kinase) gene. Thirty-one uninterrupted
PAK3-like sequences have been identified in the zebra finch genome,
of which 29 are expressed in testis and/or brain (Supplementary Note
2). The second involves the PHF7 gene, which encodes a zinc-finger-
containing transcriptional control protein. Humans only have a
single PHF7 gene, but remarkably the gene has been duplicated inde-
pendently, many times in both the zebra finch and chicken lineages to
form species-specific clades of 17 and 18 genes, respectively (Sup-
plementary Fig. 6). In the zebra finch these genes are expressed in the
brain (Supplementary Note 2).
An intriguing puzzle in avian genomics has been the evident lack of
a chromosome-wide dosage compensation mechanism to balance the
expression of genes on the Z sex chromosome, which is present in two
copies in males but only one in females22,23. The chicken has been
suspected of exerting dosage compensation on a more local level, by
the non-coding RNA MHM (male hypermethylated)24,25, to cause a
characteristic variation of gene expression along the Z chromosome.
The zebra finch genome assembly, however, lacks an MHM sequence,
and genes adjacent to the comparable MHM chromosomal position
show no special cluster of dosage compensation (Fig. 1 and Sup-
plementary Note 2). Thus, the putative MHM-mediated mechanism
of restricted Z-chromosome dosage compensation is not common to
all birds. Chromosomal sex differences in the brain could have a direct
role in the sex differences so evident in zebra finch neuroanatomy and
singing behaviour.
In mammals, as much as half of their genomes represent inter-
spersed repeats derived from mobile elements, whereas the inter-
spersed repeat content of the chicken genome is only 8.5%. We
find that the zebra finch genome also has a low overall interspersed
repeat content (7.7%), containing a little over 200,000 mobile ele-
ments (Supplementary Tables 4 and 5). The zebra finch, however, has
about three times as many retrovirus-derived long terminal repeat
(LTR) element copies as the chicken, and a low copy number of short
interspersed elements (SINEs), which the chicken lacks altogether.
Expressed sequence tag (EST) analysis shows that mobile elements
are present in about 4% of the transcripts expressed in the zebra finch
brain, and some of these transcripts are regulated by song exposure
(next section, Table 1). Figure 2 shows an example of an RNA that
was identified in a microarray screening for genes specifically
enriched in song control nuclei26 and now seems to represent a long
non-coding RNA (ncRNA) containing a CR1-like mobile element.
These results indicate that further experiments investigating a possible
role of mobile-element-derived repeated sequences in vocal commu-
nication are warranted.
A large portion of the genome is directly engaged by vocal com-


















Figure 1 | Divergent patterns of dosage compensation in birds. a, b, The
male to female (M/F) ratio of gene expression, measured by species-specific
microarrays, is plotted along the Z chromosome of chicken (a) and zebra
finch (b). Each point represents the average M/F ratio of a sliding window of
30 genes plotted at the median gene position and stepping one gene at a time
along the chromosome. Note region of lower M/F ratios in chicken
surrounding the locus of the MHM (male hypermethylated) ncRNA. In
zebra finch, genes adjacent to the comparable MHM position (asterisk) show
no special cluster of dosage compensation (low M/F ratios), and no MHM
sequence appears in the genome assembly. bp, base pairs.
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auditory forebrain that respond in different ways to song playbacks
during the process of song-specific habituation, a form of learning16.
We now map each of these song-responsive RNAs to the genome
assembly (Table 1 and Supplementary Note 3). Notably, we find
evidence that ,40% of transcripts in the unstimulated auditory fore-
brain are non-coding and derive from intronic or intergenic loci
(Table 1). Among the RNAs that are rapidly suppressed in response
to new vocal signals (‘novel down’), two-thirds are ncRNAs.
The robust involvement of ncRNAs in the response to song led us
to ask whether song exposure alters the expression of microRNAs—
small ncRNAs that regulate gene expression by binding to target
messenger RNAs. Indeed we find that miR-124, a conserved
microRNA implicated in neurological function in other species28, is
rapidly suppressed in response to song playbacks (Fig. 3). We inde-
pendently measured this effect by direct Illumina sequencing of small
RNAs in the auditory forebrain, and also identified other known and
new microRNAs, several of which also change in expression after
song stimulation (Supplementary Note 2).
A potential site of action for microRNAs was shown by genomic
mapping of transcripts that increase rapidly after new song exposure
(Table 1, ‘novel up’). Two of the cDNA clones that measured the
most robust increases27 align to an unusually long (3 kilobases (kb))
39 untranslated region (UTR) in the human gene that encodes the
NR4A3 transcription factor protein (Fig. 4a). The entire UTR is
similar in humans and zebra finches, with several long segments of
.80% identity (Fig. 4b). Within these segments we find conserved
predicted binding sites for 11 different microRNAs, including five
new microRNAs found by direct sequencing of small RNAs from the
zebra finch forebrain (Fig. 4b). These findings indicate that this
NR4A3 transcript element may function in both humans and song-
birds to integrate many conserved microRNA regulatory pathways.
The act of singing also alters gene expression in song control
nuclei29, and we used the genome assembly to analyse the transcrip-
tional control structure of this response. Using oligonucleotide
microarrays, we identified 807 genes in which expression signifi-
cantly changed as a result of singing. These were grouped by k-means
clustering into 20 distinct expression profile clusters (Fig. 5a and
Supplementary Note 3). Gene regulatory sequences (transcription-
factor-binding sites) were predicted across the genome using a new
motif-scanning approach (Supplementary Note 1), and we observed
significant correlation between changes in expression of transcrip-
tion factor genes and their predicted targets (Fig. 5b and Sup-
plementary Table 6). Thus, the experience of singing and hearing
song engages complex gene regulatory networks in the forebrain,
altering the expression of microRNAs, transcription factor genes,
and their targets, as well as of non-coding RNA elements that may
integrate transcriptional and post-transcriptional control systems.
Learned vocal communication is crucial to the reproductive
success of a songbird, and this behaviour evolved after divergence
Table 1 | Structural features of the song responsive genome
All genes analysed Novel up Novel down Habituate up Habituate down
All ESTs 17,877 145 461 1,531 1,774
Mapped loci 15,009 125 435 1,217 1,112
Ensembl genes 8,438 136 301 1,138 1,136
Mobile element content*
Number with mobile elements 688 2 40 32 38
Percentage mobile elements 4 1 9 2 2
P-value 2 0.18 1.4 3 1025 0.005 0.004
Coding and non-coding content{
mRNA transcripts (% (P-value)) 59 86 (0.05) 32 (1 3 10210) 65 (0.05) 71 (0.001)
EST loci mapped to introns (% (P-value)) 6 1 (0.05) 21 (1 3 10210) 3 (0.001) 6
Intergenic loci (% (P-value)) 33 12 (0.001) 45 (0.05) 31 21 (0.001)
Protein-coding gene territories{
Mean gene length (kb) 30.4 21.7 78.8 34.8 31.2
Intergenic length (kb) 57.4 42.3 108.0 64.9 55.3
Territory size (kb) 87.8 64.1 186.8 99.7 86.4
P-value 2 3.9 3 1023 1.7 3 10228 9.3 3 10210 1.4 3 1024
A microarray made from non-redundant brain-derived ESTs34 was used to define four subgroups of RNAs that show different responses in auditory forebrain to song exposures (novel up and down,
habituated up and down)27. These ESTs were mapped to genome positions as described (Supplementary Note 3).
*All ESTs were analysed for mobile element content using RepeatMasker (Supplementary Note 2). P-value is for the comparison to all genes (Fisher’s exact test).
{All ESTs that could be mapped uniquely to the genome assembly were assessed for overlap with Ensembl annotations of mRNA transcripts (protein coding and UTRs), intronic regions, or intergenic
regions. P-value is for comparison to all mapped loci (Fisher’s exact test). Results are the percentage with P values in parentheses where shown.
{The size of each unique protein-coding gene territory was determined by combining the length of the Ensembl gene model with its intergenic spacing. The P-value is for the comparison to all genes,



















Figure 2 | Enriched expression of a CR1-like element in the zebra finch song
system. a, Genomic alignment of an RNA containing a CR1-like
retrotransposon element (in blue) and adjacent ESTs, with respective
GenBank accession numbers. b–d, DV949717 is expressed in the brain of
adult males with enrichment in song nuclei HVC (letter-based name) and
LMAN (lateral magnocellular nucleus of the anterior nidopallium), as
revealed by in situ hybridization. The diagram in b indicates areas shown in
photomicrographs in c and d. Cb, cerebellum; Hp, hippocampus; Meso,
mesopallium; Nido, nidopallium; Shelf, nidopallial shelf region; St, striatum.






















Figure 3 | miR-124 in the auditory forebrain is suppressed by exposure to
new song. TaqMan assays comparing samples from the auditory lobule of
adult male zebra finches in silence (open bars) or 30 min after onset of new
song playback (filled bars). a, Comparison of two sample pools, each
containing auditory forebrains of 20 birds. b, Comparisons of paired
individual subjects, n 5 6 pairs (P 5 0.03, Wilcoxon paired test). Error bars
denote s.e.m. of triplicate TaqMan assays. Parallel TaqMan analyses of the
small RNA RNU6B were performed with all samples and showed no
significant effect of treatment for this control RNA.
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of the songbird lineage5. Thus, it seems likely that genes involved in
the neurobiology of vocal communication have been influenced by
positive selection in songbirds. With this in mind, we examined the
intersection of two sets of genes: (1) those that respond to song
exposure in the auditory forebrain as discussed in the previous sec-
tion; and (2) those that contain residues that seem to have been
positively selected in the zebra finch lineage, as determined using
phylogenetic analysis by maximum likelihood (PAML) (Supplemen-
tary Note 4). There are 214 genes that are common to both lists. Of
these, 49 are suppressed by song exposure (Supplementary Table 7),
and 6 of these 49 are explicitly annotated for ion channel activity
(Table 2). This yields a highly significant statistical enrichment for
the term ‘ion channel activity’ (P 5 0.0016, false discovery rate (FDR)
adjusted Fisher’s exact test) and other related terms in this subset of
genes (Supplementary Tables 8 and 9). Independent evidence has
also demonstrated differential anatomical expression of ion channel
genes in song control nuclei26,30. Ion channel genes have important
roles in many aspects of behaviour, neurological function and
disease31. This class of genes is highly likely to be linked to song
behaviour and should be a major target for future functional studies.
Passerines represent one of the most successful and complex radia-
tions of terrestrial animals7. Here we present the first, to our know-
ledge, analysis of the genome of a passerine bird. The zebra finch was
chosen because of its well-developed status as a model organism for a
number of fields in biology, including neurobiology, ethology, ecology,
biogeography and evolution. In the zebra finch as in the chicken, we see
a smaller, tighter genome compared to mammals, with a marked
reduction of interspersed repeats. The zebra finch presents a picture
of greater genomic plasticity than might have been expected from the
chicken and other precedents, with a high degree of intrachromosomal
rearrangements between the two avian species, gene copy number
variations and transcribed mobile elements. Yet we also see an overall
similarity to mammals in protein-coding gene content and core tran-
scriptional control systems.
Our analysis suggests several channels through which evolution
may have acted to produce the unique neurobiological properties of
songbirds compared to the chicken and other animals. These include
the management of sex chromosome gene expression, accelerated
evolution of neuronal ion transport genes, gene duplications to pro-
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Figure 4 | Conserved NR4A3 39UTR is a potential region for microRNA
integration. a, zPicture alignment of 39 portion of zebra finch to human
gene35 showing UTR region of high similarity beyond the coding exons. Dark
red bars, regions with the highest sequence conservation; black rectangles,
position of song-regulated ESTs27 within the conserved UTR but outside the
Ensembl gene model (ENSTGUG00000008853). b, Alignment of zebra finch
and human 39 UTR sequences showing the per cent sequence identity for
each evolutionarily conserved region. Dots indicate positions of conserved
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Figure 5 | Transcriptional control network in area X engaged by singing.
a, Clustered (1–20) temporal expression profiles of 807 genes (rows) that
change with time and amount of singing; red, increases; blue, decreases;
white, no change relative to average 0-h control. Grey/coloured bars on left,
clusters with enrichment of specific promoter motifs (P , 0.01). b, Enriched
transcription-factor-binding motifs (abbreviations) found in the promoters
of late response genes, clusters 9–12 (coloured as in a); bold, binding sites for
known activity-dependent transcription factors (for example, CREBP1) or
transcription factor complexes (for example, CREBP1–CJUN); black, sites
for post-translationally activated transcription factors; brown, sites for
transcriptionally activated transcription factors including by singing (for
example, in cluster 1). Graph shows time course of average expression of all
genes in the late response clusters, normalized to average 0 h for that cluster.
Also plotted is the average expression of the C-FOS transcription factor
mRNA, which binds to the AP-1 site over-represented in the promoters of
cluster 10 genes.
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important genes, and a new arrangement of MHC genes. Most
notably, our analyses suggest a large recruitment of the genome
during vocal communication, including the extensive involvement
of ncRNAs. It has been proposed that ncRNAs have a contributing
role in enabling or driving the evolution of greater complexity in
humans and other complex eukaryotes32. Seeing that learned vocal
communication itself is a phenomenon that has emerged only in
some of the most complex organisms, perhaps ncRNAs are a nexus
of this phenomenon.
Much work will be needed to establish the actual functional sig-
nificance of many of these observations and to determine when they
arose in avian evolution. This work can now be expedited with the
recent development of a method for transgenesis in the zebra finch33.
An important general lesson, however, is that dynamic and seren-
dipitous aspects of the genome may have unexpected roles in the
elaborate vocal communicative capabilities of songbirds.
METHODS SUMMARY
Sequence assembly. Sequenced reads were assembled and attempts were made to
assign the largest contiguous blocks of sequence to chromosomes using a genetic
linkage map21, fingerprint map and synteny with the chicken genome assembly
Gallus_gallus-2.1, a revised version of the original draft6 (Supplementary Note 1).
Genes. Gene orthology assignment was performed using the EnsemblCompara
GeneTrees pipeline and the OPTIC pipeline (Supplementary Note 1). Orthology
rate estimation was performed with PAML (pairwise model 5 0, Nssites 5 0). In
all cases, codon frequencies were estimated from the nucleotide composition at
each codon position (F3X4 model).
Gene expression and evolution. Methods for Illumina read counting, in situ
hybridization, TaqMan RT–PCR, microarrays, regulatory motif and evolution-
ary rate analyses are given in Supplementary Notes 1–4.
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Abstract
Background: In an important model for neuroscience, songbirds learn to discriminate songs they hear during
tape-recorded playbacks, as demonstrated by song-specific habituation of both behavioral and neurogenomic
responses in the auditory forebrain. We hypothesized that microRNAs (miRNAs or miRs) may participate in the
changing pattern of gene expression induced by song exposure. To test this, we used massively parallel Illumina
sequencing to analyse small RNAs from auditory forebrain of adult zebra finches exposed to tape-recorded
birdsong or silence.
Results: In the auditory forebrain, we identified 121 known miRNAs conserved in other vertebrates. We also
identified 34 novel miRNAs that do not align to human or chicken genomes. Five conserved miRNAs showed
significant and consistent changes in copy number after song exposure across three biological replications of the
song-silence comparison, with two increasing (tgu-miR-25, tgu-miR-192) and three decreasing (tgu-miR-92, tgu-
miR-124, tgu-miR-129-5p). We also detected a locus on the Z sex chromosome that produces three different novel
miRNAs, with supporting evidence from Northern blot and TaqMan qPCR assays for differential expression in males
and females and in response to song playbacks. One of these, tgu-miR-2954-3p, is predicted (by TargetScan) to
regulate eight song-responsive mRNAs that all have functions in cellular proliferation and neuronal differentiation.
Conclusions: The experience of hearing another bird singing alters the profile of miRNAs in the auditory forebrain
of zebra finches. The response involves both known conserved miRNAs and novel miRNAs described so far only in
the zebra finch, including a novel sex-linked, song-responsive miRNA. These results indicate that miRNAs are likely
to contribute to the unique behavioural biology of learned song communication in songbirds.
Background
Songbirds are important models for exploring the neural
and genomic mechanisms underlying vocal communica-
tion, social experience and learning (reviewed in [1]).
Songbirds communicate using both innate calls and
learned vocalizations (songs), and unique specializations
of the brain evolved to support this behavior (reviewed
in [2]). In the zebra finch, only the male produces
songs, although both sexes process and discriminate
specific songs [3-6]. The genome is actively engaged by
song communication, as first shown in an early
demonstration of how gene responses in the brain dis-
criminate among different song stimuli [7]. The genomic
response is not a simple correlate of neural activity and
it can vary significantly according to the salience and
behavioral context of the experience [8-13]. Recent stu-
dies using microarray technology have now shown that
song exposure affects the expression of thousands of
genes in the auditory forebrain [14,15]. Repeated expo-
sure to one song leads to an altered gene expression
profile, correlated with habituation of both the beha-
vioral and immediate genomic responses to that specific
song. These observations suggest the involvement of
large and dynamic transcriptional network in the recog-
nition and memory of complex vocal signals [14].
MicroRNAs (miRNAs or miRs) are emerging as
potential control points in transcriptional networks, and
* Correspondence: dclayton@uiuc.edu
† Contributed equally
4Department of Cell and Developmental Biology, University of Illinois,
Urbana-Champaign, IL 61801, USA
Full list of author information is available at the end of the article
Gunaratne et al. BMC Genomics 2011, 12:277
http://www.biomedcentral.com/1471-2164/12/277
© 2011 Gunaratne et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
may be particularly important for the evolution of brain
and behavior. Many miRNAs are expressed in the brain
[16], often in different patterns in different species
[17-19]. Brain miRNAs undergo dramatic changes in
expression during development [20-22] and aging [23]
and have been functionally implicated in neurological
disease [24]. They may also function in the normal phy-
siological operation of the nervous system as suggested
by evidence for involvement of miR-132 and miR-219 in
circadian clock regulation [25] and miR-134 in control
of dendritic translation [26,27].
Here we apply massively parallel Illumina sequencing
to probe the involvement of miRNAs in the processing
of song experience in the zebra finch auditory forebrain.
We begin by identifying 155 different miRNA sequences
and the genomic loci of their precursor sequences in the
zebra finch genome, including 34 miRNA genes that
have not been detected in the genomes of other species.
We then ask whether the miRNA content changes after
song exposure and find robust evidence of miRNA
responses to song playbacks. We also assess correlations
between expression changes of a novel miRNA and its
predicted target mRNAs during song habituation. The
results indicate an active role for miRNAs in the neural
processing of a natural perceptual experience - hearing
the sound of another bird singing.
Results
The miRNAs of the zebra finch auditory forebrain
We carried out Illumina small RNA sequencing (RNA-
seq) on the small RNA (~18-30 nucleotides) fraction of
total RNA isolated from adult zebra finch auditory fore-
brain. Ultimately, we performed 6 Illumina runs on 6 dif-
ferent RNA samples, to assess the effects of song
exposure (next section). First we describe the overall
small RNA profile obtained by combining the results of
all the runs, representing 36 adult zebra finches (equal
numbers of males and females). A total of 20 million
reads were obtained (Table 1) and aligned to reference
miRNA sequences from other species (miRBase version
13.0). Overall we identified 107 non-redundant miRNAs
representing 52% of sequences that have been previously
identified in chicken, rodent and human. The remaining
sequences mapping to the piRNA database were denoted
as piRNA reads (~30%) (Additional File 1, Table S1).
Reads that did not align to known RNAs were
assessed for miRNA potential through a novel miRNA
discovery pipeline described by Creighton et al.[28]
which tests for properties that are characteristic of
known miRNAs. These properties include the following:
1) The mature sequence must map to the stem region
of the hairpin sequence of the putative precursor
extracted from the zebra finch genome. 2) The mature
miRNA sequence must map to the precursor such that
it can be processed following the Drosha processing
rules [29]. All novel miRNA candidates that map to the
loop region and/or lack appropriate Drosha processing
sites are failed. 3) Known miRNAs have stable 5’-ends
that vary at the most by +/- 1 nucleotide. 4) By contrast
the 3’-ends of miRNAs are highly heterogeneous in
length due to imprecise Dicer processing [29,30] and
exhibit non-templated nucleotide sequence changes due
to RNA editing [29-31]. 5) Consequently, the putative
precursor must give a strong signal of sequence align-
ments in a tight area of 18-25 nucleotides. Small RNA
sequences that are distributed fairly evenly along the
entire length of the precursor are rejected since they
likely represent degraded products of a large RNA. The
candidates that also demonstrate the presence of the
miRNA star sequence (miR*) mapping on the opposite
side of the mature miRNA and occurring at a lower
abundance in the deep sequencing data are considered
to be confirmed novel miRNAs in zebra finch. Using
this pipeline (Figure 1) we discovered 48 putative novel
miRNAs that map on the zebra finch genome to a stem
loop structure that folds with a minimum free energy of
< -20 kcal/mol [32]. The complete analysis and mapping
information for all the novel miRNA candidates is given
in Additional File 1, Tables S2 and S3.
All novel miRNA candidates were mapped to genomic
loci in the zebra finch genome assembly [33], and also
to human and chicken genomes using the BLAT func-
tion of the UCSC Genome Browser (Additional File 1,
Table S3). In the zebra finch genome, the loci include
both annotated exons and introns as well as unanno-
tated intergenic regions. Thirty-four (34) novel micro-
RNAs uncovered from zebra finch are not presently
detected in the human or chicken genome assemblies.
Eleven (11) map to genome positions in chicken, and six
to positions in the human (with three of these found in
Table 1 Summary statistics for the read alignments
Male silence Male song Female silence Female song Mix silence Mix song
Total Reads 2,704,778 2,056,391 3,173,108 3,546,038 3,962,050 4,738,528
Total Usable Reads 1,179,330 1,155,168 2,244,376 2,498,648 2,249,188 2,950,398
Reads aligning with Total 401,934 209,944 1,638,528 1,755,748 1,348,109 2,113,006
known miRNA Fraction 34% 18% 73% 70% 60% 72%
Six different pools of auditory forebrain were analyzed independently by Illumina small RNA sequencing, as described in the text.
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Figure 1 Pipeline with yields for analysis of putative novel miRNAs. 52 small RNA sequences did not align to miRBase reference sequences
and were assessed for miRNA potential. 48 sequences passed the minimum criteria and were categorized into three groups according to
strength of evidence (sequences are color-coded in Additional File 1, Table S3, as indicated). Seven (7) are confirmed novel miRNAs since they
had all the characteristics of known miRNAs and in addition also had a less abundant miR* sequence that maps on the opposite side of the
stem from the putative novel miRNA. These are labelled green in Additional File 1, Table S3. Twenty-one (21) putative novel miRNAs are highly
confident (labelled blue) since they also shared characteristics of known miRNAs but no sequence was found aligning to the miR* region. Given
that the miR and miR* sequences for most known miRNAs have vastly different copy numbers such that the miR* sequence is sometimes not
found, the highly confident candidates are also highly likely to be genuine novel miRNAs, Twenty (20) candidates (labelled grey) had a subset of
the characteristics of known miRNAs but not all and therefore were deemed potential candidates that require more evidence.
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human but not chicken assemblies). Tgu-mir-2976 maps
to three loci in the finch and 14 in the chicken, indicat-
ing a probable expansion of this miRNA in the chicken
lineage. This putative novel miRNA is not currently
detected in the human assembly HG18. Tgu-mir-2985 is
intriguing as it is located within two stem loops within
the introns of two functionally related genes: the gluta-
mate receptor subunits GRIA2 and GRIA4 in all three
genomes.
miRNA responses to song exposure
When zebra finches are exposed to playback of a song
they have not heard recently, changes occur in the
expression of many different mRNAs as detected 30
min after stimulus onset [14]. To determine whether
specific miRNAs also change in expression, we counted
the Illumina reads in samples of RNA pooled from the
auditory forebrain of birds either 30 min after onset of
song playback (Song group) or from matched controls
(Silence group). In our first such experiment, the birds
in both groups were all males (n = 6 each). The read
count for each miRNA in each sample was normalized
to the total number of usable reads mapped in that sam-
ple. We then calculated the ratio of the normalized
count in the Song-stimulated condition compared to the
Silence condition and performed a Fisher’s exact test
(with correction for multiple testing) to evaluate
whether the ratio differed significantly from the range of
expected values at a 95% confidence interval. In the
initial experiment with males, 49 of the known con-
served miRNAs showed a significant difference, with 28
decreasing and 21 increasing in the group exposed to
song (Additional File 1, Table S4).
To address the biological reproducibility of the miRNA
responses to song more broadly, we then repeated the
small RNA-seq comparison two additional times using
new groups of birds. In the second experiment, we used
only females, and in the third we used an equal mix of
males and females. In total, therefore, we performed
three independent “song-silence” pairwise comparisons
by small RNA-seq, with an overall sex balance but differ-
ent sex ratios in each individual comparison. These sec-
ond and third experiments were done six months after
the first and Illumina technology had improved by this
time so that we obtained twice as many read counts
(Table 1) - but again we normalized to the total mapped
read number in each individual sample for our statistic
analyses. As in the first experiment, we again observed
differential read counts for roughly a third of the miR-
NAs, but the identities of the miRNAs affected were
somewhat different in each comparison. This is summar-
ized graphically as a Venn diagram (Additional File 2,
Figure S1), and comprehensive read count data are pre-
sented in Additional File 1, Table S4. Across all three
experiments, five conserved miRNAs showed changes
that were both significant and in same direction in all
comparisons (Table 2). For a number of other miRNAs,
including let-7f, an apparent effect of song exposure was
measured in all three experiments but the direction of
change was not consistent (Additional File 1, Table S4).
We performed TaqMan assays on RNA from additional
birds, probing for eleven of the “significantly affected”
miRNAs, and obtained fluorescent signals in PCR for
ten. In nine out of ten cases, we observed the same
direction of song response by TaqMan as in the small
RNA-seq experiment, although the P-value by TaqMan
was below 0.05 in only five cases (tgu-miR-124, tgu-
miR-29a, tgu-miR-92, tgu-129-5p, and tgu-miR-2954-3p,
Additional File 1, Table S4). The lack of statistical sig-
nificance in the TaqMan assay for the others could
reflect differences in the sensitivity and resolution of
Illumina vs. TaqMan assays, or the operation of other
uncontrolled factors in our experiments that lead to
variability in the expression of some miRNAs.
The transcriptional response in the auditory forebrain
of zenk and other mRNAs is specific to song relative to
Table 2 Conserved miRNAs with consistent responses to song exposure
Male Female Mix
Silence Song Fold Change FDR-P Silence Song Fold Change FDR-P Silence Song Fold Change FDR-P
Increasing
tgu-miR-25 227 423 3.57 1.6E-27 55 212 3.60 1.4E-10 35 160 2.92 2.1E-05
tgu-miR-192 26 69 5.08 1.2E-06 36 90 2.33 5.5E-03 11 97 5.63 4.3E-06
Decreasing
tgu-miR-92 359 100 0.53 1.1E-04 5479 5398 0.92 5.5E-03 7461 6887 0.59 6.3E-108
tgu-miR-124 24624 7056 0.55 2.1E-251 56802 46434 0.76 1.1E-206 50955 77220 0.97 1.6E-04
tgu-miR-129-5p 2020 602 0.57 4.0E-19 9778 7272 0.69 2.8E-62 12128 9284 0.49 2.6E-293
Shown are the Illumina read data for the five miRNAs that show a consistent response to song (same direction of change, significant in all three comparisons).
“Song” and “Silence” list raw counts from the Illumina read analysis (Additional File 1, Table S4). “Fold Change” is the ratio of Song versus Silence read counts,
after the raw counts were normalized within each run to the sum of mapped reads for that sample. Thus a value of > 1 indicates a relative increase in the group
exposed to song, and < 1 indicates a decrease. “FDR-P” indicates the result of the Fisher’s exact test (FDR adjusted) for this comparison. See Additional File 1,
Table S4 for full list of values for all miRNAs, and associated TaqMan values for a subset of these miRNAs (measured in a different set of males and females).
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non-song auditory stimuli [6,7,34,35]. To test for song-
specificity of the miRNA response, we conducted a
further TaqMan experiment assessing the levels of six
miRNAs (tgu-miR-124, tgu-miR-92, tgu-miR-129-5p,
and three miRNAs derived from the tgu-miR-2954
locus, next section), in birds who had heard either a
normal song or a carefully matched non-song acoustic
stimulus, “song enveloped noise” (SEN). SEN has the
same amplitude envelope as the song from which it is
derived but spectral content has been randomized so it
does not sound like a song [34]. By TaqMan PCR, we
confirmed that normal song induced a larger increase in
zenk mRNA in these birds than did SEN (Additional
File 2, Figure S3 panel D). In these same animals, nor-
mal song, but not SEN, triggered a significant decrease
in the levels of tgu-miR-124, tgu-mir-129-5p, tgu-miR-
92 and tgu-miR-2954-3p (Additional File 2, Figure S3
panels A-C, H). Thus we conclude that there is indeed a
unique miRNA response in the auditory forebrain that
is selective for song over non-song acoustic stimuli.
A complex sex-linked miRNA locus in zebra finch and
other birds
The novel miRNA, tgu-mir-2954, that was detected
most frequently in our Illumina assays maps to the
sense strand of an intron in the XPA gene, on the Z
chromosome (Figure 2A). The precursor hairpin con-
tains reads from both arms, thus meeting our bioinfor-
matic criteria for a confirmed miRNA (Figure 2B). By
contrast to most known miRNAs, the numbers of reads
from both 5’ and 3’ arms were found at similar copy
numbers, suggesting that both arms may make func-
tional mature miRNAs. BLAST analysis of the mir-2954
hairpin precursor sequence against the NCBI nr data-
base identified a putative mature miRNA in chicken (gi|
145279910|emb|AM691163.1|), and BLAT analysis of a
collection of transcripts from crocodile and 11 other
bird species [36] detected mir-2954 transcripts in 2 non-
passerine species (two hummingbirds) and 3 passerine
species (the American crow, the pied flycatcher, and the
golden collared manakin) (Additional File 2, Figure S2).
There was no BLAT hit in the crocodile, the remaining
3 non-passerine birds (Emu, budgerigar, and ringneck
dove), and 3 passerine species (collared flycatcher, blue
tit and Eastern phoebe). The lack of a hit does not
necessarily mean absence of the gene as these datasets
represent incomplete transcriptomes derived by 454
sequencing [36]. These results clarify that the sequence
is not unique to the zebra finch or passerines, but may
nevertheless have a restricted distribution within birds.
To validate the existence of these two miRNAs in
zebra finch, we performed TaqMan analyses for both,
using their reverse complements as controls. Interest-
ingly, we got significant expression values not only for
the predicted miRNAs but also for one of the reverse-
complement miRNAs (tgu-miR-2954R-5p) although no
significant song regulation for miR-2954R-5p was found
(Additional File 2, Figure S3 panels I-J). With respect to
the XPA gene within which this locus is embedded (Fig-
ure 2A), these data suggest that precursor-miRNA-stem
loops are produced from both the sense (same orienta-
tion as XPA) and antisense strands. The stem loop pre-
cursor processed by Drosha from the sense RNA (tgu-
mir-2954) generates two active miRNAs from its both
arms (tgu-miR-2954-3p and tgu-miR-2954-5p). The
stem loop precursor processed by Drosha from the anti-
sense RNA (tgu-mir-2954R) generates at least one active
miRNA (tgu-miR-2954R-5p) from its 5’ end sequence.
We carried out Northern analysis on tgu-miR-2954-
3p, which is the miRNA that has the highest number of
read counts detected in our Illumina assays among the
three miRNAs from the tgu-mir-2954 locus. A robust
signal at ~22 nucleotides is evident in mixed-sex pools
of RNA from birds hearing either song or silence, and a
weaker signal is also detectable in two female-only pools
of RNA (Figure 2C). Greater expression in males is con-
sistent with the ZZ genotype of males and the lack of
efficient sex chromosome dosage compensation in the
zebra finch [37,38].
By TaqMan as well as by Illumina, we observed an
apparent sex difference in the direction of the response
of tgu-miR-2954-3p to song - up in males and down in
females (Figure 3 and Additional File 1, Table S4). This
suggests this locus may be under complex regulation,
integrating information about sex, auditory or social
experience and perhaps also other factors related to
XPA gene expression.
To gain insight into the potential functional role of
tgu-miR-2954-3p in the response to song, we used a
conservative strategy to predict gene targets that are
both conserved in birds and responsive to song expo-
sure in the zebra finch. Potential targets of miRNAs are
described as mRNAs that have sequences that can
undergo Watson-Crick base pairing with the 5’-seed
(nucleotide 2-7) of the miRNA [39]. For target predic-
tion we applied the TargetScan (5.1) algorithm using the
chicken genome as an initial reference, and then con-
firmed presence of the target sequence in the zebra
finch. For evidence of song responsiveness, we used the
data set of Dong et al. [14]. Eight genes met all these
criteria (Table 3) and are thus both song-responsive and
also subject to regulation by tgu-miR-2954-3p. These
genes all have functions in control of cell proliferation
or neurite outgrowth (see below).
Discussion
Here we show that a natural perceptual experience,
hearing the sound of another bird singing, alters the
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profile of miRNAs in parts of the songbird brain respon-
sible for auditory perception, integration and memory.
The song-regulated population includes both known
(conserved) and novel miRNAs. We highlight one sex-
linked song-responsive miRNA and identify mRNAs
that are potential targets of its action during song expo-
sure. Thus miRNAs may have roles in the information
processing functions of the brain, in addition to their
roles in brain development and evolution.
To demonstrate this, we first catalogued the miRNAs
expressed in the adult zebra finch auditory forebrain.
We used massively parallel Illumina sequencing of small
RNAs to perform this cataloguing efficiently. In addition
to known conserved miRNAs, our analysis identified 48
small RNA sequences that meet the structural criteria
for miRNAs but had not been described in miRBase in
any organism at the time of our analysis. Fourteen of
these are detected in the chicken or human genome
Figure 2 The genome locus for tgu-mir-2954 produces three different miRNAs. A. Alignments via the UCSC Genome Browser of the three
detected miRNAs to the intron of the zebra finch XPA gene. B. Hairpin precursors for the three miRNAs. C. Northern blot analysis using an RNA
probe complementary to novel miRNA tgu-miR-2954-3p.
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Figure 3 Analysis of miRNAs produced at the tgu-mir-2954 locus. TaqMan and Illumina RNA-seq data generated from independent sets of
birds (n = 6 in each data set) for expression from the tgu-mir-2954 locus. A) TaqMan results, where the relative gene expression of each
individual bird (open circle) was obtained by using the 2^-ddCt method [98]; the relative gene expression of either Silence (white bar) or Song
(gray bar) group was the mean of six individuals; the P value was calculated by paired t test since each song stimulated animal was explicitly
paired with a silence control animal collected simultaneously. B) Read counts from the Illumina RNA-seq for miR-2954-3p and miR-2954-5p (also
shown in the Additional File 1, Table S4).
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assemblies and may give rise to miRNAs that have not
yet been described elsewhere due to low copy number,
restricted tissue distribution or other factors. The
remaining novel miRNAs, 34 in number, may be unique
to the zebra finch or the songbird lineage. Few studies
have attempted de novo identification of miRNAs from
the brain [18] and ours is the first to report direct
sequencing of songbird brain miRNAs. A previous study
did identify precursor sequences for five conserved miR-
NAs in the developing zebra finch brain [40]. Also, in
parallel with our own Illumina analysis, Li and her col-
leagues used 454 sequencing to identify miRNAs in the
brain and liver of adult zebra finches. These different
sets of annotations are compared and collated in a sup-
plement to the analysis of the zebra finch genome
assembly [33].
By comparing birds hearing novel song playbacks or
silence, we found evidence for experience-dependent
fluctuations in large numbers of miRNAs in the auditory
forebrain. We performed three separate pairwise com-
parisons by Illumina, where all aspects of the experi-
mental conditions were carefully counterbalanced
between the two groups in each comparison. The three
comparisons were not direct replications of each other,
as each had a different sex ratio. Our reasons for varying
the sex ratio were partly pragmatic (limited numbers of
birds of the same sex that could be removed from our
aviary) and partly analytical (males and females have dif-
ferent behavioral responses to songs). Some of the dif-
ferences between the three sets of results may reflect
real biological differences in the responses of males and
females. Indeed, our Northern analysis of the tgu-miR-
2954-3p confirms a sex difference in expression of this
Z-linked miRNA gene. This is especially intriguing
because we also obtained TaqMan evidence for both
sense and antisense transcripts of this miRNA. One can
imagine scenarios where different ratios of sense and
antisense transcription occur in males (two copies of the
gene) and females (one copy of the gene) with different
consequences on the transcriptional networks affected
by song exposure in the two sexes.
Ignoring the potential effects of sex, we identified five
miRNAs that showed significant and consistent changes
in response to song across all three Illumina compari-
sons. Three miRNAs consistently decreased after song
(tgu-miR-92, tgu-miR-124, tgu-miR-129-5p) and two
increased (tgu-miR-25, tgu-miR-192). The down-regu-
lated miRNAs are at much higher abundance (> 1000
reads in each run) and perhaps for this reason we were
more successful at detecting them and replicating their
song regulation by TaqMan assay in subsequent experi-
ments with additional groups of birds. The most abun-
dant miRNA in our regulated set, tgu-miR-124,
consistently met the statistical test for significant down-
regulation by song, in each of six separate experiments
(three Illumina comparisons, two TaqMan analyses in
Additional File 1, Table S4, and the TaqMan compari-
son of song vs. SEN in Additional File 2, Figure 3).
In studies in other species, miR-124 has been linked to
brain plasticity and development in several contexts.
Chronic cocaine administration results in down-regula-
tion of miR-124 in the rodent mesolimbic dopaminergic
system [41]. In the developing chick neural tube, miR-
124a is a component of a regulatory network that con-
trols the transition between neural progenitors and
post-mitotic neurons [42]. miR-124 also regulates adult
neurogenesis, and its overexpression promotes neuronal
differentiation [42,43] and neurite outgrowth [44]. Intri-
guingly, in songbirds neurogenesis continues in the fore-
brain throughout adulthood, from a population of
precursor cells that line the walls of the lateral ventricles
and have the characteristics of neural stem cells [45-47].
Table 3 Song-regulated targets of tgu-miR-2954-3p
Ensembl ID Gene Symbol EST Gene Name
ENSTGUG00000001349 ELAVL2 CK313262 ELAV-like protein 2 (Hu-antigen B)(HuB)(ELAV-like neuronal protein 1)(Nervous system-specific
RNA-binding protein Hel-N1)
ENSTGUG00000001404 LINGO2 DV957508 Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting
protein 2 Precursor (Leucine-rich repeat neuronal protein 6C)(Leucine-rich repeat neuronal
protein 3)
ENSTGUG00000003073 TLK2 CK305975 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1)(Tousled-like kinase 2)(PKU-alpha)
ENSTGUG00000008207 BTG1 CK303273 Protein BTG1 (B-cell translocation gene 1 protein)
ENSTGUG00000008540 CHD2 DV958991 Chromodomain-helicase-DNA-binding protein 2 (CHD-2)(EC 3.6.1.)(ATP-dependent helicase
CHD2)
ENSTGUG00000010181 XP_002196848.1 CK304764 crk-like protein (v-crk avian sarcoma virus CT10 oncogene homolog-like) (CRKL)
ENSTGUG00000010364 NEGR1 DV954047 Neuronal growth regulator 1 Precursor
ENSTGUG00000011700 HMGB1 CK314519 High mobility group protein B1 (High mobility group protein 1)(HMG-1)
We used TargetScan to find binding sites of tgu-miR-2954-3p on eight chicken genes and here are listed the information of their homologous genes in the zebra
finch genome including Ensembl IDs, Gene Symbols, EST (Accession numbers of song-regulated EST identified in the previous microarray study) and Gene Names
(or aliases in parenthesis).
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The net rate of neuronal addition and loss in the adult
songbird has been shown to depend on social and envir-
onmental influences [48-51]. Perhaps tgu-miR-124 is a
regulatory link between experience and neurogenesis -
further study of this fascinating possibility is clearly
warranted.
Although miRNAs can have diverse functions, they
often act by altering the concentrations of specific
mRNAs they target via complementary base pairing. We
used the TargetScan algorithm [52] to predict binding
sites of tgu-miR-2954-3p in chicken genes, and then we
confirmed the presence of the same conserved target
sequence in the zebra finch genome assembly. We
found eight targets that met these criteria and were also
regulated by song in the Dong et al. microarray data
[14]. These eight genes have a provocative coherence in
their function, as they are all implicated in control of
cell proliferation and neuronal differentiation. Six oper-
ate by affecting gene expression and chromatin remodel-
ing as we briefly review here. ELAVL2 is a member of a
protein family that binds AU-rich regions in the 3’UTR
of genes such as c-fos and promotes the shift from cell
proliferation into cellular differentiation [53-57]. TLK2
is a kinase tightly associated with DNA replication dur-
ing cell division [58]. At least one of its targets, the his-
tone chaperone Asf1, controls chromatin assembly, thus
TLK2 activity can regulate transcription and elongation
[59-61]. BTG1 is also regulated during the cell cycle
[62]. It acts as a cofactor for Hoxb9, a transcription fac-
tor that controls cell proliferation and differentiation,
and BTG1 reduces rates of cell proliferation [62-64].
CHD2 can potentially affect transcription of many genes
by remodeling chromatin [65,66]; disruption of CHD2
has profound consequences for development and is
implicated in many human diseases [67-69]. HMGB1 is
another DNA binding protein that facilitates transcrip-
tion by altering chromatin structure to ease promoter
binding [70-73]. Some of the genes regulated by
HMGB1 may play a role in cell proliferation and migra-
tion [74,75]. Neuronal migration and neurite outgrowth
are affected by CRKL, a transcriptional activator that is
a component of the reelin pathway [76-79]. Unlike the
other six genes, NEGR1 and LINGO2 do not seem to
alter transcription but they do have established roles in
neuronal differentiation. NEGR1 affects cell-cell adhe-
sion to modulate neurite outgrowth and synapse forma-
tion [80-82]. LINGO2 is one member of a family of
transmembrane proteins that are involved in neural and
axonal regeneration [83,84]. The function of LINGO2 is
untested, but expression of a related protein, LINGO1,
is attenuated in cortical areas deprived of sensory input
and is a partner in a signaling pathway that correlates
with neuronal activity during a learning paradigm
[85,86].
Conclusions
In conclusion, these data reveal a network of miRNAs in
the zebra finch’s auditory forebrain, responsive to the
experience of hearing another bird sing. The network
includes well-characterized conserved miRNA known to
have roles in neuronal differentiation (miR-124), and
novel miRNAs that can target genes that control neuro-
nal differentiation (tgu-miR-2954-3p). Our data suggest
this miRNA network may influence the fundamental shift
we have observed in the transcriptional and metabolic
state of the auditory forebrain during the process of
song-specific habituation [14,87]. Further study of song
responses in the zebra finch may reveal general insights
into the neurogenomic mechanisms that underlie learn-
ing, memory and the ongoing adaptation to experience.
Methods
Song stimulation and brain dissections
Zebra finches were obtained from aviaries maintained at
the University of Illinois. All procedures involving ani-
mals were conducted with the approval of the University
of Illinois Institutional Animal Care and Use Commit-
tee. The birds were raised in a standard breeding aviary
and were tutored under normal social conditions (i.e.,
by their parents or other adult birds in the breeding col-
ony). All birds used in this study were adults (older than
90 days after hatching). The song playback procedures
and brain dissections were performed exactly as in pre-
vious microarray analyses, using the same equipment
[14,88]. Briefly, each bird was put individually into a
sound isolation chamber for 18 hours on the first day,
and on the second day those in the song group heard
30 minutes of a song not heard previously ("novel
song”). Matched controls collected in parallel heard no
song playback ("silence”). Birds were sacrificed in song-
silence pairs, so that 5 minutes before the end of the
song playback to one bird, a bird in the silence group
was sacrificed and its auditory forebrain was dissected
and frozen in dry ice. Then the auditory forebrain of the
song-stimulated bird was dissected and frozen in dry
ice. The auditory forebrain dissection (also referred to
as auditory lobule) is described in [89] and collects
NCM (caudomedial nidopallium), CMM (caudomedial
mesopallium) and the enclosed Field L subregions. At
the end of the song stimulation procedure, all auditory
forebrains were transferred and stored at -80C until
RNA isolation. For the comparison of responses after
overnight isolation to song versus SEN (Additional File
2, Figure S3), we used two matched stimuli derived
from bird “C7” as previously described [34].
RNA Samples
For Illumina analyses: Total RNA was extracted using
the mirVana miRNA Isolation Kit (Ambion) from three
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pairs of pooled auditory forebrain samples. 1) Males
(samples S7 and S8): 6 birds per pool, collected in
November 2008. 2) Females (samples S1 and S2): 6
birds per pool, collected in May 2009. 3) Mixed (sam-
ples S3 and S4), 3 males and 3 females each pool, col-
lected in May 2009. Samples with odd numbers were
from birds hearing song, and even number hearing
silence.
For Northern analysis: Auditory forebrains of 22 birds
(12 females and 10 males) were collected in April 2009,
and total RNA was extracted by Tri-Reagent (Ambion).
Male and female samples were pooled after extraction.
For TaqMan analysis: Analyses were performed on
total RNA extracted either by mirVana or Tri-Reagent
(Ambion), from the auditory forebrains of individual
males or females, collected in April-August 2009, March
2010 or December 2010.
Illumina small RNA sequencing and novel miRNA
discovery
Fifteen micrograms of total RNA from auditory fore-
brain of song bird samples described above were gel-
fractionated to isolate 18-30 nt small RNAs. 3’ and 5’
adapters were ligated to the small RNAs and constructs
amplified following RT-PCR following the conditions
specified in the small RNA kit (FC-102-1009, Illumina)
protocol. The small RNA library was sequenced using a
Solexa/Illumina GA-1 Genome analyzer. Small RNA
sequences were analyzed through a high-throughput
computational pipeline described by [28,29,90,91]. To
identify zebra finch miRNAs that are also conserved in
chicken, human and mouse, we performed a local
Smith-Waterman alignment of each unique sequence
read against each of the mature miRNAs in miRBase
version 13.0 for each of these species. We allowed for a
3 base overhang on the 5’ end and a 6 base overhang on
the 3’ end. In the case of redundantly aligning reads,
mature miRNA sequences were equally apportioned
among each of the hairpins. For each sample, all
sequence reads were aligned to a reference set of pre-
cursor miRNAs from miRBase version 13.0. The reads
that did not align to any known miRNA were passed to
our novel miRNA discovery platform as previously
described [28]. Briefly, each sequence is first mapped to
the reference genome sequence (WUGSC 3.2.4) and 200
bases of flanking sequence are extracted to further
define the putative hairpin. This extracted sequence is
then folded using the Vienna RNA folding package [92]
and those sequences that form a plausible hairpin are
selected as potential novel miRNA hairpins. These can-
didates are filtered through a set of three Ambros cri-
teria: 1) the mature putative miRNA sequence must rest
on one side of a single hairpin; 2) the putative miRNA
sequence must bind relatively tightly within the hairpin
stem containing no large or energetically unfavorable
loops; and 3) the putative hairpin must have a miRNA-
appropriate energy (free energy below -20 kcal/mol). All
sequences that passed were then carefully curated to
determine if Drosha and Dicer processing could yield
the resulting mature sequence from the predicted hair-
pin. These candidates are then divided into four differ-
ent categories: “not likely”, “potential”, “high
confidence”, and “confirmed” (as in red, gray, blue and
green colors in Additional File 1, Tables S2 and S3).
Candidates that are flagged red as “not likely” either
failed to map in a pile of sequences in a very tight space
of 15-25 nt of the predicted hairpin (e.g. were scattered
evenly across the full length of the hairpin), mapped
within the loop of the hairpin, or mapped to known
tRNAs or rRNAs. Candidates that passed all of the
above criteria, and also mapped within a hairpin with
predicted Drosha and Dicer cut sites were categorized
as “high confidence” (blue annotation in Additional File
1, Tables S2 and S3). All high confidence candidates for
which we detected both the mature sequence and the
putative star sequence from the same hairpin we cate-
gorized as “confirmed” (green annotation in Additional
File 1, Table S3). In addition to miRNA precursors, the
reads were also mapped to the reference zebra finch
genome using the Pash software package [93,94], and
uploaded to the Genboree platform (http://www.gen-
boree.com) to identify potential mappings to piRNAs,
snoRNAs and other annotations in addition to miRNAs
(data shown in Additional File 1, Table S1). PiRNAs (i.
e., Piwi-interacting RNAs) have a central role in the
maintenance of the integrity of genomes through the
silencing of transposable elements [95]. SnoRNAs (small
nucleolar RNAs) function in site-specific ribosomal
RNA modification, rRNA processing and more recently
have been found to guide alternate splicing and RNA
editing of mRNA transcripts [96].
TaqMan qPCR
To measure the mature miRNA, the TaqMan Micro-
RNA Assay Kit (Applied Biosystems) was used accord-
ing to the manufacturer’s instructions. Probe sequences
used for each target miRNA are given in Table 4.
Northern Blot Analysis
Northern blotting to confirm novel miRNA tgu-miR-
2954-3p was performed by modifying the protocol of
[97]. 2 μg of total RNA was heated at 65°C for 5 min
with 2X loading dye (Ambion), quenched on ice, and
loaded on a 15% TBE Urea gel (Invitrogen). Total RNA
was separated by electrophoresis at 200V for 50 min.
The gel was stained with with EtBr in 1x TBE (4 μL of
10 mg/ml EtBr per 100 ml of 1x TBE) for 3 minutes with
gentle shaking and transferred to nylon membrane for 90
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min at 200V using 1X TBE buffer at room temperature.
The membrane was cross-linked at 1200 kJ for 45 sec-
onds. RNA probes were synthesized for tgu-miR-2954-3p
probe 5’ - UGCUAGGAGUGGAAUGGGGAU G - 3’ by
Integrated DNA Technologies. Radio labeling was carried
out in a reaction of 12.0ul dH2O + 2.0ul PNK buffer +
1.0ul (100ng/ul) probe + 1.0ul PNK polymerase (Pro-
mega) + 4.0ul P32-gamma-ATP (10mCi/ml) (PerkinEl-
mer). The reaction was incubated at 37°C for 1 hour and
inactivated at 65°C for 10 min. The probe was purified
using Nick columns from GE following manufacturer’s
instructions. The membranes were pre-hybridized for 30
min with 20 ml of pre-hybridization buffer (5X SSC + 20
mM NaPO4 + 7X SDS + 2X Denhardt (pre warmed) at
60° C) in a rotating hybridization oven. Hybridization
was carried out at 50°C in a rotating incubator for 24h.
The membranes were washed for 10 min at 50°C with
20-30mL of wash buffer (2X SSC + 0.5% SDS). When
background was ~0.5 cpm, the membranes were
wrapped in saran wrap and exposed at -80°C for ~72h.
Additional material
Additional file 1: Supplemental tables.xls. This one file contains all
four Supplemental Tables, each as a separate worksheet. Table S1 ("1
overview”) is a summary of Illumina sequence read alignments for six
pools of RNA from zebra finch auditory forebrain responding to song
versus silence, and shows the distribution of sequence reads in relation
to multiple genomes and multiple annotations in the current genomic
databases. Table S2 ("2 novel hairpins”) gives detailed alignments of
putative pre-miRNAs and read sequences. Table S3 ("3 novel genes”)
shows annotations of all novel miRNA loci mapped in genome
assemblies of zebra finch, chicken or human. Table S4 ("4 all read
counts”) gives read counts and current annotation in miRBase of all
conserved and novel miRNAs, with statistics.
Additional file 2: Supplemental figures.doc. This one file contains all
three supplemental figures. Figure S1 is a Venn diagram of numbers of
miRNAs with significant differential expression in response to novel song
in three Illumina experiments. Figure S2 shows a comparative mapping
in other avian transcriptomes of tgu-mir-2954. Figure S3 demonstrates
the song-specificity of the miRNA response, using TaqMan to compare
the levels of specific miRNAs in animals from groups that heard song,
matching song-enveloped noise, or silence.
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ABSTRACT
Summary: RNA interference (RNAi) is known to play an important part
in defence against viruses in a range of species. Second-generation
sequencing technologies allow us to assay these systems and the
small RNAs that play a key role with unprecedented depth.
However, scientists need access to tools that can condense, analyse
and display the resulting data. Here, we present viRome, a package
for R that takes aligned sequence data and produces a range of
essential plots and reports.
Availability and implementation: viRome is released under the BSD
license as a package for R available for both Windows and Linux
http://virome.sf.net. Additional information and a tutorial is avail-
able on the ARK-Genomics website: http://www.ark-genomics.org/
bioinformatics/virome.
Contact: mick.watson@roslin.ed.ac.uk
Received on December 20, 2012; revised on May 17, 2013; accepted
on May 21, 2013
1 INTRODUCTION
RNA interference (RNAi) is mediated by small RNAs, such as
micoRNAs (miRNAs) of 21–22nt (Lagos-Quintana et al., 2001),
small interfering RNAs (siRNAs) of 21–22nt (Bernstein et al.,
2001; Zamore et al., 2000) and PIWI-interacting RNAs (piRNAs)
of 24–30nt (Aravin et al., 2003; Brennecke et al., 2007), and these
molecules regulate many biological processes. These pathways are
also a major part of the antiviral response in both insects and
plants, including a variety of important mosquito-borne diseases
of humans and animals, such as West Nile Virus, Dengue Virus
and Chikungunya Virus. In arthropods, these are characterized
by the production of 21–22nt virus-derived small interfering
RNAs (viRNAs) or 24–30nt viral piRNA-like molecules (Blair,
2011; Donald et al., 2012; Myles et al., 2009).
Second-generation sequencing allows scientists to assay these
systems in unprecedented depth, and short reads capture both
the 21–22nt siRNAs and the 24–30nt piRNAs. However, there
is a need for scientists to be able to summarize, analyse and
visualize the results of such experiments. Here, we present
viRome, a package for R, which takes aligned sequencing data
in the BAM format (Li et al., 2009) and produces a variety of
plots and reports that are essential to the analysis of data from
viral siRNA datasets.
Software packages to analyse viral siRNA data exist.
Paparrazi (Vodovar et al., 2011) is designed to reconstruct viral
genomes from siRNA data and produces some similar plots to
viRome. Alternatively, Visitor (Antoniewski, 2011), an infor-
matic pipeline for analysing short-read viRNA data, also pro-
duces several similar plots. However, both are implemented in
Perl and are limited to the Linux/Unix operating system; they
include alignment as part of the analysis; therefore, using an
alternative aligner would require programming skills; finally,
the plots are generated in batch mode; hence, there is no inter-
action between the user and the software.
As a package for R, viRome improves on these software pack-
ages in several ways, including (i) viRome allows interaction be-
tween the user and the software during report and graph
generation, (ii) viRome is available on any operating system
that supports R and has been tested on Microsoft Windows
and several Linux distributions, (iii) viRome separates visualiza-
tion from alignment; therefore, the user is free to use any align-
ment software they wish and (iv) as an R package, viRome
integrates seamlessly with other R packages from the
Bioconductor project (Gentleman et al., 2004).
2 ANALYSIS AND VISUALIZATION
As input, viRome takes aligned sequence data in the BAM for-
mat. Many tools exist for alignment (Fonseca et al., 2012) and
provided they support the SAM/BAM format, viRome is cap-
able of working with their output. Many of the functions within
viRome attempt to summarize millions of data points into tables
and plots that allow biological interpretation. One of the benefits
of viRome is that most functions return the summarized data, as
well as creating a plot. This allows users to create their own plots
if they wish. Figure 1 shows a selection of plots produced by
viRome.
Global analyses: One of the first requirements is to plot a
histogram of the lengths of mapped reads—a peak at 21–22 nt
implying an siRNA response, and a high frequency of 24–30 nt
with a peak at 28 a piRNA response. In viRome, this can be
created using the barplot.bam function. Users may also create
a report using the sequence.report function. This produces a
data.frame in R that summarizes and counts the sequences
aligned to each base in a given reference sequence. Users can
see the exact sequence, its length, the location and strand of
the alignment plus a count of how many times that sequence*To whom correspondence should be addressed.
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occurs. As a data.frame, this can be easily exported to Excel or
other spreadsheet software.
Location-based analyses: Although many viruses are targeted
by the siRNA pathway throughout the genome, others are tar-
geted only in limited regions (Sabin et al., 2013). A heatmap
representing the occurrence of all mapped read lengths
across all genomic locations can be produced using the
size.position.heatmap function, and barplots showing counts for
each genomic location for each read length generated using the
stacked.barplot function.
Read-based analyses: Read-based analyses allow users to focus
on patterns in particular subsets of reads. Single barplots show-
ing the location, strand and count of reads mapping through-
out the genome can be visualized using the position.barplot
function. The base composition of subsets of reads can be calcu-
lated with the make.pwm function. Sequence signatures of the
piRNA pathway include a strong U1 bias in primary, antisense
piRNAs and following ‘ping-pong’ cycle amplification involving
AGO3 and Aub, a strong A10 bias in secondary sense piRNAs in
Drosophila (Brennecke et al., 2007). Similar motifs have been
found in piRNAs and viral piRNA-like molecules in mosquitoes
or derived cell lines (Morazzani et al., 2012; Schnettler et al.,
2013; Vodovar et al., 2012). The output of make.pwm can be
plotted as a heatmap using the pwm.heatmap function, or used
with external packages such as seqLogo and motifStack to pro-
duce sequence logos. Finally, the 50-ends of complementary
piRNAs are most frequently separated by 10nt (Brennecke
et al., 2007; Vodovar et al., 2012) because of the earlier described
‘ping-pong’ amplification. The distance between 50-ends of
piRNAs mapping to opposite strands can be summarized and
visualized using the read.dist.plot function.
3 CONCLUSIONS
Deep sequencing experiments have revealed a variety of interest-
ing and unique signatures of the miRNA, siRNA and piRNA
pathways, and there is a need for software that allows scientists
to process such data. We have developed viRome, a package for
R that allows the interactive generation of a range of informative
plots and reports. As an R package, viRome is available on
a range of operating systems. viRome is released under an
open-source license and can be downloaded from http://
virome.sf.net, where a tutorial is also available.
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